Wikipedia bxrwiki https://bxr.wikipedia.org/wiki/%D0%9D%D1%8E%D1%83%D1%80_%D1%85%D1%83%D1%83%D0%B4%D0%B0%D2%BB%D0%B0%D0%BD MediaWiki 1.46.0-wmf.22 first-letter Меди Тусхай Хэлэлсэхэ Хэрэглэгшэ Хэрэглэгшые хэлэлсэхэ Википеэди Википеэди тухай хэлэлсэхэ Файл Файл хэлэлсэхэ MediaWiki MediaWiki хэлэлсэхэ Загбар Загбар хэлэлсэхэ Туһаламжа Туһаламжа хэлэлсэл Категори Категори хэлэлсэхэ TimedText TimedText talk Модуль Обсуждение модуля Event Event talk 0 2624 74555 74536 2026-04-07T17:57:19Z InternetArchiveBot 12366 Rescuing 1 sources and tagging 0 as dead.) #IABot (v2.0.9.5 74555 wikitext text/x-wiki [[Файл:10 sharing book cover background.jpg|right|thumb]] [[Файл:Russian Wikipedia Main Page 1 June 2012.png|250px|right|thumb|Ород Википеэди<ref>ru.wikipedia.org Ород Википеэди</ref>]] [[Файл:English_Wikipedia_screenshot.png|250px|right|thumb|Англи Википеди<ref>en.wikipedia.org [[Англи Википеэди]]</ref>]] '''Википеэди''' ({{lang-en|Wikipedia}}) — [[нэбтэрхы толи]] бэшэгынь сүлөөтэ контенттай, Creative Commons Attribution-ShareAlike лицензитэй бидэнэй һайн дүрын оролсоотойгоор баяшадаг нэбтэрхэй толи юм. Вэб сайт — http://www.wikipedia.org/. Хэнээшье оролсожо энэ сайт баяшуулжа болохо, хамагай баялиг, олон хэлэн дээрэхи нэбтэрхэй толиин түсэл, нэбтэрхэй толи. Тухайн мэдээллые өөршэлхэ, баяшуулха боломжо хүн бүридэ нээлтэтэй байдаг. Энэнь өөрын мэдэлээ бусадтай хубаалсаха үргэн боломжые хүн бүхэндэ олгожо байха юм.<ref>{{cite news |url = http://www.time.com/time/business/article/0,8599,1595184,00.html |title = Look Who's Using Wikipedia |first = Bill |last = Tancer |date = 2007-05-01 |publisher = [[Time (magazine)|Time]] |accessdate = 2007-12-01 |quote = The sheer volume of content [...] is partly responsible for the site's dominance as an online reference. When compared to the top 3,200 educational reference sites in the U.S., Wikipedia is #1, capturing 24.3% of all visits to the category |archivedate = 2012-08-03 |archiveurl = https://web.archive.org/web/20120803185245/http://www.time.com/time/business/article/0,8599,1595184,00.html }} ([http://weblogs.hitwise.com/bill-tancer/2007/03/wikipedia_search_and_school_ho.html the author’s blog post on the article])</ref><ref name="go-to site"> {{cite news | url = http://www.reuters.com/article/internetNews/idUSN0819429120070708 | title = Wikipedia remains go-to site for online news | date = 2007-07-08 | accessdate = 2007-12-16 | first = Alex | last = Woodson | publisher = [[Reuters]] | quote = Online encyclopedia Wikipedia has added about 20 million unique monthly visitors in the past year, making it the top online news and information destination, according to Nielsen//NetRatings }} </ref><ref name="AlexaTop500">{{cite web |url = http://www.alexa.com/site/ds/top_sites?ts_mode=global&lang=none |title = Top 500 |accessdate = 2007-12-04 |publisher = [[Alexa Internet|Alexa]] |archiveurl = https://web.archive.org/web/20081224031856/http://www.alexa.com/site/ds/top_sites?ts_mode=global |archivedate = 2008-12-24 }}</ref> == Түүхэ == Википеэди түсэлэг [[2001]] оной [[1 һарын 15]]-һаа [[Джимми Уэйлс]] «Сүлөөтэ<ref name=autogenerated1>Некоторые разделы также содержат несвободные материалы.</ref> нэбтэрхэй толи» нэрэ доро хэрэгжүүлжэ эхилһэн байна. Википеэди нэбтэрхэй толи бэшэгынь [[GNU FDL|ГНУ cүлөөтэ баримта бэшэгэй лицеэнзитэй]], энэнь [[Wikipedia:free-content|сүлөөтэ агуулгатай]] бидэнэй һайн дүрын оролсоотойгоор баяжаха нэбтэрхэй толи юм.<ref name="AlexaStats">{{cite web |url = http://www.alexa.com/data/details/traffic_details/wikipedia.org?range=5y&size=large&y=t |title = Five-year traffic statistics for wikipedia.org |publisher = [[Alexa Internet]] |accessdate = 2008-07-15 |archiveurl = https://web.archive.org/web/20220124042758/https://www.alexa.com/siteinfo/wikipedia.org?range=5y |archivedate = 2022-01-24 }}</ref> == Хэлэнүүд == 2011 оной 1 һарын 8-ны байдалаар ниитэдээ [[Special:SiteMatrix|285 хэлэнэй]] Википеэдидэ [[meta:List of Wikipedias#Grand Total|17,607,990 үгүүлэл]] байгааһаа<ref name="meta">[http://meta.wikimedia.org/wiki/List_of_Wikipedias List of Wikipedias]</ref>, 3 сая 500 мянга гаран эгээн түрүүшын Википеэди болохо [[англи хэлэн|англи хэлэт]]эй [[:en:Main page|Википеэдидэ]], 1 сая гаран [[герман хэлэн|герман хэлэт]]эй [[:de:Wikipedia:Hauptseite|википеэдидэ]], 1 сая гаран [[франци хэлэн|франци хэлэт]]эй [[:fr:Wikip%C3%A9dia:Accueil_principal|Википеэдидэ]] агуулагдажа байна. Энэ түсэл анха [[англи хэлэн|англи хэлээр]] 2001 оной 1 һараһаа эхилһэн болоод одоо 1.5 сая гаран үгэ хэлэлгын тайлбариие агуулжа байна.<ref>[http://www.wikipedia.org/wiki/Special:Statistics Wikipedia statistics]</ref> [[Халха-Монгол хэлэн]] дээрэхи хубилбари 2004 оной 2 һарада эхилһэн. [[Буряад хэлэн]] дээрэхи хубилбари 2006 оной 2 һарада эхилһэн. [[{{CURRENTYEAR}}]] оной [[{{CURRENTMONTH}}]]-р hарын {{CURRENTDAY}} [[Special:Statistics|{{NUMBEROFARTICLES}}]] [[Буряад хэлэн]]эй үгүүллүүд. Мүнөөгэй байдалаар хамагай түрүүндэ хэрэгтэй байгаа зүйлнүүд. Нюур хуудаһан болон систеэмын хэлэлгэнүүдые [[Буряад хэлэн]] рүү оршуулха үйлэ ябасад хубита нэмэриеэ оруулаарайгты.<ref>{{cite news |url = http://www10.nytimes.com/2007/07/01/magazine/01WIKIPEDIA-t.html?_r=5&pagewanted=print&oref=slogin&oref=slogin&oref=slogin&oref=slogin |title = All the News That's Fit to Print Out |author = Jonathan Dee |publisher = The New York Times Magazine |date = 2007-07-01 |accessdate = 2007-12-01 |archivedate = 2018-08-21 |archiveurl = https://web.archive.org/web/20180821133657/http://www10.nytimes.com/2007/07/01/magazine/01WIKIPEDIA-t.html?_r=5&pagewanted=print&oref=slogin&oref=slogin&oref=slogin&oref=slogin }}</ref><ref>{{cite journal |author = Andrew Lih |title = Wikipedia as Participatory Journalism: Reliable Sources? Metrics for evaluating collaborative media as a news resource |journal = 5th International Symposium on Online Journalism |location = University of Texas at Austin |date = 2004-04-16 |url = http://jmsc.hku.hk/faculty/alih/publications/utaustin-2004-wikipedia-rc2.pdf |format = PDF |accessdate = 2007-10-13 }} {{Webarchive|url=https://web.archive.org/web/20071029051749/http://jmsc.hku.hk/faculty/alih/publications/utaustin-2004-wikipedia-rc2.pdf |date=2007-10-29 }} {{Cite web |title=Archive copy |url=http://jmsc.hku.hk/faculty/alih/publications/utaustin-2004-wikipedia-rc2.pdf |accessdate=2012-11-26 |archivedate=2007-10-29 |archiveurl=https://web.archive.org/web/20071029051749/http://jmsc.hku.hk/faculty/alih/publications/utaustin-2004-wikipedia-rc2.pdf }}</ref> === 500 000-һаа олон үгүүлэлтэй === 500 000-һаа олон үгүүлэлтэй википеэдиууд энэ Англи, Германи, Испани, Франци, Итали, Нидерланд, Япон, Польшо, Португали, Ород, Вьетнам ба Хитад хэлэнүүд.<ref>[http://ru.wikipedia.org/wiki/%D0%92%D0%B8%D0%BA%D0%B8%D0%BF%D0%B5%D0%B4%D0%B8%D1%8F:%D0%A1%D0%BF%D0%B8%D1%81%D0%BE%D0%BA_%D0%92%D0%B8%D0%BA%D0%B8%D0%BF%D0%B5%D0%B4%D0%B8%D0%B9 Википеэди: Список Википедий]</ref> === 100 000-һаа олон үгүүлэлтэй === 100 000-һаа олон үгүүлэлтэй Википеэдинууд — Араб, Индонез, Чех, Дат, Эсперанто, Солонгос, Венгр, Букмол, Ром, Словак, Серб, Фин, Турк ба Украин хэлэнүүд дээрэ бэшэгдэнхэй.<ref>[http://mhr.wikipedia.org/wiki/%D0%92%D0%B8%D0%BA%D0%B8%D0%BF%D0%B5%D0%B4%D0%B8%D0%B9:%D0%92%D0%B8%D0%BA%D0%B8%D0%BF%D0%B5%D0%B4%D0%B8%D0%B9-%D0%B2%D0%BB%D0%B0%D0%BA%D1%8B%D0%BD_%D0%BB%D3%B1%D0%BC%D0%B5%D1%80%D1%8B%D1%88%D1%82 Википедий-влакын лӱмерышт]</ref> == Нэрэ == Википедеэди (Wikipedia) гэһэн үгэ гээшэ «'''Wiki'''» — [[Хавай хэлэн|Һаваии хэлэн]]һээ «хурдан», «Encyclo'''pedia'''» — [[Аангли хэлэн|Англи хэлэн]]һээ «[[нэбтэрхэй толи|нэбтэрхы толи]]» гэһэн үгэнһөө бүтэһэн шэнэ ниилэмэл үгэ юм. == Буряад Википеэди == {{main|Буряад Википеэди}} [[Буряад хэлэн]] дээрэхи хубилбари 2006 оной 2 һарада эхилһэн. Мүнөөгэй байдалаар хамагай түрүүндэ хэрэгтэй байгаа зүйлнүүд. Нюур хуудаһан болон систеэмын хэлэлгэнүүдые [[Буряад хэлэн]] рүү оршуулха үйлэ ябасад хубита нэмэриеэ оруулаарайгты. Үүнэй тулада доорохи холбооһонууд дээрэ даража ороод, [[Өөршэлхэ]] гэһэн хэһэг дээрэ дарагты. Энэ хадаа [[Буряад хэлэн|буряад]] Википеэди. Буряадаар бэшэжэ шадаха хүн бүхэн тус нэбтэрхэй толиие зохёолсохо аргатай. == Зурагай сомоо == <gallery> Mongolian wikipedia preview.png|Хуушан монгол Википеэди German Wikipedia screenshot.png|[[Гермаан Википеэди]]<ref>de.wikipedia.org Гермаан Википеэди</ref> French Wikipedia screenshot.png|[[Франц Википеэди]]<ref>fr.wikipedia.org Франц Википеэди</ref> WikipediaNL-20150905.png|[[Нидерланд Википеэди]]<ref>nl.wikipedia.org Франц Википеэди</ref> Italian-wikipedia-screenshot.png|[[Итал Википеэди]]<ref>it.wikipedia.org Итал Википеэди</ref> Spanish Wikipedia.png|[[Испан Википеэди]]<ref>es.wikipedia.org Испан Википеэди</ref> Polish Wikipedia Main Page - 2007-04-24.png|[[Польска Википеэди]]<ref>pl.wikipedia.org Польска Википеэди</ref> Current Japanese Wikipedia main page.png|[[Жибээн Википеэди]]<ref>ja.wikipedia.org [[Жибээн Википеэди]]</ref> </gallery> == Зүүлтэ == {{зүүлтэ}} == Холбооһон == * [http://www.wikipedia.org/ Wikipedia] — multilingual portal (contains links to all language editions of the project) * [http://mobile.wikipedia.org/ Wikipedia mobile phone portal] {{Webarchive|url=https://web.archive.org/web/20110829015926/http://mobile.wikipedia.org/ |date=2011-08-29 }} * [[tools:~johang/wikitrends/english-most-visited-today.html|Wikitrends: most visited Wikipedia articles]] * [http://topics.nytimes.com/top/news/business/companies/wikipedia/index.html Wikipedia] topic page at ''[[The New York Times]]'' * [http://www.ted.com/index.php/talks/jimmy_wales_on_the_birth_of_wikipedia.html Video of TED Talk by Jimmy Wales on the birth of Wikipedia] {{Webarchive|url=https://web.archive.org/web/20091201111459/http://www.ted.com/index.php/talks/jimmy_wales_on_the_birth_of_wikipedia.html |date=2009-12-01 }} * [http://www.econtalk.org/archives/2009/03/wales_on_wikipe.html Audio of interview with Jimmy Wales about Wikipedia in general] on the [[EconTalk]] podcast * [http://www.stanford.edu/class/ee380/Abstracts/020116.html Wikipedia and why it matters] — Larry Sanger’s 2002 talk at [[Stanford University]]. [http://stanford-online.stanford.edu/courses/ee380/020116-ee380-100.asx video archive] {{Webarchive|url=https://web.archive.org/web/20121221140312/http://stanford-online.stanford.edu/courses/ee380/020116-ee380-100.asx |date=2012-12-21 }} and [[meta:Wikipedia and why it matters|transcript of the talk]] * [http://wikipapers.referata.com WikiPapers] — compilation of conference papers, journal articles, theses, books, datasets and tools about Wikipedia and wikis [[Категори:Википеэди| ]] nx37ek0cmavvn3jay9emyrtrtd36cjv 0 4558 74556 70822 2026-04-07T18:08:05Z InternetArchiveBot 12366 Rescuing 1 sources and tagging 0 as dead.) #IABot (v2.0.9.5 74556 wikitext text/x-wiki {{Улас |буряад_нэрэ = '''Бүгэдэ Найрамдаха Грек Улас''' |уугуул_нэрэ = Ελληνική Δημοκρατία |богони_нэрэ = Греци |һүлдын_зураг =Coat of arms of Greece.svg |тугай_зураг =Flag of Greece.svg |түрын_уряа = {{lang-el|Ελευθερία ή Θάνατος}}<br />«Эрхэ сүлөө гү, али үхэл» |түрын_дуулал = {{lang-el|Ὕμνος εἰς τὴν Ἐλευθερίαν}}<br />«Эрхэ сүлөөнэй дуудал» <!-- |Аудио=--> |засаглалай_хэлбэри = [[Бүгэдэ Найрамдаха Улас]] |газарай_зураг = EU location GRE.png |албан_ёһоной_хэлэн = [[Грек хэлэн]] |үндэһэ_язгуур =94% - [[Грекүүд|Грек]]<br />4% - [[Албанишууд|Албани]]<br />2% - бусад<ref>These statistics refer to nationality (υπηκοότητα) and not ethnicity (εθνικότητα), as Greece does not collect statistics on ethnicity and self-determination.</ref><ref>{{cite web |url=http://www.eurfedling.org/Greece.htm |title=Demographics of Greece |publisher=European Union National Languages |accessdate=19 December 2010 |archivedate=15 January 2021 |archiveurl=https://web.archive.org/web/20210115154100/http://www.eurfedling.org/Greece.htm }}</ref><ref>{{cite web |url=https://www.cia.gov/library/publications/the-world-factbook/geos/gr.html |title=Greece |work=[[The World Factbook]] |publisher=[[Central Intelligence Agency]] |accessdate=16 April 2011 |archivedate=25 August 2016 |archiveurl=https://web.archive.org/web/20160825033157/https://www.cia.gov/library/publications/the-world-factbook/geos/gr.html }}</ref><ref>{{cite web|url=http://www.statistics.gr/portal/page/portal/ESYE/BUCKET/A1602/Other/A1602_SAM07_TB_DC_00_2001_07_F_GR.pdf|title=Πίνακας 7: Αλλοδαποί κατά υπηκοότητα, φύλο και επίπεδο εκπαίδευσης – Σύνολο Ελλάδας και Νομοί|trans_title=Table 7: Foreigners by citizenship, gender and educational level -Whole of Greece and Prefectures|language=Greek|publisher=[[Hellenic Statistical Authority|Greek National Statistics Agency]]|accessdate=16 April 2011|archivedate=28 April 2011|archiveurl=https://web.archive.org/web/20110428131729/http://www.statistics.gr/portal/page/portal/ESYE/BUCKET/A1602/Other/A1602_SAM07_TB_DC_00_2001_07_F_GR.pdf}}</ref><ref>{{cite web|url=http://epp.eurostat.ec.europa.eu/portal/page/portal/population/documents/Tab/report.pdf|title=Demography Report 2010 |work=Eurostat Yearbook 2010 |publisher=[[Eurostat]]|accessdate=16 April 2011 }}</ref> |тогтносон_үйл_явдал1 =[[Османай эзэнтэ гүрэн]]һээ сүлөөлгэ |үйл_явдалын_огноо1 =[[1822]] оной [[3 һарын 21]] |тогтносон_үйл_явдал2 =Хүл. зүбшөөрэгдэбэ |үйл_явдалын_огноо2 =[[1830]] оной [[2 һарын 3]] |тогтносон_үйл_явдал3 =Шэнэ үндэһэн хуули |үйл_явдалын_огноо3 =[[1975]] оной [[6 һарын 11]] |ниислэл_хото = [[Афина]] |тэргүүнэй_класс1 = [[Юрэнхылэгшэ]] |тэргүүнэй_класс2 = [[Юрэнхы сайд]] |тэргүүнэй_нэрэ1 = [[Катерина Сакелларопулу]] |тэргүүнэй_нэрэ2 = [[Кириакос Мицотакис]] |хуули_тогтоогшо = [[Грек хэлэн|грек]] "Βουλή των Ελλήνων"<br />(«[[Эллин]]эй зүблэлгөөн») |газар_нютаг_км2 = 131,990 |нутгийн_талбайгаарх_эрэмбэ_дэс =96 |уһанай_процент = 0.8669 % |хүн_амай_тоосоо = 11,305,118<ref name="Eurostat">{{cite web|url=http://epp.eurostat.ec.europa.eu/tgm/table.do?tab=table&language=en&pcode=tps00001&tableSelection=1&footnotes=yes&labeling=labels&plugin=1|title=Total Population |publisher=[[Eurostat]] |date=1 January 2010 |accessdate=8 January 2010}}</ref> |хүн_ам_тооцоолсон_он = 2010 |хүн_амай_нягтрал_нэгжэ_км2 = 85.3 |хүн_амын нягтрал_эрэмбэ_дэс =88 |хүн_амын_тоогоор_эрэмбэ_дэс =74 |хүн_амын_тооллого =10,787,690<ref name="2011census">{{cite web |publisher=National Statistical Service of Greece: Ανακοίνωση προσωρινών αποτελεσμάτων Απογραφής Πληθυσμού 2011, 22 Ιουλίου 2011 |url=http://www.tovima.gr/files/1/2011/07/22/apografh22.pdf |title='Πίνακας 1: Προσωρινά αποτελέσματα του Μόνιμου Πληθυσμού της Ελλάδος' }}</ref> |хүн_ам_тоолсон_он =2011 |хүн_амын_тооллого_эрэмбэ_тоологдсоноор = |ДНБ_ХАЧ =[[Америк доллар|$]]294.339&nbsp;тэрбүм<ref name="imf2">{{cite web|url=http://www.imf.org/external/pubs/ft/weo/2012/01/weodata/weorept.aspx?pr.x=78&pr.y=5&sy=2009&ey=2012&scsm=1&ssd=1&sort=country&ds=.&br=1&c=174&s=NGDPD%2CNGDPDPC%2CPPPGDP%2CPPPPC%2CLP&grp=0&a=|title=Greece|publisher=[[International Monetary Fund]]|accessdate=18 April 2012}}</ref> |ДНБ_ХАЧ_он =2011 |ДНБ_ХАЧ_эрэмбэ = |ДНБ_ХАЧ_Нэг_хүнд =$26,293<ref name=imf2/> |ДНБ_ХАЧ_Нэг_хүнд_эрэмбэ = |ДНБ_нэрлэсэн =$303.065&nbsp;тэрбүм<ref name=imf2/> |ДНБ_нэрлэсэн_он =2011 |ДНБ_нэрлэсэн_эрэмбэ = |ДНБ_нэрлэсэн_нэг_хүнд =$27,073<ref name=imf2/> |ДНБ_нэрлэсэн_нэг_хүнд_эрэмбэ = |ХТББИ =33<ref>{{cite web|url=https://www.cia.gov/library/publications/the-world-factbook/fields/2172.html|title=Distribution of Family Income&nbsp;– Gini Index|work=[[The World Factbook]]|publisher=[[Central Intelligence Agency]]|accessdate=9 July 2010|archivedate=13 May 2009|archiveurl=https://web.archive.org/web/20090513124910/https://www.cia.gov/library/publications/the-world-factbook/fields/2172.html}}</ref> |Илтгэлцүүр_он =2005 |Илтгэлцүүр_ангилал = |Илтгэлцүүр_эрэмбэ = |ХХИ ={{increase}} 0.861 |ХХИ_он =2011 |ХХИ_ангилал =<span style="color:#090;">маша һайн</span> |ХХИ_эрэмбэ =29 |мүнгэн_тэмдэгтэ =[[Евро]] (€) |мүнгэн_тэмдэгтэ_код = EUR |сагай_бүһэ = | utc_offset = +2 | зуны_цагийн_бүсийн_нэр = [[Дорнод Европын зуны цаг|ДЕЗЦ]] | utc_offset_DST = +3 |интернет_домэйн =.gr¹ |телефоной_код =+30 |зүүлтэ = ¹[[Европын холбоо]]ны гишүүн тул [[.eu]]-г бас хэрэглэнэ }} '''Греци''' ({{lang-el|Ελλάδα, Эллада / Ελλάς, Эллас}}), албан ёһоор '''Бүгэдэ Найрамдаха Грек Улас''' ({{lang-el|Ελληνική Δημοκρατία}}) — [[Балканай хахад арал]]ай урда хэһэгтэ оршох зүүн урда [[Европо|Европын]] орон юм. Хойто таладаа [[Албани]], [[Бүгэдэ Найрамдаха Македони Улас|Македони]], [[Болгари]], зүүн таладаа [[Турк]] оронуудтай хилэлдэг. Зүүн болон урда таладань [[Эгейн тэнгис]], баруун таладань [[Ионой тэнгис]] оршоно. Зүүн [[Газарай дундада тэнгис]]эй һаба газарай хоёр талын хоюуландань маша олон арал байдаг. Грециинь [[Европо]], [[Ази]], [[Африка]] гурбые холбоһон газар оршодог. Мүн [[Эртэнэй Грек]], [[Эртэнэй Рома|Рома]], [[Византиин эзэнтэ гүрэн|Византиин гүрэнүүд]], [[Османай эзэнтэ гүрэн]]эй 4 зуунай туршаха захиргаанай үбые залгамжалагша юм. Грецида [[арадшалал]], баруунай [[гүн ухаан]], [[Олимпиин наадан]], баруунай [[удха зохёол]], историографи, [[улас түрэ|улас түрын шэнжэлхэ ухаан]], [[шэнжэлхэ ухаан]]ай болон [[тооной ухаан]]ай гол заршамууд, баруунай зүжэгэй уралиг (эмгэнэлт болон хошон) зэргэ анха гаража хүгжэбэ. Грециинь хүгжэнгүй орон болоод 1981 онһоо [[Европын Холбоо]]ной, 2001 онһоо ЕХ-ной Эдэй засаг, Санхүүгэй Холбооной, 1952 онһоо [[НАТО]]-гай, 1961 онһоо Эдэй засагай хамтын ажалалгаа, хүгжэлэй байгуулалгын (OECD), 1995 онһоо Баруун Европын Холбооной (WEU), 2005 онһоо [[Европын Сансарын Агентлиг]]ай гэшүүн болобо. Ниислэлиинь [[Афина]] болоод бусад томобтор хотонуудта Салоники, Патрас, Ираклио, Волос, Янина, Лариса, Валака зэргэ ороно. [[Православи]]ин шажаниие «зонхилхо шажан» гэжэ үндэһэн хуулидаа зааһан байдаг. == Зүүлтэ == {{зүүлтэ}} == Холбооһон == * {{Commons|Greece}} {{Европо}} [[Категори:Греци| ]] [[Категори:1891 ондо Европодо байгуулагдаhан]] [[Категори:Балканай уласууд]] [[Категори:Европын уласууд]] [[Категори:НАТО-гай гэшүүн уласууд]] [[Категори:Европын Зүблэлэй гэшүүн уласууд]] [[Категори:Европын Холбооной гэшүүн уласууд]] [[Категори:НҮБ-эй гэшүүн уласууд]] [[Категори:Шэнэ Гэрээнэй һуурин]] [[Категори:Бүгэдэ Найрамдаха Уласууд]] [[Категори:Зүүн Урда Европын уласууд]] [[Категори:Урда Европын уласууд]] [[Категори:Грек хэлээр хэлэлсэдэг уласууд ба газар нютагууд]] [[Категори:1891 ондо байгуулагдаhан улас ба газар нютаг]] [[Категори:Христосой шажантай уласууд]] {{stub}} 617hjlo8p0mkfqqc9khmosykclusu5u 0 6845 74557 74538 2026-04-07T18:22:01Z InternetArchiveBot 12366 Rescuing 4 sources and tagging 0 as dead.) #IABot (v2.0.9.5 74557 wikitext text/x-wiki {{Гараг | bgcolour=#00b7b5 | name = Дэлхэй | symbol = [[Файл:Earth symbol (small, bold).svg|32px|🜨]] | image = [[Файл:The Blue Marble (remastered).jpg|frameless|center|Дэлхэй]] | flag = {{flagicon|world}} | caption = [[Аполлон 17]]-һоо абаһан дэлхэйн үнгэтэ зураг | epoch = [[J2000.0]] | apoapsis = 152,097,701&nbsp;км <br />1.0167103335&nbsp;[[Одон ороной нэгэжэ|а.н.]] | periapsis = 147,098,074&nbsp;км <br /> 0.9832898912&nbsp;А.Н. | semimajor = 149,597,887.5&nbsp;км <br /> 1.0000001124&nbsp;А.Н. | eccentricity = 0.016710219 | inclination = 1°34'43.3"<ref name=Allen294>{{cite book | title=Allen's Astrophysical Quantities | а.н.thor=Allen, Clabon Walter; Cox, Arthur N. | publisher=Springer | year=2000 | isbn=0387987460 | url=http://books.google.com/books?id=w8PK2XFLLH8C&pg=PA294 | pages=294}}</ref> <br /> [[тогтомол хабтан|тогтомол хабтанда]] | asc_node = 348.73936° | arg_peri = 114.20783° | period = 365.256366&nbsp;үдэр<br /> 1.0000175&nbsp;[[Юлианай жэл (одон орон)|Юлианай жэл]] | avg_speed = 29.783&nbsp;км/с <br /> 107,218&nbsp;км/саг | satellites = 1&nbsp;([[Һара]]) | physical_characteristics = yes | flattening = 0.0033528<ref name=iers/> | equatorial_radius = 6,378.1&nbsp;км<ref name=iers>{{cite conference | а.н.thor=IERS Working Groups | editor=McCarthy, Dennis D.; Petit, Gérard | title=General Definitions and Numerical Standards | year=2003 | booktitle=IERS Technical Note No. 32 | publisher=U.S. Naval Observatory and Bureа.н. International des Poids et Mesures | url=http://www.iers.org/MainDisp.csl?pid=46-25776 | accessdate=2008-08-03 }}</ref> | polar_radius = 6,356.8&nbsp;км<ref>{{cite book | first=Anny | last=Cazenave | editor=Ahrens, Thomas J. | year=1995 | chaptertitle=Geoid, Topography and Distribution of Landforms | title=Global earth physics a handbook of physical constants | publisher=American Geophysical Union | location=Washington, DC | isbn=0-87590-851-9 | url=http://www.agu.org/reference/gephys/5_cazenave.pdf | accessdate=2008-08-03 | format=PDF }} {{Webarchive|url=https://web.archive.org/web/20061016024803/http://www.agu.org/reference/gephys/5_cazenave.pdf |date=2006-10-16 }}</ref> | mean_radius = 6,371.0&nbsp;км<ref>{{cite book | а.н.thor=Various | editor=David R. Lide | year=2000 | title=Handbook of Chemistry and Physics | edition=81st | publisher=CRC | isbn=0849304814 }}</ref> | circumference = 40,075.02&nbsp;км&nbsp;([[экватор]]ын)<br />40,007.86&nbsp;км&nbsp;([[уртрагийн]])<br />40,041.47&nbsp;км&nbsp;(дундаж) | surface_area = 510,072,000&nbsp;км²<ref>{{cite journal | last = Pidwirny | first = Michael | date=2006-02-02 | title=Surface area of our planet covered by oceans and continents.(Table 8o-1) | publisher=University of British Columbia, Okanagan | url=http://www.physicalgeography.net/fundamentals/8o.html | accessdate=2007-11-26 }}</ref><ref name=cia>{{cite web | author=Staff | date=2008-07-24 | url=https://www.cia.gov/library/publications/the-world-factbook/geos/xx.html | title=World | work=The World Factbook | publisher=Central Intelligence Agency | accessdate=2008-08-05 | archivedate=2010-01-05 | archiveurl=https://web.archive.org/web/20100105171656/https://www.cia.gov/library/publications/the-world-factbook/geos/xx.html }}</ref> 148,940,000&nbsp;км²&nbsp;- хуурай газар &nbsp;&nbsp;(29.2 %)<br /> 361,132,000&nbsp;км²&nbsp;- ус &nbsp;(70.8 %) | volume = [[Дэлхэйн эзлэхүүн|1.0832073{{e|12}}]]&nbsp;км³ | mass = 5.9736{{e|24}}&nbsp;кг<ref name="earth_fact_sheet">{{cite web | last = Williams | first = David R. | date = 2004-09-01 | url = http://nssdc.gsfc.nasa.gov/planetary/factsheet/earthfact.html | title = Earth Fact Sheet | publisher = NASA | accessdate = 2007-03-17 | archivedate = 2013-05-08 | archiveurl = https://web.archive.org/web/20130508021904/http://nssdc.gsfc.nasa.gov/planetary/factsheet/earthfact.html }}</ref> | density = 5.5153&nbsp;г/см³ | surface_grav = [[Дэлхийн татах хүч|9.780327]] м/с²<ref name="yoder12">Yoder, C. F. (1995) p. 12.</ref><br />0.99732&nbsp;[[хүндийн хүчний хурдатгал|''g'']] | escape_velocity = 11.186&nbsp;км/с&nbsp; | sidereal_day = 0.99726968&nbsp;өдөр<ref name=Allen296>{{cite book | title=Allen's Astrophysical Quantities | а.н.thor=Allen, Clabon Walter; Cox, Arthur N. | publisher=Springer | year=2000 | isbn=0387987460 | url=http://books.google.com/books?id=w8PK2XFLLH8C&pg=PA296 | pages=296}}</ref><br />23{{smallsup|ц}}&nbsp;56{{smallsup|м}}&nbsp;4.100{{smallsup|с}} | rot_velocity = 1,674.4 км/саг (465.1 м/с) | axial_tilt = 23.439281° | albedo = 0.367<ref name="earth_fact_sheet"/> | atmosphere = yes | temperatures = yes | temp_name1 = [[Кельвин]] | min_temp_1 = 184&nbsp;K | mean_temp_1 = 287&nbsp;K | max_temp_1 = 331&nbsp;K | temp_name2 = [[Цельс]] | min_temp_2 = −89&nbsp;°C | mean_temp_2 = 14&nbsp;°C | max_temp_2 = 57.7&nbsp;°C | surface_pressure = 101.3&nbsp;[[кПа]] ([[Далайн түвшин|Дундаж далайн түвшин]]) | atmosphere_composition = 78.08%&nbsp;[[Азот]] (N₂)<br /> 20.95%&nbsp;[[Хүшэлтүрэгшэ]] (O₂)<br /> 0.93%&nbsp;[[Аргон]]<br /> 0.038%&nbsp;[[Нүүрһэнхүшэлэй хии]]<br /> 1% оршомой [[уһанай уурал]] ([[уурал амисхал]]һаа хамаарша өөр байна)<ref name="earth_fact_sheet"/> |note=no }} {{Хадмал |style = {{floatleft}} |монгол_бэшэг = [[Файл:Delehei.PNG|21px]] |кирилл_буряад = Дэлхэй |кирилл_монгол = Дэлхий |кирилл_хальмаг = [[:xal:Делкә|Делкә]] }} '''Дэлхэй''' (тэмдэг: [[File:Earth symbol (fixed width).svg|16px|🜨]]) — [[Наранай аймаг|наранай аймагай]] гурбадахи [[гараг]], сори ганса [[амидарал]]тай [[юртэмсэ]] юм. Дэлхэйнь 4,57 [[тэрбум]] [[жэл]]эй урда тээ бии болоһон<ref name="age_earth">{{cite book | first=G.B. | last=Dalrymple | year=1991 | title=The Age of the Earth | publisher=Stanford University Press | location=California | id=ISBN 0-8047-1569-6 }}</ref>, нэгэ дахуултай ([[Һара]]), 365,26 [[үдэр]] соо [[Наран]]иие бүтэн тойродог).<ref>Энэ үеые [[сидеральна жэл]] гэжэ нэрлэдэг. Наранай үдэрэй тоо [[сидеральна үдэр]]эй тооһоо нэгээр бага, юундэб гэхэдэ Дэлхэйн Наранай тойрохо хүдэлөөн гарагай тэнхэлигэй тойрогто нэгэ нэмэлтэ эрьелтэ үүсхэнэ.</ref>. Дэлхэйн эрьелтын тэнхэлиг 23,5° хазайһан байдаг, дэлхэй дээрэхи [[Жэлэй дүрбэн уларил|уларилай]] хубилалтын шалтагаан болоно<ref>Ahrens, ''Global Earth Physics: A Handbook of Physical Constants'', p. 8.</ref>. Дэлхэй болбол шулуун гараг мүн. Дэлхэй ойролсоогоор бүмбэрсэг шэнги дүрсэтэй. Дэлхэйн Наранһаа дунда зэргын зайнь 149,6 сая км болоод энэнь 1 [[одон орон шудалалгын нэгэжэ]]тэй адли болоно.<ref name=SNL>{{Cite web|author=Ringnes, Truls; Aksnes, Kaare; Ramberg, Ivar; Bryhni, Inge|date=2024 |url=https://snl.no/Jorden |title=Jorden |publisher=Store norske leksikon |accessdate=2024-07-04}}</ref> Дэлхэй хадаа [[агаар мандал]]тай, гадаргуунь 71 % [[далай]] ([[уһан]]), үлэһэн 29 % — хуурай газар ([[түби]]нүүд, [[арал]]нууд). Дэлхэйн гадаргуунь [[Тектоник плита|тектоник плитануудта]] хубаагдаха ба тэдэгээрэнь таһаралтагүй нүүжэ (хүбжэ) байдаг. Эрьелдэдэг, багахан хабшагар Дэлхэйн бүмбэрсэг бүһэлүүрлиг тогтосотой болоод [[Дэлхэйн сүм|сүм]], [[манти]], [[Дэлхэйн холтоһон|холтоһонһоо]] тогтоно. == Дэлхэйн бойжолго == 4.57 тэрбум жэлэй үмэнэ<ref name="age_earth" /> Дэлхэй болон [[Наранай аймаг|Hаранай аймагай]] бусад [[гараг]]ууд, хиин манарһаа (''Solar Nebula'') үүдэһэн гэжэ [[Шэнжэлхэ ухаанай таамаглал|таамаглажа]] байгаа болоод Дэлхэйнь эхилээд халуун хайламаг байгаад аажамаар хүрэжэ, хатуу холтоһотой болоһон байна. Дэлхэйн дахуул [[Һара]]нь, Дэлхэйе [[Мягмар (гараг)|Мягмар]] гарагтай ойролсоо хэмжээтэй бэетэ («Тейя» гэжэ нэрэлдэг) мүргэхэ үедэ үүдэһэн гэжэ таамагладаг<ref>{{cite journal | last = R. Canup and E. Asphа.н.g | title = Origin of the Moon in a giant impact near the end of the Earth's formation | journal = Nature | volume = 412 | pages = 708-712 | date = 2001 | url = http://www.nature.com/nature/journal/v412/n6848/abs/412708a0.html }}</ref>. Аажамаар Дэлхэйн [[температура]] 100 °C (212 °F) оршом болоход эртын [[агаар мандал]] дахи [[уһан]]ай уурал конденсат болоһон, [[далай]] үүдэжэ эхилһэн байна. Агаар мандалда [[хүшэлтүрэгшэ]], уламаар агаар мандалай дээд дабхаргад [[озон]] (O₃) үүдэһэнээр, [[наран|наранһаа]] ерэхэ [[ультраягаан туяа]] багадхажа, анханай ниилэмэл эстэй амитад, улмаар жинхэнэ [[олон эстэй амитад]] үүдэжэ эхилбэ<ref>{{cite web | last = Burton | first = Kathleen | date = [[November 29]], [[2000]] | url = http://www.nasa.gov/centers/ames/news/releases/2000/00_79AR.html | title = Astrobiologists Find Evidence of Early Life on Land | publisher = NASA | accessdate = 2007-03-05 | archivedate = 2011-10-11 | archiveurl = https://web.archive.org/web/20111011032824/http://www.nasa.gov/centers/ames/news/releases/2000/00_79AR.html }}</ref>. Дэлхэйн гадаргуу байнга, таһаралтагүй хубилагдажа байһан гэжэ үзэдэг. Ондоогоор хэлэбэл, эхэ газарнууд нүүжэ, хоорондоо нэгэдэн [[түби|супертүби]] үүсхэн, һүүлдэнь задаржа байһанһаа нилээд шухала [[супертүби]]нь 600—540 [[сая]] [[жэл]]эй үмэнэ бии боложо, 180 сая [[жэл]]эй үмэнэ задарһан ([[супертүби|Гондвана]], [[супертүби|Лаврази]] 2 супертүби үүсхэһэн) [[Пангея]] юм<ref>{{cite journal | а.н.thor=Murphy, J. B.; Nance, R. D. | title=How do supercontinents assemble? | journal=American Scientist | year=1965 | volume=92 | pages=324–33 | url=http://scienceweek.com/2004/sa040730-5.htm | accessdate=2007-03-05 }} {{Webarchive|url=https://web.archive.org/web/20070713194319/http://scienceweek.com/2004/sa040730-5.htm |date=2007-07-13 }} {{Cite web |title=Archive copy |url=http://scienceweek.com/2004/sa040730-5.htm |accessdate=2014-01-21 |archivedate=2007-07-13 |archiveurl=https://web.archive.org/web/20070713194319/http://scienceweek.com/2004/sa040730-5.htm }}</ref>. Дэлхэй дээрэ хэд хэдэн томохон [[мүльһэтэлгэ|мүльһэтэлгүүд]] ябагдаһан гэжэ таамагладаг ба эхинэйхэнь 750—580 сая жэлэй үмэнэ ([[Неопротерозой]]), һүүлынхэнь 10,000 жэлэй үмэнэ дууһаһан байна<ref>{{cite web | а.н.thor=Staff | url = http://www.lakepowell.net/sciencecenter/paleoclimate.htm | title = Paleoclimatology - The Study of Ancient Climates | publisher = Page Paleontology Science Center | accessdate = 2007-03-02 }}</ref>. Дэлхэйн хүгжөөлэй түүхэдэ [[махабад|амиды махабадай]] томохон задаралганууд тохёолдожо байһанһаа һүүлынхинь 65 [[сая]] жэлэй үмэнэ болоһон [[үлэг гүрбэл|үлэг гүрбэлнүүдэй]] мүхэл юм (шалтагааниинь дэлхэй дээрэ [[солир]] унаһантай холбон таамагладаг). Уг задаралгын дараагаар жажаг амитад, жэшээлбэл, [[һүн тэжээлтэн]] амитад эршэмтэй тархажа эхилһэн ба хэдэн сая жэлэй үмэнэ [[Африка|Африкын]] [[мэшэн|мэшэтэй]] түһөөтэй амитадые хоёр хүлэ дээрээ ябадаг болоһон гэжэ [[Шэнжэлхэ ухаанай таамаглал|таамагладаг]]<ref>{{cite journal | last = Gould | first = Stephan J. | title=The Evolution of Life on Earth | journal=Scientific American | date=October , 1994 | url=http://brembs.net/gould.html | accessdate=2007-03-05 }}</ref>. == Дэлхэйн бүтэсэ == [[Наранай аймaг|Наранай аймагай]] 4 гараг (Наранда ойрхон 4 гараг) хатуу, шулуурхаг гадаргуутай («Хүрьһэтэ гараг») болоод тэдгээрһээ Дэлхэйнь хамагай томо, ехэ [[нягта]]тай, хүсэтэй [[суранзан орон]]той, газарай [[татадаг хүсэн]] хамагай ехэтэй [[гараг]] юм. Дэлхэйнь юрэнхыдөө үндэгэлиг бүмбэлэг хэлбэритэй болобош, үнэндээ гадаргуунь тэгшэ бэшэ ушар Дэлхэйн хэлбэриие [[Геоид]] гэжэ нэрэлнэ. === Химиин найралга === Дэлхэйн [[масса]] ойролсоогоор 5,98 ×10²⁴ [[кг]]. Гол бүрдүүлэгшэ [[химиин элемент|элементүүд]] [[түмэр]] (32.1 %), [[хүшэлтүрэгшэ]] (30.1 %), [[сахюур]] (15.1 %), [[магни]] (13.9 %), [[хүхэр]] (2.9 %), [[никель]] (1.8 %), [[кальци]] (1.5 %), [[хүнгэнсагаан]] (1.4 %) ба үлэхэ 1,2 % бусад [[химиин элемент]]ууд юм<ref>{{cite journal | а.н.thor=Morgan, J. W.; Anders, E. | title=Chemical composition of Earth, Venus, and Mercury | journal=Proceedings of the National Academy of Science | year=1980 | volume=71 | issue=12 | pages=6973–6977 | url=http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=350422 | accessdate=2007-02-04 }} {{Webarchive|url=https://archive.today/20130718075202/http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=350422 |date=2013-07-18 }} {{Cite web |title=Archive copy |url=http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=350422 |accessdate=2014-01-22 |archivedate=2013-07-18 |archiveurl=https://archive.today/20130718075202/http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=350422 }}</ref>. [[АНУ|АНУ-ай]] [[геохими]]к [[Франк Уиглсуорт Кларк|Франк Кларкын]] тоосоогоор, Дэлхэйн холтоһоной 47 % [[хүшэлтүрэгшэ]] болоод ниитэ шулуулагай 99,22 % [[сахюур]], [[хүнгэнсагаан]], [[түмэр]], [[кальци]] зэргэ ниитэ 11 эһэлһээ тогтодог байна. {| {{prettytable}} |+ Ф.Кларкын хүсэнэгтэ <br />(Дэлхэйн холтоһоной үндэһэн эһэлнүүд) !Найралга !Химиин томьёо !Тархалта |- |[[Сахюурай эһэл]] |style="text-align: center;"|SiO₂ |style="text-align: right;"|59.71 % |- |[[Хүнгэнсагаан эһэл]] |style="text-align: center;"|Al₂O₃ |style="text-align: right;"|15.41 % |- |[[Кальциин эһэл]] |style="text-align: center;"|CaO |style="text-align: right;"|4.90 % |- |[[Магниин эһэл]] |style="text-align: center;"|MgO |style="text-align: right;"|4.36 % |- |[[Натриин эһэл]] |style="text-align: center;"|Na₂O |style="text-align: right;"|3.55 % |- |[[Түмэрэй (II) эһэл]] |style="text-align: center;"|FeO |style="text-align: right;"|3.52 % |- |[[Калиин эһэл]] |style="text-align: center;"|K₂O |style="text-align: right;"|2.80 % |- |[[Түмэрэй (III) эһэл]] |style="text-align: center;"|Fe₂O₃ |style="text-align: right;"|2.63 % |- |[[Уһан]] |style="text-align: center;"|H₂O |style="text-align: right;"|1.52 % |- |[[Титанай дабхар эһэл]] |style="text-align: center;"|TiO₂ |style="text-align: right;"|0.60 % |- |[[Фосфорой тавч эһэл]] |style="text-align: center;"|P₂O₅ |style="text-align: right;"|0.22 % |- !colspan="2"|Ниитэ !style="text-align: right;"|99.22 % |} === Дэлхэйн дотоодо бүтэсэ === [[Файл:Earth-crust-cutaway-bxr.png|thumbnail|upright=1.25|right|Дэлхэйн бүтэсэ (хэмжээ харгалзаагүй, cхем).]] Дэлхэйнь гүн тээшээ дабхар бүтэсэтэй болоод химиин найралгынгаа хубида: * Эгээн гадна таладаа, cиликатлиг найралгатай, хатуу [[Дэлхэйн холтоһон|холтоһон]], * Тэрэнэй дотор талада шэнгэн [[манти]], * [[Манти|Mантитай]] харисуулхада харисангы аглуун [[Дэлхэйн сүм|гадаада сүм]], * Эгээн түбтөө хатуу [[Дэлхэйн сүм|дотоодо сүм]] гэжэ хубаагдана. Харин [[геологи]]ин хубида [[литосферэ]], [[астеносферэ]], [[манти|дээдэ манти]], [[манти|доодо манти]], [[Дэлхэйн сүм|гадаада]] болон [[Дэлхэйн сүм|дотоодо сүм]] гэһэн үе дабхаргуудтай<ref>{{cite book | first=Toshiro | last=Tanimoto | editor=Thomas J. Ahrens | year=1995 | title=Crustal Structure of the Earth | booktitle=Global Earth Physics: A Handbook of Physical Constants | publisher=American Geophysical Union | location=Washington, DC | id=ISBN 0-87590-851-9 | url=http://www.agu.org/reference/gephys/15_tanimoto.pdf | accessdate=2007-02-03 }} {{Webarchive|url=https://web.archive.org/web/20061016194153/http://www.agu.org/reference/gephys/15_tanimoto.pdf |date=2006-10-16 }} {{Cite web |title=Archive copy |url=http://www.agu.org/reference/gephys/15_tanimoto.pdf |accessdate=2014-01-22 |archivedate=2006-10-16 |archiveurl=https://web.archive.org/web/20061016194153/http://www.agu.org/reference/gephys/15_tanimoto.pdf }}</ref> . {| {{prettytable}} class="wikitable" !colspan=2 style="width: 33%;"|Гүн !rowspan=2 valign="bottom"|Үе дабхарга !rowspan=2 style="width: 15%;"|Нягта<br />гр/см³ |- !Километр !Мили |- |style="text-align: center;"|0-60 |style="text-align: center;"|0-37 |[[Литосферэ]] (Зузааниинь 5-200 км хүрэтэр өөршэлэгдэдэг) |style="text-align: center;"|— |- style="background: #FEFEFE;" |style="text-align: center;"|0-35 |style="text-align: center;"|0-22 |… [[Дэлхэйн холтоһон|холтоһон]] (Зузааниинь 5-70 км хүрэтэр өөршэлэгдэдэг) |style="text-align: center;"| 2.2-2.9 |- style="background: #FEFEFE;" |style="text-align: center;"|35-60 |style="text-align: center;"|22-37 |… Мантиин дээдэ хэһэг |style="text-align: center;"| 3.4-4.4 |- |style="text-align: center;"|35-2890 |style="text-align: center;"|22-1790 |[[Манти]] |style="text-align: center;"| 3.4-5.6 |- style="background: #FEFEFE;" |style="text-align: center;"|100-700 |style="text-align: center;"|62-435 |… [[Астеносферэ]] |style="text-align: center;"|— |- |style="text-align: center;"|2890-5100 |style="text-align: center;"|1790-3160 |[[Дэлхэйн сүм|Гадаада сүм]] |style="text-align: center;"| 9.9-12.2 |- |style="text-align: center;"|5100-6378 |style="text-align: center;"|3160-3954 |[[Дэлхэйн сүм|Дотоодо сүм]] |style="text-align: center;"| 12.8-13.1 |} ==== Сүм ==== {{main|Сүм}} Дэлхэйн дундажа [[нягта]] 5515 кг/м³, харин гадаргуугай дундажа [[нягта]] 3017 кг/м³ тула [[Дэлхэйн сүм]]ые харисангы дэлюун нягтатай гэжэ үзэдэг ба энэнь [[геофизика|сейсмическа]] шудалгаагаар баталагдадаг байна. Сейсмическа (шэшэргэлэлэй) S долгиной хурданай һааралтаар гадаада сүмые шэнгэн зуурмаг гээд баталаа. Ушарынь S долгиниинь шэнгэн бэеэ нэбтэрдэггүй байна. Дэлхэйн бойжолгын эхинэй үедэ, ойролсоогоор 4.52 [[тэрбум]] [[жэл]]эй оршом, хүндэ химиин нэгэдэлнүүд дэлхэйн түб руу һуужа гү, али бөөгнэрэн, хүнгэниинь дэлхэйн холтоһон гү, али гадаргуу руу шэлжэнэ, илгаралта ябагдаһанай үрэ дүндэ сүмынь бойжоһон гэжэ үзэдэг. Сүмынь үндэһэндөө [[түмэр]] (80 %), [[никель]], мүн багахан хэмжээнэй бусад [[химиин элемент|химиин элементһээ]] тогтоно. Эдэ хүхэр, карбон, уһантүрэгшэ зэргын бусад элементүүдые багтаха магадгүй гэжэ үзэдэг. ==== Манти ==== [[Файл:Slice_earth.svg|thumbnail|right|Дэлхэйн дотоодо бүтэсэ. 1. Эхэ газарай холтоһон — 2. Далайн холтоһон — 3. Дээдэ манти — 4. Доодо манти — 5. Гадаада сүм — 6. Дотоодо сүм <br />A: [[Мохиин зааг]] <br /> B: [[Гутенбергай зааг]] <br />C: [[Лехманай зааг]]]] {{main|Манти}} Мантинь Дэлхэйн ниитэ [[эзэлхүүн]]эй 70%-ийг эзэлдэг, ниитэдээ 2,890 [[км]] зузаан. Даралта [[манти]] ба [[Дэлхэйн сүм|сүмэй]] заагта ~140 [[Паскаль|ГПа]] (1.4 Maтм), [[температура]] 500&nbsp;°C-900&nbsp;°C (932&nbsp;°F-1,652&nbsp;°F) хоорондо хэлбэлзэхэ ба [[манти]], [[Дэлхэйн сүм|гадаада сүмэй]] зааг дээрэ 4,000&nbsp;°C (7,200&nbsp;°F) байна. Мантиие үндэһэн 2 хэһэгтэ хубаадаг. Дээдэ болон доодо манти. Энэ хоёр үень бүрдүүлэгшэ эрдэс минералаараа илгагдана. ==== Холтоһон ==== {{main|Дэлхэйн холтоһон}} Геологиин үүдэнһээ, [[Дэлхэйн холтоһон]]иинь Дэлхэйн хамагай гадана талын хатуу бүрхөөл ([[литосфери]]ин дээдэ хэһэг) болоод [[магмын шулуулаг|базальтлаг]] болон [[магмын шулуулиг|боржинлиг]] шулуунһаа тогтоно. Дэлхэйн ниитэ эзэлхүүнэй < 1 % эзэлнэ. === Тектоникын плита === {{main|Плитануудай тектоника}} [[Плитануудай тектоника|Литосферэнь]] [[Плитануудай тектоника|тектоникын плитанууд]] гэжэ нэрэлэгдэхэ хэһэгүүдтэ хубаагдаһан (эбдэрһэн) байдаг болоод [[Плитануудай тектоника|астеносферэ]] дээгүүр нүүжэ (хүбэжэ) байдаг байна. Ниитэдээ 7 томо [[Плитануудай тектоника|плита]], олон тооной жэжэг [[Плитануудай тектоника|плитанууд]] байна. === Дэлхэйн гадаргуу === Дэлхэйн ниитэ гадаргуугай 70,8 % [[уһан|уһаар]] ([[Далай]]гаар) бүрхэгдэнэ<ref name="Pidwirny2006">{{cite web | last = Pidwirny | first = Michael | year = 2006 | url = http://www.physicalgeography.net/fundamentals/7h.html | title = Fundamentals of Physical Geography | edition = 2nd Edition | publisher = PhysicalGeography.net | accessdate = 2007-03-19 }}</ref>. [[Далай]]н ёроолын гадаргуунь тэгшэ бус болоод уула нюрганууд ([[Далайн голшо нюруу]]), [[галта уула]], хабсал, дэбисэг зэргэтэй байна<ref name="ngdc2006">{{cite web | author=Sandwell, D. T.; Smith, W. H. F. | date = 2006-07-07 | url =http://www.ngdc.noaa.gov/mgg/bathymetry/predicted/explore.HTML | title =Exploring the Ocean Basins with Satellite Altimeter Data | publisher = NOAA/NGDC | accessdate = 2007-04-21 }}</ref>. Үлдэх 29,2 % нь [[түби|хуурай газар]] болоод [[сүл]], тэгшэ тала, үндэр уулас зэргэ [[геоморфологи]]ин олон элементүүдһээ бүрдэнэ. Хуурай газарай гадаргуугай 75 % [[шулуу|тунамал шулуулгаар]] хушагдана<ref>{{cite web | last = Jessey | first = David | url = http://geology.csupomona.edu/drjessey/class/Gsc101/Weathering.html | title = Weathering and Sedimentary Rocks | publisher = Cal Poly Pomona | accessdate = 2007-03-20 | archivedate = 2007-07-03 | archiveurl = https://web.archive.org/web/20070703170212/http://geology.csupomona.edu/drjessey/class/Gsc101/Weathering.html }}</ref>. үлэхэ хэһэгтэнь [[шулуу|магмын]] болон [[шулуу|хубирмал шулуулаг]] тархана. Дэлхэйн газарай гадаргуу дээрэ хамагай үргэн тархалтатай [[эрдэс]]үүд бол [[Силикатын бүлэгэй эрдэс|кварц]], [[Силикатын бүлэгэй эрдэс|хээрын жоншо]], [[Силикатын бүлгийн эрдэс|амфибол]], [[Силикатын бүлэгэй эрдэс|гялтгануур]], [[Силикатын бүлэгэй эрдэс|пироксен]], [[Силикатын бүлэгэй эрдэс|оливин]], [[Карбонатын бүлэгэй эрдэс|кальцит]], [[Карбонатын бүлэгэй эрдэс|доломит]] зэргэ юм<ref>{{cite web | а.н.thor = Staff | url = http://natural-history.uoregon.edu/Pages/web/mineral.htm | title = Minerals | publisher = Museum of Natural History, Oregon | accessdate = 2007-03-20 | archivedate = 2007-07-03 | archiveurl = https://web.archive.org/web/20070703170251/http://natural-history.uoregon.edu/Pages/web/mineral.htm }}</ref>. Дэлхэйн гадаргуунь тектоник хүдэлгөөн болон элэгдэл, [[үгэршэл|үгэршһээ]] хамааран тасаралтагүй өөршэлэгдэдэг байна. Дэлхэйн [[түби|хуурай газарай]] хамагай нам дор сэгэнь [[далай]]н түбшэнһөө доошо 418 м-т оршохо [[Һүнэһэн тэнгис]], хамагай үргэгдэһэн сэгэнь 8,848 м үргэгдэһэн [[Эверест]] орьёл юм. Эхэ газар дундажаар далайн түбшэнһөө дээшэ 686 м үргэгдэһэн байдаг<ref name="hr_mill">{{cite journal | last=Mill | first=Hugh Robert | title=The Permanence of Ocean Basins | journal=The Geographical Journal | year=1893 | volume=1 | issue=3 | pages=230-234 | url=http://www.wku.edu/~smithch/wallace/S453.htm | accessdate=2007-02-25 }} {{Webarchive|url=https://web.archive.org/web/20070225054604/http://www.wku.edu/~smithch/wallace/S453.htm |date=2007-02-25 }} {{Cite web |title=Archive copy |url=http://www.wku.edu/~smithch/wallace/S453.htm |accessdate=2014-01-22 |archivedate=2007-02-25 |archiveurl=https://web.archive.org/web/20070225054604/http://www.wku.edu/~smithch/wallace/S453.htm }}</ref>. === Уһан мандал === {{main|Уһан мандал}} [[Файл:Atmosphere-Biosphere-Hydrosphere-Lithosphere.png|мини|Дэлхэйн уһан мандал]] Дэлхэйн ниитэ гадаргуугай ехэнхинь [[уһан|уһаар]] бүрхэгдэһэн байдагаараа [[наранай аймаг|Наранай аймагайн]] бусад [[гараг|гарагуудһаа]] илгаатай болоод «Сэнхир Гараг» гэжэ нэрэлэгдэдэг. Дэлхэйн уһан мандал үндэһэндээ [[далай|Дэлхэйн далайнуудһаа]] бүрдэхэ болобош, үүндэ баһа [[Түби|эхэ газарай]] [[тэнгис]], [[нуур]], [[гол|гол мүрэн]], газарай гадаргууһаа 2000 [[метр|м]] хүрэтэр гүндэ оршохо гүнэй [[уһан]]ые оруулдаг байна. Дэлхэйн хамагай гүн [[уһан|уһатай]] газар бол [[Номгон далай]]да оршохо [[Марианай хотигор]] (10,911 м гүн)<ref name="rain.org">{{cite web | а.н.thor=Staff | url = http://www.rain.org/ocean/ocean-studies-challenger-deep-mariana-trench.html | title = "Deep Ocean Studies" | work = Ocean Studies | publisher = RAIN National Public Internet and Community Technology Center | accessdate = 2006-04-02 }}</ref>. Далайн дундажа гүн 3,794 м байдаг. [[Далай]]н ниитэ [[масса]] 1.35 х 10¹⁸ [[тонно]] гү, али Дэлхэйн ниитэ массын 1/4400, [[эзэлхүүн]]иинь 1,386 × 109 км³. Дэлхэй дээрхи ниитэ уһанай 97,5 % [[дабһатай]] [[уһан]] болоод үлэхэ 2,5 % сэбэр уһан юм. Сэбэр уһанай 68,7 % [[уһан|мүльһэн]] хэлбэрээр оршоно<ref>{{cite web | а.н.thor = Igor A. Shiklomanov ''et al'' | year = 1999 | url = http://espejo.unesco.org.uy/ | title = World Water Resources and their use Beginning of the 21st Century" Prepared in the Framework of IHP UNESCO | publisher = State Hydrological Institute, St. Petersburg | accessdate = 2006-08-10 | archivedate = 2006-08-08 | archiveurl = https://web.archive.org/web/20060808204116/http://espejo.unesco.org.uy/ }}</ref>. Далайн уһаниинь [[наран]]ай [[энерги]]ие ехэ хэмжээгээр шэнгээдэг ушар далайн уһанай [[температура|температурын]] тархалтаар дэлхэйн [[саг уурал]] тодорхойлогдоно<ref>{{cite web | last = Scott | first = Michon | date = [[April 24]], [[2006]] | url = http://earthobservatory.nasa.gov/Study/HeatBucket/ | title = Earth's Big heat Bucket | publisher = NASA Earth Observatory | accessdate = 2007-03-14 }}</ref>. Үүнэй тод жэшээ бол [[Эль Ниньо|ЭНСО]] (El Niño-Southern Oscillation) юм<ref>{{cite web | first =Sharron | last =Sample | date =June 21, 2005 | url =http://science.hq.nasa.gov/oceans/physical/SST.html | title =Sea Surface Temperature | publisher =NASA | accessdate =2007-04-21 | archivedate =2007-04-29 | archiveurl =https://web.archive.org/web/20070429030121/http://science.hq.nasa.gov/oceans/physical/SST.html }}</ref>. === Агаар мандал === {{main|Агаар мандал}} [[Файл:Atmosfeer.png|thumb|upright|Дэлхэйн агаар мандал]] [[Файл:Atmosphere layers-bxr.svg|thumb|left|upright=0.5| alt=A.| ''[[Агаар мандал]]''.]] Дэлхэйн агаар мандал гэжэ [[Дэлхэйн татаха хүсэн]]дэ захирагдан, Дэлхэйн гадна талаар хүрээлэн байгаа [[хиин түлэб|хиин]] дабхргые хэлэнэ. Агаар мандалай 78 % [[азот]], 20,95 % [[хүшэлтүрэгшэ]], 0,93 % [[аргон]], 0,038 % [[нүүрһэнтүрэгшын дабхар эһэл]], 1 % [[уһан|уһанай уурал]] болон маша бага хэмжээтэй бусад [[хиин түлэб|хиинүүд]] байна. Эдэгээр хиинүүдые ниүлүүлээд бидэ [[агаар]] гэжэ нэрэлдэг. Агаар мандалиинь [[Наран]]һаа ерэхэ [[ультраягаан туяа]]е шэнгээжэ, [[үдэр]], [[һүни]]ин [[температура|температурын]] илгаае тогтоборжуулан, Дэлхэй дээрэ [[амидарал]] байха нүхэсэлые бүрдүүлнэ<ref name="atmosphere">{{cite web | а.н.thor = Staff | date = October 8, 2003 | url = http://www.nasa.gov/а.н.dience/forstudents/9-12/features/912_liftoff_atm.html | title = Earth's Atmosphere | publisher = NASA | accessdate = 2007-03-21 }}{{Dead link|date=October 2023 |bot=InternetArchiveBot |fix-attempted=yes }}</ref>. Гaзарай гадаргуу оршомын агаар мандалай дундажа [[температура]] 15&nbsp;°C байдаг. Дэлхэйн агаар мандал бол олон дабхартай: * [[тропосфера]] * [[стратосфера]] * [[мезосфера]] * [[ионосфера]] * [[термосфера]] * [[экзосфера]] == Һара == {{main|Һара}} [[Файл:Earth-Moon2.jpg|thumb|center|upright=4|Дэлхэйн, Һарын хороондо зай болон хэмжээн нюруутай масштабтай зураг]] Һара — дэлхэйн ганса [[байгаалиин дахуул]] юм. == Дэлхэйн эрьелтэ ба орбита == Дэлхэй тэнхлэгээрээ 23 саг, 56 минут, 4.091 секундта нэгэ бүтэн эрьедэг болоод<ref>{{cite web | last = Fisher | first = Rick | date = January, 30, 1996 | url = http://www.cv.nrao.edu/~rfisher/Ephemerides/times.html | title = Astronomical Times | publisher = National Radio Astronomy Observatory | accessdate = 2007-03-21 | archivedate = 2011-08-18 | archiveurl = https://web.archive.org/web/20110818022038/http://www.cv.nrao.edu/~rfisher/Ephemerides/times.html }}</ref> Наранһаа дундажаар 150 сая км зайда, 30 км/сек (108,000 км/саг) хурдатайгаар 365.2564 үдэртэ Нараниие нэгэ бүтэн тойрожо эрьелдэдэг. Дэлхэйн тэнхэлигэнь Наран-Дэлхэйе дайраһан хабтагайтай харисуулхада 23,5 градусаар хазайһан байха ба энэнь Дэлхэй дээрэхи үбэл зунай уларил һолигдохо шалтагаан болоно. == Ниигэмэй газарзүй == {{main|Ниигэмэй газарзүй}} Дэлхэйн [[хүн зон]]иинь [[2006]] [[он]]ой [[2 һара|2 һарын]] байдалаар 6,600,000,000 байгаа<ref>Currently it is closer to 6.6 billion than 6.5 billion. It will reach 6.6 billion in June 2007.</ref><ref name="LiveScience"> {{cite news | first= Leonard | last= David | url= http://www.livescience.com/othernews/060224_world_population.html | title= Planet's Population Hit 6.5 Billion Saturday | work= Live Science | date= [[2006-02-24]] | accessdate= 2006-04-02 }} </ref> болоод [[2013]] ондо 7 тэрбум, [[2050]] ондо 9.2 тэрбум хүрнэ гэһэн тоосоо байдаг<ref>{{cite web | а.н.thor=Staff | url = http://www.un.org/esa/population/publications/wpp2006/wpp2006.htm | title = World Population Prospects: The 2006 Revision | publisher = United Nations | accessdate = 2007-03-07 }}</ref>. Хүн зоной үсэлтэ ехэнхидээ хүгжэжэ бай гүрэнүүдтэ болоно. Дэлхэйн ниитэ гадаргуугай 1/8 хубинь хүнэй амидархада таарамжатай гэжэ тоосогдодог (2/3 хэһэгынь [[далай]], үлэһэн газарай тэн хахадынь [[сүл]] газар (14 %)<ref>{{cite journal | а.н.thor=Peel, M. C.; Finlayson, B. L.; McMahon, T. A. | title=Updated world map of the Köppen-Geiger climate classification | journal=Hydrology and Earth System Sciences Discussions | year=2007 | volume=4 | pages=439-473 | url=http://overview.sref.org/1812-2116/hessd/2007-4-439 | accessdate=2007-03-31 }}</ref>, өндөр уулс (27 %) зэргэ)<ref>{{cite web | а.н.thor = Staff | url = http://www.biodiv.org/programmes/defа.н.lt.shtml | title = Themes & Issues | publisher = Secretariat of the Convention on Biological Diversity | accessdate = 2007-03-29 }}{{Dead link|date=October 2023 |bot=InternetArchiveBot |fix-attempted=yes }}</ref>. 2007 оной байдалаар тусгаар статустай 201 бэеэ даанхай [[улас|орон]], [[НҮБ]]-ын гишүүн 192 [[улас]] байна. == Мүн үзэхэ == * [[Наранай аймаг]] == Зүүлтэ == {{Зүүлтэ}} == Гадаада холбооһон == * [http://www.wikimapia.org/ WikiSatellite view of Earth at WikiMapia] * [http://geomag.usgs.gov USGS Geomagnetism Program] * [http://earthobservatory.nasa.gov/Newsroom/BlueMarble NASA Earth Observatory] * [http://solarsystem.nasa.gov/planets/profile.cfm?Object=Earth Earth Profile] by [http://solarsystem.nasa.gov NASA’s Solar System Exploration] * [http://www.co-intelligence.org/newsletter/comparisons.html The size of Earth compared with other planets/stars] * [http://www.nasa.gov/centers/goddard/earthandsun/earthshape.html Climate changes cа.н.ses the earth’s shape to change — Nasa] {{Webarchive|url=https://web.archive.org/web/20090122063915/http://www.nasa.gov/centers/goddard/earthandsun/earthshape.html |date=2009-01-22 }} * [http://www.funonthenet.in/content/view/282/31/ Beа.н.tiful Views of Planet Earth] {{Webarchive|url=https://web.archive.org/web/20071116132744/http://www.funonthenet.in/content/view/282/31/ |date=2007-11-16 }} Pictures of Earth from space * [http://www.flashearth.com/ Flash Earth] A Flash-based viewer for satellite and aerial imagery of the Earth * [http://www.projectshum.org/Planets/earth.html Projectshum.org’s Earth fact file] {{Webarchive|url=https://web.archive.org/web/20130218015318/http://www.projectshum.org/Planets/earth.html |date=2013-02-18 }} (for younger folk) * [http://www.geody.com/?world=terra Geody Earth] World’s search engine that supports Google Earth, NASA World Wind, Celestia, GPS, and other applications. * [http://reference.aol.com/earth Planet Earth] {{Webarchive|url=https://web.archive.org/web/20080724111431/http://reference.aol.com/earth/earth-from-space |date=2008-07-24 }} From AOL Research & Learn: Photos, quizzes and info about Earth’s climate, creatures and science. * [http://reference.aol.com/earth/earth-from-space Earth From Space] {{Webarchive|url=https://web.archive.org/web/20080724111431/http://reference.aol.com/earth/earth-from-space |date=2008-07-24 }} Some Photos From the Exhibit {{1000 үгүүлэл}} {{Наранай аймаг}} [[Категори:Шэнжэлхэ ухаан]] [[Категори:Гарагууд]] [[Категори:Одон орон шудалал]] [[Категори:Наранай аймаг]] idvpxuylif5472s0tdpmv1miaszzg0z 0 7093 74553 71762 2026-04-07T17:22:41Z InternetArchiveBot 12366 Rescuing 1 sources and tagging 0 as dead.) #IABot (v2.0.9.5 74553 wikitext text/x-wiki {{Инфобокс улас | conventional_long_name = Арабай Нэгэдэһэн Эмиртэ Улас | common_name = АНЭУ | native_name = {{native name|ar|الإمارات العربية المتحدة}}<br />{{transliteration|ar|al-ʾImārāt al-ʿArabīyah al-Muttaḥidah}} | image_flag = Flag of the United Arab Emirates.svg | flag_type = [[Арабай Нэгэдэһэн Эмиртэ Уласай Туг|Туг]] | image_coat = Emblem of the United Arab Emirates.svg | symbol_type = [[Арабай Нэгэдэһэн Эмиртэ Уласай Һүлдэ|Һүлдэ]] | national_motto = {{lang|ar|الله الوطن الرئيس}} | englishmotto = Бурхан, Үндэһэтэн, Юрэнхылэгшэ | national_anthem = {{lang|ar|عيشي بلادي}}<br />"''[[Иши Билади|{{transliteration|ar|Īšiy Bilādī}}]]''"<br />"Эхэ Оромни Ута Удаан Наһалагты"<br />{{parabr}}{{center| }} | image_map = United Arab Emirates (orthographic projection).svg | map_caption = {{map caption |location_color= ногоон |region=[[Аравиин хахад арал]] |region_color= none}} | image_map2 = | capital = [[Абу-Даби]] | coordinates = {{Coord|24|28|N|54|22|E|type:city}} | largest_city = <!-- Don't change to Abu Dhabi without a citation -->[[Дубай]]<br />{{coord|25|15|N|55|18|E|display=inline}} | official_languages = [[Араб хэлэн|Араб]]<ref>{{cite web |title=Fact sheet |url=https://u.ae/en/about-the-uae/fact-sheet |website=United Arab Emirates |publisher=U.ae |access-date=31 August 2020}}</ref> | common_languages = [[Англи хэлэн|Англи]]<ref>{{cite web|url=https://www.stalawfirm.com/en/news/view/english-translation-abu-dhabi-courts.html |title=A mandatory requirement for an English translation under Abu Dhabi Courts |publisher=STA Law Firm |date= |access-date=2022-02-26}}</ref> | ethnic_groups = 35.0% [[Арабай Нэгэдэһэн Эмиртэ Улас дахи Энэдхэгшүүд|Энэдхэг]]</br> 15.0% [[Эмират]]</br> 10.7% [[Ойрохи Дурна дахи Бангладешчууд|Бангладеш]]</br> 9.7% [[Арабай Нэгэдэһэн Эмиртэ Улас дахи Пакистаншууд|Пакистан]]</br> 8.8% [[Арабай Нэгэдэһэн Эмиртэ Улас дахи Эмигрантууд#Египетшүүд|Египет]]</br> 5.5% [[Арабай Нэгэдэһэн Эмиртэ Улас дахи Филиппиншууд|Филиппин]]</br> 3.1% [[Арабай Нэгэдэһэн Эмиртэ Улас дахи Индонезшууд|Индонези]]</br> 2.0% [[Арабай Нэгэдэһэн Эмиртэ Улас дахи Эмигрантууд#Йеменшууд|Йемен]]</br> 1.6% [[Арабай Нэгэдэһэн Эмиртэ Улас дахи Йорданшууд|Йордан]]</br> 1.3% [[Арабай Нэгэдэһэн Эмиртэ Улас дахи Эмигрантууд#Суданшууд|Судан]]</br> 9.7% [[Арабай Нэгэдэһэн Эмиртэ Улас дахи Эмигрантууд|Бусад]] | ethnic_groups_ref = <ref>{{Cite web|title=UAE Population and Demographics|year=2020|work=Dubai Online|url=https://www.dubai-online.com/essential/uae-population-and-demographics/}}</ref> <ref>{{Cite web|title=United Arab Emirates Population Statistics 2022|author=GMI Blogger|work=Global Media Insight - Dubai Digital Interactive Agency|date=|access-date=|url=https://www.globalmediainsight.com/blog/uae-population-statistics/|archive-url=|archive-date=}}{{Better source needed|reason=Source is a blog|date=May 2022}}</ref> | ethnic_groups_year = 2020 | religion = 76.0% [[Арабай Нэгэдэһэн Эмиртэ Улас дахи Ислам|Ислам]] ([[Гүрэнэй шажан|албан]])</br> 9.0% [[Арабай Нэгэдэһэн Эмиртэ Улас дахи Христосой шажан|Христос]]</br> 8.0% [[Арабай Нэгэдэһэн Эмиртэ Улас дахи Индуизм|Индуизм]]</br> 1.8% [[Арабай Нэгэдэһэн Эмиртэ Улас дахи Буддизм|Буддизм]]</br> 5.0% [[Арабай Нэгэдэһэн Эмиртэ Улас дахи Шажанай эрхэ сүлөө|Бусад]] | religion_year = 2022 | demonym = [[Эмиратшууд]]<ref name=WorldFactbook/> | government_type = [[Холбооной хаанта засаг|Холбооной]] [[Лалын хаанта засаг|Лалын]] [[парламентын системэ|парламентын]] [[Һунгагдадаг хаанта засаг|һунгагдадаг]] [[үндэһэн хуулита хаанта засаглал|хахад-үндэһэн хуулита хаанта засаглал]]<ref>{{cite book|last=Stewart|first=Dona J.|title=The Middle East Today: Political, Geographical and Cultural Perspectives|publisher=Routledge|date=2013|location=London and New York|isbn=978-0415782432|page=155}}</ref><ref>{{cite book|last=Day|first=Alan John|title=Political Parties of The World|publisher=Stockton|date=1996|isbn=1561591440|page=599}}</ref><ref>{{cite web|url=https://elaws.moj.gov.ae/MainArabicTranslation.aspx?val=UAE-MOJ_LC-En/00_CONSTITUTION/UAE-LC-En_1971-07-18_00000_Dos.html&np=&lmp=undefined|title=United Arab Emirates Constitution|work=UAE Ministry of Justice|access-date=10 October 2018|accessdate=2022-06-12|archivedate=2018-10-11|archiveurl=https://web.archive.org/web/20181011053637/https://elaws.moj.gov.ae/MainArabicTranslation.aspx?val=UAE-MOJ_LC-En/00_CONSTITUTION/UAE-LC-En_1971-07-18_00000_Dos.html&np=&lmp=undefined}}</ref> | leader_title1 = [[Арабай Нэгэдэһэн Эмиртэ Уласай Юрэнхылэгшэ|Юрэнхылэгшэ]] | leader_name1 = [[Мухаммад ибн Заид Аль Нахайян]]<ref>{{cite news |title=Sheikh Mohamed bin Zayed Al Nahyan elected as new UAE president |url=https://gulfnews.com/amp/uae/government/sheikh-mohamed-bin-zayed-al-nahyan-elected-as-new-uae-president-1.1652518419842 |access-date=14 May 2022 |work=[[Gulf News]] |date=14 May 2022}}</ref> | leader_title2 = [[Арабай Нэгэдэһэн Эмиртэ Уласай юрэнхы сайдай жагсаалта|Вице-Юрэнхылэгшэ ба Юрэнхы Сайд]] | leader_name2 = [[Мохаммед ибн Рашид Аль Мактум]] | legislature = [[Холбооной Дээдэ Зүблэл]]</br> [[Холбооной Үндэһэнэй Зүблэл]] | sovereignty_type = [[Арабай Нэгэдэһэн Эмиртэ Уласай Түүхэ|Түүхэ]] | established_event1 = [[Рас эль-Хайма (эмират)|Эмират Рас эль-Хайма]] | established_date1 = 1708 | established_event2 = [[Шарджа (эмират)|Шарджа]] | established_date2 = 1727 | established_event3 = [[Абу-Даби (эмират)|Абу-Даби]] | established_date3 = 1761 | established_event4 = [[Умм эль-Кувейн]] | established_date4 = 1768 | established_event5 = [[Аджман (эмират)|Аджман]] | established_date5 = 1816 | established_event6 = [[Дубай (эмират)|Дубай]] | established_date6 = 1833 | established_event7 = [[Фуджейра (эмират)|Фуджейра]] | established_date7 = 1879 | established_event8 = Ехэ Британи ба [[Хэрээнэй Оман]]һаа [[Үндэһэнэй Үдэр (Арабай Нэгэдэһэн Эмиртэ Улас)|Тусгаар тогтонобо]] | established_date8 = 1971 оной 12 һарын 2 | established_event9 = [[Нэгэдэһэн Үндэһэтэнэй Байгуулга|НҮБ-дэ]] [[НҮБ-ын Аюулгүйн Зүблэлэй 304-р тогтоол|оруулба]] | established_date9 = 1971 оной 12 һарын 9 | established_event10 = АНЭУ-ай бүридэлдэ [[Рас эль-Хаймагай эмиратые]] абаба | established_date10 = 1972 оной 2 һарын 10 | area_km2 = 83,600 | area_rank = 114 | area_sq_mi = 32,278 <!--Do not remove per [[Wikipedia:Manual of Style/Dates and numbers]]--> | percent_water = заахан | population_estimate_year = 2020 | population_estimate = 9,282,410<ref name="u.ae">{{cite web|url=https://u.ae/en/about-the-uae/fact-sheet/|title=United Arab Emirates Population (2020) |website=u.ae}}</ref> | population_census = 4,106,427 | population_estimate_rank = 92 | population_census_year = 2005 | population_density_km2 = 121 | population_density_sq_mi = 256 <!--Do not remove per [[Wikipedia:Manual of Style/Dates and numbers]]--> | population_density_rank = 110 | GDP_PPP = $779.234 тэрбум<ref name=imf2>{{cite web |url= https://www.imf.org/en/Publications/WEO/weo-database/2021/April/weo-report |title=United Arab Emirates |publisher=[[International Monetary Fund]]}}</ref> | GDP_PPP_year = 2022 | GDP_PPP_rank = 34 | GDP_PPP_per_capita = $78,255 <ref name=imf2/> | GDP_PPP_per_capita_rank = 7 | GDP_nominal = $501.354 billion<ref name=imf2/> | GDP_nominal_year = 2022 | GDP_nominal_rank = 32 | GDP_nominal_per_capita = $50,349 <ref name=imf2/> | GDP_nominal_per_capita_rank = 21 | Gini = 26.0 <!--number only--> | Gini_year = 2018 | Gini_change = <!--increase/decrease/steady--> | Gini_ref = <ref>{{cite web|title=GINI index (World Bank estimate) – United Arab Emirates|url=https://data.worldbank.org/indicator/SI.POV.GINI?locations=AE|website=data.worldbank.org |publisher=World Bank|access-date=30 March 2020}}</ref> | Gini_rank = | HDI = 0.890 <!--number only--> | HDI_year = 2019 <!-- Please use the year to which the data refers, not the publication year--> | HDI_change = increase <!--increase/decrease/steady--> | HDI_ref = <ref name="UNHDR">{{cite web|url=http://hdr.undp.org/sites/default/files/hdr2020.pdf|title=Human Development Report 2020|language=en|publisher=[[United Nations Development Programme]]|date=15 December 2020|access-date=15 December 2020}}</ref> | HDI_rank = 31 | currency = [[Арабай Нэгэдэһэн Эмиртэ Уласай Дирхам|АНЭУ Дирхам]] | currency_code = AED | time_zone = [[Арабай Нэгэдэһэн Эмиртэ Улас дахи Саг|АНЭУ-ай Стандарт Саг]] | utc_offset = +04:00 | date_format = үү/һһ/жжжж | drives_on = баруун<!-- The steering wheel is on the left hand side of the car, but they drive on the right hand side of the road – that is driving on the right--> | calling_code = [[Арабай Нэгэдэһэн Эмиртэ Улас дахи Телефоной номер|+971]] <!--- | Communication Companies = Etisalat<ref>{{cite web|url=http://www.etisalat.ae/|title=Welcome to Etisalat|publisher=Etisalat.ae}}</ref> | Communication Companies = du<ref>{{cite web|url=http://www.du.ae/|title=Emirates Integrated Telecommunications Company|publisher=Du.ae}}</ref> | Local calling_code = {{unbulleted list|[[Abu Dhabi]]: 02|[[Dubai]]: 04|[[Sharjah (emirate)|Sharjah]] nd [[Ajman]] : 06|[[Al-Ain]]: 03|[[Fujairah]]: 09|[[Umm al-Quwain]] and [[Ras al-Khaimah]]: 07}} ---->| cctld = {{unbulleted list |[[.ae]] |[[имарат|امارات.]]}} | footnotes = | linking_name = | today = }} '''Арабай Нэгэдэһэн Эмиртэ Улас''' ('''АНЭУ'''; {{lang-ar|الإمارات العربية المتحدة}} {{transliteration|ar|al-ʾImārāt al-ʿArabīyah al-Muttaḥidah}}), гү, али юрынээр '''Эмиратууд''' ({{lang-ar|الإمارات}} {{transliteration|ar|al-ʾImārāt}}), болбол [[Баруун Ази|Баруун Азиин]] улас юм. Долоон эмиратһаа ([[Абу-Даби (эмират)|Абу-Даби]], [[Аджман (эмират)|Аджман]], [[Дубай (эмират)|Дубай]], [[Рас-эль-Хайма (эмират)|Рас-эль-Хайма]], [[Умм-эль-Кайвайн (эмират)|Умм-эль-Кайвайн]], [[Фуджейра (эмират)|Фуджейра]] ба [[Шарджа (эмират)|Шарджа]]) буридэдэг холбооной улас. Эмират бүхэн — бага улас юм. Тэдэнь, өөдэйнгөө амяараа толгойлогшотой. Эмир Уласай ниислэл — [[Абу-Даби]]. Уласай толгойлогшо — Арабын Нэгэдэһэн Эмир Уласай президент (тэрэл сагта Абу-Дабиин эмир). == Газар зүй == Арабын Нэгэдэһэн Эмир Улас Азиин урда-баруунтэй һуудаг улас. Арабиин хойгой зүүн талада һуудаг. Хойто талаһаа Персиин буланаар эрьеэ угаадаг. Зүүн тээшээ Оман буланда гарадаг. Сауд Арабитэй баруун ба урда зүгһөө хилэтэй, Оман уластай зүүн-урдаһаа ба зүүн-хойноһоо (Оманай Мусандам гэжэ анклавтай) хилэтэй. АНЭУгэй хүн зон — 5 сая (млн) хүн, 70%-нь Урда болон Зүүн-Урда Азиһаа гараһан үндэһэтэй ажалшад. Нютагай үнтэһэтэй зониин — ислам шажанай сунну таһагай хүүнүүд. Газарай тоһотой аад лэ, энэ гүрэн тоһоёо хари гүрэнөөр тараадаг (экспорт) болижо байна. Жаа жаагаар диверсификэйшн хээд, хара тоһоной хэблэл, улас досоохи бараагай хэблэлһээ (ВВП) 7-9 % хүртэр 2010 ондо унаад байна. Харин, 1980 ондо 73 %, 1998 ондо — 32 % байгаа. == Хотонууд == Ниислэл хото — [[Дубай]]. [[Файл:Tc-map.png|thumb|380px|Арабын Нэгдсэн Эмирт Улс]] * [[Абу-Даби]] * [[Аджман]] * [[Аль-Айн]] * [[Дибба]] * [[Дубай]] * [[Калба]] * [[Рас эль-Хайма]] * [[Сила]] * [[Умм эль-Кувейн]] * [[Фуджейра]] * [[Хор-Факкан]] * [[Шарджа]] == Мүн үзэхэ == * [[Араб хэлэн]] == Зүүлтэ == {{зүүлтэ}} == Холбооһон == {{commons|United Arab Emirates|Арабын Нэгдсэн Эмирт Улас}} * [http://www.government.ae/web/guest/home/en UAE Government Official Portal] {{Webarchive|url=https://web.archive.org/web/20121002073351/http://www.government.ae/web/guest/home/en |date=2012-10-02 }} * [http://www.bbc.co.uk/news/world-middle-east-14703998 United Arab Emirates profile] from the [[BBC News]] * [http://lebanese-economy-forum.com/world-facts/show/ae/ United Arab Emirates country profile] from the Lebanese Economy Forum, extracted from the CIA Factbook & Worldbank data {{Ази}} [[Категори:Арабай Нэгэдэһэн Эмиртэ Улас| ]]<!---leave the empty space as standard (eponymous category)---> [[Категори:Аравиин хахад арал]] [[Категори:Араб хэлээр хэлэлсэдэг уласууд ба газар нютаг]] [[Категори:Холбооной хаанта засаг]] [[Категори:ОПЕК-эй гэшүүн улас]] [[Категори:Арабай Лигын гэшүүн улас]] [[Категори:Булангын Хамтын Ажаллалгын Зүблэлэй гэшүүн улас]] [[Категори:Исламай Хамтын Ажаллалгын Байгуулгын гэшүүн улас]] [[Категори:НҮБ-эй гэшүүн уласууд]] [[Категори:Дунда Дурнын уласууд]] [[Категори:Баруун Азиин уласууд]] [[Категори:Арабай юртэмсэ]] [[Категори:1971 ондо байгуулагдаhан улас ба газар нютаг]] [[Категори:1971 ондо Арабай Нэгэдэһэн Эмиртэ Уласда байгуулагдаhан]] [[Категори:Азиин уласууд]] [[Категори:Лалын хаанта засаг]] {{stub}} i53gca6mm9ctrtvfpa5d1b7f0nfvhz7 74554 74553 2026-04-07T17:22:45Z KiranBOT 16848 removed AMP tracking from URLs ([[:m:User:KiranBOT/AMP|details]]) ([[User talk:Usernamekiran|report error]]) v2.2.9s 74554 wikitext text/x-wiki {{Инфобокс улас | conventional_long_name = Арабай Нэгэдэһэн Эмиртэ Улас | common_name = АНЭУ | native_name = {{native name|ar|الإمارات العربية المتحدة}}<br />{{transliteration|ar|al-ʾImārāt al-ʿArabīyah al-Muttaḥidah}} | image_flag = Flag of the United Arab Emirates.svg | flag_type = [[Арабай Нэгэдэһэн Эмиртэ Уласай Туг|Туг]] | image_coat = Emblem of the United Arab Emirates.svg | symbol_type = [[Арабай Нэгэдэһэн Эмиртэ Уласай Һүлдэ|Һүлдэ]] | national_motto = {{lang|ar|الله الوطن الرئيس}} | englishmotto = Бурхан, Үндэһэтэн, Юрэнхылэгшэ | national_anthem = {{lang|ar|عيشي بلادي}}<br />"''[[Иши Билади|{{transliteration|ar|Īšiy Bilādī}}]]''"<br />"Эхэ Оромни Ута Удаан Наһалагты"<br />{{parabr}}{{center| }} | image_map = United Arab Emirates (orthographic projection).svg | map_caption = {{map caption |location_color= ногоон |region=[[Аравиин хахад арал]] |region_color= none}} | image_map2 = | capital = [[Абу-Даби]] | coordinates = {{Coord|24|28|N|54|22|E|type:city}} | largest_city = <!-- Don't change to Abu Dhabi without a citation -->[[Дубай]]<br />{{coord|25|15|N|55|18|E|display=inline}} | official_languages = [[Араб хэлэн|Араб]]<ref>{{cite web |title=Fact sheet |url=https://u.ae/en/about-the-uae/fact-sheet |website=United Arab Emirates |publisher=U.ae |access-date=31 August 2020}}</ref> | common_languages = [[Англи хэлэн|Англи]]<ref>{{cite web|url=https://www.stalawfirm.com/en/news/view/english-translation-abu-dhabi-courts.html |title=A mandatory requirement for an English translation under Abu Dhabi Courts |publisher=STA Law Firm |date= |access-date=2022-02-26}}</ref> | ethnic_groups = 35.0% [[Арабай Нэгэдэһэн Эмиртэ Улас дахи Энэдхэгшүүд|Энэдхэг]]</br> 15.0% [[Эмират]]</br> 10.7% [[Ойрохи Дурна дахи Бангладешчууд|Бангладеш]]</br> 9.7% [[Арабай Нэгэдэһэн Эмиртэ Улас дахи Пакистаншууд|Пакистан]]</br> 8.8% [[Арабай Нэгэдэһэн Эмиртэ Улас дахи Эмигрантууд#Египетшүүд|Египет]]</br> 5.5% [[Арабай Нэгэдэһэн Эмиртэ Улас дахи Филиппиншууд|Филиппин]]</br> 3.1% [[Арабай Нэгэдэһэн Эмиртэ Улас дахи Индонезшууд|Индонези]]</br> 2.0% [[Арабай Нэгэдэһэн Эмиртэ Улас дахи Эмигрантууд#Йеменшууд|Йемен]]</br> 1.6% [[Арабай Нэгэдэһэн Эмиртэ Улас дахи Йорданшууд|Йордан]]</br> 1.3% [[Арабай Нэгэдэһэн Эмиртэ Улас дахи Эмигрантууд#Суданшууд|Судан]]</br> 9.7% [[Арабай Нэгэдэһэн Эмиртэ Улас дахи Эмигрантууд|Бусад]] | ethnic_groups_ref = <ref>{{Cite web|title=UAE Population and Demographics|year=2020|work=Dubai Online|url=https://www.dubai-online.com/essential/uae-population-and-demographics/}}</ref> <ref>{{Cite web|title=United Arab Emirates Population Statistics 2022|author=GMI Blogger|work=Global Media Insight - Dubai Digital Interactive Agency|date=|access-date=|url=https://www.globalmediainsight.com/blog/uae-population-statistics/|archive-url=|archive-date=}}{{Better source needed|reason=Source is a blog|date=May 2022}}</ref> | ethnic_groups_year = 2020 | religion = 76.0% [[Арабай Нэгэдэһэн Эмиртэ Улас дахи Ислам|Ислам]] ([[Гүрэнэй шажан|албан]])</br> 9.0% [[Арабай Нэгэдэһэн Эмиртэ Улас дахи Христосой шажан|Христос]]</br> 8.0% [[Арабай Нэгэдэһэн Эмиртэ Улас дахи Индуизм|Индуизм]]</br> 1.8% [[Арабай Нэгэдэһэн Эмиртэ Улас дахи Буддизм|Буддизм]]</br> 5.0% [[Арабай Нэгэдэһэн Эмиртэ Улас дахи Шажанай эрхэ сүлөө|Бусад]] | religion_year = 2022 | demonym = [[Эмиратшууд]]<ref name=WorldFactbook/> | government_type = [[Холбооной хаанта засаг|Холбооной]] [[Лалын хаанта засаг|Лалын]] [[парламентын системэ|парламентын]] [[Һунгагдадаг хаанта засаг|һунгагдадаг]] [[үндэһэн хуулита хаанта засаглал|хахад-үндэһэн хуулита хаанта засаглал]]<ref>{{cite book|last=Stewart|first=Dona J.|title=The Middle East Today: Political, Geographical and Cultural Perspectives|publisher=Routledge|date=2013|location=London and New York|isbn=978-0415782432|page=155}}</ref><ref>{{cite book|last=Day|first=Alan John|title=Political Parties of The World|publisher=Stockton|date=1996|isbn=1561591440|page=599}}</ref><ref>{{cite web|url=https://elaws.moj.gov.ae/MainArabicTranslation.aspx?val=UAE-MOJ_LC-En/00_CONSTITUTION/UAE-LC-En_1971-07-18_00000_Dos.html&np=&lmp=undefined|title=United Arab Emirates Constitution|work=UAE Ministry of Justice|access-date=10 October 2018|accessdate=2022-06-12|archivedate=2018-10-11|archiveurl=https://web.archive.org/web/20181011053637/https://elaws.moj.gov.ae/MainArabicTranslation.aspx?val=UAE-MOJ_LC-En/00_CONSTITUTION/UAE-LC-En_1971-07-18_00000_Dos.html&np=&lmp=undefined}}</ref> | leader_title1 = [[Арабай Нэгэдэһэн Эмиртэ Уласай Юрэнхылэгшэ|Юрэнхылэгшэ]] | leader_name1 = [[Мухаммад ибн Заид Аль Нахайян]]<ref>{{cite news |title=Sheikh Mohamed bin Zayed Al Nahyan elected as new UAE president |url=https://gulfnews.com/uae/government/sheikh-mohamed-bin-zayed-al-nahyan-elected-as-uae-president-1.1652518419842 |access-date=14 May 2022 |work=[[Gulf News]] |date=14 May 2022}}</ref> | leader_title2 = [[Арабай Нэгэдэһэн Эмиртэ Уласай юрэнхы сайдай жагсаалта|Вице-Юрэнхылэгшэ ба Юрэнхы Сайд]] | leader_name2 = [[Мохаммед ибн Рашид Аль Мактум]] | legislature = [[Холбооной Дээдэ Зүблэл]]</br> [[Холбооной Үндэһэнэй Зүблэл]] | sovereignty_type = [[Арабай Нэгэдэһэн Эмиртэ Уласай Түүхэ|Түүхэ]] | established_event1 = [[Рас эль-Хайма (эмират)|Эмират Рас эль-Хайма]] | established_date1 = 1708 | established_event2 = [[Шарджа (эмират)|Шарджа]] | established_date2 = 1727 | established_event3 = [[Абу-Даби (эмират)|Абу-Даби]] | established_date3 = 1761 | established_event4 = [[Умм эль-Кувейн]] | established_date4 = 1768 | established_event5 = [[Аджман (эмират)|Аджман]] | established_date5 = 1816 | established_event6 = [[Дубай (эмират)|Дубай]] | established_date6 = 1833 | established_event7 = [[Фуджейра (эмират)|Фуджейра]] | established_date7 = 1879 | established_event8 = Ехэ Британи ба [[Хэрээнэй Оман]]һаа [[Үндэһэнэй Үдэр (Арабай Нэгэдэһэн Эмиртэ Улас)|Тусгаар тогтонобо]] | established_date8 = 1971 оной 12 һарын 2 | established_event9 = [[Нэгэдэһэн Үндэһэтэнэй Байгуулга|НҮБ-дэ]] [[НҮБ-ын Аюулгүйн Зүблэлэй 304-р тогтоол|оруулба]] | established_date9 = 1971 оной 12 һарын 9 | established_event10 = АНЭУ-ай бүридэлдэ [[Рас эль-Хаймагай эмиратые]] абаба | established_date10 = 1972 оной 2 һарын 10 | area_km2 = 83,600 | area_rank = 114 | area_sq_mi = 32,278 <!--Do not remove per [[Wikipedia:Manual of Style/Dates and numbers]]--> | percent_water = заахан | population_estimate_year = 2020 | population_estimate = 9,282,410<ref name="u.ae">{{cite web|url=https://u.ae/en/about-the-uae/fact-sheet/|title=United Arab Emirates Population (2020) |website=u.ae}}</ref> | population_census = 4,106,427 | population_estimate_rank = 92 | population_census_year = 2005 | population_density_km2 = 121 | population_density_sq_mi = 256 <!--Do not remove per [[Wikipedia:Manual of Style/Dates and numbers]]--> | population_density_rank = 110 | GDP_PPP = $779.234 тэрбум<ref name=imf2>{{cite web |url= https://www.imf.org/en/Publications/WEO/weo-database/2021/April/weo-report |title=United Arab Emirates |publisher=[[International Monetary Fund]]}}</ref> | GDP_PPP_year = 2022 | GDP_PPP_rank = 34 | GDP_PPP_per_capita = $78,255 <ref name=imf2/> | GDP_PPP_per_capita_rank = 7 | GDP_nominal = $501.354 billion<ref name=imf2/> | GDP_nominal_year = 2022 | GDP_nominal_rank = 32 | GDP_nominal_per_capita = $50,349 <ref name=imf2/> | GDP_nominal_per_capita_rank = 21 | Gini = 26.0 <!--number only--> | Gini_year = 2018 | Gini_change = <!--increase/decrease/steady--> | Gini_ref = <ref>{{cite web|title=GINI index (World Bank estimate) – United Arab Emirates|url=https://data.worldbank.org/indicator/SI.POV.GINI?locations=AE|website=data.worldbank.org |publisher=World Bank|access-date=30 March 2020}}</ref> | Gini_rank = | HDI = 0.890 <!--number only--> | HDI_year = 2019 <!-- Please use the year to which the data refers, not the publication year--> | HDI_change = increase <!--increase/decrease/steady--> | HDI_ref = <ref name="UNHDR">{{cite web|url=http://hdr.undp.org/sites/default/files/hdr2020.pdf|title=Human Development Report 2020|language=en|publisher=[[United Nations Development Programme]]|date=15 December 2020|access-date=15 December 2020}}</ref> | HDI_rank = 31 | currency = [[Арабай Нэгэдэһэн Эмиртэ Уласай Дирхам|АНЭУ Дирхам]] | currency_code = AED | time_zone = [[Арабай Нэгэдэһэн Эмиртэ Улас дахи Саг|АНЭУ-ай Стандарт Саг]] | utc_offset = +04:00 | date_format = үү/һһ/жжжж | drives_on = баруун<!-- The steering wheel is on the left hand side of the car, but they drive on the right hand side of the road – that is driving on the right--> | calling_code = [[Арабай Нэгэдэһэн Эмиртэ Улас дахи Телефоной номер|+971]] <!--- | Communication Companies = Etisalat<ref>{{cite web|url=http://www.etisalat.ae/|title=Welcome to Etisalat|publisher=Etisalat.ae}}</ref> | Communication Companies = du<ref>{{cite web|url=http://www.du.ae/|title=Emirates Integrated Telecommunications Company|publisher=Du.ae}}</ref> | Local calling_code = {{unbulleted list|[[Abu Dhabi]]: 02|[[Dubai]]: 04|[[Sharjah (emirate)|Sharjah]] nd [[Ajman]] : 06|[[Al-Ain]]: 03|[[Fujairah]]: 09|[[Umm al-Quwain]] and [[Ras al-Khaimah]]: 07}} ---->| cctld = {{unbulleted list |[[.ae]] |[[имарат|امارات.]]}} | footnotes = | linking_name = | today = }} '''Арабай Нэгэдэһэн Эмиртэ Улас''' ('''АНЭУ'''; {{lang-ar|الإمارات العربية المتحدة}} {{transliteration|ar|al-ʾImārāt al-ʿArabīyah al-Muttaḥidah}}), гү, али юрынээр '''Эмиратууд''' ({{lang-ar|الإمارات}} {{transliteration|ar|al-ʾImārāt}}), болбол [[Баруун Ази|Баруун Азиин]] улас юм. Долоон эмиратһаа ([[Абу-Даби (эмират)|Абу-Даби]], [[Аджман (эмират)|Аджман]], [[Дубай (эмират)|Дубай]], [[Рас-эль-Хайма (эмират)|Рас-эль-Хайма]], [[Умм-эль-Кайвайн (эмират)|Умм-эль-Кайвайн]], [[Фуджейра (эмират)|Фуджейра]] ба [[Шарджа (эмират)|Шарджа]]) буридэдэг холбооной улас. Эмират бүхэн — бага улас юм. Тэдэнь, өөдэйнгөө амяараа толгойлогшотой. Эмир Уласай ниислэл — [[Абу-Даби]]. Уласай толгойлогшо — Арабын Нэгэдэһэн Эмир Уласай президент (тэрэл сагта Абу-Дабиин эмир). == Газар зүй == Арабын Нэгэдэһэн Эмир Улас Азиин урда-баруунтэй һуудаг улас. Арабиин хойгой зүүн талада һуудаг. Хойто талаһаа Персиин буланаар эрьеэ угаадаг. Зүүн тээшээ Оман буланда гарадаг. Сауд Арабитэй баруун ба урда зүгһөө хилэтэй, Оман уластай зүүн-урдаһаа ба зүүн-хойноһоо (Оманай Мусандам гэжэ анклавтай) хилэтэй. АНЭУгэй хүн зон — 5 сая (млн) хүн, 70%-нь Урда болон Зүүн-Урда Азиһаа гараһан үндэһэтэй ажалшад. Нютагай үнтэһэтэй зониин — ислам шажанай сунну таһагай хүүнүүд. Газарай тоһотой аад лэ, энэ гүрэн тоһоёо хари гүрэнөөр тараадаг (экспорт) болижо байна. Жаа жаагаар диверсификэйшн хээд, хара тоһоной хэблэл, улас досоохи бараагай хэблэлһээ (ВВП) 7-9 % хүртэр 2010 ондо унаад байна. Харин, 1980 ондо 73 %, 1998 ондо — 32 % байгаа. == Хотонууд == Ниислэл хото — [[Дубай]]. [[Файл:Tc-map.png|thumb|380px|Арабын Нэгдсэн Эмирт Улс]] * [[Абу-Даби]] * [[Аджман]] * [[Аль-Айн]] * [[Дибба]] * [[Дубай]] * [[Калба]] * [[Рас эль-Хайма]] * [[Сила]] * [[Умм эль-Кувейн]] * [[Фуджейра]] * [[Хор-Факкан]] * [[Шарджа]] == Мүн үзэхэ == * [[Араб хэлэн]] == Зүүлтэ == {{зүүлтэ}} == Холбооһон == {{commons|United Arab Emirates|Арабын Нэгдсэн Эмирт Улас}} * [http://www.government.ae/web/guest/home/en UAE Government Official Portal] {{Webarchive|url=https://web.archive.org/web/20121002073351/http://www.government.ae/web/guest/home/en |date=2012-10-02 }} * [http://www.bbc.co.uk/news/world-middle-east-14703998 United Arab Emirates profile] from the [[BBC News]] * [http://lebanese-economy-forum.com/world-facts/show/ae/ United Arab Emirates country profile] from the Lebanese Economy Forum, extracted from the CIA Factbook & Worldbank data {{Ази}} [[Категори:Арабай Нэгэдэһэн Эмиртэ Улас| ]]<!---leave the empty space as standard (eponymous category)---> [[Категори:Аравиин хахад арал]] [[Категори:Араб хэлээр хэлэлсэдэг уласууд ба газар нютаг]] [[Категори:Холбооной хаанта засаг]] [[Категори:ОПЕК-эй гэшүүн улас]] [[Категори:Арабай Лигын гэшүүн улас]] [[Категори:Булангын Хамтын Ажаллалгын Зүблэлэй гэшүүн улас]] [[Категори:Исламай Хамтын Ажаллалгын Байгуулгын гэшүүн улас]] [[Категори:НҮБ-эй гэшүүн уласууд]] [[Категори:Дунда Дурнын уласууд]] [[Категори:Баруун Азиин уласууд]] [[Категори:Арабай юртэмсэ]] [[Категори:1971 ондо байгуулагдаhан улас ба газар нютаг]] [[Категори:1971 ондо Арабай Нэгэдэһэн Эмиртэ Уласда байгуулагдаhан]] [[Категори:Азиин уласууд]] [[Категори:Лалын хаанта засаг]] {{stub}} bhsbqjd4qfgdmk1shierjme0oeopsnz 0 12578 74552 74534 2026-04-07T17:05:30Z InternetArchiveBot 12366 Rescuing 2 sources and tagging 0 as dead.) #IABot (v2.0.9.5 74552 wikitext text/x-wiki National [[regulation of therapeutic goods|regulatory authorities]] have granted emergency use authorizations for thirty-four [[COVID-19 vaccine]]s. Nine vaccines have been approved for emergency or full use by at least one [[List of stringent regulatory authorities|stringent regulatory authority]] recognized by the [[World Health Organization]] (WHO): [[Pfizer–BioNTech COVID-19 vaccine|Pfizer–BioNTech]], [[Oxford–AstraZeneca COVID-19 vaccine|Oxford–AstraZeneca]], [[Sinopharm BIBP COVID-19 vaccine|Sinopharm BIBP]], [[Moderna COVID-19 vaccine|Moderna]], [[Janssen COVID-19 vaccine|Janssen]], [[CoronaVac]], [[Covaxin]], [[Novavax COVID-19 vaccine|Novavax]] and [[Convidecia]]. Five others are under assessment by the WHO: [[Sputnik V COVID-19 vaccine|Sputnik V]], [[Sinopharm WIBP COVID-19 vaccine|Sinopharm WIBP]], [[Sanofi–GSK COVID-19 vaccine|Sanofi–GSK]] and [[SCB-2019]].<ref name="WHO status">{{#invoke:Cite web||title=Status of COVID-19 Vaccines within WHO EUL/PQ evaluation process|url=https://extranet.who.int/pqweb/key-resources/documents/status-covid-19-vaccines-within-who-eulpq-evaluation-process|publisher=[[World Health Organization]] (WHO)}}</ref> Specific versions of six vaccines have been authorized by the [[European Medicines Agency]] (EMA): [[Pfizer–BioNTech COVID-19 vaccine|Pfizer–BioNTech]], [[Janssen COVID-19 vaccine|Janssen]], [[Novavax COVID-19 vaccine|Novavax]], [[Moderna COVID-19 vaccine|Moderna]], [[Oxford–AstraZeneca COVID-19 vaccine|Oxford–AstraZeneca]], and [[Valneva COVID-19 vaccine|Valneva]].<ref>{{cite web |title=COVID-19 vaccines: authorised |url=https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/treatments-vaccines/vaccines-covid-19/covid-19-vaccines-authorised |website=[[European Medicines Agency]] (EMA)}}</ref> Specific versions of another three vaccines are under evaluation by the EMA: [[Sputnik V COVID-19 vaccine|Sputnik V]], [[CoronaVac]], and [[Sanofi–GSK COVID-19 vaccine|Sanofi–GSK]].<ref name="ema.europa.eu">{{cite web |title=COVID-19 vaccines: under evaluation |url=https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/treatments-vaccines/vaccines-covid-19/covid-19-vaccines-under-evaluation |website=[[European Medicines Agency]] (EMA)}}</ref> Note that in some countries, vaccines may be authorized solely for travel purposes. They may not be approved for the general population. For example, the [[CoronaVac]], [[Covishield]], [[Sinopharm BIBP COVID-19 vaccine|BBIBP-CorV]] and [[Covaxin]] vaccines are not part of Australia's [[COVID-19 vaccination in Australia|national vacciation program]], however, they are recognised for the purpose of travel to Australia.<ref>{{cite web |title=International COVID-19 vaccines recognised by Australia |url=https://www.tga.gov.au/international-covid-19-vaccines-recognised-australia |website=Therapeutic Goods Administration |publisher=Australian Government Department of Health |access-date=12 January 2022 |accessdate=25 December 2021 |archivedate=7 February 2022 |archiveurl=https://web.archive.org/web/20220207080016/https://www.tga.gov.au/international-covid-19-vaccines-recognised-australia }}</ref><ref>{{cite web |title=COVID-19 and the border - Vaccinated travellers |url=https://covid19.homeaffairs.gov.au/vaccinated-travellers#toc-0 |website=Department of Home Affairs |publisher=Australian Government Department of Home Affairs |access-date=12 January 2022 |accessdate=6 July 2022 |archivedate=14 March 2022 |archiveurl=https://web.archive.org/web/20220314092238/https://covid19.homeaffairs.gov.au/vaccinated-travellers#toc-0 }}</ref><ref>{{cite web |url=https://www.smartraveller.gov.au/COVID-19/COVID-19-vaccinations#TGA-approved |website=Smartraveller |publisher=Australian Government Department of Foreign Affairs and Trade |access-date=12 January 2022|title=COVID-19 vaccinations }}</ref> {{Horizontal TOC}} == Overview maps == {| class=center | <gallery mode="nolines" widths="400" heights="300"> File:COVID-19 RNA and DNA vaccines authorization map.svg|<div style="text-align:left">[[RNA vaccine]]s and [[DNA vaccine]]s{{Legend|#800080|[[Pfizer–BioNTech COVID-19 vaccine|Pfizer–BioNTech]]}}{{Legend|#008800|[[Moderna COVID-19 vaccine|Moderna]]}}{{Legend|#008CFF|[[ZyCoV-D]]}}</div> File:COVID-19 adenovirus vaccines authorization map.svg|<div style="text-align:left">[[Viral vector vaccine|Adenovirus vector vaccines]]{{Legend|#000088|[[Oxford–AstraZeneca COVID-19 vaccine|Oxford–AstraZeneca]]}}{{Legend|#008800|[[Janssen COVID-19 vaccine|Janssen]]}}{{Legend|#880000|[[Sputnik V COVID-19 vaccine|Sputnik V]]}}{{Legend|#FF008C|[[Sputnik Light]]}}{{Legend|#888800|[[Convidecia]]}}</div> </gallery> <gallery mode="nolines" widths="400" heights="300"> File:COVID-19 inactivated vaccines authorization map.svg|<div style="text-align:left">[[Inactivated vaccine|Inactivated virus vaccines]]{{Legend|#008888|[[Sinopharm BIBP COVID-19 vaccine|Sinopharm BIBP]]}}{{Legend|#888800|[[CoronaVac]]}}{{Legend|#FF008C|[[Valneva COVID-19 vaccine|Valneva]]}}{{Legend|#800080|[[Covaxin]]}}{{Legend|#FF8C00|[[Sinopharm WIBP COVID-19 vaccine|Sinopharm WIBP]]}}{{Legend|#666666|Others}}</div> File:COVID-19 subunit and VLP vaccines authorization map.svg|<div style="text-align:left">[[Subunit vaccine]]s{{Legend|#FF8C00|[[Novavax COVID-19 vaccine|Novavax]]}}{{Legend|#008CFF|[[Abdala (vaccine)|Abdala]]}}{{Legend|#008888|[[EpiVacCorona]]}}{{Legend|#8C00FF|[[ZF2001|Zifivax]]}}{{Legend|#8CFF00|[[Soberana 02]]}}{{Legend|#666666|Others}}</div> </gallery> |} == Oxford–AstraZeneca == <section begin="oxfordauthmap"/> {{infobox | image = {{Graph:Map|scale=65|defaultValue=gainsboro |AD=dodgerblue|AE=dodgerblue|AF=dodgerblue|AG=dodgerblue|AI=dodgerblue|AL=dodgerblue|AM=dodgerblue|AO=dodgerblue|AR=dodgerblue|AT=dodgerblue|AU=blueviolet|AW=dodgerblue|AZ=dodgerblue |BA=limegreen|BB=dodgerblue|BD=dodgerblue|BE=dodgerblue|BF=dodgerblue|BG=dodgerblue|BH=dodgerblue|BJ=dodgerblue|BM=dodgerblue|BN=limegreen|BO=dodgerblue|BQ=dodgerblue|BR=blueviolet|BS=dodgerblue|BT=dodgerblue|BW=dodgerblue|BZ=dodgerblue |CA=blueviolet|CD=dodgerblue|CF=dodgerblue|CG=dodgerblue|CH=turquoise|CI=dodgerblue|CK=dodgerblue|CL=dodgerblue|CM=dodgerblue|CO=dodgerblue|CR=dodgerblue|CV=dodgerblue|CW=dodgerblue|CY=dodgerblue|CZ=dodgerblue |DE=dodgerblue|DJ=dodgerblue|DK=dodgerblue|DM=dodgerblue|DO=dodgerblue|DZ=dodgerblue |EC=dodgerblue|EE=dodgerblue|EG=dodgerblue|ES=dodgerblue|ET=dodgerblue |FI=darkred|FJ=dodgerblue|FK=dodgerblue|FM=dodgerblue|FR=dodgerblue |GB=dodgerblue|GD=dodgerblue|GE=dodgerblue|GG=dodgerblue|GH=dodgerblue|GL=dodgerblue|GM=dodgerblue|GN=dodgerblue|GP=dodgerblue|GR=dodgerblue|GT=dodgerblue|GW=dodgerblue|GY=dodgerblue |HK=turquoise|HN=dodgerblue|HR=dodgerblue|HT=dodgerblue|HU=dodgerblue |ID=dodgerblue|IE=dodgerblue|IM=dodgerblue|IN=blueviolet|IQ=dodgerblue|IR=dodgerblue|IS=dodgerblue|IT=dodgerblue |JE=dodgerblue|JP=dodgerblue|JM=dodgerblue|JO=dodgerblue |KE=dodgerblue|KG=dodgerblue|KH=dodgerblue|KI=dodgerblue|KM=dodgerblue|KN=dodgerblue|KP=limegreen|KR=dodgerblue|KW=dodgerblue|KY=dodgerblue |LA=dodgerblue|LB=dodgerblue|LC=dodgerblue|LI=dodgerblue|LK=dodgerblue|LR=dodgerblue|LS=dodgerblue|LT=dodgerblue|LU=dodgerblue|LV=dodgerblue|LY=dodgerblue |MA=dodgerblue|MC=limegreen|MD=dodgerblue|ME=dodgerblue|MG=dodgerblue|MH=limegreen|MK=dodgerblue|ML=dodgerblue|MM=dodgerblue|MN=dodgerblue|MR=dodgerblue|MS=dodgerblue|MT=dodgerblue|MU=dodgerblue|MV=dodgerblue|MW=dodgerblue|MX=dodgerblue|MY=dodgerblue|MZ=dodgerblue |NA=dodgerblue|NE=dodgerblue|NG=dodgerblue|NI=dodgerblue|NL=dodgerblue|NO=darkred|NP=dodgerblue|NR=limegreen|NZ=dodgerblue |OM=dodgerblue |PA=dodgerblue|PE=dodgerblue|PF=dodgerblue|PG=dodgerblue|PH=dodgerblue|PK=dodgerblue|PL=dodgerblue|PN=dodgerblue|PS=dodgerblue|PT=dodgerblue|PY=dodgerblue |QA=dodgerblue |RO=dodgerblue|RS=dodgerblue|RW=dodgerblue |SA=dodgerblue|SB=dodgerblue|SC=dodgerblue|SD=dodgerblue|SE=dodgerblue|SG=dodgerblue|SH=dodgerblue|SI=dodgerblue|SK=darkred|SL=dodgerblue|SN=dodgerblue|SO=dodgerblue|SR=dodgerblue|SS=dodgerblue|ST=dodgerblue|SV=dodgerblue|SX=dodgerblue|SY=dodgerblue|SZ=dodgerblue |TD=limegreen|TG=dodgerblue|TH=dodgerblue|TJ=dodgerblue|TL=dodgerblue|TM=dodgerblue|TN=dodgerblue|TO=dodgerblue|TR=turquoise|TT=dodgerblue|TV=dodgerblue|TW=dodgerblue |UA=dodgerblue|UG=dodgerblue|US=turquoise|UY=dodgerblue|UZ=dodgerblue |VC=dodgerblue|VE=limegreen|VG=dodgerblue|VN=dodgerblue|VU=dodgerblue |WF=dodgerblue|WS=limegreen |XK=dodgerblue |YE=dodgerblue |ZA=darkred|ZM=dodgerblue|ZW=dodgerblue }} | caption = {{leftlegend|blueviolet|Full authorization}} {{leftlegend|dodgerblue|Emergency authorization}} {{leftlegend|turquoise|Allowed for travel}} {{leftlegend|limegreen|Eligible [[COVAX]] recipient}} {{leftlegend|darkred|Usage stopped}} }} <section end="oxfordauthmap"/> The [[Oxford–AstraZeneca COVID-19 vaccine]], sold under the brand names Vaxzevria<ref name="Vaxzevria EPAR">{{cite web | title=Vaxzevria (previously COVID-19 Vaccine AstraZeneca) EPAR | publisher=[[European Medicines Agency]] (EMA) | url=https://www.ema.europa.eu/en/medicines/human/EPAR/vaxzevria-previously-covid-19-vaccine-astrazeneca }}</ref> and Covishield,<ref>{{cite news|date=4 March 2021|title=Covishield and Covaxin: What we know about India's Covid-19 vaccines|work=BBC News|url=https://www.bbc.com/news/world-asia-india-55748124|access-date=8 March 2021|archive-date=7 March 2021|archive-url=https://web.archive.org/web/20210307222320/https://www.bbc.com/news/world-asia-india-55748124|url-status=live}}</ref> is a [[viral vector vaccine]]<ref name="NCT044008383">{{#invoke:Cite web||date=26 May 2020|title=Investigating a Vaccine Against COVID-19|url=https://clinicaltrials.gov/ct2/show/NCT04400838|url-status=live|archive-url=https://web.archive.org/web/20201011084750/https://clinicaltrials.gov/ct2/show/NCT04400838/|archive-date=11 October 2020|access-date=14 July 2020|website=[[ClinicalTrials.gov]]|publisher=[[United States National Library of Medicine]]|id=NCT04400838}}</ref> produced by the British [[University of Oxford]], British-Swedish company [[AstraZeneca]], and the [[Coalition for Epidemic Preparedness Innovations|Coalition for Epidemic Preparedness Innovations<wbr />]].<ref name="NCT044008383"/><ref name="EudraCT-2020-001228-322">{{#invoke:Cite web||date=21 April 2020|title=A Phase 2/3 study to determine the efficacy, safety and immunogenicity of the candidate Coronavirus Disease (COVID-19) vaccine ChAdOx1 nCoV-19|url=https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001228-32/GB|url-status=live|archive-url=https://web.archive.org/web/20201005201654/https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001228-32/GB|archive-date=5 October 2020|access-date=3 August 2020|website=EU Clinical Trials Register|publisher=European Union|id=[[EudraCT]] 2020-001228-32}}</ref><ref name="ISRCTN899514242">{{cite journal|last1=O'Reilly|first1=Peter|date=26 May 2020|title=A Phase III study to investigate a vaccine against COVID-19|doi=10.1186/ISRCTN89951424|id=ISRCTN89951424|doi-access=free|website=ISRCTN|name-list-style=vanc}}</ref> Finland, Denmark and Norway suspended the use of the Oxford–AstraZeneca vaccine due to a small number of reports of a rare blood clot disorder.<ref>{{cite web |title=THL temporarily suspends the use of the AstraZeneca COVID-19 vaccine - Press release - THL |url=https://thl.fi/en/web/thlfi-en/-/thl-temporarily-suspends-the-use-of-the-astrazeneca-covid-19-vaccine |website=Finnish Institute for Health and Welfare (THL), Finland |access-date=5 December 2021 }}{{Dead link|date=March 2025 |bot=InternetArchiveBot |fix-attempted=yes }}</ref><ref>{{cite web | title=Denmark continues its vaccine rollout without the COVID-19 vaccine from AstraZeneca | website=Danish Health Authority | date=14 April 2021 | url=https://www.sst.dk/en/english/news/2021/denmark-continues-its-vaccine-rollout-without-the-covid-19-vaccine-from-astrazeneca | access-date=31 July 2021 | quote=That is why it is important to emphasise that it is still an approved vaccine. | accessdate=6 October 2021 | archivedate=31 July 2021 | archiveurl=https://web.archive.org/web/20210731185815/https://www.sst.dk/en/english/news/2021/denmark-continues-its-vaccine-rollout-without-the-covid-19-vaccine-from-astrazeneca }}</ref><ref>{{cite news |last1=Peltier |first1=Elian |title=Denmark says it's permanently stopping use of the AstraZeneca vaccine. |url=https://www.nytimes.com/2021/04/14/world/europe/denmark-astrazeneca-vaccine.html |work=The New York Times |date=14 April 2021}}</ref><ref>{{#invoke:Cite web||last=omsorgsdepartementet|first=Helse-og|date=12 May 2021|title=AstraZeneca-vaksinen tas ut av koronavaksinasjons-programmet|url=https://www.regjeringen.no/no/aktuelt/astrazeneca-vaksinen-tas-ut-av-koronavaksinasjonsprogrammet/id2849494/|access-date=12 May 2021|website=Regjeringen.no|language=no}}</ref> Slovakia suspended its use after the death of a predisposed recipient.<ref>{{cite news |title=Slovakia suspends use of AstraZeneca COVID-19 vaccine as a recipient dies |url=https://www.reuters.com/business/healthcare-pharmaceuticals/slovakia-halting-use-astrazeneca-covid-vaccine-first-doses-2021-05-11/ |access-date=23 June 2021 |date=11 May 2021 |work=Reuters |location=Prague}}</ref> South Africa suspended its use because a small trial found only minimal protection against mild to moderate disease from the locally predominant [[SARS-CoV-2 Beta variant|Beta variant]].<ref>{{cite news |title=South Africa sells AstraZeneca COVID-19 vaccines to other African countries |url=https://www.reuters.com/article/us-health-coronavirus-safrica-vaccine-idUSKBN2BD0K4 |access-date=23 June 2021 |work=Reuters |date=21 March 2021 |location=Johannesburg}}</ref> Japan approved the vaccine for emergency use in May 2021, but did not plan to use them immediately because of rare cases of a blood clotting disorder reported overseas.<ref>{{cite news | title = Japan to donate millions more AstraZeneca vaccine doses across Asia | date = 25 June 2021 | url = https://english.kyodonews.net/news/2021/06/082ff96b4bdb-japan-to-donate-millions-more-astrazeneca-vaccines-across-asia.html | work = Kyodo News }}</ref> Later, Japan started to use the vaccine for people aged 40 or over to mitigate the surge of the [[SARS-CoV-2 Delta variant|Delta variant]] in August.<ref>{{cite web|date=4 August 2021|title=Japan to give COVID-19 emergency areas AstraZeneca vaccine|url=https://www.japantimes.co.jp/news/2021/08/04/national/japan-give-covid-19-emergency-areas-astrazeneca-vaccine/|access-date=28 August 2021|website=The Japan Times|accessdate=6 October 2021|archivedate=28 August 2021|archiveurl=https://web.archive.org/web/20210828022422/https://www.japantimes.co.jp/news/2021/08/04/national/japan-give-covid-19-emergency-areas-astrazeneca-vaccine/}}</ref> Finland ceased use of the vaccine as the last batch expired on 30 November 2021. Until then it was only offered for those aged 65 or more due to extremely rare coagulation disorders among younger recipients of the vaccine. After this Finland will not procure more of the vaccine.<ref name="thl.fi">{{cite web |title=Suspension of AstraZeneca COVID-19 vaccines for those under the age of 65 extended – THL evaluating how it affects the vaccination programme - Press release - THL |url=https://thl.fi/en/web/thlfi-en/-/suspension-of-astrazeneca-covid-19-vaccines-for-those-under-the-age-of-65-extended-thl-evaluating-how-it-affects-the-vaccination-programme |website=Finnish Institute for Health and Welfare (THL), Finland |access-date=5 December 2021 |accessdate=25 December 2021 |archivedate=5 December 2021 |archiveurl=https://web.archive.org/web/20211205163524/https://thl.fi/en/web/thlfi-en/-/suspension-of-astrazeneca-covid-19-vaccines-for-those-under-the-age-of-65-extended-thl-evaluating-how-it-affects-the-vaccination-programme }}</ref><ref name="Use of AstraZeneca coronavirus vacc">{{cite web |title=Use of AstraZeneca coronavirus vaccine to end in Finland in November - News - THL |url=https://thl.fi/en/web/thlfi-en/-/use-of-astrazeneca-coronavirus-vaccine-to-end-in-finland-in-november |website=Finnish Institute for Health and Welfare (THL), Finland |access-date=5 December 2021 |accessdate=25 December 2021 |archivedate=5 December 2021 |archiveurl=https://web.archive.org/web/20211205155743/https://thl.fi/en/web/thlfi-en/-/use-of-astrazeneca-coronavirus-vaccine-to-end-in-finland-in-november }}</ref><ref name="Adenovirus vaccines: FAQ - THL">{{cite web |title=Adenovirus vaccines: FAQ - THL |url=https://thl.fi/en/web/infectious-diseases-and-vaccinations/what-s-new/coronavirus-covid-19-latest-updates/vaccines-and-coronavirus/adenovirus-vaccines-faq |website=Finnish Institute for Health and Welfare (THL), Finland |access-date=3 December 2021 |accessdate=25 December 2021 |archivedate=3 December 2021 |archiveurl=https://web.archive.org/web/20211203222207/https://thl.fi/en/web/infectious-diseases-and-vaccinations/what-s-new/coronavirus-covid-19-latest-updates/vaccines-and-coronavirus/adenovirus-vaccines-faq }}</ref><ref name="Getting vaccinated against COVID-19">{{cite web |title=Getting vaccinated against COVID-19: how, why and when? - THL |url=https://thl.fi/en/web/infectious-diseases-and-vaccinations/what-s-new/coronavirus-covid-19-latest-updates/vaccines-and-coronavirus/getting-vaccinated-against-covid-19-how-why-and-when- |website=Finnish Institute for Health and Welfare (THL), Finland |access-date=3 December 2021 |accessdate=25 December 2021 |archivedate=14 March 2022 |archiveurl=https://web.archive.org/web/20220314032806/https://thl.fi/en/web/infectious-diseases-and-vaccinations/what-s-new/coronavirus-covid-19-latest-updates/vaccines-and-coronavirus/getting-vaccinated-against-covid-19-how-why-and-when- }}</ref> The AstraZeneca vaccine is the most widely accepted internationally,<ref>{{cite news|date=23 July 2021|title=Which covid-19 vaccine is the most widely accepted for international travel?|url=https://www.economist.com/graphic-detail/2021/07/20/which-covid-19-vaccine-is-the-most-widely-accepted-for-international-travel|access-date=11 June 2022|newspaper=The Economist}}</ref> and the most popular in terms of total inoculated worldwide, over 1.3 billion.<ref>{{cite web|date=21 October 2021|title=India celebrates 1 billion COVID-19 vaccine doses with song and dance|url=https://www.reuters.com/world/india/india-celebrates-1-bln-covid-19-vaccine-doses-with-song-film-2021-10-21/|access-date=11 June 2022|website=REUTERS}}</ref><ref>{{cite web|date=29 July 2021|title=Oxford vaccine reaches one billion doses released|url=https://www.ox.ac.uk/news/2021-07-29-oxford-vaccine-reaches-one-billion-doses-released|access-date=11 June 2022|website=University of Oxford}}</ref><ref>{{cite web|date=16 November 2021|title=Two billion doses of AstraZeneca's COVID-19 vaccine supplied to countries across the world less than 12 months after first approval|url=https://www.astrazeneca.com/media-centre/press-releases/2021/two-billion-doses-of-astrazenecas-covid-19-vaccine-supplied-to-countries-across-the-world-less-than-12-months-after-first-approval.html|access-date=11 June 2022|website=AstraZeneca}}</ref><ref>{{cite web|date=8 June 2022|title=Vaxzevria COVID-19 Vaccine (AstraZeneca)|url=https://www.precisionvaccinations.com/vaccines/vaxzevria-covid-19-vaccine-astrazeneca|access-date=11 June 2022|website=precisionvaccinations.com|accessdate=6 July 2022|archivedate=26 June 2022|archiveurl=https://web.archive.org/web/20220626080401/https://www.precisionvaccinations.com/vaccines/vaxzevria-covid-19-vaccine-astrazeneca}}</ref> The AstraZeneca vaccine is administered in more countries than any other vaccine.<ref name="covid.cdc.gov">{{cite web|date=9 June 2022|title=Where are Vaccines (Company and Brand) Administered Globally?|url=https://covid.cdc.gov/covid-data-tracker/#global-vaccinations|access-date=13 June 2022|website=CDC Covid Data Tracker}}</ref> ;Full (<section begin="Oxford–AstraZeneca_FN"/>5<section end="Oxford–AstraZeneca_FN"/>) # Australia<ref>{{cite news|date=16 February 2021|title=AstraZeneca coronavirus vaccine approved for use in Australia by TGA|newspaper=[[ABC News (Australia)|ABC News]] (Australia)|url=https://www.abc.net.au/news/2021-02-16/coronavirus-astrazeneca-vaccine-approved-for-use-in-australia/13115784|access-date=16 February 2021}}</ref><ref>{{#invoke:Cite web||date=16 February 2021|title=TGA provisionally approves AstraZeneca's COVID-19 vaccine|url=https://www.tga.gov.au/media-release/tga-provisionally-approves-astrazenecas-covid-19-vaccine|access-date=16 February 2021|publisher=[[Therapeutic Goods Administration]] (TGA)}}</ref> # Brazil<ref>{{cite news|date=12 March 2021|title=Brazil grants full approval to Oxford vaccine, orders Sputnik|publisher=[[France 24]]|agency=[[Agence France-Presse]]|location=Brasilia|url=https://www.france24.com/en/live-news/20210312-brazil-grants-full-approval-to-oxford-vaccine-orders-sputnik|access-date=13 March 2021}}</ref> # Canada<ref>{{cite web | title=Regulatory Decision Summary - Vaxzevria | website=[[Health Canada]] | url=https://covid-vaccine.canada.ca/info/regulatory-decision-summary-detail.html?linkID=RDS00889 | access-date=26 November 2021}}</ref> # India<ref name=":1">{{Cite news|last1=Sharma|first1=Milan|last2=Mordani|first2=Sneha|date=27 January 2022|title=Covaxin, Covishield granted market approval in India but conditions apply|work=[[India Today]]|url=https://www.indiatoday.in/coronavirus-outbreak/vaccine-updates/story/covaxin-covishield-granted-regular-market-approval-india-1905218-2022-01-27|access-date=29 January 2022}}</ref> # Israel<ref name="covid.cdc.gov"/><ref>{{cite web|date=18 October 2021|title=Israel to offer AstraZeneca vaccines starting Thursday|url=https://www.timesofisrael.com/israel-to-offer-astrazeneca-vaccines-starting-thursday/|access-date=13 June 2022|website=The Times of Israel}}</ref><ref>{{cite web|date=31 May 2022|title=Vaccines "Three vaccines have been approved for use in Israel for protection from coronavirus, by Pfizer, Moderna and AstraZeneca."|url=https://corona.health.gov.il/en/vaccine-for-covid/fully-vaccinated/|access-date=13 June 2022|website=Vaccines - Corona Traffic Light Model (Ramzor) Website}}</ref> {{-}} ;Emergency (<section begin="Oxford–AstraZeneca_EN" />170<section end="Oxford–AstraZeneca_EN" />) <div style="margin-top: 0.3em; column-width: 15em;"> # Afghanistan<ref>{{cite news|last=Sediqi|first=Abdul Qadir|date=7 February 2021|title=First doses of COVID-19 vaccine arrive in Afghanistan from India|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-afghanistan-vaccine-idUSKBN2A707M|access-date=24 February 2021}}</ref><ref>{{#invoke:Cite web||title=India donates 500,000 COVID vaccines to Afghanistan|url=https://www.aljazeera.com/news/2021/2/8/afghanistan-gets-first-doses-of-covid-19-vaccine-from-india|access-date=24 February 2021|publisher=Al Jazeera}}</ref> # Albania<ref name=":0" /> # Algeria<ref>{{#invoke:Cite web||last=Kreo|title=البلاد الوطني / وزارة الصناعات الصيدلانية ترخص باستعمال لقاح "أسترا زينيكا -أوكسفورد " المضاد لكورونا|url=http://elbilad.net/article/detail?id=113247|access-date=1 April 2021|website=elbilad.net|language=AR}}</ref> # Andorra<ref name="Andorra vaccines" /> # Angola<ref>{{#invoke:Cite web||last=AfricaNews|date=3 March 2021|time=CET13:13:37+01:00|title=Angola begins Covid immunization fight with COVAX vaccines|url=https://www.africanews.com/2021/03/03/angola-begins-covid-immunization-fight-with-covax-vaccines/|access-date=14 April 2021|website=Africanews}}</ref> # Argentina<ref>{{cite news|date=30 December 2020|title=Argentine regulator approves AstraZeneca/Oxford COVID-19 vaccine|url=https://www.reuters.com/article/us-health-coronavirus-argentina-astrazen/argentine-regulator-approves-astrazeneca-oxford-covid-19-vaccine-astrazeneca-idUSKBN29421P|access-date=30 December 2020|publisher=Reuters}}</ref> # Armenia<ref>{{cite web |title=Armenia Scraps Restrictions For AstraZeneca Vaccine |url=https://www.azatutyun.am/a/31226006.html |website=«Ազատ Եվրոպա/Ազատություն» ռադիոկայան |language=hy}}</ref> # Azerbaijan<ref name="cdctracker"/> # Bahrain<ref>{{#invoke:Cite web||date=25 January 2021|title=Bahrain approves Oxford/AstraZeneca coronavirus vaccine produced in India|url=http://saudigazette.com.sa/article/602862|access-date=30 January 2021|website=Saudigazette}}</ref> # Bangladesh<ref>{{#invoke:Cite web||title=Oxford University-Astrazeneca vaccine: Bangladesh okays it for emergency use|url=https://www.thedailystar.net/frontpage/news/oxford-university-astrazeneca-vaccine-bangladesh-okays-it-emergency-use-2022381|access-date=6 January 2021|website=[[The Daily Star (Bangladesh)|The Daily Star]]|date=4 January 2021}}</ref><ref>{{#invoke:Cite web||title=Bangladesh approves Oxford-AstraZeneca COVID-19 vaccine|url=https://www.aa.com.tr/en/asia-pacific/bangladesh-approves-oxford-astrazeneca-covid-19-vaccine/2099147|access-date=6 January 2021|website=aa.com.tr}}</ref> # Benin<ref name="cdctracker"/> # Bhutan<ref>{{#invoke:Cite web||title=Bhutan receives 400,000 doses of COVID-19 vaccine from India |url=http://www.xinhuanet.com/english/asiapacific/2021-03/22/c_139827645.htm|access-date=1 April 2021|publisher=Xinhuanet}}</ref><ref>{{#invoke:Cite web||title=Bhutan begins biggest vaccination drive against COVID-19|url=https://www.channelnewsasia.com/news/asia/bhutan-begins-biggest-covid-19-vaccination-drive-astrazeneca-14504644|access-date=1 April 2021|website=CNA}}</ref> # Bolivia<ref name="cdctracker"/> # Bosnia and Herzegovina<ref name=":3" /> # Botswana<ref>{{#invoke:Cite web||title=Botswana starts COVID-19 vaccine rollout |url=http://www.xinhuanet.com/english/2021-03/26/c_139838942.htm|access-date=1 April 2021|publisher=Xinhuanet}}</ref> # Brunei<ref name="auto"/> # Burkina Faso<ref name="whotracker"/> # Cambodia<ref name="cdctracker"/> # Cameroon<ref name="cdctracker"/> # Cape Verde<ref>{{#invoke:Cite web||title=COVID-19 vaccines sent by COVAX arrive in Cabo Verde |url=https://reliefweb.int/report/cabo-verde/covid-19-vaccines-sent-covax-arrive-cabo-verde|access-date=17 April 2021|website=ReliefWeb}}</ref> # Central African Republic<ref name="whotracker"/> # Chile<ref>{{#invoke:Cite web||title=Instituto de Salud Pública de Chile|url=https://www.ispch.cl/noticia/isp-aprueba-la-tercera-vacuna-para-combatir-covid-19/|access-date=1 April 2021|language=es}}</ref> # Colombia<ref>{{cite news|title=Colombia approves emergency use of AstraZeneca coronavirus vaccine |url=https://www.reuters.com/article/us-health-coronavirus-colombia-idUSKBN2AO01A|publisher=Reuters|access-date=22 March 2021|location=Bogotá|date=23 February 2021}}</ref> # Comoros<ref name="cdctracker"/> # Congo-Brazzaville<ref name="cdctracker"/> # Congo-Kinshasa<ref>{{#invoke:Cite web||title=More than 1.7 million COVID-19 vaccines arrive in the Democratic Republic of Congo|url=https://www.unicef.org/press-releases/more-17-million-covid-19-vaccines-arrive-democratic-republic-congo|access-date=25 April 2021|website=www.unicef.org}}</ref> # Costa Rica<ref>{{cite web |title=Costa Rica approves use of AstraZeneca's COVID-19 vaccine |url=https://qcostarica.com/costa-rica-approves-use-of-astrazenecas-covid-19-vaccine/ |website=Q COSTA RICA |date=9 April 2021}}</ref> # Djibouti<ref name="cdctracker"/> # Dominican Republic<ref>{{cite news|date=31 December 2020|title=La República Dominicana aprueba la vacuna de AstraZeneca contra la covid-19|language=es|work=Agencia EFE|url=https://www.efe.com/efe/america/sociedad/la-republica-dominicana-aprueba-vacuna-de-astrazeneca-contra-covid-19/20000013-4431079}}</ref> # East Timor<ref>{{#invoke:Cite web||date=1 April 2021|title=First vaccines for East Timor arrive in Dili on Monday – LUSA|url=https://covid19.gov.tl/en/first-vaccines-for-east-timor-arrive-in-dili-on-monday-lusa/|url-status=live|archive-url=https://web.archive.org/web/20210402144040/https://covid19.gov.tl/en/first-vaccines-for-east-timor-arrive-in-dili-on-monday-lusa/|archive-date=2 April 2021|website=COVID-19 Timor-Leste Dashboard}}</ref> # Ecuador<ref>{{cite news|date=24 January 2021|title=Ecuador approves use of AstraZeneca vaccine for COVID-19|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-ecuador-astrazeneca-idUSL1N2JZ0HC|access-date=30 January 2021}}</ref> # Egypt<ref name="Gulf News"/> # El Salvador<ref>{{cite news|date=30 December 2020|title=El Salvador greenlights AstraZeneca, Oxford University COVID-19 vaccine|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-el-salvador-vaccin/el-salvador-greenlights-astrazeneca-oxford-university-covid-19-vaccine-idINKBN2942HQ}}</ref> # Eswatini<ref>{{#invoke:Cite web||title=Eswatini launches nationwide COVID-19 vaccination campaign|url=https://www.afro.who.int/news/eswatini-launches-nationwide-covid-19-vaccination-campaign|access-date=1 April 2021|publisher=[[World Health Organization]] (WHO) }}</ref> # Ethiopia<ref>{{#invoke:Cite web||title=Ethiopia begins COVID-19 vaccine rollout|url=https://www.aa.com.tr/en/africa/ethiopia-begins-covid-19-vaccine-rollout/2174904|access-date=19 March 2021|website=aa.com.tr}}</ref><ref>{{#invoke:Cite web||title=Ethiopia introduces COVID-19 vaccine in a national launching ceremony|url=https://www.afro.who.int/news/ethiopia-introduces-covid-19-vaccine-national-launching-ceremony|access-date=19 March 2021|website=[[World Health Organization]] (WHO)}}</ref><ref>{{cite news|date=9 February 2021|title=Ethiopia says it has secured 9 million doses of COVID-19 vaccines till April|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-ethiopia-idUSKBN2A916S|access-date=19 March 2021}}</ref> # Fiji<ref name="cdctracker"/> # Gambia<ref>{{#invoke:Cite web||title=The Arrival of COVAX vaccines Raises Hope in The Gambia|url=https://www.afro.who.int/news/arrival-covax-vaccines-raises-hope-gambia|access-date=19 March 2021|website=[[World Health Organization]] (WHO)}}</ref> # Georgia<ref>{{#invoke:Cite web||title=Georgia to receive first doses of COVID-19 vaccine in early March instead of February|url=https://agenda.ge/en/news/2021/477|access-date=22 March 2021|website=Agenda.ge}}</ref> # Ghana<ref>{{#invoke:Cite web||title=Welcome to Ghana Food And Drug Authority |url=http://fdaghana.gov.gh/news-media.php?page=78|access-date=1 April 2021|website=fdaghana.gov.gh}}</ref> # Guatemala<ref name="auto3"/> # Guinea-Bissau<ref>{{cite web |title=Today, 28,800 doses of COVID-19 vaccine arrive in Bissau |url=https://www.unicef.org/guineabissau/press-releases/today-28800-doses-covid-19-vaccine-arrive-bissau |website=www.unicef.org}}</ref> # Guinea<ref name="whotracker"/> # Honduras<ref name="cdctracker"/> # Indonesia<ref>{{#invoke:Cite web||title=BPOM Terbitkan Izin Penggunaan Darurat Vaksin Covid-19 AstraZeneca|url=https://nasional.kompas.com/read/2021/03/09/12124611/bpom-terbitkan-izin-penggunaan-darurat-vaksin-covid-19-astrazeneca|access-date=10 February 2021|website=Kompas}}</ref> # Iran<ref>{{cite web |date=17 February 2021|title=Iran issues permit for emergency use for three other COVID-19 vaccines: Official|url=https://en.irna.ir/news/84233593/Iran-issues-permit-for-emergency-use-for-three-other-COVID-19|access-date=1 April 2021|website=IRNA English}}</ref> # Iraq<ref name="bignewsnetwork.com">{{#invoke:Cite web||title=Iraq approves Sinopharm, AstraZeneca vaccines|url=https://www.bignewsnetwork.com/news/267583081/iraq-approves-sinopharm-astrazeneca-vaccines|access-date=30 January 2021|website=Big News Network}}</ref> # Ivory Coast<ref>{{cite news|date=1 March 2021|title=Covax: Ivory Coast and Ghana begin mass Covid vaccination rollouts|work=BBC News|url=https://www.bbc.com/news/world-africa-56239136|access-date=19 March 2021}}</ref> # Japan<ref name="jp">{{cite news | title=Japan Approves Moderna, AstraZeneca Coronavirus Vaccines | website=Bloomberg | date=20 May 2021 | url=https://www.bloomberg.com/news/articles/2021-05-20/japan-approves-moderna-astra-covid-shots-report-says | access-date=2 July 2021}}</ref> # Jordan<ref>{{#invoke:Cite web||title=COVAX roll-out - Jordan|url=https://www.gavi.org/covax-vaccine-roll-out/jordan|access-date=14 May 2021|website=www.gavi.org}}</ref> # Kenya<ref>{{#invoke:Cite web||title=Kenya Receives 1M Vaccine Doses, Will Distribute to Health Workers First |url=https://www.voanews.com/covid-19-pandemic/kenya-receives-1m-vaccine-doses-will-distribute-health-workers-first|access-date=19 March 2021|publisher=Voice of America}}</ref> # Kiribati<ref name="whotracker"/> # Kosovo<ref>{{#invoke:Cite web||date=29 March 2021|title=Kosovo receives first COVID-19 vaccines through Covax scheme|url=https://www.euronews.com/2021/03/29/kosovo-receives-first-covid-19-vaccines-through-covax-programme|access-date=14 April 2021|website=euronews}}</ref><ref>{{#invoke:Cite web||title=Kosovo PM Becomes Nation's First Person To Receive COVID-19 Vaccine|url=https://www.rferl.org/a/kosovo-covid-vaccines-immunization-last-europe-astrazeneca-covax/31174048.html|access-date=14 April 2021|website=RadioFreeEurope/RadioLiberty}}</ref> # Kuwait<ref>{{#invoke:Cite web||last=Godinho|first=Varun|date=31 January 2021|title=Kuwait authorises emergency use of Oxford-AstraZeneca Covid-19 vaccine|url=https://gulfbusiness.com/kuwait-authorises-emergency-use-of-oxford-astrazeneca-covid-19-vaccine/|access-date=1 April 2021|website=Gulf Business}}</ref> # Kyrgyzstan<ref name="whotracker"/> # Laos<ref name="whotracker"/> # Lebanon<ref>{{#invoke:Cite web||title=Lebanon Received 33600 Doses of The AstraZeneca Vaccine as First Batch|url=https://www.moph.gov.lb/en/Drugs/index/0/48177/page:3/sort:Drug.brand_name/direction:ASC|website=Ministry of Public Health of Lebanon}}</ref> # Lesotho<ref>{{#invoke:Cite web||title=Lesotho receives 1st batch of COVID-19 vaccines|url=https://www.aa.com.tr/en/africa/lesotho-receives-1st-batch-of-covid-19-vaccines/2164388|access-date=19 March 2021|website=aa.com.tr}}</ref> # Liberia<ref>{{#invoke:Cite web||title=96,000 Doses of COVID-19 Vaccine Arrives in Liberia|url=https://www.afro.who.int/news/96000-doses-covid-19-vaccine-arrives-liberia|access-date=11 April 2021|publisher=[[World Health Organization]] (WHO)}}</ref> # Libya<ref name="auto4">{{#invoke:Cite web||title=Libya kicks off delayed COVID-19 vaccination drive|url=https://www.aljazeera.com/news/2021/4/10/libya-launches-covid-19-vaccination-drive-after-delays|access-date=25 April 2021|website=Al Jazeera}}</ref><ref name="auto5">{{#invoke:Cite web||title=57,600 COVID-19 vaccine doses received today in Tripoli, Libya|url=https://reliefweb.int/report/libya/57600-covid-19-vaccine-doses-received-today-tripoli|access-date=25 April 2021|website=ReliefWeb}}</ref> # Madagascar<ref name="cdctracker"/> # Malawi<ref>{{#invoke:Cite web||title=Malawi to receive COVID-19 vaccines in late February – Xinhua |url=http://www.xinhuanet.com/english/2021-02/02/c_139716241.htm|access-date=19 March 2021|publisher=Xinhuanet}}</ref><ref>{{#invoke:Cite web||title=Malawi Sticks to AstraZeneca Despite Concerns Over Efficacy |url=https://www.voanews.com/covid-19-pandemic/malawi-sticks-astrazeneca-despite-concerns-over-efficacy|access-date=19 March 2021|publisher=Voice of America}}</ref> # Malaysia<ref name="MYS approves">{{cite news|last1=Sipalan|first1=Joseph|last2=Donovan|first2=Kirsten|date=3 March 2021|title=Malaysia approves Sinovac, AstraZeneca COVID-19 vaccines for use|agency=Reuters|url=https://www.msn.com/en-au/lifestyle/wellbeing/malaysia-approves-sinovac-astrazeneca-covid-19-vaccines-for-use/ar-BB1e9q01|access-date=7 March 2021}}</ref> # Maldives<ref>{{#invoke:Cite web||title=Maldives starts training healthcare workers on COVID-19 vaccine distribution – Xinhua |url=http://www.xinhuanet.com/english/2021-01/23/c_139691718.htm|access-date=19 February 2021|publisher=Xinhuanet}}</ref> # Mali<ref>{{#invoke:Cite web||last=AfricaNews|date=6 March 2021 |title=Mali receives first batch of COVID-19 vaccines|url=https://www.africanews.com/2021/03/06/mali-receives-first-batch-of-covid-19-vaccines/|access-date=1 April 2021|website=Africanews}}</ref> # Mauritania<ref name="whotracker"/> # Mauritius<ref>{{#invoke:Cite web||last=AfricaNews|date=26 January 2021|title=Mauritius begins vaccinating frontline health workers against covid-19|url=https://www.africanews.com/2021/01/26/mauritius-begins-vaccinating-frontline-health-workers-against-covid-19/|access-date=24 February 2021|website=Africanews}}</ref> # Mexico<ref>{{cite news|date=5 January 2021|title=Mexico approves AstraZeneca COVID-19 vaccine, minister says|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-mexico-vaccine-idUSKBN29A04O|access-date=14 January 2021}}</ref> # Micronesia<ref name="whotracker"/> # Moldova<ref name=":2" /> # Mongolia<ref name="news.mn">{{#invoke:Cite web||date=11 January 2021|title=Mongolia approved three Covid-19 vaccines |url=https://news.mn/en/795048/|access-date=1 April 2021|website=News.MN}}</ref> # Montenegro<ref name="cdctracker"/> # Morocco<ref>{{Cite news|date=7 January 2021|title=Morocco approves AstraZeneca/Oxford COVID-19 vaccine – Minister|publisher=Reuters|url=https://www.reuters.com/article/uk-health-coronavirus-morocco-idUSKBN29C0QA|access-date=22 March 2021}}</ref> # Mozambique<ref name="cdctracker"/> # Myanmar<ref>{{cite news|date=27 January 2021|title=Myanmar launches nationwide COVID-19 vaccination program|website=Xinhua News|url=http://www.xinhuanet.com/english/2021-01/27/c_139700809.htm|accessdate=7 July 2021|archivedate=27 January 2021|archiveurl=https://web.archive.org/web/20210127163302/http://www.xinhuanet.com/english/2021-01/27/c_139700809.htm}}</ref> # Namibia<ref name="mhss.gov.na">{{cite web|url=https://mhss.gov.na/documents/119527/775250/SKM_36721030413220.pdf/7a4534bb-022f-46e4-9113-571432290194|title=Importation of COVID-19 Vaccines into Namibia for Public Use and Guidance on Administration of Vaccines by Private Health Care Providers|date=31 March 2021|website=Republic of Namibia Ministry of Health and Social Services|others=Public Notice No.: 05/032021|accessdate=7 July 2021|archivedate=22 April 2021|archiveurl=https://web.archive.org/web/20210422075829/https://mhss.gov.na/documents/119527/775250/SKM_36721030413220.pdf/7a4534bb-022f-46e4-9113-571432290194}}</ref> # Nauru<ref name=Reliefweb>{{#invoke:Cite web||title=Samoa receives 24,000 doses of COVID-19 vaccines through the COVAX facility - Samoa|url=https://reliefweb.int/report/samoa/samoa-receives-24000-doses-covid-19-vaccines-through-covax-facility|access-date=7 June 2021|website=ReliefWeb}}</ref> # Nepal<ref>{{cite news|date=15 January 2021|title=Nepal approves AstraZeneca COVID vaccine for emergency use – government statement|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-nepal/nepal-approves-astrazeneca-covid-vaccine-for-emergency-use-government-statement-idUSKBN29K140}}</ref> # New Zealand<ref name="whotracker"/> # Nicaragua<ref name="cdctracker"/> # Niger<ref name="cdctracker"/> # Nigeria<ref>{{cite news|title=Wetin we sabi about NAFDAC approval of Oxford AstraZeneca vaccine use for Nigeria|publisher=BBC News Pidgin|url=https://www.bbc.com/pidgin/media-56084858|access-date=24 February 2021}}</ref> # North Macedonia<ref>{{cite web |title=Сѐ за вакцините |url=https://kovid19vakcinacija.mk/za-vakcinite/ |website=Официјална веб-страница за вакцинација против КОВИД19 |language=mk-MK |accessdate=2021-07-07 |archivedate=2021-05-03 |archiveurl=https://web.archive.org/web/20210503232352/https://kovid19vakcinacija.mk/za-vakcinite/ }}</ref> # Oman<ref name="cdctracker"/> # Pakistan<ref>{{cite news|date=16 January 2021|title=Pakistan approves AstraZeneca COVID-19 vaccine for emergency use|url=https://www.reuters.com/article/us-health-coronavirus-pakistan-astrazene/pakistan-approves-astrazeneca-covid-19-vaccine-for-emergency-use-idUKKBN29L0DO}}</ref> # Palestine<ref name="cdctracker"/> # Panama<ref name="cdctracker"/> # Papua New Guinea<ref>{{#invoke:Cite web||date=30 March 2021|title=PNG prime minister first to be vaccinated with Australian-supplied doses 'to show it's safe'|url=http://www.theguardian.com/world/2021/mar/30/png-prime-minister-first-to-be-vaccinated-with-australian-supplied-doses-to-show-its-safe|access-date=1 April 2021|website=The Guardian}}</ref><ref>{{#invoke:Cite web||date=17 March 2021|title=Australia gives Covid-19 vaccine doses to hard-hit Papua New Guinea|url=https://www.france24.com/en/asia-pacific/20210317-australia-gives-covid-19-vaccine-doses-to-hard-hit-papua-new-guinea|access-date=1 April 2021|publisher=France 24}}</ref> # Paraguay<ref name="whotracker"/> # Peru<ref>{{cite web |title=DIGEMID |url=http://www.digemid.minsa.gob.pe/main.asp?Seccion=1065 |website=www.digemid.minsa.gob.pe |language=es |access-date=2 May 2021 |archive-date=7 May 2021 |archive-url=https://web.archive.org/web/20210507204150/http://www.digemid.minsa.gob.pe/main.asp?Seccion=1065 |url-status=dead |accessdate=7 July 2021 |archivedate=7 May 2021 |archiveurl=https://web.archive.org/web/20210507204150/http://www.digemid.minsa.gob.pe/main.asp?Seccion=1065 }}</ref> # Philippines<ref>{{cite news|date=28 January 2021|title=Philippine regulator approves emergency use of AstraZeneca vaccine|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-philippines-vaccin-idUSKBN29X0CY|access-date=28 January 2021}}</ref> # Qatar<ref name="whotracker"/> # Rwanda<ref>{{#invoke:Cite web||title=Rwanda receives COVID-19 Vaccines through COVAX|url=https://www.afro.who.int/news/rwanda-receives-covid-19-vaccines-through-covax|access-date=19 March 2021|website=[[World Health Organization]] (WHO)}}</ref> # Samoa<ref name=Reliefweb /> # São Tomé and Príncipe<ref name="cdctracker"/> # Saudi Arabia<ref name="gulfnews.com" /> # Senegal<ref name="whotracker"/> # Serbia<ref>{{cite news|date=21 February 2021|title=Serbia receives first shipment of AstraZeneca COVID-19 vaccine|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-serbia-vaccines-idUSL1N2KR03M|access-date=19 March 2021}}</ref> # Seychelles<ref>{{Cite news|last=Bhattacherjee|first=Kallol|date=22 January 2021|title=Coronavirus {{!}} Myanmar, Mauritius, Seychelles receive Covishield vaccine|work=The Hindu|url=https://www.thehindu.com/news/national/coronavirus-myanmar-mauritius-seychelles-receive-covishield-vaccine/article33638057.ece|access-date=1 April 2021}}</ref> # Sierra Leone<ref>{{#invoke:Cite web||title=COVID-19 vaccines shipped by COVAX arrive in Sierra Leone|url=https://www.afro.who.int/news/covid-19-vaccines-shipped-covax-arrive-sierra-leone|access-date=19 March 2021|website=[[World Health Organization]] (WHO)}}</ref> # Singapore<ref name="channelnewsasia.com">{{#invoke:Cite web||title=Those who opt for Sinovac, other vaccines under WHO emergency list to be considered fully vaccinated |url=https://www.channelnewsasia.com/singapore/sinovac-vaccine-covid19-sinopharm-astrazeneca-fully-vaccinated-2096576 |access-date=6 August 2021 |work=CNA |date=6 August 2021}}</ref> ''(restricted)'' # Solomon Islands<ref name="cdctracker"/> # Somalia<ref>{{#invoke:Cite web||title=Somalia Receives Its First Batch of COVID-19 Vaccines |url=https://www.voanews.com/covid-19-pandemic/somalia-receives-its-first-batch-covid-19-vaccines|access-date=1 April 2021|publisher=Voice of America}}</ref> # South Korea<ref>{{cite news|last1=Kim|first1=Han-joo|date=10 February 2021|title=S. Korea approves AstraZeneca's COVID-19 vaccine for all adults|publisher=Yonhap News |url=https://en.yna.co.kr/view/AEN20210210006351320|access-date=10 February 2021}}</ref><ref>{{cite news|last1=Maresca|first1=Thomas|date=10 February 2021|title=South Korea approves AstraZeneca COVID-19 vaccine|publisher=United Press International|url=https://www.upi.com/Top_News/World-News/2021/02/10/South-Korea-approves-AstraZeneca-COVID-19-vaccine/4231612945438/|access-date=10 February 2021}}</ref> # South Sudan<ref>{{#invoke:Cite web||title=COVID-19 vaccination kicks-off in South Sudan|url=https://www.afro.who.int/news/covid-19-vaccination-kicks-south-sudan|access-date=14 April 2021|publisher=[[World Health Organization]] (WHO)}}</ref> # Sri Lanka<ref>{{#invoke:Cite web||date=22 January 2021|title=Sri Lanka approves vaccine amid warnings of virus spread|url=https://apnews.com/article/sri-lanka-coronavirus-pandemic-340488c48ab372050825e70e057dd294|access-date=22 January 2021|publisher=Associated Press}}</ref> # Sudan<ref>{{#invoke:Cite web||title=COVID-19 vaccination in Sudan|url=https://www.unicef.org/sudan/stories/covid-19-vaccination-sudan|access-date=19 March 2021|website=[[UNICEF]]}}</ref><ref>{{#invoke:Cite web||title=Sudan receives first delivery of COVID-19 vaccines with over 800,000 doses|url=https://www.unicef.org/press-releases/sudan-receives-first-delivery-covid-19-vaccines-over-800000-doses|access-date=19 March 2021|website=[[UNICEF]]}}</ref> # Syria<ref name="whotracker"/> # Taiwan<ref>{{cite news|date=20 February 2021|title=Taiwan grants emergency authorisation for AstraZeneca COVID-19 vaccine|url=https://www.reuters.com/article/us-health-coronavirus-taiwan-idUSKBN2AK05R|access-date=13 March 2021|publisher=Reuters}}</ref> # Tajikistan<ref>{{#invoke:Cite web||title=Tajikistan becomes first country in Central Asia to receive COVID-19 vaccine through COVAX Facility|url=https://www.unicef.org/tajikistan/press-releases/tajikistan-becomes-first-country-central-asia-receive-covid-19-vaccine-through-0|access-date=14 April 2021|website=unicef.org}}</ref> # Thailand<ref>{{#invoke:Cite web||date=23 January 2021|title=Thai Food and Drug registers COVID-19 vaccine developed by AstraZeneca|url=https://www.pattayamail.com/thailandnews/thai-food-and-drug-registers-covid-19-vaccine-developed-by-astrazeneca-341186|website=Pattaya Mail}}</ref> # Togo<ref>{{#invoke:Cite web||last=First|first=Togo|title=Covid-19: First vaccination campaign to soon begin|url=https://www.togofirst.com/en/health/1602-7300-covid-19-first-vaccination-campaign-to-soon-begin|access-date=19 March 2021|website=togofirst}}</ref> # Tonga<ref>{{#invoke:Cite web||title=Over 500 people given first COVID-19 vaccine shot in Tonga – Xinhua |url=http://www.xinhuanet.com/english/asiapacific/2021-04/16/c_139885080.htm|access-date=25 April 2021|website=xinhuanet}}</ref><ref>{{#invoke:Cite web||date=16 April 2021|title=Tonga's Princess takes the lead on Covid-19 vaccination|url=https://www.rnz.co.nz/international/pacific-news/440580/tonga-s-princess-takes-the-lead-on-covid-19-vaccination|access-date=25 April 2021|website=RNZ}}</ref><ref>{{#invoke:Cite web||title=Kingdom of Tonga receives 24,000 doses of COVID-19 vaccines through the COVAX facility|url=https://www.who.int/westernpacific/about/how-we-work/pacific-support/news/detail/31-03-2021-kingdom-of-tonga-receives-24-000-doses-of-covid-19-vaccines-through-the-covax-facility|access-date=25 April 2021|publisher=[[World Health Organization]] (WHO)}}</ref> # Tunisia<ref name="whotracker"/> # Turkmenistan<ref name="whotracker">{{cite web |title=WHO Coronavirus (COVID-19) Dashboard |url=https://covid19.who.int/ |publisher=[[World Health Organization]] (WHO) }}</ref> # Tuvalu<ref name="Reliefweb"/> # Uganda<ref>{{#invoke:Cite web||last=AfricaNews|date=10 March 2021|title=Uganda starts COVID-19 vaccinations|url=https://www.africanews.com/2021/03/10/uganda-starts-covid-19-vaccinations/|access-date=19 March 2021|website=Africanews}}</ref> # Ukraine<ref>{{#invoke:Cite web||title=COVID-19: AstraZeneca vaccine certified for use in Ukraine|url=https://covid.unian.info/covid-19-astrazeneca-vaccine-certified-for-use-in-ukraine-11330906.html|access-date=10 March 2021|website=covid.unian.info}}</ref> # United Arab Emirates<ref name="cdctracker"/> # United Kingdom<ref>{{#invoke:Cite web||date=30 December 2020|title=Information for Healthcare Professionals on COVID-19 Vaccine AstraZeneca|url=https://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/information-for-healthcare-professionals-on-covid-19-vaccine-astrazeneca|access-date=4 January 2021|website=[[Medicines and Healthcare products Regulatory Agency]] (MHRA)}}</ref><ref>{{cite press release|title=Oxford University/AstraZeneca vaccine authorised by UK medicines regulator|url=https://www.gov.uk/government/news/oxford-universityastrazeneca-vaccine-authorised-by-uk-medicines-regulator|publisher=Department of Health and Social Care|access-date=30 December 2020|date=30 December 2020}}</ref><ref>{{#invoke:Cite web||date=30 December 2020|title=Conditions of Authorisation for COVID-19 Vaccine AstraZeneca|url=https://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/conditions-of-authorisation-for-covid-19-vaccine-astrazeneca|access-date=4 January 2021|website=[[Medicines and Healthcare products Regulatory Agency]] (MHRA)}}</ref> # Uruguay<ref name="cdctracker"/> # Uzbekistan<ref name="cdctracker"/> # Vanuatu<ref name="whotracker"/> # Vietnam<ref>{{#invoke:Cite web||title=Vietnam approves AstraZeneca COVID-19 vaccine, cuts short Communist Party congress|url=https://www.channelnewsasia.com/news/asia/vietnam-approves-astrazeneca-vaccine-reports-34-new-covid-19-14074712|access-date=5 February 2021|website=CNA}}</ref> # Yemen<ref>{{#invoke:Cite web||title=Yemen receives 360,000 COVID-19 vaccine doses through the COVAX Facility|url=https://www.unicef.org/press-releases/yemen-receives-360000-covid-19-vaccine-doses-through-covax-facility|access-date=7 June 2021|website=www.unicef.org}}</ref> # Zambia<ref name=":5">{{Cite news|date=25 March 2021|title=Zambia sets out plans to vaccinate all people over 18 against COVID-19|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-zambia-vaccine-idUSKBN2BH2NS|access-date=17 April 2021}}</ref><ref name=":6">{{#invoke:Cite web||title=Zambia launches the COVID-19 vaccination|url=https://reliefweb.int/report/zambia/zambia-launches-covid-19-vaccination|access-date=17 April 2021|website=ReliefWeb}}</ref><ref name=":8">{{#invoke:Cite web||title=Zambia gets 1st 228,000 vaccine doses from COVAX|url=https://www.aa.com.tr/en/latest-on-coronavirus-outbreak/zambia-gets-1st-228-000-vaccine-doses-from-covax/2206521|access-date=17 April 2021|website=aa.com.tr}}</ref> # Zimbabwe<ref name="whotracker"/> '''{{nowrap|[[European Medicines Agency|EMA]] countries}}'''<ref name="Vaxzevria EPAR" /><ref name="EU Marketing authorisation" /><ref>{{cite web | title=Vaxzevria | website=Union Register of medicinal products | url=https://ec.europa.eu/health/documents/community-register/html/h1529.htm | access-date=26 November 2021}}</ref> # Austria # Belgium # Bulgaria # Croatia # Cyprus # Czech Republic # Denmark # Estonia # Finland # France # Germany # Greece # Hungary # Iceland # Ireland # Italy # Latvia # Liechtenstein # Lithuania # Luxembourg # Malta # Netherlands # Norway # Poland # Portugal # Romania # Slovakia # Slovenia # Spain # Sweden '''{{nowrap|[[Caribbean Public Health Agency|CARPHA]] countries}}'''<ref name="carpha-oxford">{{cite web |title=CARPHA Issues its First Emergency Use Recommendation for a COVID-19 Vaccine |url=https://www.carpha.org/More/Media/Articles/ArticleID/435/CARPHA-Issues-its-First-Emergency-Use-Recommendation-for-a-COVID-19-Vaccine |website=Caribbean Public Health Agency}}</ref> # Antigua and Barbuda # Bahamas # Barbados # Belize # Dominica # Grenada # Guyana # Haiti # Jamaica # Saint Kitts and Nevis # Saint Lucia # Saint Vincent and the Grenadines # Suriname<ref>{{cite news|date=23 February 2021|title=Suriname begins coronavirus vaccination campaign with donated doses|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-suriname-vaccine-idUSKBN2AN2AT|access-date=28 February 2021}}</ref> # Trinidad and Tobago <!-- not counted -->'''[[List of ISO 3166-1 codes|Non-country entities]]''' * Anguilla{{efn|name=carphance|via CARPHA authorization<ref name="carpha-oxford"/>}} * Aruba{{efn|name=carphance}} * British Virgin Islands{{efn|name=carphance}} * Bermuda{{efn|name=carphance}} * Caribbean Netherlands{{efn|name=carphance}} * Cayman Islands{{efn|name=carphance}} * Curaçao{{efn|name=carphance}} * Cook Islands<ref name="cdctracker"/> * Falkland Islands<ref name="cdctracker"/> * French Polynesia<ref name="cdctracker"/> * Greenland<ref name="NYT vaccine tracker"/> * Guadeloupe<ref name="whotracker"/> * Guernsey<ref name="cdctracker"/> * Isle of Man<ref name="cdctracker"/> * Jersey<ref name="cdctracker"/> * Montserrat{{efn|name=carphance}} * Northern Cyprus<ref name=":4">{{#invoke:Cite web||last=Psyllides|first=George|title=Coronavirus: 10,000 vaccines handed over to north |url=https://cyprus-mail.com/2021/03/31/coronavirus-10000-vaccines-handed-over-to-north/|access-date=17 April 2021|website=cyprus-mail.com/}}</ref> * Pitcairn<ref name="whotracker"/> * Saint Helena, Ascension and Tristan da Cunha<ref name="whotracker"/> * Sint Maarten{{efn|name=carphance}} * Turks and Caicos Islands{{efn|name=carphance}} * Wallis and Futuna<ref name="cdctracker"/> * ''[[World Health Organization]]''<ref name="WHO status" /><ref>{{#invoke:Cite web||title=Interim recommendations for use of the AZD1222 (ChAdOx1-S (recombinant)) vaccine against COVID-19 developed by Oxford University and AstraZeneca|url=https://www.who.int/publications/i/item/WHO-2019-nCoV-vaccines-SAGE_recommendation-AZD1222-2021.1|access-date=27 February 2021|publisher=[[World Health Organization]] (WHO)}}</ref><ref>{{cite news|title=AstraZeneca/Oxford Covid-19 Vaccine Gets Emergency Approval From WHO|website=Forbes|url=https://www.forbes.com/sites/alisondurkee/2021/02/15/astrazeneca-oxford-covid-19-vaccine-gets-emergency-approval-from-who/|access-date=16 February 2021}}</ref><ref>{{cite web | title=WHO Recommendation AstraZeneca/SKBio - COVID-19 Vaccine (ChAdOx1-S [recombinant]) | website=[[World Health Organization]] (WHO) | date=15 February 2021 | url=https://extranet.who.int/pqweb/vaccines/covid-19-vaccine-chadox1-s-recombinant | access-date=8 May 2021 | accessdate=7 July 2021 | archivedate=4 July 2021 | archiveurl=https://web.archive.org/web/20210704174442/https://extranet.who.int/pqweb/vaccines/covid-19-vaccine-chadox1-s-recombinant }}</ref><ref>{{cite web | title=WHO recommendation Serum Institute of India Pvt Ltd - COVID-19 Vaccine (ChAdOx1-S [recombinant]) - Covishield | website=[[World Health Organization]] (WHO) | date=15 February 2021 | url=https://extranet.who.int/pqweb/vaccines/covid-19-vaccine-chadox1-s-recombinant-covishield | access-date=8 May 2021 | accessdate=7 July 2021 | archivedate=6 July 2021 | archiveurl=https://web.archive.org/web/20210706125046/https://extranet.who.int/pqweb/vaccines/covid-19-vaccine-chadox1-s-recombinant-covishield }}</ref> ;Travel-only * Hong Kong<ref name="HK">{{cite web |title=List of COVID-19 Vaccines Recognised for Specified Purposes |url=https://www.coronavirus.gov.hk/pdf/list_of_recognised_covid19_vaccines.pdf |publisher=Hong Kong Department of Health |access-date=24 November 2021}}</ref> * Switzerland<ref>{{cite web|last=FOPH|first=Federal Office of Public Health|title=Coronavirus: Entering Switzerland|url=https://www.bag.admin.ch/bag/en/home/krankheiten/ausbrueche-epidemien-pandemien/aktuelle-ausbrueche-epidemien/novel-cov/empfehlungen-fuer-reisende/quarantaene-einreisende.html|access-date=19 November 2021|website=www.bag.admin.ch|accessdate=25 December 2021|archivedate=24 July 2020|archiveurl=https://web.archive.org/web/20200724080307/https://www.bag.admin.ch/bag/en/home/krankheiten/ausbrueche-epidemien-pandemien/aktuelle-ausbrueche-epidemien/novel-cov/empfehlungen-fuer-reisende/quarantaene-einreisende.html}}</ref> * Turkey<ref name="visasturkey.com">{{cite web|date=10 April 2019|title=Vaccinations for Turkey: Do I need an Approved COVID Vaccine?|url=https://www.easyturkeyvisa.com/news/vaccinations-for-turkey|access-date=24 November 2021|website=Turkey Visa}}{{Dead link|date=December 2023 |bot=InternetArchiveBot |fix-attempted=yes }}</ref> * United States<ref>{{cite web|date=11 February 2020|title=COVID-19 and Your Health|url=https://www.cdc.gov/coronavirus/2019-ncov/travelers/proof-of-vaccination.html|access-date=17 November 2021|website=U.S. [[Centers for Disease Control and Prevention]] (CDC)}}</ref> </div> == Pfizer–BioNTech == <section begin="pfizerauthmap"/> {{infobox|image={{Graph:Map|scale=65|defaultValue=gainsboro |AD=dodgerblue|AE=dodgerblue|AF=dodgerblue|AG=dodgerblue|AI=dodgerblue|AL=dodgerblue|AM=dodgerblue|AO=limegreen|AR=dodgerblue|AS=dodgerblue|AT=dodgerblue|AU=blueviolet|AW=dodgerblue|AZ=dodgerblue |BA=dodgerblue|BB=dodgerblue|BD=dodgerblue|BE=dodgerblue|BF=limegreen|BG=dodgerblue|BH=dodgerblue|BJ=dodgerblue|BM=dodgerblue|BN=limegreen|BO=dodgerblue|BQ=dodgerblue|BR=blueviolet|BS=dodgerblue|BT=dodgerblue|BW=dodgerblue|BZ=dodgerblue |CA=blueviolet|CD=dodgerblue|CF=limegreen|CG=limegreen|CH=blueviolet|CI=dodgerblue|CK=dodgerblue|CL=dodgerblue|CM=dodgerblue|CO=dodgerblue|CR=dodgerblue|CV=dodgerblue|CW=dodgerblue|CY=dodgerblue|CZ=dodgerblue |DE=dodgerblue|DJ=dodgerblue|DK=dodgerblue|DM=dodgerblue|DO=dodgerblue|DZ=dodgerblue |EC=dodgerblue|EE=dodgerblue|EG=dodgerblue|ES=dodgerblue|ET=limegreen |FI=dodgerblue|FJ=limegreen|FM=blueviolet|FO=dodgerblue|FR=dodgerblue |GA=dodgerblue|GB=dodgerblue|GD=dodgerblue|GE=dodgerblue|GH=dodgerblue|GI=dodgerblue|GL=dodgerblue|GM=limegreen|GN=dodgerblue|GP=dodgerblue|GR=dodgerblue|GT=dodgerblue|GU=dodgerblue|GY=dodgerblue |HK=dodgerblue|HN=dodgerblue|HR=dodgerblue|HT=dodgerblue|HU=dodgerblue |ID=dodgerblue|IE=dodgerblue |IL=dodgerblue|IM=dodgerblue|IN=limegreen|IQ=dodgerblue|IR=limegreen|IS=dodgerblue|IT=dodgerblue |JE=dodgerblue|JM=dodgerblue|JO=dodgerblue|JP=dodgerblue |KE=dodgerblue|KG=dodgerblue|KH=limegreen|KI=limegreen|KM=limegreen|KN=dodgerblue|KP=limegreen|KR=dodgerblue|KW=dodgerblue|KY=dodgerblue|KZ=dodgerblue |LA=dodgerblue|LB=limegreen|LC=dodgerblue|LI=dodgerblue|LK=dodgerblue|LR=limegreen|LS=limegreen|LT=dodgerblue|LU=dodgerblue|LV=dodgerblue|LY=dodgerblue |MA=dodgerblue|MC=dodgerblue|MD=dodgerblue|ME=dodgerblue|MH=blueviolet|MK=dodgerblue|ML=limegreen|MM=limegreen|MN=dodgerblue|MO=dodgerblue|MP=dodgerblue|MQ=dodgerblue|MR=limegreen|MS=dodgerblue|MT=dodgerblue|MU=limegreen|MV=dodgerblue|MW=dodgerblue|MX=dodgerblue|MY=dodgerblue|MZ=limegreen |NA=dodgerblue|NC=dodgerblue|NE=limegreen|NG=dodgerblue|NI=dodgerblue|NL=dodgerblue|NO=dodgerblue|NP=dodgerblue|NR=limegreen|NU=dodgerblue|NZ=blueviolet |OM=dodgerblue |PA=dodgerblue|PE=dodgerblue|PF=dodgerblue|PG=dodgerblue|PH=dodgerblue|PK=dodgerblue|PL=dodgerblue|PR=dodgerblue|PS=dodgerblue|PT=dodgerblue|PW=blueviolet|PY=dodgerblue |QA=dodgerblue |RO=dodgerblue|RS=dodgerblue|RW=dodgerblue |SA=blueviolet|SB=limegreen|SD=dodgerblue|SE=dodgerblue|SG=dodgerblue|SI=dodgerblue|SK=dodgerblue|SL=limegreen|SM=dodgerblue|SN=limegreen|SO=limegreen|SR=dodgerblue|SS=limegreen|ST=limegreen|SV=dodgerblue|SX=dodgerblue|SY=limegreen|SZ=dodgerblue |TC=dodgerblue|TD=limegreen|TG=limegreen|TH=dodgerblue|TJ=dodgerblue|TK=dodgerblue|TL=dodgerblue|TN=dodgerblue|TO=dodgerblue|TR=dodgerblue|TT=dodgerblue|TV=limegreen|TW=dodgerblue|TZ=dodgerblue |UA=dodgerblue|UG=dodgerblue|US=blueviolet|UY=dodgerblue|UZ=dodgerblue |VA=dodgerblue|VC=dodgerblue|VE=limegreen|VG=dodgerblue|VN=dodgerblue|VU=limegreen |WS=limegreen |XK=dodgerblue |YE=limegreen |ZA=dodgerblue|ZM=dodgerblue|ZW=limegreen }} |caption= {{leftlegend|blueviolet|Full authorization}} {{leftlegend|dodgerblue|Emergency authorization}} {{leftlegend|limegreen|Eligible [[COVAX]] recipient}} }} <section end="pfizerauthmap"/> The [[Pfizer–BioNTech COVID-19 vaccine]], sold under the brand name Comirnaty,<ref name="Comirnaty EPAR">{{#invoke:Cite web||title=Comirnaty EPAR|url=https://www.ema.europa.eu/en/medicines/human/EPAR/comirnaty|access-date=23 December 2020|publisher=[[European Medicines Agency]] (EMA)}}</ref> is an [[mRNA vaccine]]<ref name="hcreg">{{#invoke:Cite web||date=9 December 2020|title=Regulatory Decision Summary – Pfizer-BioNTech COVID-19 Vaccine|url=https://covid-vaccine.canada.ca/info/regulatory-decision-summary-detailTwo.html?linkID=RDS00730|access-date=9 December 2020|publisher=Health Canada, Government of Canada}}</ref> produced by the German company [[BioNTech]] and the American company [[Pfizer]].<ref name="hcreg"/><ref name="NCT04368728">{{#invoke:Cite web||date=30 April 2020|title=Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Adults|url=https://clinicaltrials.gov/ct2/show/NCT04368728|url-status=live|archive-url=https://web.archive.org/web/20201011084828/https://clinicaltrials.gov/ct2/show/NCT04368728/|archive-date=11 October 2020|access-date=14 July 2020|website=[[ClinicalTrials.gov]]|publisher=[[United States National Library of Medicine]]|id=NCT04368728}}</ref><ref name="EudraCT-2020-001038-36">{{#invoke:Cite web||date=14 April 2020|title=A Multi-site Phase I/II, 2-Part, Dose-Escalation Trial Investigating the Safety and Immunogenicity of four Prophylactic SARS-CoV-2 RNA Vaccines Against COVID-19 Using Different Dosing Regimens in Healthy Adults|url=https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001038-36/DE|url-status=live|archive-url=https://web.archive.org/web/20200422111024/https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001038-36/DE|archive-date=22 April 2020|access-date=22 April 2020|website=EU Clinical Trials Register|publisher=European Union|id=[[EudraCT]] 2020-001038-36}}</ref> In Hong Kong, Macau, and Taiwan, Comirnaty is distributed by [[Fosun Pharma]].<ref>{{#invoke:Cite web||title=BioNTech and China partner, not Pfizer, to produce HK shots|url=https://www.thestandard.com.hk/section-news/section/11/225661/BioNTech-and-China-partner,-not-Pfizer,-to-produce-HK-shots|website=The Standard}}</ref><ref>{{#invoke:Cite web||title=Pfizer and BioNTech's overlooked third partner will distribute the vaccine in China – and it's facing some resistance |url=https://fortune.com/2021/01/09/covid-vaccine-china-fosun-pfizer-biontech/|access-date=18 April 2021}}</ref><ref>{{Cite news|last=Burger|first=Ludwig|date=16 March 2020|title=BioNTech in China alliance with Fosun over potential coronavirus vaccine|work=Reuters|url=https://www.reuters.com/article/us-biontech-fosunpharma-vaccine-collabor-idUKKBN2130O5|access-date=18 April 2021}}</ref><ref>{{Cite news|date=25 November 2020|title=BioNTech, Fosun start Phase II trial of COVID-19 vaccine in China|work=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-biontech-fosunphar-idUSKBN2850ZZ|access-date=18 April 2021}}</ref><ref name="RTHK 20210711" /><ref name="BioNTech PR 20210712" /> ;Full (<section begin="Pfizer-BioNTech_FN"/>10<section end="Pfizer-BioNTech_FN"/>) # Australia<ref>{{#invoke:Cite web||title=Comirnaty|url=https://www.tga.gov.au/apm-summary/comirnaty|date=25 January 2021|access-date=25 January 2021|publisher=[[Therapeutic Goods Administration]] (TGA)}}</ref><ref>{{cite report | url=https://www.tga.gov.au/sites/default/files/auspar-bnt162b2-mrna-210125.pdf | title=Australian Public Assessment Report for BNT162b2 (mRNA) | publisher=[[Therapeutic Goods Administration]] (TGA) | access-date=25 January 2021 | archive-date=26 January 2021 | archive-url=https://web.archive.org/web/20210126144716/https://www.tga.gov.au/sites/default/files/auspar-bnt162b2-mrna-210125.pdf | url-status=dead }}</ref> # Brazil<ref name="Brazil approves full vaccine">{{#invoke:Cite web||url=https://g1.globo.com/bemestar/vacina/noticia/2021/02/23/anvisa-concede-registro-definitivo-a-vacina-da-pfizer.ghtml|title=Vacina da Pfizer é a 1ª a obter registro definitivo no Brasil|publisher=G1|date=23 February 2021|access-date=23 February 2021|language=pt-br}}</ref> # Canada<ref>{{cite web|date=23 August 2021|title=U.S. gives Pfizer COVID-19 vaccine full approval - CityNews Toronto|url=https://toronto.citynews.ca/2021/08/23/us-pfizer-covid-19-vaccine-full-approval/|access-date=23 August 2021|website=CityNews Toronto}}</ref><ref>{{cite news|author1=The Associated Press|date=23 August 2021|title=U.S. regulators give full approval of Pfizer-BioNTech's COVID-19 vaccine|url=https://www.cbc.ca/news/health/us-pfizer-fda-approval-1.6149959|access-date=23 August 2021|website=CBC News}}</ref><ref name=":13">{{Cite news|last=Osman|first=Laura|date=16 September 2021|title=Goodbye Pfizer, hello Comirnaty: Top COVID-19 vaccines given brand names in Canada|work=CBC News|url=https://www.cbc.ca/news/health/vaccine-name-change-canada-1.6178484|access-date=16 September 2021}}</ref> # Marshall Islands{{efn|name=CFA}}{{efn|name=useua|Full approval only for those aged 16+. EUA still applies for recipients aged 5-15.}} # Micronesia{{efn|name=CFA}}{{efn|name=useua}} # New Zealand<ref>{{#invoke:Cite web||date=3 February 2021|title=Robust assessment ahead of Medsafe approval of vaccine|url=https://www.health.govt.nz/news-media/media-releases/robust-assessment-ahead-medsafe-approval-vaccine|access-date=6 February 2021|work=Ministry of Health}}</ref> # Palau{{efn|name=CFA|via United States authorization through [[Compact of Free Association]]<ref>{{cite press release | title=Interior Applauds Inclusion of Insular Areas through Operation Warp Speed to Receive COVID-19 Vaccines | publisher=[[United States Department of the Interior]] (DOI) | date=12 December 2020 | url=https://www.doi.gov/oia/press/interior-applauds-inclusion-insular-areas-through-operation-warp-speed-receive-covid-19 | access-date=13 January 2021}} {{PD-notice}}</ref><ref>{{cite news|url=https://www.hawaiipublicradio.org/post/asia-minute-palau-administers-vaccines-keep-country-free-covid#stream/0|publisher=[[Hawaii Public Radio]]|title=Asia Minute: Palau Administers Vaccines to Keep Country Free of COVID|first=Bill|last=Dorman|date=6 January 2021|access-date=13 January 2021|name-list-style=vanc}}</ref>}}{{efn|name=useua}} # Saudi Arabia<ref>{{#invoke:Cite web||date=10 December 2020|title=Coronavirus: Saudi Arabia approves Pfizer COVID-19 vaccine for use|url=https://english.alarabiya.net/en/coronavirus/2020/12/10/Coronavirus-Saudi-Arabia-approves-Pfizer-COVID-19-vaccine-for-use|access-date=10 December 2020|website=Al Arabiya English}}</ref><ref name="NYT vaccine tracker">{{cite news|last1=Zimmer|first1=Carl|last2=Corum|first2=Jonathan|last3=Wee|first3=Sui-Lee|title=Coronavirus Vaccine Tracker|work=[[The New York Times]]|url=https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html|name-list-style=vanc}}</ref> # Switzerland<ref name="Swiss authorization">{{cite press release|title=Swissmedic grants authorisation for the first COVID-19 vaccine in Switzerland|url=https://www.bag.admin.ch/bag/en/home/das-bag/aktuell/medienmitteilungen.msg-id-81761.html|publisher=[[Swissmedic|Swiss Agency for Therapeutic Products (Swissmedic)]]|date=19 December 2020|access-date=19 December 2020}}</ref><ref>{{#invoke:Cite web||title=Comirnaty Product information|url=https://www.swissmedicinfo.ch/ShowText.aspx?textType=FI&lang=DE&authNr=68225|access-date=31 January 2021|language=DE|trans-quote=Due to incomplete clinical data at the time of the assessment of the authorization application, the Comirnaty medicinal product is authorized for a limited period (Art. 9a Medicinal Products Act).}}</ref> # United States{{efn|name=useua}}<ref>{{cite press release|title=FDA Takes Key Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for First COVID-19 Vaccine|publisher=U.S. [[Food and Drug Administration]] (FDA)|date=11 December 2020|url=https://www.fda.gov/news-events/press-announcements/fda-takes-key-action-fight-against-covid-19-issuing-emergency-use-authorization-first-covid-19|access-date=11 December 2020}} {{PD-notice}}</ref><ref name="Pfizer-BioNTech COVID-19 Vaccine EUA fact sheet">{{#invoke:Cite web||date=25 February 2021|title=Pfizer-BioNTech COVID-19 Vaccine EUA Fact Sheet for Healthcare Providers|url=https://www.fda.gov/media/144413/download|access-date=25 February 2021|publisher=Pfizer|format=PDF}}</ref><ref name="FDA PR 20210823">{{Cite press release |title=FDA Approves First COVID-19 Vaccine |date=23 August 2021 |publisher=U.S. [[Food and Drug Administration]] (FDA) |url=https://www.fda.gov/news-events/press-announcements/fda-approves-first-covid-19-vaccine |access-date=23 August 2021 |archive-url=https://web.archive.org/web/20210823143040/https://www.fda.gov/news-events/press-announcements/fda-approves-first-covid-19-vaccine |archive-date=23 August 2021 |url-status=live}}</ref> {{-}} ;Emergency (<section begin="Pfizer-BioNTech_EN"/>140<section end="Pfizer-BioNTech_EN"/>) <div style="margin-top: 0.3em; column-width: 15em;"> # Afghanistan<ref name="cdctracker"/> # Albania<ref>{{#invoke:Cite web||title=Albania to start COVID-19 immunisation with Pfizer vaccine in January – report|url=https://seenews.com/news/albania-to-start-covid-19-immunisation-with-pfizer-vaccine-in-jan-report-726470|website=Seenews}}</ref> # Algeria<ref>{{cite web|date=5 May 2021|title=Canada allows Pfizer COVID-19 vaccine for children aged 12-15|url=https://www.reuters.com/world/americas/canada-authorizes-pfizer-covid-19-vaccine-children-aged-12-15-2021-05-05/|access-date=19 August 2021|website=Reuters}}</ref> # Andorra<ref>{{#invoke:Cite web||title=Andorra COVID-19|url=https://www.govern.ad/covid19_newsletter/en/|access-date=19 February 2021|website=govern.ad}}</ref> # Argentina<ref>{{cite news|title=Coronavirus en la Argentina: La ANMAT aprobo el uso de emergencia de la vacuna Pfizer|url=https://www.lanacion.com.ar/sociedad/coronavirus-argentina-anmat-aprobo-uso-emergencia-vacuna-nid2548852|access-date=23 December 2020|website=La Nación|language=es}}</ref> # Armenia<ref>{{#invoke:Cite web||date=30 June 2021|title=Dashboard: Vaccinating Eurasia- June|url=https://eurasianet.org/dashboard-vaccinating-eurasia-june|access-date=4 August 2021|website=[[Eurasianet]]}}</ref> # Azerbaijan<ref name="whotracker"/> # Bahrain<ref>{{#invoke:Cite web||title=Bahrain becomes second country to approve Pfizer COVID-19 vaccine|url=https://www.aljazeera.com/news/2020/12/4/bahrain-becomes-second-country-to-approve-pfizer-covid-19-vaccine|access-date=5 December 2020|publisher=[[Al Jazeera]]}}</ref><ref>{{cite web | title=The Pfizer-BioNTech COVID-19 Vaccine Was Granted Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) & Bahrain National Health Regulatory Authority (NHRA) | website=cvdvaccine | url=https://www.cvdvaccine-bh.com/ | access-date=18 April 2021 | accessdate=7 July 2021 | archivedate=21 April 2021 | archiveurl=https://web.archive.org/web/20210421145401/https://www.cvdvaccine-bh.com/ }}</ref> # Bangladesh<ref>{{#invoke:Cite web||title=Bangladesh approves Pfizer Covid-19 vaccine for emergency use|date=27 May 2021|url=https://www.dhakatribune.com/bangladesh/2021/05/27/bangladesh-approves-pfizer-covid-19-vaccine-for-emergency-use|access-date=27 May 2021|publisher=[[Dhaka Tribune]]}}</ref> # Benin<ref name="whotracker"/> # Bhutan<ref name="whotracker"/> # Bolivia<ref name="cdctracker"/> # Bosnia and Herzegovina<ref name=":3">{{#invoke:Cite web||title=Pfizer/BioNTech COVID-19 vaccines shipped by COVAX arrive in Bosnia and Herzegovina|url=https://bosniaherzegovina.un.org/en/123137-pfizerbiontech-covid-19-vaccines-shipped-covax-arrive-bosnia-and-herzegovina|access-date=14 April 2021|publisher=United Nations}}</ref> # Botswana<ref>{{Cite news|title=Botswana expects to welcome multiple COVID-19 vaccines|url=http://www.xinhuanet.com/english/africa/2021-02/27/c_139771113.htm|access-date=1 April 2021|publisher=Xinhuanet|accessdate=7 July 2021|archivedate=27 February 2021|archiveurl=https://web.archive.org/web/20210227224341/http://www.xinhuanet.com/english/africa/2021-02/27/c_139771113.htm}}</ref> # Brunei<ref name="auto">{{#invoke:Cite web||title=COVID-19: Brunei to begin mass vaccination on April 3 |url=https://thescoop.co/2021/04/02/covid-19-brunei-to-begin-mass-vaccination-on-april-3/|access-date=6 April 2021|website=TheScoop|date=2 April 2021}}</ref> # Cameroon<ref name="whotracker"/> # Cape Verde<ref name="cdctracker"/> # Chile<ref name="chile">{{#invoke:Cite web||date=17 December 2020|title=Chile approves Pfizer-BioNTech Covid-19 vaccine for emergency use|url=https://www.straitstimes.com/world/chile-approves-pfizer-biontech-covid-19-vaccine-for-emergency-use|access-date=17 December 2020|website=The Straits Times}}</ref> # Colombia<ref>{{cite news|date=6 January 2021|title=Colombia regulator approves Pfizer-BioNTech vaccine for emergency use|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-colombia-vaccine/colombia-regulator-approves-pfizer-biontech-vaccine-for-emergency-use-idINL1N2JH00P/|access-date=6 January 2021}}</ref> # Congo-Kinshasa<ref name="DRC">{{cite web|date=2021-12-07|title=Covid-19 en RDC: des officiers et agents de la Police se font vacciner après échanges avec le ministre de la Santé|url=https://actualite.cd/2021/12/07/covid-19-en-rdc-des-officiers-et-agents-de-la-police-se-font-vacciner-apres-echanges|access-date=2022-01-12|website=Actualite.cd|language=fr}}</ref> # Costa Rica<ref name="costa">{{#invoke:Cite web||date=16 December 2020|title=Costa Rica authorizes Pfizer-BioNTech coronavirus vaccine|url=https://ticotimes.net/2020/12/16/costa-rica-authorizes-pfizer-biontech-coronavirus-vaccine|access-date=16 December 2020|website=The Tico Times}}</ref> # Djibouti<ref name="whotracker"/> # Dominican Republic<ref>[https://covid-19pharmacovigilance.paho.org/pfizer-biontech Pfizer-BioNTech COVID-19 vaccine]. Pan American Health Organization.</ref> # East Timor<ref name="whotracker"/> # Ecuador<ref name="ecuador">{{#invoke:Cite web||title=Arcsa autoriza ingreso al país de vacuna Pfizer-BioNTech para el Covid-19 – Agencia Nacional de Regulación, Control y Vigilancia Sanitaria|url=https://www.controlsanitario.gob.ec/arcsa-autoriza-ingreso-al-pais-de-vacuna-pfizer-biontech-para-el-covid-19/|access-date=17 December 2020|language=es}}</ref> # Egypt<ref name="whotracker"/> # El Salvador<ref name="cdctracker"/><ref>{{#invoke:Cite web||last=McGwin|first=Kevin|date=30 December 2020|title=Greenland to begin new year with COVID vaccinations|url=https://www.arctictoday.com/greenland-to-begin-new-year-with-covid-vaccinations/|access-date=21 March 2021|website=ArcticToday}}</ref> # Eswatini<ref name="whotracker"/> #Fiji<ref>{{cite web|title=Vaccine FAQs – MINISTRY OF HEALTH & MEDICAL SERVICES| date=24 March 2021 |url=https://www.health.gov.fj/covid-vaccine/vaccine-faqs/|access-date=2022-01-06|language=en-US}}</ref> # Gabon<ref name="whotracker"/> # Georgia<ref name="whotracker"/> # Ghana<ref>{{cite web|title=Ghana approves two more COVID-19 vaccines - Xinhua &#124; English.news.cn|url=http://www.xinhuanet.com/english/africa/2021-07/29/c_1310092883.htm|access-date=30 November 2021|website=xinhuanet|accessdate=25 December 2021|archivedate=30 November 2021|archiveurl=https://web.archive.org/web/20211130221511/http://www.xinhuanet.com/english/africa/2021-07/29/c_1310092883.htm}}</ref> # Guatemala<ref name="auto3">{{cite web |title=COVID-19 Information |url=https://gt.usembassy.gov/alert-covid-19-2/ |website=U.S. Embassy in Guatemala |date=25 February 2020 |accessdate=7 July 2021 |archivedate=7 May 2021 |archiveurl=https://web.archive.org/web/20210507124017/https://gt.usembassy.gov/alert-covid-19-2/ }}</ref> # Guinea<ref name="whotracker"/> # Honduras<ref name="whotracker"/> # Indonesia<ref>{{cite news|url=https://www.cnnindonesia.com/nasional/20210715145336-20-668159/bpom-terbitkan-izin-penggunaan-darurat-vaksin-covid-19-pfizer|title=BPOM Terbitkan Izin Penggunaan Darurat Vaksin COVID-19 Pfizer|work=CNN Indonesia|date=15 July 2021|access-date=15 July 2021|language=id}}</ref> # Iraq<ref>{{#invoke:Cite web||title=Iraq grants emergency approval for Pfizer COVID-19 vaccine|url=https://www.msn.com/en-ae/news/other/iraq-grants-emergency-approval-for-pfizer-covid-19-vaccine/ar-BB1cgvD6|access-date=27 December 2020|publisher=MSN}}</ref> # Israel<ref>{{#invoke:Cite web||title=Israeli Health Minister 'pleased' as FDA approves Pfizer COVID-19 vaccine|url=https://www.jpost.com/breaking-news/fda-approves-pfizer-biontech-covid-19-vaccine-for-emergency-use-nyt-651871|access-date=28 December 2020|website=The Jerusalem Post}}</ref> # Ivory Coast<ref name="whotracker"/> # Japan<ref name="jp" /><ref>{{cite news|date=14 February 2021|title=Japan approves Pfizer's COVID-19 vaccine, 1st for domestic use|work=[[Nikkei Asia]]|url=https://asia.nikkei.com/Spotlight/Coronavirus/Japan-approves-Pfizer-s-COVID-19-vaccine-1st-for-domestic-use|access-date=14 February 2021|name-list-style=vanc|accessdate=7 July 2021|archivedate=18 March 2021|archiveurl=https://web.archive.org/web/20210318232113/https://asia.nikkei.com/Spotlight/Coronavirus/Japan-approves-Pfizer-s-COVID-19-vaccine-1st-for-domestic-use}}</ref><ref>{{#invoke:Cite web||last=Tsukimori|first=Osamu|date=15 February 2021|title=Japan gives OK to Pfizer coronavirus vaccine, with rollout to begin this week|url=https://www.japantimes.co.jp/news/2021/02/15/national/science-health/pfizer-vaccine-approval-japan/|access-date=1 April 2021|website=The Japan Times}}</ref> # Jordan<ref>{{#invoke:Cite web||date=15 December 2020|title=Jordan approves Pfizer-BioNTech Covid vaccine|url=https://www.france24.com/en/live-news/20201215-jordan-approves-pfizer-biontech-covid-vaccine|access-date=15 December 2020|publisher=France 24}}</ref> # Kazakhstan<ref name="whotracker"/> # Kenya<ref name="auto13">{{#invoke:Cite news||date=2 August 2021|title=Kenya Approves J&J, Pfizer Covid-19 Vaccines as Cases Surge|work=Bloomberg.com|url=https://www.bloomberg.com/news/articles/2021-08-02/kenya-approves-j-j-pfizer-covid-19-vaccines-as-cases-surge|access-date=24 September 2021}}</ref> # Kosovo<ref name="whotracker"/> # Kuwait<ref>{{#invoke:Cite web||date=13 December 2020|title=Kuwait authorizes emergency use of Pfizer-BioNTech COVID-19 vaccine|url=https://arab.news/427j9|access-date=15 December 2020|website=Arab News}}</ref> # Kyrgyzstan<ref name="whotracker"/> # Laos<ref name="whotracker"/> # Lebanon<ref>{{#invoke:Cite web||date=14 February 2021|title=Lebanon starts Covid-19 vaccination campaign|url=https://www.france24.com/en/middle-east/20210214-lebanon-starts-covid-19-vaccination-campaign|access-date=16 March 2021|publisher=France 24}}</ref> # Libya<ref name="cdctracker"/> # Malawi<ref name="auto7">{{cite web|title=Malawi Ministry of Health on Facebook|url=https://www.facebook.com/login/?next&#61;https%253A%252F%252Fwww.facebook.com%252Fmalawimoh%252Fposts%252F4098884300167054|access-date=14 September 2021|website=Facebook}}</ref> # Malaysia<ref>{{cite news|last=Lim|first=Ida|date=8 January 2021|title=Khairy: Malaysia can use Pfizer's Covid-19 vaccine now as conditional registration granted|work=[[The Malay Mail]]|url=https://www.msn.com/en-my/news/national/khairy-malaysia-can-use-pfizer-e2-80-99s-covid-19-vaccine-now-as-conditional-registration-granted/ar-BB1czVUU|access-date=8 January 2021|name-list-style=vanc}}</ref> # Maldives<ref>{{#invoke:Cite web||date=15 March 2021|title=Sinopharm & Pfizer approved for use in Maldives|url=https://timesofaddu.com/2021/03/15/breaking-sinopharm-pfizer-approved-for-use-in-maldives/|access-date=1 April 2021|website=The Times of Addu}}</ref> # Mexico<ref>{{cite news|date=12 December 2020|title=Mexico Approves Pfizer Vaccine for Emergency Use as Covid Surges|publisher=Bloomberg|url=https://www.bloomberg.com/news/articles/2020-12-12/mexico-approves-pfizer-vaccine-for-emergency-use-as-covid-surges|access-date=12 December 2020}}</ref><ref>{{cite news|date=12 December 2020|title=Mexico authorizes emergency use of Pfizer-BioNTech coronavirus vaccine|website=The Economic Times|url=https://economictimes.indiatimes.com/news/international/world-news/mexico-authorizes-emergency-use-of-pfizer-biontech-coronavirus-vaccine/articleshow/79696221.cms|access-date=14 January 2021}}</ref> # Moldova<ref name=":2">{{cite news|last=Foundation|first=Thomson Reuters|title=Moldova approves Russia's Sputnik V vaccine as political row simmers|url=https://news.trust.org/item/20210227162136-o0jx5/|access-date=1 April 2021|website=news.trust.org|accessdate=7 July 2021|archivedate=3 April 2021|archiveurl=https://web.archive.org/web/20210403221351/https://news.trust.org/item/20210227162136-o0jx5/}}</ref> # Monaco<ref>{{#invoke:Cite web||title=First Vaccines Arrive in Monaco – COVID-19 vaccination campaign begins tomorrow / Actualités / Coronavirus (Covid-19) / Policy & Practice / Portail du Gouvernement – Monaco|url=https://en.gouv.mc/Policy-Practice/Coronavirus-Covid-19/Actualites/FIRST-VACCINES-ARRIVE-IN-MONACO-COVID-19-vaccination-campaign-begins-tomorrow|access-date=19 February 2021|website=en.gouv.mc}}</ref> # Mongolia<ref>{{#invoke:Cite web||title=Mongolia will receive 300,000 doses of COVID-19 vaccine developed by China|url=https://akipress.com/news:654794:Mongolia_will_receive_300,000_doses_of_COVID-19_vaccine_developed_by_China/|access-date=19 March 2021|website=AKIpress News Agency}}</ref> # Montenegro<ref name="whotracker"/> # Morocco<ref name="whotracker"/> # Namibia<ref name="whotracker"/> # Nepal<ref>{{cite web|date=14 November 2021|title=People to get Pfizer vaccine from today|url=https://thehimalayantimes.com/nepal/people-to-get-pfizer-vaccine-from-today|access-date=28 December 2021|website=himalayantimes}}</ref> # Nicaragua<ref name="whotracker"/> # Nigeria<ref>{{#invoke:Cite web||date=30 April 2021|title=NAFDAC approves Pfizer Biotech Vaccine for emergency use authorisation|url=https://editor.guardian.ng/news/nafdac-approves-pfizer-biotech-vaccine-for-emergency-use-authorisation/|access-date=21 July 2021|website=The Guardian Nigeria News - Nigeria and World News}}</ref> # North Macedonia<ref>{{#invoke:Cite web||title=North Macedonia Kicks Off COVID-19 Vaccinations As Serbia Looks To Highlight Regional Efforts|url=https://www.rferl.org/a/north-macedonia-kicks-off-covid-19-vaccinations/31108206.html|access-date=19 February 2021|website=RadioFreeEurope/RadioLiberty}}</ref> # Oman<ref name="oman">{{cite news|date=15 December 2020|title=Oman issues licence to import Pfizer BioNTech Covid vaccine – TV|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-oman-vaccine-int-idUSKBN28P1RA|access-date=16 December 2020}}</ref> # Pakistan<ref>{{cite web |title=DRAP gives emergency approval for Pfizer's coronavirus vaccine |url=https://www.geo.tv/latest/352816-drap-gives-emergency-approval-for-pfizers-coronavirus-vaccine |website=www.geo.tv }}</ref> # Palestine<ref name="cdctracker"/> # Panama<ref name="panama">{{#invoke:Cite web||title=Panama approves Pfizer's COVID-19 vaccine – health ministry|url=https://finance.yahoo.com/news/panama-approves-pfizers-covid-19-010942802.html|access-date=16 December 2020|publisher=Yahoo! Finance}}</ref> # Papua New Guinea<ref>{{#invoke:Cite web||date=12 August 2021|title=Vaccination is not compulsory, Prime Minister tells Parliament|url=https://covid19.info.gov.pg/vaccination-is-not-compulsory-prime-minister-tells-parliament/|access-date=24 September 2021|website=PNG &#124; COVID 19}}</ref> # Paraguay<ref>{{#invoke:Cite web||title=DNVS otorga registro sanitario de emergencia a Pfizer - MSPBS Py|url=https://www.mspbs.gov.py/portal/23306/dnvs-otorga-registro-sanitario-de-emergencia-a-pfizer.html}}</ref><ref>{{#invoke:Cite web||title=Pfizer: la nueva vacuna que compró Paraguay. MSPBS Paraguay|url=https://www.mspbs.gov.py/portal/23192/pfizer-la-nueva-vacuna-que-compro-paraguay.html}}</ref> # Peru<ref>{{#invoke:Cite web||title=Peru regulators approve Pfizer vaccine against COVID-19: filing|url=https://news.yahoo.com/peru-regulators-approve-pfizer-vaccine-173719455.html|access-date=31 March 2021|publisher=Yahoo! News}}</ref> # Philippines<ref>{{#invoke:cite news||date=14 January 2021|title=PH authorizes Pfizer's COVID-19 vaccine for emergency use|publisher=CNN Philippines|url=https://cnnphilippines.com/news/2021/1/14/Pfizer-COVID-19-vaccine-Philippines-FDA-emergency-use-EUA.html|access-date=14 January 2021}}</ref> # Qatar<ref>{{#invoke:cite news||title=Qatar, Oman to receive Pfizer-BioNTech COVID-19 vaccine this week|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-vaccine-qatar/qatar-oman-to-receive-pfizer-biontech-covid-19-vaccine-this-week-idUSKBN28U0VE|access-date=24 December 2020}}</ref> # Rwanda<ref name="cdctracker"/> # San Marino<ref name="cdctracker"/> # Serbia<ref>{{#invoke:cite news||date=21 December 2020|title=Serbia leads region in expecting COVID-19 vaccines within days|work=BalkanInsight|url=https://balkaninsight.com/2020/12/21/serbia-leads-region-in-expecting-covid-19-vaccines-within-days/|access-date=26 December 2020}}</ref><ref>{{cite news|date=22 December 2020|title=First shipment of Pfizer-BioNTech vaccine arrives in Serbia|work=Serbian government website|url=https://www.srbija.gov.rs/vest/en/165409/first-shipment-of-pfizer-biontech-vaccine-arrives-in-serbia.php|access-date=26 December 2020}}</ref> # Singapore<ref>{{#invoke:Cite web||date=14 December 2020|title=Singapore approves use of Pfizer's COVID-19 vaccine|url=https://apnews.com/article/science-singapore-coronavirus-pandemic-lee-hsien-loong-coronavirus-vaccine-5bf8461b9d2d32ec08d56fcf5958317a|access-date=15 December 2020|publisher=Associated Press}}</ref> # South Africa<ref>{{#invoke:Cite web||title=South Africa approves Pfizer Covid-19 vaccine for emergency use|url=https://businesstech.co.za/news/trending/476360/south-africa-approves-pfizer-covid-19-vaccine-for-emergency-use/|access-date=18 March 2021}}</ref><ref>{{#invoke:Cite web||title=Pfizer-BioNTec approved for emergency use in SA: here is what you need to know about the vaccine|url=https://www.timeslive.co.za/news/south-africa/2021-03-18-pfizer-biontec-approved-for-emergency-use-in-sa-here-is-what-you-need-to-know-about-the-vaccine/|access-date=19 March 2021|website=TimesLIVE}}</ref> # South Korea<ref>{{cite news|last1=Lee|first1=Kyung-eun|date=27 February 2021|title=S. Korea begins rolling out Pfizer vaccines on second day of national vaccination program|work=Arirang News|url=https://www.arirang.com/news/News_View.asp?nseq=273056|access-date=28 February 2021|accessdate=7 July 2021|archivedate=10 March 2021|archiveurl=https://web.archive.org/web/20210310013846/https://www.arirang.com/news/News_View.asp?nseq=273056}}</ref><ref>{{cite news|last1=Kim|first1=Han-joo|date=5 March 2021|title=S. Korea approves Pfizer's COVID-19 vaccine amid immunization push|publisher=Yonhap News |url=https://en.yna.co.kr/view/AEN20210305001500320|access-date=5 March 2021}}</ref> # Sri Lanka<ref>{{cite web |title=Sri Lanka approves Pfizer COVID vaccine for emergency use |url=https://www.reuters.com/business/healthcare-pharmaceuticals/sri-lanka-approves-pfizer-covid-vaccine-emergency-use-2021-05-08/ |website=Reuters |date=8 May 2021}}</ref> # Sudan<ref name="cdctracker"/> # Taiwan<ref name="RTHK 20210711">{{cite web | last=Kemp | first=Robert | title=Fosun says it has struck deal to send Taiwan vaccines | website=RTHK | date=11 July 2021 | url=https://news.rthk.hk/rthk/en/component/k2/1600277-20210711.htm? | access-date=11 July 2021}}</ref><ref name="BioNTech PR 20210712">{{cite press release | title=10 Million Doses of mRNA-based COVID-19 Vaccine to be supplied to Taiwan Region | website=BioNTech | date=12 July 2021 | url=https://investors.biontech.de/news-releases/news-release-details/10-million-doses-mrna-based-covid-19-vaccine-be-supplied-taiwan | access-date=18 July 2021}}</ref> # Tajikistan<ref name="whotracker"/> # Tanzania<ref name="whotracker"/> # Thailand<ref>{{cite news | title = Thailand approves Pfizer-Biontech vaccine for emergency use | date = 24 June 2021 | url = https://www.reuters.com/world/asia-pacific/thailand-approves-pfizer-biontech-vaccine-emergency-use-2021-06-24/ | work = Reuters }}</ref> # Tonga<ref name="whotracker"/> # Tunisia<ref name="NYT vaccine tracker" /> # Turkey<ref>{{cite web |author=Gözde Bayar |date=18 March 2021 |url=https://www.aa.com.tr/en/latest-on-coronavirus-outbreak/turkey-to-receive-45m-doses-of-pfizer-vaccine-this-month/2179702 |title=Turkey to receive 4.5M doses of Pfizer vaccine this month |publisher=Anadolu Agency}}</ref> # Uganda<ref name="whotracker"/> # Ukraine<ref>{{#invoke:Cite web||title=Наказ МОЗ України від 22.02.2021 № 308 "Про державну реєстрацію лікарського засобу (медичного імунобіологічного препарату) для екстреного медичного застосування"|url=https://moz.gov.ua/article/ministry-mandates/nakaz-moz-ukraini-vid-22022021--308-pro-derzhavnu-reestraciju-likarskogo-zasobu-medichnogo-imunobiologichnogo-preparatu-dlja-ekstrenogo-medichnogo-zastosuvannja|access-date=19 March 2021|website=moz.gov.ua}}</ref> # United Arab Emirates<ref>{{#invoke:Cite web||date=23 December 2020|title=Dubai approves the Pfizer-BioNTech vaccine which will be free of charge|url=https://emirateswoman.com/dubai-approves-the-pfizer-biontech-vaccine-for-free/|access-date=28 December 2020|website=Emirates Woman}}</ref> # United Kingdom<ref name="ukgov12-2">{{#invoke:Cite web||date=2 December 2020|title=UK medicines regulator gives approval for first UK COVID-19 vaccine|url=https://www.gov.uk/government/news/uk-medicines-regulator-gives-approval-for-first-uk-covid-19-vaccine|access-date=2 December 2020|publisher=Medicines and Healthcare Products Regulatory Agency, Government of the UK}}</ref><ref name="MHRA 2020-12-08">{{#invoke:Cite web||date=8 December 2020|title=Information for Healthcare Professionals on Pfizer/BioNTech COVID-19 vaccine|url=https://www.gov.uk/government/publications/regulatory-approval-of-pfizer-biontech-vaccine-for-covid-19/information-for-healthcare-professionals-on-pfizerbiontech-covid-19-vaccine|access-date=13 December 2020|website=Medicines & Healthcare products Regulatory Agency (MHRA)}}</ref><ref>{{#invoke:Cite web||date=3 December 2020|title=Conditions of Authorisation for Pfizer/BioNTech COVID-19 vaccine|url=https://www.gov.uk/government/publications/regulatory-approval-of-pfizer-biontech-vaccine-for-covid-19/conditions-of-authorisation-for-pfizerbiontech-covid-19-vaccine|access-date=13 December 2020|website=Medicines & Healthcare products Regulatory Agency (MHRA)}}</ref> # Uruguay<ref>{{cite web |title=Uruguay acquired Pfizer and Sinovac vaccines; details will be announced Saturday |url=https://en.mercopress.com/2021/01/23/uruguay-acquired-pfizer-and-sinovac-vaccines-details-will-be-announced-saturday |website=MercoPress }}</ref> # Uzbekistan<ref>{{cite web|date=12 September 2021|title=U.S. Donates Over 1.2 million COVID-19 Pfizer Vaccines to Uzbekistan|url=https://uz.usembassy.gov/u-s-donates-over-1-2-million-covid-19-pfizer-vaccines-to-uzbekistan/|access-date=4 October 2021|website=<nowiki>[[U.S. Embassy in Uzbekistan</nowiki>}}</ref> # Vatican City<ref>{{cite news|last=McElwee|first=Joshua J.|date=11 December 2020|title=Vatican to offer coronavirus vaccine to residents and staff in early 2021|publisher=[[National Catholic Reporter]]|url=https://www.ncronline.org/news/coronavirus/vatican-offer-coronavirus-vaccine-residents-and-staff-early-2021|access-date=9 February 2021}}</ref><ref>{{cite press release|url=https://www.vaticannews.va/it/vaticano/news/2020-12/in-vaticano-parte-il-piano-vaccinale-anticovid.html|title=In Vaticano parte il piano vaccinale anticovid|date=11 December 2020|access-date=9 February 2021|first=Massimiliano|last=Menichetti|website=vatican.va}}</ref> # Vietnam<ref>{{Cite news|last=Le|first=Nga|date=12 June 2021|title=Vietnam approves Pfizer Covid vaccine for emergency use|work=[[VnExpress]]|url=https://e.vnexpress.net/news/news/vietnam-approves-pfizer-covid-vaccine-for-emergency-use-4293267.html}}</ref> # Zambia<ref name="TrackVax">{{cite web|title=COVID19 Vaccine Tracker|url=https://covid19.trackvaccines.org/|access-date=2022-01-12|website=covid19.trackvaccines.org}}</ref> '''{{nowrap|[[European Medicines Agency|EMA]] countries}}'''<ref name="Comirnaty EPAR" /><ref name="EU Marketing authorisation" /><ref>{{cite web | title=Comirnaty | website=Union Register of medicinal products | date=21 December 2020 | url=https://ec.europa.eu/health/documents/community-register/html/h1528.htm | access-date=26 November 2021}}</ref> # Austria # Belgium # Bulgaria # Croatia # Cyprus # Czech Republic # Denmark # Estonia # Finland # France # Germany # Greece # Hungary # Iceland # Ireland # Italy # Latvia # Liechtenstein # Lithuania # Luxembourg # Malta # Netherlands # Norway # Poland # Portugal # Romania # Slovakia # Slovenia # Spain # Sweden '''{{nowrap|[[Caribbean Public Health Agency|CARPHA]] countries}}'''<ref name="carpha-pfizer">{{cite web | title=Caribbean Public Health Agency > Who We Are > Member States | website=The Caribbean Public Health Agency (CARPHA) | url=https://www.carpha.org/Who-We-Are/Member-States | access-date=7 April 2021}}</ref><ref>{{#invoke:Cite web||date=6 January 2021|title=Pfizer vaccine approved for region but Health Ministry wants more info|url=https://newsday.co.tt/2021/01/06/pfizer-vaccine-approved-for-region-but-health-ministry-wants-more-info/|access-date=24 February 2021|website=Trinidad and Tobago Newsday}}</ref> # Antigua and Barbuda # Bahamas # Barbados # Belize # Dominica # Grenada # Guyana # Haiti # Jamaica # Saint Kitts and Nevis # Saint Lucia # Saint Vincent and the Grenadines # Suriname # Trinidad and Tobago <!-- not counted --><br /> '''[[List of ISO 3166-1 codes|Non-country entities]]''' * American Samoa<ref name="whotracker"/> * Anguilla{{efn|name=carphance}} * Aruba{{efn|name=carphance}} * Bermuda{{efn|name=carphance}} * British Virgin Islands{{efn|name=carphance}} * Caribbean Netherlands{{efn|name=carphance}} * Cayman Islands{{efn|name=carphance}} * Cook Islands<ref name="whotracker"/> * Curaçao{{efn|name=carphance}} * Faroe Islands<ref>{{#invoke:Cite web||last=Nielsdóttir|first=Alda|date=30 December 2020|title=First Covid-19 vaccines administered in the Faroe Islands|url=https://local.fo/first-covid-19-vaccines-administered-in-the-faroe-islands/|access-date=29 March 2021|website=Local.fo}}</ref> * French Polynesia<ref name="whotracker"/> * Gibraltar<ref name="cdctracker"/> * Greenland<ref>{{#invoke:Cite web||last1=Sevunts|first1=Levon|last2=International|first2=Radio Canada|date=4 January 2021|title=Greenland launches COVID-19 vaccination campaign|url=https://www.rcinet.ca/eye-on-the-arctic/2021/01/04/greenland-launches-covid-19-vaccination-campaign-1/|access-date=21 March 2021|website=Eye on the Arctic}}</ref> * Guadeloupe<ref name="whotracker"/> * Guam<ref name="whotracker"/> * Guernsey<ref name="cdctracker"/> * Hong Kong<ref>{{#invoke:Cite web||date=25 January 2021|title=Use of vaccine approved|url=https://www.news.gov.hk/eng/2021/01/20210125/20210125_175428_123.html|access-date=15 February 2021|publisher=Government of Hong Kong}}</ref> * Isle of Man<ref name="cdctracker"/> * Jersey<ref name="cdctracker"/> * Macau<ref>{{#invoke:cite web||title=Local BioNTech vaccination to resume on April 5 |url=https://www.macaubusiness.com/local-biontech-vaccination-to-resume-on-april-5/ |website=macaubusiness.com |access-date=15 April 2021}}</ref> * Martinique<ref name="whotracker"/> * Montserrat{{efn|name=carphance}} * New Caledonia<ref name="cdctracker"/> * Niue<ref name="whotracker"/> * Northern Cyprus<ref name=":4" /> * Northern Mariana Islands<ref name="whotracker"/> * Puerto Rico<ref name="whotracker"/> * Sint Maarten{{efn|name=carphance}} * Tokelau<ref name="whotracker"/> * Turks and Caicos Islands{{efn|name=carphance}} * ''[[World Health Organization]]''<ref name="WHO status"/><ref>{{cite press release|title=WHO issues its first emergency use validation for a COVID-19 vaccine and emphasizes need for equitable global access|website=[[World Health Organization]] (WHO)|url=https://www.who.int/news/item/31-12-2020-who-issues-its-first-emergency-use-validation-for-a-covid-19-vaccine-and-emphasizes-need-for-equitable-global-access|date=31 December 2020|access-date=6 January 2021}}</ref><ref>{{cite web | title=WHO recommendation Tozinameran – COVID-19 mRNA vaccine (nucleoside modified) – Comirnaty | website=[[World Health Organization]] (WHO) | date=31 December 2020 | url=https://extranet.who.int/pqweb/vaccines/who-recommendation-covid-19-mrna-vaccine-nucleoside-modified-comirnaty | access-date=8 May 2021 | accessdate=7 July 2021 | archivedate=9 May 2021 | archiveurl=https://web.archive.org/web/20210509155424/https://extranet.who.int/pqweb/vaccines/who-recommendation-covid-19-mrna-vaccine-nucleoside-modified-comirnaty }}</ref> </div> == Janssen == <section begin="janssenauthmap"/> {{infobox|image={{Graph:Map|scale=65|defaultValue=gainsboro |AD=dodgerblue|AF=dodgerblue|AG=dodgerblue|AI=dodgerblue|AL=limegreen|AM=limegreen|AO=limegreen|AR=dodgerblue|AS=dodgerblue|AT=dodgerblue|AU=lightpink|AW=dodgerblue|AZ=limegreen |BA=limegreen|BB=dodgerblue|BD=dodgerblue|BE=dodgerblue|BF=dodgerblue|BG=dodgerblue|BH=dodgerblue|BJ=dodgerblue|BM=dodgerblue|BN=dodgerblue|BO=dodgerblue|BR=dodgerblue|BS=dodgerblue|BT=limegreen|BW=dodgerblue|BZ=dodgerblue |CA=blueviolet|CD=dodgerblue|CF=dodgerblue|CG=limegreen|CH=blueviolet|CI=dodgerblue|CL=dodgerblue|CM=dodgerblue|CO=dodgerblue|CR=limegreen|CV=limegreen|CW=dodgerblue|CY=dodgerblue|CZ=dodgerblue |DE=dodgerblue|DJ=dodgerblue|DK=darkred|DM=dodgerblue|DO=limegreen|DZ=limegreen |EC=limegreen|EE=dodgerblue|EG=dodgerblue|ES=dodgerblue|ET=dodgerblue |FI=dodgerblue|FJ=limegreen|FM=dodgerblue|FO=dodgerblue|FR=dodgerblue |GA=dodgerblue|GB=dodgerblue|GD=dodgerblue|GE=limegreen|GH=dodgerblue|GL=dodgerblue|GM=limegreen|GN=dodgerblue|GR=dodgerblue|GT=limegreen|GU=dodgerblue|GY=dodgerblue |HK=turquoise|HN=dodgerblue|HR=dodgerblue|HT=dodgerblue|HU=dodgerblue |ID=dodgerblue|IE=dodgerblue|IN=dodgerblue|IQ=limegreen|IR=dodgerblue|IS=dodgerblue|IT=dodgerblue |JM=dodgerblue|JO=dodgerblue |KE=dodgerblue|KG=limegreen|KH=dodgerblue|KI=limegreen|KM=limegreen|KN=dodgerblue|KP=limegreen|KR=dodgerblue|KW=dodgerblue|KY=dodgerblue |LA=dodgerblue|LB=limegreen|LC=dodgerblue|LI=dodgerblue|LK=limegreen|LR=dodgerblue|LS=dodgerblue|LT=dodgerblue|LU=dodgerblue|LV=dodgerblue|LY=dodgerblue |MA=dodgerblue|MC=limegreen|MD=dodgerblue|ME=limegreen|MG=dodgerblue|MH=dodgerblue|MK=limegreen|ML=dodgerblue|MM=limegreen|MN=limegreen|MP=dodgerblue|MR=dodgerblue|MS=dodgerblue|MT=dodgerblue|MU=limegreen|MV=dodgerblue|MW=dodgerblue|MX=dodgerblue|MY=dodgerblue|MZ=dodgerblue |NA=dodgerblue|NC=dodgerblue|NE=limegreen|NG=dodgerblue|NI=dodgerblue|NL=dodgerblue|NO=darkred|NP=dodgerblue|NR=limegreen|NZ=dodgerblue |OM=limegreen |PA=limegreen|PE=dodgerblue|PF=dodgerblue|PG=dodgerblue|PH=dodgerblue|PK=limegreen|PL=dodgerblue|PR=dodgerblue|PS=dodgerblue|PT=dodgerblue|PW=dodgerblue|PY=limegreen |QA=dodgerblue |RO=dodgerblue|RS=limegreen|RW=dodgerblue |SA=dodgerblue|SB=limegreen|SD=dodgerblue|SE=dodgerblue|SG=limegreen|SI=darkred|SK=dodgerblue|SL=limegreen|SN=dodgerblue|SO=dodgerblue|SR=dodgerblue|SS=dodgerblue|ST=limegreen|SV=limegreen|SX=dodgerblue|SY=dodgerblue|SZ=dodgerblue |TC=dodgerblue|TD=limegreen|TH=dodgerblue|TG=limegreen|TJ=limegreen|TL=limegreen|TN=dodgerblue|TO=limegreen|TR=turquoise|TT=dodgerblue|TV=limegreen|TW=dodgerblue|TZ=dodgerblue |UA=dodgerblue|UG=dodgerblue|US=dodgerblue|UY=limegreen|UZ=limegreen |VC=dodgerblue|VE=limegreen|VG=dodgerblue|VN=dodgerblue|VU=limegreen |WS=limegreen |XK=limegreen |YE=dodgerblue |ZA=dodgerblue|ZM=dodgerblue|ZW=dodgerblue }} |caption= {{leftlegend|blueviolet|Full authorization}} {{leftlegend|lightpink|Full authorization, not used}} {{leftlegend|dodgerblue|Emergency authorization}} {{leftlegend|turquoise|Allowed for travel}} {{leftlegend|limegreen|Eligible [[COVAX]] recipient}} {{leftlegend|darkred|Usage stopped}} }} <section end="janssenauthmap"/> The [[Janssen COVID-19 vaccine]]<ref>{{cite web | title=Janssen COVID-19 Emergency Use Authorization (EUA) Official Website | website=Janssen | date=28 February 2021 | url=https://www.janssencovid19vaccine.com/hcp.html | access-date=28 February 2021}}</ref> is a [[viral vector vaccine]]<ref>{{cite techreport|type=Briefing|date=26 February 2021|title=Janssen Ad26.COV2.S Vaccine for the Prevention of COVID-19|publisher=U.S. [[Food and Drug Administration]] (FDA)|url=https://www.fda.gov/media/146217/download|page=6|access-date=6 March 2021|quote=The vaccine, known as Ad26.COV2.S, is a replication-incompetent adenovirus type 26 (Ad26) vectored vaccine encoding a stabilized variant of the SARS-CoV-2 S protein.}}</ref> produced by [[Janssen Pharmaceutica]] (a subsidiary of [[Johnson & Johnson]]) and [[Beth Israel Deaconess Medical Center]].<ref name=":22">{{#invoke:Cite web||date=4 August 2020|title=A Study of Ad26.COV2.S in Adults|url=https://clinicaltrials.gov/ct2/show/NCT04436276|url-status=live|archive-url=https://web.archive.org/web/20200916063346/https://clinicaltrials.gov/ct2/show/NCT04436276|archive-date=16 September 2020|access-date=23 August 2020|website=[[ClinicalTrials.gov]]}}</ref><ref name=":32">{{#invoke:Cite web||title=A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants|url=https://clinicaltrials.gov/ct2/show/NCT04505722|url-status=live|archive-url=https://web.archive.org/web/20200926145744/https://clinicaltrials.gov/ct2/show/NCT04505722|archive-date=26 September 2020|website=[[ClinicalTrials.gov]]|publisher=US National Library of Medicine}}</ref> It is also known as Johnson & Johnson COVID-19 Vaccine and as COVID-19 Vaccine Janssen.<ref name="COVID-19 Vaccine Janssen EPAR">{{#invoke:Cite web||date=5 March 2021|title=COVID-19 Vaccine Janssen EPAR|url=https://www.ema.europa.eu/en/medicines/human/EPAR/covid-19-vaccine-janssen|access-date=16 March 2021|publisher=[[European Medicines Agency]] (EMA)}}</ref> Three countries, Denmark, Finland, and Norway, discontinued the use of the Janssen vaccine in favor of other available vaccines due to a possible link between the vaccine and a rare blood clot disorder.<ref>{{cite web |title=The Danish COVID-19 vaccine rollout continues without the COVID-19 vaccine from Johnson & Johnson |url=https://www.sst.dk/en/english/news/2021/the-danish-covid-19-vaccine-rollout-continues-without-the-covid-19-vaccine-from-johnson-johnson |website=www.sst.dk |accessdate=2021-07-07 |archivedate=2021-07-01 |archiveurl=https://web.archive.org/web/20210701225047/https://www.sst.dk/en/english/news/2021/the-danish-covid-19-vaccine-rollout-continues-without-the-covid-19-vaccine-from-johnson-johnson }}</ref><ref name="thl.fi"/><ref>{{cite web |title=Decision on using the Johnson & Johnson coronavirus vaccine in Finland to come after European Medicines Agency issues recommendations - News - THL |url=https://thl.fi/en/web/thlfi-en/-/decision-on-using-the-johnson-johnson-coronavirus-vaccine-in-finland-to-come-after-european-medicines-agency-issues-recommendations |website=Finnish Institute for Health and Welfare (THL), Finland |access-date=5 December 2021 |accessdate=25 December 2021 |archivedate=5 December 2021 |archiveurl=https://web.archive.org/web/20211205171139/https://thl.fi/en/web/thlfi-en/-/decision-on-using-the-johnson-johnson-coronavirus-vaccine-in-finland-to-come-after-european-medicines-agency-issues-recommendations }}</ref> The use of the Janssen adenovirus vector vaccine began in Finland in October 2021. It is only offered for those aged 65 and over because of a very rare risk of thrombosis in younger age groups.<ref name="Use of AstraZeneca coronavirus vacc"/><ref name="Getting vaccinated against COVID-19"/><ref name="Adenovirus vaccines: FAQ - THL"/> ;Full (<section begin="Janssen_FN"/>3<section end="Janssen_FN"/>) # Australia (not used)<ref>{{cite web | title=COVID-19 Vaccine Janssen | website=Therapeutic Goods Administration | date=25 June 2021 | url=https://www.tga.gov.au/apm-summary/covid-19-vaccine-janssen | access-date=26 June 2021 | accessdate=7 July 2021 | archivedate=28 August 2021 | archiveurl=https://web.archive.org/web/20210828190300/https://www.tga.gov.au/apm-summary/covid-19-vaccine-janssen }}</ref><ref>{{#invoke:Cite web||date=25 June 2021|title=TGA grants third provisional approval to COVID-19 vaccine: Janssen|url=https://www.tga.gov.au/media-release/tga-grants-third-provisional-approval-covid-19-vaccine-janssen|access-date=28 June 2021|website=[[Therapeutic Goods Administration]] (TGA)}}</ref> # Canada<ref>{{cite web | title=Janssen (Johnson & Johnson) COVID-19 vaccine | website=[[Health Canada]] | date=5 March 2021 | url=https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/vaccines/janssen.html | access-date=24 November 2021}}</ref><ref>{{cite web | title=Regulatory Decision Summary - Janssen COVID-19 Vaccine | website=[[Health Canada]] | url=https://covid-vaccine.canada.ca/info/regulatory-decision-summary-detail.html?linkID=RDS00890 | access-date=24 November 2021}}</ref> # Switzerland<ref>{{cite news|agency=Keystone-SDA/Reuters/sb|title=Johnson & Johnson Covid vaccine approved for use in Switzerland|url=https://www.swissinfo.ch/eng/johnson---johnson-covid-vaccine-approved-for-use-in-switzerland/46469458|access-date=1 April 2021|website=SWI swissinfo.ch}}</ref><ref>{{cite news | title=Swissmedic regulator approves Johnson & Johnson COVID-19 vaccine | publisher=Reuters | date=22 March 2021 | url=https://www.reuters.com/article/health-coronavirus-swiss-johnsonjohnson-idUSZ8N2K8003 | access-date=3 April 2021}}</ref> {{-}} ;Emergency (<section begin="Janssen_EN"/>126<section end="Janssen_EN"/>) <div style="margin-top: 0.3em; column-width: 15em;"> # Afghanistan<ref name="whotracker"/> # Andorra<ref name="Andorra vaccines">{{cite news|title=Informació en relació amb la vacunació contra la COVID-19|publisher=Govern d'Andorra|url=https://www.govern.ad/vacunacio/faqs/FAQS_Vacunacio_COVID19.pdf|access-date=14 March 2021 | language=ca }}</ref> # Argentina<ref>{{cite web|last=de 2021|first=6 de Octubre|title=COVID-19: la ANMAT aprobó el uso de emergencia de la vacuna de Johnson & Johnson|url=https://www.infobae.com/salud/2021/10/06/covid-19-la-anmat-aprobo-el-uso-de-emergencia-de-la-vacuna-de-janssen/|access-date=6 October 2021|website=infobae|language=es-ES}}</ref> # Bahamas<ref>{{cite web|title=Farmacovigilancia de vacunas para COVID-19 - Janssen|url=https://covid-19pharmacovigilance.paho.org/|access-date=9 October 2021|website=Farmacovigilancia de vacunas para COVID-19}}</ref> # Bahrain<ref>{{cite news | title=Bahrain first to approve Johnson & Johnson COVID-19 vaccine for emergency use | publisher=Reuters | date=25 February 2021 | url=https://www.reuters.com/article/health-coronavirus-bahrain-idUSS8N2I4021 | access-date=25 February 2021}}</ref><ref>{{cite news | title=Bahrain becomes 1st nation to grant J&J shot emergency use | website=ABC News (United States) | date=25 February 2021 | url=https://abcnews.go.com/International/wireStory/bahrain-1st-nation-grant-jj-shot-emergency-76112143 | access-date=25 February 2021}}</ref> # Bangladesh<ref>{{cite news | title=Bangladesh approves Johnson & Johnson's Covid-19 vaccine for emergency use| publisher=Dhaka Tribune | date=15 June 2021| url=https://www.dhakatribune.com/bangladesh/2021/06/15/johnson-johnson-s-covid-19-vaccine-approved-for-emergency-use | access-date=15 June 2021}}</ref><ref>{{cite news |url=https://www.thedailystar.net/coronavirus-deadly-new-threat/news/single-dose-covid-19-vaccine-janssen-gets-emergency-use-authorization-bangladesh-2111557| title=Single-dose Covid-19 vaccine Janssen gets emergency use authorization in Bangladesh| website=[[The Daily Star (Bangladesh)|The Daily Star]]| date=15 June 2021|access-date=15 June 2021}}</ref> # Benin<ref name="whotracker"/> # Bolivia<ref name="whotracker" /> # Botswana<ref>{{cite web |title=COVID-19 Vaccines Approved by BoMRA |url=https://www.bomra.co.bw/index.php/news-updates/177-covid-19-vaccines-approved-by-bomra |website=www.bomra.co.bw |accessdate=2021-07-07 |archivedate=2021-06-13 |archiveurl=https://web.archive.org/web/20210613171202/https://www.bomra.co.bw/index.php/news-updates/177-covid-19-vaccines-approved-by-bomra }}</ref> # Brazil<ref>{{cite news |date=31 March 2021 |title=Brazil health regulator approves emergency use of Johnson & Johnson COVID-19 vaccine |url=https://www.reuters.com/article/health-coronavirus-brazil-janssen/brazil-health-regulator-approves-emergency-use-of-johnson-johnson-covid-19-vaccine-idUSL1N2LT2PS |publisher=Reuters |location=Rio de Janeiro |access-date=1 April 2021}}</ref> # Brunei<ref name="whotracker"/> # Burkina Faso<ref name="whotracker"/> # Cambodia<ref name="whotracker"/> # Cameroon<ref name="whotracker"/> # Central African Republic<ref name="TrackVax"/> # Chile<ref>{{cite web |title=Chile authorizes emergency use of Johnson & Johnson's Janssen vaccine through COVAX|url=https://www.ispch.cl/noticia/isp-valida-uso-de-emergencia-de-la-vacuna-janssen-de-johnson-johnson-a-traves-de-mecanismo-covax/|publisher=Public Health Institute, [[Ministry of Health (Chile)|Ministry of Health of Chile]]|date=10 June 2021}}</ref> # Colombia<ref>{{cite news|last=Acosta|first=Luis Jaime|location=Bogotá|title=Colombia grants emergency use for J&J coronavirus vaccine |url=https://www.reuters.com/article/health-coronavirus-colombia/colombia-grants-emergency-use-for-jj-coronavirus-vaccine-idUSL1N2LO01O |access-date=25 March 2021 |publisher=Reuters |date=25 March 2021}}</ref> # Congo-Kinshasa<ref name="DRC"/> # Djibouti<ref name="whotracker"/> # Egypt<ref name="whotracker"/> # Eswatini<ref name="whotracker"/> # Ethiopia<ref name="whotracker"/> # Gabon<ref name="TrackVax"/> # Ghana<ref>{{#invoke:cite web ||title=Johnson & Johnson COVID-19 vaccine to be available in Ghana by August |url=https://www.graphic.com.gh/news/general-news/johnson-johnson-covid-19-vaccine-to-be-available-in-ghana-by-august.html |website=Graphic Online}}</ref> # Guinea<ref name="whotracker"/> # Honduras<ref name="cdctracker"/> # India<ref>{{#invoke:Cite web||date=7 August 2021|title=India approves J&J COVID-19 vaccine for emergency use|url=https://www.reuters.com/world/india/india-approves-jj-covid-19-vaccine-emergency-use-2021-08-07/|access-date=7 August 2021|website=Reuters}}</ref> # Indonesia<ref name="auto6">{{cite web|last=|first=|date=7 September 2021|title=BPOM Terbitkan Izin Penggunaan Darurat Vaksin Covid-19 Produksi Johnson & Johnson dan Cansino|url=https://nasional.kompas.com/read/2021/09/07/18330171/bpom-terbitkan-izin-penggunaan-darurat-vaksin-covid-19-produksi-johnson|access-date=7 September 2021|website=KOMPAS.com|language=id}}</ref> # Iran<ref name="TrackVax"/> # Ivory Coast<ref name="whotracker"/> # Jordan<ref name="whotracker"/> # Kenya<ref name="auto13"/> # Kuwait<ref>{{cite web |title=Kuwait authorises emergency use of Johnson & Johnson vaccine |url=https://www.kuna.net.kw/ArticleDetails.aspx?id=2980741&language=en |publisher=Kuwait News Agency (KUNA) |date=8 June 2021}}</ref> # Laos<ref name="whotracker"/> # Lesotho<ref name="whotracker"/> # Liberia<ref name="TrackVax"/> # Libya<ref name="cdctracker"/> # Madagascar<ref name="whotracker"/> # Malawi<ref name="whotracker"/> # Malaysia<ref>{{cite news|date=15 June 2021|title=Malaysia grants conditional approval for CanSino, J&J COVID-19 vaccines|url= https://www.reuters.com/business/healthcare-pharmaceuticals/malaysia-grants-conditional-approval-cansino-jj-covid-19-vaccines-2021-06-15/|work=[[Reuters]]|access-date= 15 June 2021}}</ref> # Maldives<ref>{{cite web |title=Approval to use of Covid-19 vaccine Janssen |url=http://health.gov.mv/Uploads/Downloads//Informations/Informations(381).pdf |publisher=Maldives Food and Drug Authority |date=6 June 2021 |accessdate=7 July 2021 |archivedate=11 June 2021 |archiveurl=https://web.archive.org/web/20210611230415/http://health.gov.mv/Uploads/Downloads//Informations/Informations(381).pdf }}</ref> # Mali<ref name="TrackVax"/> # Marshall Islands{{efn|name=CFA}} # Mauritania<ref name="TrackVax"/> # Mexico<ref>{{cite web |title= El Comité de Moléculas Nuevas de COFEPRIS informa sobre los resultados de votación para la vacuna COVID-19 (Ad26.COV2-S [Recombinante]) |url=https://www.gob.mx/cofepris/articulos/el-comite-de-moleculas-nuevas-de-cofepris-informa-sobre-los-resultados-de-votacion-para-la-vacuna-covid-19-ad26-cov2-s-recombinante |website=www.gob.mx/cofepris |language=es}}</ref><ref>{{cite web |title= COFEPRIS emite autorización para uso de emergencia a vacuna contra COVID-19 Ad26.COV2.S de Janssen (Johnson & Johnson) |url=https://www.gob.mx/cofepris/articulos/cofepris-emite-autorizacion-para-uso-de-emergencia-a-vacuna-contra-covid-19-ad26-cov2-s-de-janssen-johnson-johnson |website=www.gob.mx/cofepris |language=es}}</ref> # Micronesia{{efn|name=CFA}} # Moldova<ref name="msmps.gov.md"/> # Morocco<ref name="whotracker"/> # Mozambique<ref name="whotracker"/> # Namibia<ref name="whotracker"/> # Nepal<ref>{{#invoke:Cite web||title=1.5 million doses of J&J vaccine arrive in Nepal|url=https://kathmandupost.com/health/2021/07/12/1-5-million-doses-of-j-j-vaccine-arrive-in-nepal|access-date=12 July 2021|website=kathmandupost}}</ref> # New Zealand<ref name="whotracker"/> # Nicaragua<ref name="whotracker"/> # Nigeria<ref>{{#invoke:Cite web||date=20 April 2021|title=905m COVID-19 shots administered worldwide – Report|url=https://www.premiumtimesng.com/health/456360-905m-covid-19-shots-administered-worldwide-report.html|access-date=7 June 2021}}</ref> # Palau{{efn|name=CFA}} # Palestine<ref name="whotracker"/> # Papua New Guinea<ref name="whotracker"/> # Peru<ref>{{#invoke:Cite web||date=9 July 2021|title=Peru authorizes use of Johnson & Johnson COVID-19 vaccine|url=https://andina.pe/ingles/noticia-peru-authorizes-use-of-johnson-johnson-covid19-vaccine-852510.aspx|access-date=3 August 2021|website=[[ATV (Peruvian TV channel)|Andina]]}}</ref> # Philippines<ref>{{#invoke:Cite web||url=https://cnnphilippines.com/news/2021/4/19/covaxin-janssen-emergency-use-authorization.html|title=Covaxin, Janssen approved for emergency use in PH |work=CNN Philippines|date=19 April 2021}}</ref> # Qatar<ref name="whotracker"/> # Rwanda<ref name="whotracker"/> # Saudi Arabia<ref name="whotracker"/> # Senegal<ref name="whotracker"/> # Singapore<ref name="channelnewsasia.com"/> ''(restricted)'' # Somalia<ref name="whotracker"/> # South Africa<ref>{{cite news|url=https://www.bbc.com/news/world-africa-55675806|title=Coronavirus: South Africa rolls out vaccination programme|date=17 February 2021|access-date=19 February 2021|work=BBC News}}</ref> # South Korea<ref>{{cite news |last1=Lardieri |first1=Alexa |title=South Korea Approves Johnson & Johnson Vaccine |url=https://www.usnews.com/news/health-news/articles/2021-04-07/south-korea-grants-conditional-approval-to-johnson-johnson-coronavirus-vaccine |access-date=8 April 2021 |work=U.S. News & World Report |date=7 April 2021}}</ref> # South Sudan<ref name="whotracker"/> # Sudan<ref name="whotracker"/> # Syria<ref name="whotracker"/> # Taiwan (not used)<ref>{{Cite news|date=10 June 2021|title=嬌生疫苗通過我緊急使用授權 BNT僅「有條件通過」|publisher=The Liberty Times|url=https://news.ltn.com.tw/news/life/breakingnews/3565594}}</ref> # Tanzania<ref name="whotracker"/> # Thailand<ref>{{Cite news|date=25 March 2021|title=Thailand approves Johnson & Johnson's COVID-19 vaccine|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-thailand-idUSKBN2BH1L7|access-date=1 April 2021}}</ref> # Tunisia<ref>{{cite news |title=Tunisia approve Johnson & Johnson COVID-19 vaccine |url=https://www.reuters.com/article/uk-health-coronavirus-tunisia/tunisia-approve-johnson-johnson-covid-19-vaccine-idUSKBN2BV1SQ |website=Reuters |date=8 April 2021}}</ref> # Uganda<ref name="whotracker"/> # Ukraine<ref name="whotracker"/> # United Kingdom<ref>{{cite news |title=Janssen single-dose Covid vaccine approved by UK |url=https://www.bbc.com/news/health-57283837 |publisher=BBC News |date=28 May 2021}}</ref> # United States<ref name="FDA PR 20210227">{{cite press release | title=FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine | publisher=U.S. [[Food and Drug Administration]] (FDA) | date=27 February 2021 | url=https://www.fda.gov/news-events/press-announcements/fda-issues-emergency-use-authorization-third-covid-19-vaccine | access-date=27 February 2021}}</ref><ref name="FDA EUA">{{cite web|url=https://www.fda.gov/media/146303/download|title=Janssen COVID-19 Vaccine EUA Letter of Authorization 06102021|date=10 June 2021|website=U.S. Food & Drug Administration}}</ref> # Vietnam<ref name=ldo1507>{{Cite news|date=15 July 2021|title=Việt Nam phê duyệt khẩn cấp vaccine COVID-19 của Johnson & Johnson|work=Lao Động|url=https://laodong.vn/y-te/viet-nam-phe-duyet-khan-cap-vaccine-covid-19-cua-johnson--johnson-930853.ldo}}</ref><ref name=vnp1507>{{Cite news|date=15 July 2021|title=Bộ Y tế phê duyệt vaccine phòng COVID-19 Janssen của Johnson & Johnson|work=Vietnam+|url=https://www.vietnamplus.vn/bo-y-te-phe-duyet-vaccine-phong-covid19-janssen-cua-johnson-johnson/726931.vnp}}</ref> # Yemen<ref name="whotracker"/> # Zambia<ref name=":5" /><ref name=":6" /><ref name=":8" /> # Zimbabwe<ref>{{#invoke:Cite web||date=28 July 2021|title=Zimbabwe approves J&J COVID-19 vaccine for emergency use|url=https://www.reuters.com/business/healthcare-pharmaceuticals/zimbabwe-approves-jj-covid-19-vaccine-emergency-use-2021-07-28/|access-date=23 August 2021|website=Reuters}}</ref> '''{{nowrap|[[European Medicines Agency|EMA]] countries}}'''<ref name="COVID-19 Vaccine Janssen EPAR" /><ref name="EU Marketing authorisation">{{#invoke:Cite web||title=Marketing authorisation|url=https://www.ema.europa.eu/en/human-regulatory/marketing-authorisation|access-date=23 March 2021|publisher=[[European Medicines Agency]] (EMA)}}</ref><ref>{{cite web | title=COVID-19 Vaccine Janssen | website=Union Register of medicinal products | url=https://ec.europa.eu/health/documents/community-register/html/h1525.htm | access-date=26 November 2021}}</ref> # Austria # Belgium # Bulgaria # Croatia # Cyprus # Czech Republic # Denmark # Estonia # Finland # France # Germany # Greece # Hungary # Iceland # Ireland # Italy # Latvia # Liechtenstein # Lithuania # Luxembourg # Malta # Netherlands # Norway # Poland # Portugal # Romania # Slovakia # Slovenia # Spain # Sweden '''{{nowrap|[[Caribbean Public Health Agency|CARPHA]] countries}}'''<ref name="COVID-19 Vaccine Information">{{cite web |title=COVID-19 Vaccine Information |url=https://www.carpha.org/What-We-Do/Public-Health/Novel-Coronavirus/COVID-19-Vaccine-Information |website=www.carpha.org}}</ref> # Antigua and Barbuda # Bahamas # Barbados # Belize # Dominica # Grenada # Guyana # Haiti # Jamaica # Saint Kitts and Nevis # Saint Lucia # Saint Vincent and the Grenadines<ref name="auto2"/> # Suriname # Trinidad and Tobago <!-- not counted --> <!-- not counted --><br /> '''Non-country entities''' * American Samoa<ref name="whotracker"/> * Anguilla{{efn|name=carphance}} * Aruba{{efn|name=carphance}} * Bermuda{{efn|name=carphance}} * British Virgin Islands{{efn|name=carphance}} * Caribbean Netherlands{{efn|name=carphance}} * Cayman Islands{{efn|name=carphance}} * Curaçao{{efn|name=carphance}} * French Polynesia<ref name="whotracker"/> * Greenland<ref name="NYT vaccine tracker" /> * Guam<ref name="whotracker"/> * Montserrat{{efn|name=carphance}} * New Caledonia<ref name="whotracker"/> * Northern Cyprus<ref>{{cite web|title=Aşı Türleri - K.K.T.C. Sağlık Bakanlığı - Aşı Bilgi Sistemi|url=https://asi.saglik.gov.ct.tr/content/vaccine-types|access-date=19 November 2021|website=asi.saglik.gov.ct.tr|accessdate=25 December 2021|archivedate=19 November 2021|archiveurl=https://web.archive.org/web/20211119085117/https://asi.saglik.gov.ct.tr/content/vaccine-types}}</ref> * Northern Mariana Islands<ref name="whotracker"/> * Puerto Rico<ref name="whotracker"/> * Sint Maarten{{efn|name=carphance}} * Turks and Caicos Islands{{efn|name=carphance}} * ''Africa Regulatory Taskforce''<ref>{{#invoke:Cite web||title=UPDATE: Statement to Member States regarding thromboembolic events after vaccination with Janssen COVID-19 vaccine (Johnson & Johnson)|url=https://africacdc.org/news-item/update-statement-to-member-states-regarding-thromboembolic-events-after-vaccination-with-janssen-covid-19-vaccine-johnson-johnson/|access-date=7 June 2021|website=Africa CDC}}</ref> * ''[[World Health Organization]]''<ref>{{cite news |title=WHO approves J&J's COVID-19 vaccine for emergency listing |url=https://www.channelnewsasia.com/news/world/covid-19-who-approves-johnson-jj-vaccine-emergency-listing-14394654 |access-date=13 March 2021 |publisher=Channel NewsAsia |date=13 March 2021 |accessdate=7 July 2021 |archivedate=18 March 2021 |archiveurl=https://web.archive.org/web/20210318014950/https://www.channelnewsasia.com/news/world/covid-19-who-approves-johnson-jj-vaccine-emergency-listing-14394654 }}</ref><ref>{{cite web | title=WHO recommendation Janssen–Cilag International NV (Belgium) COVID-19 Vaccine (Ad26.COV2-S [recombinant]) | website=[[World Health Organization]] (WHO) | date=12 March 2021 | url=https://extranet.who.int/pqweb/vaccines/who-recommendation-janssen-cilag-international-nv-belgium-covid-19-vaccine-ad26cov2-s | access-date=8 May 2021 | accessdate=7 July 2021 | archivedate=8 May 2021 | archiveurl=https://web.archive.org/web/20210508195419/https://extranet.who.int/pqweb/vaccines/who-recommendation-janssen-cilag-international-nv-belgium-covid-19-vaccine-ad26cov2-s }}</ref> ;Travel-only * Hong Kong<ref name="HK"/> * Turkey<ref name="visasturkey.com"/> </div> == Moderna == <section begin="modernaauthmap" /> {{infobox|image={{Graph:Map|scale=65|defaultValue=gainsboro |AD=dodgerblue|AE=dodgerblue|AF=limegreen|AG=dodgerblue|AI=dodgerblue|AL=limegreen|AM=dodgerblue|AO=limegreen|AR=dodgerblue|AS=dodgerblue|AU=blueviolet|AT=dodgerblue|AW=dodgerblue|AZ=limegreen |BA=limegreen|BB=dodgerblue|BD=dodgerblue|BE=dodgerblue|BF=limegreen|BG=dodgerblue|BH=dodgerblue|BJ=limegreen|BM=dodgerblue|BN=dodgerblue|BO=limegreen|BQ=dodgerblue|BR=dodgerblue|BS=dodgerblue|BT=dodgerblue|BW=dodgerblue|BZ=dodgerblue |CA=blueviolet|CD=dodgerblue|CF=limegreen|CG=dodgerblue|CH=blueviolet|CI=limegreen|CL=dodgerblue|CM=limegreen|CO=dodgerblue|CR=limegreen|CV=dodgerblue|CW=dodgerblue|CY=dodgerblue|CZ=dodgerblue |DE=dodgerblue|DJ=limegreen|DK=dodgerblue|DM=dodgerblue|DO=limegreen|DZ=limegreen |EC=limegreen|EE=dodgerblue|EG=dodgerblue|ES=dodgerblue|ET=limegreen |FI=dodgerblue|FJ=dodgerblue|FM=dodgerblue|FO=dodgerblue|FR=dodgerblue |GB=blueviolet|GD=dodgerblue|GE=limegreen|GF=dodgerblue|GH=dodgerblue|GL=dodgerblue|GM=limegreen|GN=limegreen|GP=dodgerblue|GR=dodgerblue|GT=dodgerblue|GU=dodgerblue|GY=dodgerblue |HK=turquoise|HN=dodgerblue|HR=dodgerblue|HT=dodgerblue|HU=dodgerblue |ID=dodgerblue|IE=dodgerblue|IL=dodgerblue|IM=dodgerblue|IN=dodgerblue|IQ=limegreen|IR=limegreen|IS=dodgerblue|IT=dodgerblue |JE=dodgerblue|JP=dodgerblue|JM=dodgerblue|JO=dodgerblue |KE=dodgerblue|KG=dodgerblue|KH=limegreen|KI=limegreen|KM=limegreen|KN=dodgerblue|KP=limegreen|KR=dodgerblue|KW=dodgerblue|KY=dodgerblue |LA=limegreen|LB=limegreen|LC=dodgerblue|LK=dodgerblue|LR=limegreen|LS=limegreen|LT=dodgerblue|LU=dodgerblue|LV=dodgerblue|LY=dodgerblue |MA=limegreen|MC=limegreen|MD=dodgerblue|ME=limegreen|MH=dodgerblue|MK=limegreen|ML=limegreen|MM=limegreen|MN=dodgerblue|MP=dodgerblue|MR=limegreen|MS=dodgerblue|MT=dodgerblue|MU=limegreen|MV=dodgerblue|MW=dodgerblue|MX=dodgerblue|MY=dodgerblue|MZ=limegreen |NA=limegreen|NE=limegreen|NG=dodgerblue|NI=limegreen|NL=dodgerblue|NO=dodgerblue|NP=dodgerblue|NR=limegreen|NZ=turquoise |OM=limegreen |PA=limegreen|PE=dodgerblue|PG=limegreen|PH=dodgerblue|PK=dodgerblue|PL=dodgerblue|PR=dodgerblue|PS=dodgerblue|PT=dodgerblue|PW=dodgerblue|PY=dodgerblue |QA=dodgerblue |RO=dodgerblue|RS=dodgerblue|RW=dodgerblue |SA=dodgerblue|SB=limegreen|SD=limegreen|SE=dodgerblue|SG=dodgerblue|SI=dodgerblue|SK=dodgerblue|SL=limegreen|SN=limegreen|SO=limegreen|SR=dodgerblue|SS=limegreen|ST=limegreen|SV=dodgerblue|SX=dodgerblue|SY=limegreen|SZ=limegreen |TC=dodgerblue|TD=limegreen|TG=limegreen|TH=dodgerblue|TJ=dodgerblue|TL=limegreen|TN=|TR=turquoise |TO=limegreen|TT=dodgerblue|TV=limegreen|TW=dodgerblue |UA=dodgerblue|UG=dodgerblue|US=blueviolet|UY=limegreen|UZ=dodgerblue |VC=dodgerblue|VE=limegreen|VG=dodgerblue|VU=limegreen|VN=dodgerblue |WF=dodgerblue|WS=limegreen |XK=limegreen |YE=limegreen |ZA=limegreen|ZM=limegreen|ZW=limegreen }} |caption= {{leftlegend|blueviolet|Full authorization}} {{leftlegend|dodgerblue|Emergency authorization}} {{leftlegend|turquoise|Allowed for travel}} {{leftlegend|limegreen|Eligible [[COVAX]] recipient}} }} <section end="modernaauthmap" /> The [[Moderna COVID-19 vaccine]], also known as Spikevax,<ref name="COVID-19 Vaccine Moderna EPAR" /> is an [[RNA vaccine|mRNA vaccine]]<ref name="NCT04283461">{{#invoke:Cite web||date=16 March 2020|title=Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19)|url=https://clinicaltrials.gov/ct2/show/NCT04283461|access-date=5 March 2021|website=[[ClinicalTrials.gov]]|publisher=[[United States National Library of Medicine]]|id=NCT04283461}}</ref> produced by the American company [[Moderna]], the U.S. [[National Institute of Allergy and Infectious Diseases]], the U.S. [[Biomedical Advanced Research and Development Authority]], and the [[Coalition for Epidemic Preparedness Innovations]].<ref name="NCT044704272">{{#invoke:Cite web||date=14 July 2020|title=A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19|url=https://clinicaltrials.gov/ct2/show/NCT04470427|url-status=live|archive-url=https://web.archive.org/web/20201011084833/https://clinicaltrials.gov/ct2/show/NCT04470427/|archive-date=11 October 2020|access-date=27 July 2020|website=[[ClinicalTrials.gov]]|publisher=[[United States National Library of Medicine]]|id=NCT04470427}}</ref><ref name="palca2">{{cite news|last1=Palca|first1=Joe|date=27 July 2020|title=COVID-19 vaccine candidate heads to widespread testing in U.S.|publisher=NPR|url=https://www.npr.org/sections/coronavirus-live-updates/2020/07/27/895672859/us-vaccine-candidate-heads-to-widespread-testing-in-people|url-status=live|access-date=27 July 2020|archive-url=https://web.archive.org/web/20201011084836/https://www.npr.org/sections/coronavirus-live-updates/2020/07/27/895672859/us-vaccine-candidate-heads-to-widespread-testing-in-people/|archive-date=11 October 2020|name-list-style=vanc}}</ref> The Moderna vaccine is not offered for men under 30 years of age in Finland as a precaution to reduce a very rare risk of myocarditis.<ref>{{cite web |title=THL issues instructions that men under 30 years of age should only be offered the Comirnaty coronavirus vaccine - Press release - THL |url=https://thl.fi/en/web/thlfi-en/-/thl-issues-instructions-that-men-under-30-years-of-age-should-only-be-offered-the-comirnaty-coronavirus-vaccine |website=Finnish Institute for Health and Welfare (THL), Finland |access-date=5 December 2021 |accessdate=25 December 2021 |archivedate=5 December 2021 |archiveurl=https://web.archive.org/web/20211205160943/https://thl.fi/en/web/thlfi-en/-/thl-issues-instructions-that-men-under-30-years-of-age-should-only-be-offered-the-comirnaty-coronavirus-vaccine }}</ref><ref name="Getting vaccinated against COVID-19"/> ;Full (<section begin="Moderna_FN" />5<section end="Moderna_FN" />) # Australia<ref>{{#invoke:Cite web||date=9 August 2021|title=TGA provisionally approves Moderna’s COVID-19 vaccine|url=https://www.tga.gov.au/media-release/tga-provisionally-approves-modernas-covid-19-vaccine-0|website=Therapeutic Goods Administration}}</ref> # Canada<ref name="hc-moderna12-23">{{cite web|date=23 December 2020|title=Regulatory Decision Summary – Moderna COVID-19 Vaccine|url=https://covid-vaccine.canada.ca/info/regulatory-decision-summary-detailTwo.html?linkID=RDS00736|access-date=23 December 2020|publisher=Health Canada, Government of Canada}}</ref><ref name="hcapps">{{#invoke:Cite web||date=9 December 2020|title=Drug and vaccine authorizations for COVID-19: List of applications received|url=https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/authorization/applications.html|access-date=9 December 2020|publisher=Health Canada, Government of Canada}}</ref><ref name=":13" /> # Switzerland<ref>{{cite press release|title=Swissmedic grants authorisation for the COVID-19 vaccine from Moderna |url=https://www.swissmedic.ch/swissmedic/en/home/news/coronavirus-covid-19/zulassung-covid-19-impfstoff-moderna.html |publisher=[[Swissmedic|Swiss Agency for Therapeutic Products (Swissmedic)]] |date=12 January 2020 |access-date=12 January 2020}}</ref> # United Kingdom<ref>{{#invoke:Cite web||date=1 April 2021|title=Information for Healthcare Professionals on COVID-19 Vaccine Moderna|url=https://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-moderna/information-for-healthcare-professionals-on-covid-19-vaccine-moderna|access-date=6 April 2021|website=[[Medicines and Healthcare products Regulatory Agency]] (MHRA)}}</ref><ref>{{#invoke:Cite web||date=19 February 2021|title=Summary of the Public Assessment Report for COVID-19 Vaccine Moderna|url=https://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-moderna/summary-of-the-public-assessment-report-for-covid-19-vaccine-moderna|access-date=6 April 2021|website=[[Medicines and Healthcare products Regulatory Agency]] (MHRA)}}</ref> # United States<ref>{{Cite news|date=31 January 2022|title=Coronavirus (COVID-19) Update: FDA Takes Key Action by Approving Second COVID-19 Vaccine|work=[[Food and Drug Administration]]|url=https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-takes-key-action-approving-second-covid-19-vaccine|access-date=31 January 2022}}</ref> {{-}} ;Emergency (<section begin="Moderna_EN" />104<section end="Moderna_EN" />) <div style="margin-top: 0.3em; column-width: 15em;"> # Andorra<ref name="Andorra vaccines" /> # Argentina<ref>{{cite web|title=BOLETIN OFICIAL REPUBLICA ARGENTINA - MINISTERIO DE SALUD - Resolución 2711/2021|url=https://www.boletinoficial.gob.ar/detalleAviso/primera/250495|access-date=6 October 2021|website=www.boletinoficial.gob.ar}}</ref> # Armenia<ref name="whotracker" /> # Bahrain<ref name="whotracker" /> # Bangladesh<ref>{{cite web |title=Moderna gets emergency use authorisation in Bangladesh|url=https://www.thedailystar.net/coronavirus-deadly-new-threat/news/moderna-gets-emergency-use-authorisation-bangladesh-2120677 |website=[[The Daily Star (Bangladesh)|The Daily Star]] |date=29 June 2021|access-date=30 June 2021}}</ref> # Bhutan<ref name="whotracker"/> # Botswana<ref>{{cite press release |title=Moderna Announces Agreement to Supply the Republic of Botswana with its COVID-19 Vaccine |url=https://www.businesswire.com/news/home/20210603005629/en/Moderna-Announces-Agreement-to-Supply-the-Republic-of-Botswana-with-its-COVID-19-Vaccine |publisher=Moderna|via=Business Wire |date=3 June 2021}}</ref> # Bolivia<ref>{{cite web |url=https://www.swissinfo.ch/spa/coronavirus-bolivia_bolivia-recibe-1-9-millones-de-vacunas-moderna-donadas-por-espa%C3%B1a-y-alemania/47231766|title=Bolivia recibe 1,9 millones de vacunas Moderna donadas por España y Alemania}}</ref> # Brazil<ref name="Agência Brasil"/> # Brunei<ref name="whotracker"/> # Cape Verde<ref name="whotracker"/> # Chile<ref>{{Cite web |title=Instituto de Salud Pública de Chile |url=https://www.ispch.cl/noticia/el-isp-valida-el-uso-de-emergencia-de-la-vacuna-contra-covid-19-del-laboratorio-moderna/#:~:text=La%20s%C3%A9ptima%20vacuna%20aprobada%20en,s%C3%A9ptima%20vacuna%20contra%20COVID-19. |access-date=2022-05-21 |website=www.ispch.cl}}</ref> # Colombia<ref>{{cite web |url=https://www.elespectador.com/salud/colombia-autoriza-el-uso-de-la-vacuna-de-moderna-para-el-coronavirus/ |title=Colombia autoriza el uso de la vacuna de Moderna para el coronavirus|first=El|last=Espectador|date=25 June 2021|website=El Espectador}}</ref> # Congo-Brazzaville<ref name="cdctracker"/> # Congo-Kinshasa<ref name="DRC"/> # Egypt<ref>{{cite web |title=StackPath|url=https://dailynewsegypt.com/2021/10/31/egypt-receives-784280-doses-of-modernas-covid-19-vaccine/ |access-date=5 November 2021|website=dailynewsegypt}}</ref> # El Salvador<ref name="whotracker"/> # Fiji<ref name="whotracker"/> # Ghana<ref>{{cite web|title=Farmacovigilancia de vacunas para COVID-19 - Moderna|url=https://covid-19pharmacovigilance.paho.org/|access-date=24 September 2021|website=Farmacovigilancia de vacunas para COVID-19}}</ref> # Guatemala<ref name="auto3" /> # Honduras<ref>{{cite web |title=Honduras a la zaga de la vacunación en Centroamérica |url=https://proceso.hn/honduras-a-la-zaga-en-vacunacion-en-ca/ |website=Proceso Digital |language=es |date=10 April 2021}}</ref> # India<ref>{{cite news |last1=Kaul |first1=Rhythma |title=Moderna's Covid vaccine approved for use in India |url=https://www.hindustantimes.com/india-news/modernas-covid-vaccine-approved-for-use-in-india-101624990937539.html |work=Hindustan Times |date=29 June 2021 }}</ref> # Indonesia<ref>{{cite news |author= Friski Riana |editor= Laila Afifa|title=BPOM Issues Emergency Use Authorization for Moderna Vaccine |url=https://en.tempo.co/read/1478877/bpom-issues-emergency-use-authorization-for-moderna-vaccine |work=Tempo.co |date=2 July 2021 }}</ref> # Israel<ref name="israelmoderna">{{cite web|title=Israeli Ministry of Health Authorizes COVID-19 Vaccine Moderna for Use in Israel|url=https://investors.modernatx.com/news-releases/news-release-details/israeli-ministry-health-authorizes-covid-19-vaccine-moderna-use|publisher=modernatx.com|access-date=4 January 2021|date=4 January 2021|accessdate=7 July 2021|archivedate=17 February 2021|archiveurl=https://web.archive.org/web/20210217215148/https://investors.modernatx.com/news-releases/news-release-details/israeli-ministry-health-authorizes-covid-19-vaccine-moderna-use}}</ref> # Japan<ref name="jp" /><ref>{{cite press release | title=Takeda Announces Approval of Moderna's COVID-19 Vaccine in Japan | publisher=Takeda | via=Business Wire | date=21 May 2021 | url=https://www.businesswire.com/news/home/20210520006154/en/Takeda-Announces-Approval-of-Moderna%E2%80%99s-COVID-19-Vaccine-in-Japan | access-date=2 July 2021}}</ref> # Jordan<ref name="whotracker"/> # Kenya<ref name=":10">{{Cite news|title=Kenya approves Moderna Sinopharm vaccines amid fourth wave|url=https://www.bloomberg.com/news/articles/2021-08-19/kenya-approves-moderna-sinopharm-vaccines-amid-fourth-wave|access-date=28 August 2021|newspaper=Bloomberg.com|date = 19 August 2021}}</ref> # Kuwait<ref>{{cite web |title=COVID-19: Kuwait unlikely to import Sputnik V |url=https://gulfnews.com/world/gulf/kuwait/covid-19-kuwait-unlikely-to-import-sputnik-v-1.78388637 |website=gulfnews.com |access-date=21 April 2021 }}</ref> # Kyrgyzstan<ref name="whotracker"/> # Libya<ref name="cdctracker"/> # Malawi<ref name="auto7"/> # Malaysia<ref>{{cite web |author1=New Straits Times |title=DCA grants conditional approval for Moderna vaccine |url=https://www.nst.com.my/news/nation/2021/08/715318/dca-grants-conditional-approval-moderna-vaccine |date=8 August 2021}}</ref> # Maldives<ref>{{cite web |author1=Maldives Food and Drug Agency |title=Approval to use of COVID-19 vaccine Moderna dispersion for injection |url=http://health.gov.mv/Uploads/Downloads//Informations/Informations(382).pdf |date=6 June 2021 |accessdate=7 July 2021 |archivedate=6 September 2021 |archiveurl=https://web.archive.org/web/20210906115734/http://health.gov.mv/Uploads/Downloads//Informations/Informations(382).pdf }}</ref> # Marshall Islands{{efn|name=CFA}} # Mexico<ref>{{cite web |title=Comité de Moléculas Nuevas y Subcomité emiten opinión favorable para vacuna Moderna|url=https://www.gob.mx/cofepris/articulos/comite-de-moleculas-nuevas-y-subcomite-emiten-opinion-favorable-para-vacuna-moderna |website=www.gob.mx/cofepris |language=es}}</ref><ref>{{cite web |title=COFEPRIS emite autorización para uso de emergencia a vacuna Moderna|url=https://www.gob.mx/cofepris/articulos/cofepris-emite-autorizacion-para-uso-de-emergencia-a-vacuna-moderna |website=www.gob.mx/cofepris |language=es}}</ref> # Micronesia{{efn|name=CFA}} # Moldova<ref name="msmps.gov.md">{{cite web |title=Membrii NITAG au venit cu recomandări privind utilizarea vaccinurilor împotriva COVID-19 în Republica Moldova |url=https://msmps.gov.md/comunicare/comunicate/membrii-nitag-au-venit-cu-recomandari-privind-utilizarea-vaccinurilor-impotriva-covid-19-in-republica-moldova/ |website=Ministerul Sănătății, Muncii și Protecţiei Sociale |language=ro |date=3 March 2021 |accessdate=7 July 2021 |archivedate=19 May 2021 |archiveurl=https://web.archive.org/web/20210519224416/https://msmps.gov.md/comunicare/comunicate/membrii-nitag-au-venit-cu-recomandari-privind-utilizarea-vaccinurilor-impotriva-covid-19-in-republica-moldova/ }}</ref> # Mongolia<ref name="news.mn" /> # Nepal<ref>{{cite web|title=Nepal receives 1,965,600 doses of Moderna vaccine from COVAX|url=https://kathmandupost.com/health/2021/12/12/nepal-receives-1-965-600-doses-of-moderna-vaccine-from-covax|access-date=28 December 2021|website=kathmandupost.com}}</ref> # Nigeria<ref>{{#invoke:Cite web||date=15 July 2021|title=NAFDAC approves emergency use of three additional Covid-19 vaccines for Nigeria|url=https://editor.guardian.ng/news/nafdac-approves-emergency-use-of-three-additional-covid-19-vaccines-for-nigeria/|access-date=21 July 2021|website=The Guardian Nigeria News - Nigeria and World News}}</ref> # Pakistan<ref name="whotracker"/> # Palau{{efn|name=CFA}} # Palestine<ref name="cdctracker">{{cite web |title=COVID Data Tracker |url=https://covid.cdc.gov/covid-data-tracker/#global-vaccinations |website=U.S. [[Centers for Disease Control and Prevention]] (CDC) |date=28 March 2020}}</ref> # Paraguay<ref name="whotracker"/> # Peru<ref>{{cite web|date=17 September 2021|title=Gobierno suscribió acuerdo con Moderna por 20 millones de dosis contra la COVID-19|url=https://rpp.pe/peru/actualidad/gobierno-suscribio-acuerdo-con-moderna-por-20-millones-de-vacunas-contra-la-covid-19-noticia-1358438?ref=rpp|access-date=4 October 2021|website=[[RPP Noticias]]}}</ref> # Philippines<ref>{{cite news |author1=Galvez, Daphne |title=Moderna COVID-19 vaccine gets emergency use authorization |url=https://newsinfo.inquirer.net/1427462/moderna-covid-19-vaccine-gets-emergency-use-authorization |publisher=Philippine Daily Inquirer |date=5 May 2021}}</ref> # Qatar<ref name="Aljazeera">{{#invoke:Cite web||title=Qatar approves emergency use of Moderna's COVID-19 vaccine|url=https://www.aljazeera.com/news/2021/2/10/qatar-approves-emergency-use-for-modernas-covid-19-vaccine|website=Al Jazeera|access-date=31 March 2021}}</ref> # Rwanda<ref name="cdctracker" /> # Saudi Arabia<ref name="gulfnews.com">{{#invoke:Cite web||title=AstraZeneca and Moderna vaccines to be administered in Saudi Arabia|url=https://gulfnews.com/world/gulf/saudi/astrazeneca-and-moderna-vaccines-to-be-administered-in-saudi-arabia-1.76573439|access-date=19 January 2021|website=Gulf News}}</ref> # Serbia<ref>{{cite web|title=Moderna arrived to Serbia|url=https://europa.rs/moderna-arrived-to-serbia/?lang=en}}</ref> # Singapore<ref>{{cite news|date=3 February 2021|title=Singapore becomes first in Asia to approve Moderna's COVID-19 vaccine|url=https://www.reuters.com/article/us-health-coronavirus-singapore/singapore-becomes-first-in-asia-to-approve-modernas-covid-19-vaccine-idUSKBN2A30ZM|access-date=3 February 2021|publisher=Reuters}}</ref> # South Korea<ref>{{Cite news |last1=Kim |first1=Han-joo |date=21 May 2021|title=Moderna COVID-19 vaccine gets final nod in S. Korea |url=https://en.yna.co.kr/view/AEN20210521005500320|access-date=21 May 2021|work=Yonhap News Agency}}</ref> # Sri Lanka<ref name="whotracker"/> # Taiwan<ref>{{#invoke:Cite web||date=5 May 2021|title=莫德納疫苗獲緊急授權 自費AZ疫苗供應不間斷|url=https://www.cna.com.tw/news/firstnews/202105050200.aspx|website=Central News Agency}}</ref> # Tajikistan<ref>{{#invoke:Cite web||date=26 July 2021|title=1.5 million doses of Moderna Vaccines arrive in Tajikistan|url=https://www.unicef.org/tajikistan/press-releases/15-million-doses-moderna-vaccines-arrive-tajikistan|access-date=4 August 2021|website=[[UNICEF]]}}</ref> # Thailand<ref>{{cite news | title = Thai FDA approves Moderna vaccine | date = 13 May 2021 | url = https://www.bangkokpost.com/thailand/general/2115195/thai-fda-approves-moderna-vaccine | work = Bangkok Post }}</ref> # Tunisia<ref name="whotracker"/> # Uganda<ref name="whotracker"/> # Ukraine<ref>{{#invoke:Cite web||date=19 July 2021|title=U.S. Donates 2 Million Coronavirus Vaccine Doses To Ukraine|url=https://www.rferl.org/a/us-vaccine-ukraine-covid/31365604.html|access-date=4 August 2021|website=[[RadioFreeEurope]]}}</ref> # United Arab Emirates<ref>{{cite news | title = Coronavirus latest: Moderna vaccine approved for emergency use by UAE | date = 4 July 2021 | url = https://www.thenationalnews.com/coronavirus/2021/07/03/coronavirus-latest-updates-uae-cases-vaccine-covid-test/ | work = The National }}</ref> # Uzbekistan<ref>{{#invoke:Cite web||date=30 July 2021|title=U.S. Government Provides 3 Million of the Moderna COVID-19 Vaccine to Uzbekistan|url=https://uz.usembassy.gov/u-s-government-provides-3-million-doses-of-the-moderna-covid-19-vaccine-to-uzbekistan/|access-date=4 August 2021|website=}}</ref> # Vietnam<ref>{{Cite news|date=29 June 2021|title=Bộ Y tế phê duyệt có điều kiện vaccine COVID-19 Moderna|work=[[Vietnam Television]]|url=https://vtv.vn/suc-khoe/bo-y-te-phe-duyet-co-dieu-kien-vaccine-covid-19-moderna-20210629110122178.htm}}</ref><ref>{{Cite news|date=29 June 2021|title=Bộ Y tế phê duyệt có điều kiện vaccine COVID-19 Moderna|work=Vietnam Government Portal|url=http://baochinhphu.vn/Hoat-dong-Bo-nganh/Bo-Y-te-phe-duyet-co-dieu-kien-vaccine-COVID19-Moderna/436244.vgp}}</ref> '''{{nowrap|[[European Medicines Agency|EMA]] countries}}'''<ref name="COVID-19 Vaccine Moderna EPAR">{{cite web|title=Spikevax (previously COVID-19 Vaccine Moderna) EPAR|url=https://www.ema.europa.eu/en/medicines/human/EPAR/covid-19-vaccine-moderna|website=[[European Medicines Agency]] (EMA)}}</ref><ref name="EU Marketing authorisation" /><ref>{{cite web | title=Spikevax | website=Union Register of medicinal products | url=https://ec.europa.eu/health/documents/community-register/html/h1507.htm | access-date=26 November 2021}}</ref> # Austria # Belgium # Bulgaria # Croatia # Cyprus # Czech Republic # Denmark # Estonia # Finland # France # Germany # Greece # Hungary # Iceland # Ireland # Italy # Latvia # Liechtenstein # Lithuania # Luxembourg # Malta # Netherlands # Norway # Poland # Portugal # Romania # Slovakia # Slovenia # Spain # Sweden '''{{nowrap|[[Caribbean Public Health Agency|CARPHA]] countries}}'''<ref name="carpha-pfizer"/><ref name="COVID-19 Vaccine Information"/> # Antigua and Barbuda # Bahamas # Barbados # Belize # Dominica # Grenada # Guyana # Haiti # Jamaica # Saint Kitts and Nevis # Saint Lucia # Saint Vincent and the Grenadines # Suriname # Trinidad and Tobago <!-- not counted --><br /> '''Non-country entities''' * American Samoa<ref name="whotracker"/> * Anguilla{{efn|name=carphance}} * Aruba{{efn|name=carphance}} * Bermuda{{efn|name=carphance}} * British Virgin Islands{{efn|name=carphance}} * Caribbean Netherlands{{efn|name=carphance}} * Cayman Islands{{efn|name=carphance}} * Curaçao{{efn|name=carphance}} * Faroe Islands<ref name="cdctracker"/> * Greenland<ref name="cdctracker"/> * Guadeloupe<ref name="whotracker"/> * Guam<ref name="whotracker"/> * Guernsey<ref name="cdctracker"/> * Isle of Man<ref name="whotracker"/> * Jersey<ref name="cdctracker"/> * Montserrat{{efn|name=carphance}} * Northern Mariana Islands<ref name="whotracker"/> * Puerto Rico<ref name="whotracker"/> * Sint Maarten{{efn|name=carphance}} * Turks and Caicos Islands{{efn|name=carphance}} * Wallis and Futuna<ref name="whotracker"/> * ''[[World Health Organization]]''<ref>{{cite news |title=WHO lists anti-COVID Moderna vaccine for emergency use |url=https://newsinfo.inquirer.net/1425841/who-lists-anti-covid-moderna-vaccine-for-emergency-use |work=Agence France-Presse |publisher=Philippine Daily Inquirer |date=1 May 2021}}</ref><ref>{{cite web | title=WHO Recommendation COVID-19 mRNA Vaccine (nucleoside modified) | website=[[World Health Organization]] (WHO) | date=30 April 2021 | url=https://extranet.who.int/pqweb/vaccines/covid-19-mrna-vaccine-nucleoside-modified | access-date=8 May 2021 | accessdate=7 July 2021 | archivedate=7 May 2021 | archiveurl=https://web.archive.org/web/20210507220946/https://extranet.who.int/pqweb/vaccines/covid-19-mrna-vaccine-nucleoside-modified }}</ref> ;Travel-only * Hong Kong<ref name="HK"/> * New Zealand<ref name="auto9"/> * Turkey<ref name="visasturkey.com"/> </div> == Sinopharm BIBP == <section begin="bibpauthmap"/> {{infobox|image={{Graph:Map|scale=65|defaultValue=gainsboro |AD=limegreen|AE=blueviolet|AF=dodgerblue|AG=dodgerblue|AL=limegreen|AM=dodgerblue|AO=dodgerblue|AR=dodgerblue|AT=turquoise|AU=turquoise|AZ=limegreen |BA=dodgerblue|BB=dodgerblue|BD=dodgerblue|BF=dodgerblue|BG=turquoise|BH=blueviolet|BI=dodgerblue|BJ=limegreen|BN=dodgerblue|BO=dodgerblue|BR=dodgerblue|BS=limegreen|BT=dodgerblue|BW=limegreen|BY=dodgerblue|BZ=dodgerblue |CA=turquoise|CD=limegreen|CF=limegreen|CG=dodgerblue|CH=turquoise|CI=dodgerblue|CL=limegreen|CM=dodgerblue|CN=blueviolet|CO=limegreen|CR=limegreen|CU=dodgerblue|CV=dodgerblue|CY=turquoise |DJ=dodgerblue|DM=dodgerblue|DO=dodgerblue|DZ=dodgerblue |EC=limegreen|EE=turquoise|EG=dodgerblue|ES=turquoise|ET=dodgerblue |FI=turquoise|FJ=limegreen|FM=limegreen |GA=dodgerblue|GB=turquoise|GD=limegreen|GE=dodgerblue|GH=limegreen|GM=dodgerblue|GN=dodgerblue|GQ=dodgerblue|GR=turquoise|GT=limegreen|GW=dodgerblue|GY=dodgerblue |HN=limegreen|HR=turquoise|HT=limegreen|HU=dodgerblue |ID=dodgerblue|IE=turquoise|IN=limegreen|IQ=dodgerblue|IR=dodgerblue|IS=turquoise |JM=dodgerblue|JO=dodgerblue |KE=dodgerblue|KG=dodgerblue|KH=dodgerblue|KI=dodgerblue|KM=dodgerblue|KN=limegreen|KP=dodgerblue|KR=limegreen|KZ=dodgerblue |LA=dodgerblue|LB=dodgerblue|LC=limegreen|LI=turquoise|LK=dodgerblue|LR=limegreen|LS=dodgerblue|LV=turquoise|LY=dodgerblue |MA=dodgerblue|MC=limegreen|MD=dodgerblue|ME=dodgerblue|MG=dodgerblue|MH=limegreen|MK=dodgerblue|ML=limegreen|MM=dodgerblue|MN=dodgerblue|MO=blueviolet|MR=dodgerblue|MU=dodgerblue|MV=dodgerblue|MW=dodgerblue|MX=dodgerblue|MY=dodgerblue|MZ=dodgerblue |NA=dodgerblue|NE=dodgerblue|NG=dodgerblue|NI=dodgerblue|NL=turquoise|NP=dodgerblue|NR=limegreen|NZ=limegreen |OM=limegreen |PA=limegreen|PE=dodgerblue|PG=dodgerblue|PH=dodgerblue|PK=dodgerblue|PS=dodgerblue|PY=dodgerblue |QA=turquoise |RS=dodgerblue|RW=dodgerblue |SA=turquoise|SB=dodgerblue|SC=blueviolet|SD=dodgerblue|SE=turquoise|SG=dodgerblue|SI=turquoise|SK=turquoise|SL=dodgerblue|SN=dodgerblue|SO=dodgerblue|SR=dodgerblue|SS=dodgerblue|ST=limegreen|SV=dodgerblue|SY=dodgerblue|SZ=limegreen |TD=dodgerblue|TG=limegreen|TH=dodgerblue|TJ=limegreen|TL=limegreen|TM=dodgerblue|TN=dodgerblue|TO=limegreen|TR=turquoise|TT=dodgerblue|TV=limegreen|TZ=dodgerblue |UA=limegreen|UG=limegreen|US=turquoise|UY=limegreen|UZ=limegreen |VC=limegreen|VE=dodgerblue|VN=dodgerblue|VU=dodgerblue |WS=limegreen |XK=limegreen |YE=limegreen |ZA=limegreen|ZM=dodgerblue|ZW=dodgerblue }} |caption= {{leftlegend|blueviolet|Full authorization}} {{leftlegend|dodgerblue|Emergency authorization}} {{leftlegend|turquoise|Allowed for travel}} {{leftlegend|limegreen|Eligible [[COVAX]] recipient}} }} <section end="bibpauthmap"/> The [[Sinopharm BIBP COVID-19 vaccine]] is an [[inactivated vaccine|inactivated virus vaccine]] produced by the [[China National Pharmaceutical Group]] (Sinopharm) and its Beijing Institute of Biological Products.<ref name="ChiCTR20000347802">{{cite journal|last1=Chen|first1=Wei|last2=Al Kaabi|first2=Nawal|date=18 July 2020|title=A Phase III clinical trial for inactivated novel coronavirus pneumonia (COVID-19) vaccine (Vero cells)|url=http://www.chictr.org.cn/showprojen.aspx?proj=56651|journal=Chinese Clinical Trial Registry|access-date=15 August 2020|name-list-style=vanc}} {{Webarchive|url=https://web.archive.org/web/20201011084800/http://www.chictr.org.cn/showprojen.aspx?proj=56651%2F |date=11 October 2020 }} {{Cite web |title=Archive copy |url=http://www.chictr.org.cn/showprojen.aspx?proj=56651%2F |accessdate=28 September 2023 |archivedate=11 October 2020 |archiveurl=https://web.archive.org/web/20201011084800/http://www.chictr.org.cn/showprojen.aspx?proj=56651%2F }}</ref><ref name=":02">{{cite journal|display-authors=6|vauthors=Xia S, Zhang Y, Wang Y, Wang H, Yang Y, Gao GF, Tan W, Wu G, Xu M, Lou Z, Huang W, Xu W, Huang B, Wang H, Wang W, Zhang W, Li N, Xie Z, Ding L, You W, Zhao Y, Yang X, Liu Y, Wang Q, Huang L, Yang Y, Xu G, Luo B, Wang W, Liu P, Guo W, Yang X|date=October 2020|title=Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial|journal=The Lancet. Infectious Diseases|volume=21|issue=1|pages=39–51|doi=10.1016/s1473-3099(20)30831-8|pmc=7561304|pmid=33069281}}</ref> ;Full (<section begin="Sinopharm BIBP_FN"/>4<section end="Sinopharm BIBP_FN"/>) # Bahrain<ref>{{#invoke:cite web||title=Bahrain approves China's Sinopharm coronavirus vaccine |url=https://www.arabianbusiness.com/healthcare/455832-bahrain-approves-chinas-sinopharm-coronavirus-vaccine |website=Arabian Business Industries |date=13 December 2020}}</ref> # China<ref>{{#invoke:cite news||last1=Kuo |first1=Lily |title=China approves Sinopharm coronavirus vaccine, the country's first for general use |url=https://www.washingtonpost.com/world/asia_pacific/coronavirus-vaccine-china-sinopharm/2020/12/30/1cc4be9e-4a62-11eb-97b6-4eb9f72ff46b_story.html |work=The Washington Post| name-list-style=vanc}}</ref> # Seychelles<ref>{{#invoke:Cite web||title=President Ramkalawan and First Lady receives second dose SinoPharm Vaccine|url=http://www.statehouse.gov.sc/news/5090/president-ramkalawan-and-first-lady-receives-second-dose-sinopharm-vaccine|access-date=5 February 2021|website=statehouse.gov.sc}}</ref> # United Arab Emirates<ref name="nyt-uae-wee-dec-12-2020">{{#invoke:cite news||last1=Wee |first1=Sui-Lee |title=Chinese Covid-19 Vaccine Gets Key Push, but Doubts Swirl |url=https://www.nytimes.com/2020/12/09/business/china-coronavirus-vaccine-united-arab-emirates.html |access-date=12 December 2020 |work=[[The New York Times]] |date=9 December 2020| name-list-style=vanc}}</ref><ref>{{#invoke:Cite web||title=Coronavirus: UAE authorises emergency use of vaccine for frontline workers|url=https://www.thenationalnews.com/uae/health/coronavirus-uae-authorises-emergency-use-of-vaccine-for-frontline-workers-1.1077680|access-date=24 November 2020|website=The National|date=14 September 2020}}</ref> {{-}} ;Emergency (<section begin="Sinopharm BIBP_EN" />106<section end="Sinopharm BIBP_EN" />) <div style="margin-top: 0.3em; column-width: 15em;"> # Afghanistan<ref>{{#invoke:Cite web||title=China 'to provide 400,000 COVID vaccine doses' to Afghanistan|url=https://www.aljazeera.com/news/2021/3/1/china-to-provide-400000-covid-vaccine-doses-to-afghanistan|access-date=22 March 2021|publisher=Al Jazeera}}</ref> # Algeria<ref>{{#invoke:Cite web||last=Presse|first=AFP-Agence France|title=Algeria Receives 200,000 Coronavirus Jabs From China|url=https://www.barrons.com/news/algeria-receives-200-000-coronavirus-jabs-from-china-01614270916|access-date=22 March 2021|website=Barrons}}</ref> # Angola<ref>{{#invoke:Cite web||date=25 March 2021|title=Angola recebeu doação chinesa de 200 mil doses de vacinas Sinopharm|url=https://www.noticiasaominuto.com/mundo/1718180/angola-recebeu-doacao-chinesa-de-200-mil-doses-de-vacinas-sinopharm|access-date=14 April 2021|website=Notícias ao Minuto|language=pt}}</ref> # Argentina<ref>{{#invoke:cite news||last1=Biannchi|first1=Walter|date=21 February 2021|title=Argentina approves Sinopharm COVID-19 vaccine for emergency use|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-argentina-vaccine-idUSKBN2AL0P9|access-date=23 February 2021}}</ref> # Armenia<ref name="whotracker"/> # Bangladesh<ref>{{#invoke:cite news||date=29 April 2021|title=Bangladesh approves emergency use of China's Sinopharm vaccine amid supply squeeze|publisher=[[bdnews24.com]]|url=https://bdnews24.com/bangladesh/2021/04/29/bangladesh-approves-emergency-use-of-chinas-sinopharm-vaccine-amid-supply-squeeze|access-date=29 April 2021}}</ref> # Belarus<ref>{{#invoke:Cite web||date=15 March 2021|title=Belarus begins COVID-19 vaccinations with Chinese shots|url=https://eng.belta.by/society/view/belarus-begins-covid-19-vaccinations-with-chinese-shots-138222-2021/|access-date=16 March 2021|publisher=Belta}}</ref> # Bhutan<ref>{{#invoke:Cite web||title=Bhutan receives 500,000 doses of COVID-19 vaccines through COVAX|url=https://www.unicef.org/rosa/press-releases/bhutan-receives-500000-doses-covid-19-vaccines-through-covax|access-date=15 July 2021|website=www.unicef.org}}</ref> # Bolivia<ref>{{#invoke:Cite web||title=Bolivia begins inoculation with Sinopharm jabs |url=https://www.thestar.com.my/aseanplus/aseanplus-news/2021/02/26/bolivia-begins-inoculation-with-sinopharm-jabs|access-date=28 February 2021|website=The Star|location=Malaysia}}</ref> # Bosnia and Herzegovina<ref>{{cite web|url=https://www.sarajevotimes.com/finalized-contract-for-the-procurement-of-half-a-million-doses-of-sinopharm-vaccine/|title=Finalized Contract for the Procurement of half a Million Doses of Sinopharm Vaccine|date=2 July 2021}}</ref> # Brazil<ref name="Agência Brasil">{{#invoke:cite news||title=Covid-19: aumenta para sete o número de vacinas autorizadas no Brasil |url=https://agenciabrasil.ebc.com.br/radioagencia-nacional/saude/audio/2021-05/aumenta-para-sete-o-numero-de-vacinas-autorizadas-no-brasil |work=Agência Brasil |date=7 May 2021 |language=pt-br}}</ref> # Brunei<ref>{{#invoke:Cite web||title=Vaccine donation from China arrives |url=https://www.thestar.com.my/aseanplus/aseanplus-news/2021/02/12/vaccine-donation-from-china-arrives|access-date=22 March 2021|website=The Star|location=Malaysia}}</ref> # Burkina Faso<ref name="whotracker"/> # Burundi<ref name="whotracker"/> # Cambodia<ref>{{#invoke:Cite web||last1=Rinith|first1=Taing|date=4 February 2021|title=Health Ministry grants Emergency Use Authorization to China's Sinopharm vaccine|url=https://www.khmertimeskh.com/50810677/health-ministry-grants-emergency-use-authorization-to-chinas-sinopharm-vaccine/|access-date=4 February 2021|work=Khmer Times|name-list-style=vanc}}</ref> # Cameroon<ref name="cdctracker"/> # Cape Verde<ref name="whotracker"/> # Chad<ref>{{#invoke:Cite web||last=AfricaNews|date=6 June 2021|title=Chadians line up for Sinopharm as COVID-19 vaccination campaign begins|url=https://www.africanews.com/2021/06/06/chadians-line-up-for-sinopharm-as-covid-19-vaccination-campaign-begins/|access-date=6 June 2021|website=Africanews}}</ref> # Comoros<ref name="cdctracker"/> # Congo-Brazzaville<ref name="cdctracker"/> # Cuba<ref>{{cite web|date=28 August 2021|title=Cuba aplicará vacuna china Sinopharm junto a inoculaciones de desarrollo local|url=https://es.euronews.com/2021/08/28/salud-coronavirus-cuba-china|access-date=29 August 2021|website=euronews|language=es}}</ref> # Djibouti<ref name="cdctracker"/> # Dominican Republic<ref>{{#invoke:cite web||title=Ministro de Salud recibe su primera dosis de la vacuna Sinovac; asegura que el biológico es confiable |url=https://www.msp.gob.do/web/?p=11563 |website=Ministerio de Salud Pública |language=es |date=3 May 2021}}</ref> # Egypt<ref>{{#invoke:Cite web||title=Egypt licenses China's Sinopharm COVID-19 vaccine for emergency use: health minister – Xinhua |url=http://xinhuanet.com/english/2021-01/03/c_139637781.htm|publisher=Xinhuanet}}</ref> # El Salvador<ref name="whotracker"/> # Equatorial Guinea<ref>{{#invoke:Cite web||title=StackPath|url=https://dailynewsegypt.com/2021/02/17/equatorial-guinea-president-receives-1st-dose-of-chinese-covid-19-vaccine/|access-date=22 March 2021|website=dailynewsegypt}}</ref> # Ethiopia<ref>{{#invoke:Cite news||date=29 March 2021|title=Ethiopia to get 300,000 doses of Sinopharm COVID-19 shot, health minister says|publisher=Reuters|url=https://www.reuters.com/article/uk-healthcare-coronavirus-ethiopia-idUSKBN2BL1TE|access-date=14 April 2021}}</ref> # Gabon<ref>{{#invoke:Cite web||date=12 March 2021|title=Gabon receives 100,000 doses of Sinopharm's vaccine from China|url=https://gabon24.ga/en/news/gabon-receives-100000-doses-of-sinopharms-vaccine-from-china/5155/|access-date=15 March 2021|publisher=Gabon 24}}</ref> # Gambia<ref name="whotracker"/> # Georgia<ref>{{#invoke:Cite web||date=4 May 2021|title=Georgia Starts COVID-19 Vaccination with Sinopharm|url=https://civil.ge/archives/417469|access-date=9 May 2021|website=Civil.ge}}</ref> # Guinea-Bissau<ref name="cdctracker"/> # Guinea<ref name="whotracker"/> # Hungary<ref>{{#invoke:Cite web||title=Hungary signs deal for Chinese Sinopharm's COVID-19 vaccine, first in EU|url=https://nationalpost.com/pmn/health-pmn/hungary-signs-deal-for-chinese-sinopharms-covid-19-vaccine-first-in-eu|website=National Post}}</ref><ref name="WashPost Hungary" /> # Indonesia<ref>{{#invoke:Cite web||title=Indonesia approves Sinopharm COVID-19 vaccine for emergency use|url=https://english.kontan.co.id/news/indonesia-approves-sinopharm-covid-19-vaccine-for-emergency-use|website=Kontan|date=30 April 2021|access-date=30 April 2021}}</ref> # Iran<ref>{{#invoke:Cite web||date=22 February 2021|title=Iran Launches Phase Two of Mass Inoculation Campaign|url=https://financialtribune.com/articles/national/107614/iran-launches-phase-two-of-mass-inoculation-campaign|access-date=23 February 2021|website=Financial Tribune}}</ref> # Iraq<ref name="bignewsnetwork.com" /> # Ivory Coast<ref name="whotracker"/> # Jordan<ref>{{#invoke:Cite web||title=First batch of Chinese Sinopharm vaccine arrives in Jordan|url=https://en.royanews.tv/news/24716/2021-01-10|access-date=9 January 2021|publisher=Roya News}}</ref> # Kazakhstan<ref>{{#invoke:Cite web||last=Satubaldina|first=Assel|date=30 April 2021|title=Three Vaccines to Become Available to Kazakh Citizens|url=https://astanatimes.com/2021/04/three-vaccines-to-become-available-to-kazakh-citizens/|access-date=1 May 2021|website=The Astana Times}}</ref> # Kenya<ref name=":10" /> # Kiribati<ref name="whotracker"/> # Kyrgyzstan<ref>{{#invoke:Cite web||last=Kharizov|first=Ruslan|date=19 March 2021|title=150,000 doses of Sinopharm coronavirus vaccine delivered to Kyrgyzstan|url=https://24.kg/english/187138_150000_doses_of_Sinopharm_coronavirus_vaccine_delivered_to_Kyrgyzstan/|access-date=22 March 2021|website=24.kg}}</ref> # Laos<ref name="auto1" /> # Lebanon<ref>{{#invoke:Cite web||last1=Crean|first1=Rosabel|title=China donates 50,000 doses of Sinopharm vaccine to Lebanon|url=http://www.dailystar.com.lb/News/Lebanon-News/2021/Mar-01/517953-china-donates-50000-doses-of-sinopharm-vaccine-to-lebanon.ashx|access-date=2 March 2021|work=[[The Daily Star (Bangladesh)|The Daily Star]]}}</ref> # Lesotho<ref name="whotracker"/> # Libya<ref>{{#invoke:Cite web||date=2 August 2021|title=Libya gets 2 million Sinopharm doses with more expected|url=https://www.africanews.com/2021/08/02/libya-gets-2-million-sinopharm-doses-with-more-expected/|access-date=5 August 2021|website=[[Africanews]]}}</ref> # Madagascar<ref name="whotracker"/> # Malawi<ref name=":11">{{Cite news|last1=Zimmer|first1=Carl|last2=Corum|first2=Jonathan|last3=Wee|first3=Sui-Lee|date=10 June 2020|title=Coronavirus Vaccine Tracker|work=The New York Times|url=https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html|access-date=29 August 2021|issn=0362-4331}}</ref> # Malaysia<ref>{{#invoke:Cite news||last=Latiff|first=Rozanna|date=16 July 2021|title=Malaysia approves China's Sinopharm vaccine for emergency use|work=Reuters|url=https://www.reuters.com/article/health-coronavirus-malaysia-vaccine-idUSL4N2OS18D|access-date=16 July 2021}}</ref> # Maldives<ref>{{#invoke:Cite web||last1=Rasheed|first1=Aishath Hanaan Hussain|title=MFDA approves Pfizer, Sinopharm Covid-19 vaccines for emergency use|url=https://raajje.mv/96801|access-date=16 March 2021|publisher=raajje.mv}}</ref> # Mauritania<ref>{{#invoke:Cite web||title=Mauritania begins COVID-19 vaccination campaign|url=https://www.aa.com.tr/en/africa/mauritania-begins-covid-19-vaccination-campaign/2189322|access-date=29 March 2021|website=aa.com.tr}}</ref> # Mauritius<ref name="cdctracker"/> # Mexico<ref>{{cite web |title= Comité de Moléculas Nuevas emite opiniones favorables por unanimidad sobre remdesivir y vacuna Sinopharm \|url=https://www.gob.mx/cofepris/es/articulos/comite-de-moleculas-nuevas-emite-opiniones-favorables-por-unanimidad-sobre-remdesivir-y-vacuna-sinopharm |website=www.gob.mx/cofepris |language=es}}</ref><ref>{{cite web |title= Cofepris emite autorización para uso de emergencia a vacuna Sinopharm |url=https://www.gob.mx/cofepris/es/articulos/cofepris-emite-autorizacion-para-uso-de-emergencia-a-vacuna-sinopharm |website=www.gob.mx/cofepris |language=es}}</ref> # Moldova<ref>{{#invoke:Cite web||last=Cristina|date=19 March 2021|title=O mie de studenți și medici-rezidenți din cadrul USMF vor fi imunizați anti-COVID cu vaccinul BBIBP-CorV, produs de către Sinopharm Beijing Institute of Biological Products|url=https://www.zdg.md/stiri/stiri-sociale/o-mie-de-studenti-si-medici-rezidenti-din-cadrul-usmf-vor-fi-imunizati-anti-covid-cu-vaccinul-bbibp-corv-produs-de-catre-sinopharm-beijing-institute-of-biological-products/|access-date=19 March 2021|website=Ziarul de Gardă|language=ro-RO}}</ref> # Mongolia<ref>{{#invoke:Cite web||title=Deputy PM and City Governor get the first dose of Sinopharm vaccine|url=https://www.montsame.mn/en/read/256205|access-date=15 March 2021|publisher=Montsame}}</ref> # Montenegro<ref>{{#invoke:Cite web||title=Montenegro receives 30,000 doses of China's COVID-19 vaccine|url=http://seenews.com/news/montenegro-receives-30000-doses-of-chinas-covid-19-vaccine-733151|access-date=22 March 2021|website=seenews}}</ref> # Morocco<ref>{{#invoke:Cite web||title=Covid-19: Morocco authorizes use of the Sinopharm vaccine|url=https://en.yabiladi.com/articles/details/104807/covid-19-morocco-authorizes-sinopharm-vaccine.html|website=yabiladi}}</ref> # Mozambique<ref>{{#invoke:cite news||date=6 March 2021|title=Mozambique expects to vaccinate 16 million against coronavirus by 2022|url=https://www.reuters.com/article/health-coronavirus-mozambique/mozambique-expects-to-vaccinate-16-million-against-coronavirus-by-2022-idUSL5N2L35GH|access-date=7 March 2021|publisher=Reuters}}</ref> # Myanmar<ref>{{#invoke:Cite web||title=Myanmar to use China-donated Sinopharm Covid vaccine|url=https://elevenmyanmar.com/news/myanmar-to-use-china-donated-sinopharm-covid-vaccine|access-date=20 June 2021|website=Eleven Media Group Co., Ltd}}</ref> # Namibia<ref>{{#invoke:Cite web||last=Namibian|first=The|title=Khomas, Erongo first to get vaccinated|url=https://www.namibian.com.na/index.php?page=read&id=99946|access-date=17 March 2021|website=The Namibian}}</ref> # Nepal<ref>{{#invoke:Cite web||last1=Poudel|first1=Arjun|title=China's Shinopharm vaccine gets emergency use authorisation in Nepal|url=https://kathmandupost.com/health/2021/02/17/china-s-shinopharm-vaccine-gets-emergency-use-authorisation-in-nepal|access-date=19 February 2021|work=Kathmandu Post}}</ref> # Nicaragua<ref>{{cite web|url=https://www.bbc.com/news/world-asia-59633388 |title=Nicaragua receives China vaccines after cutting ties with Taiwan |date= |publisher=[[BBC News]] |access-date=2022-03-04}}</ref> # Niger<ref>{{#invoke:Cite web||title=China donates 400,000 doses of Sinopharm COVID-19 vaccine to Niger|url=https://www.channelnewsasia.com/news/world/china-donates-400-000-doses-of-sinopharm-covid-19-vaccine-to-14461352|access-date=1 April 2021|website=CNA}}</ref> # Nigeria<ref>{{cite web|date=24 August 2021|title=Nigeria approves Sinopharm COVID vaccine, expects 7.7 mln doses|url=https://www.reuters.com/world/africa/nigeria-approves-sinopharm-covid-vaccine-expects-77-mln-doses-2021-08-24/|access-date=28 August 2021|website=Reuters}}</ref> # North Korea<ref>{{#invoke:Cite news||last1=Son|first1=Hyemin|last2=Ji|first2=Jeongeun |last3=Lee|first3=Myungchul|title=North Korea Has Been Importing Chinese COVID-19 Vaccines Since Early May |url=https://www.rfa.org/english/news/korea/vax-06152021112903.html |work=[[Radio Free Asia]] |date=15 June 2021}}</ref> # North Macedonia<ref>{{#invoke:Cite web||last=|first=|title=North Macedonia looks to Chinese vaccine to revive program|url=https://abcnews.go.com/Health/wireStory/north-macedonia-chinese-vaccine-revive-program-77418628|access-date=1 May 2021|website=ABC News}}</ref> # Pakistan<ref>{{#invoke:Cite news||last1=Shahzad|first1=Asif|date=19 January 2021|title=Pakistan approves Chinese Sinopharm COVID-19 vaccine for emergency use|url=https://www.reuters.com/article/health-coronavirus-pakistan-sinopharm/pakistan-approves-chinese-sinopharm-covid-19-vaccine-for-emergency-use-idUSKBN29O049|publisher=Reuters|name-list-style=vanc}}</ref> # Palestine<ref>{{#invoke:Cite web||last=|first=|title=What we know about China's Sinopharm COVID vaccine|url=https://www.thefinancialexpress.com.bd/national/what-we-know-about-chinas-sinopharm-covid-vaccine-1619625832|access-date=1 May 2021|website=The Financial Express}}</ref> # Papua New Guinea<ref>{{#invoke:Cite web||date=7 May 2021|title=Chinese vaccine to be gazetted|url=https://postcourier.com.pg/chinese-vaccine-to-be-gazetted/|access-date=21 May 2021|website=Post Courier}}</ref> # Paraguay<ref name="whotracker"/> # Peru<ref>{{#invoke:Cite news||date=27 January 2021|title=Peru grants 'exceptional' approval for Sinopharm COVID-19 vaccine – government sources|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-peru/peru-grants-exceptional-approval-for-sinopharm-covid-19-vaccine-government-sources-idUSKBN29W2TL}}</ref> # Philippines<ref>{{#invoke:Cite news||author1=Aguilar, Krissy|title=PH approves Sinopharm COVID-19 vaccine for emergency use|url=https://newsinfo.inquirer.net/1442960/ph-approves-sinopharm-covid-19-vaccine-for-emergency-use|publisher=Philippine Daily Inquirer|date=7 June 2021}}</ref> # Rwanda<ref>{{cite web|date=12 August 2021|title=Rwanda to acquire Sinopharm vaccines next week|url=https://www.newtimes.co.rw/news/rwanda-acquire-sinopharm-vaccines-next-week|access-date=28 August 2021|website=The New Times {{!}} Rwanda}}</ref> # Senegal<ref>{{#invoke:Cite web||last1=Asala|first1=Kizzi|title=Senegal Kicks Off COVID-19 Vaccination Campaign with China's Sinopharm|url=https://www.africanews.com/2021/02/18/senegal-kicks-off-covid-19-vaccination-campaign-with-china-s-sinopharm/|access-date=23 February 2021|publisher=Africanews}}</ref> # Serbia<ref>{{#invoke:Cite web||title=Serbia Becomes First European Nation To Use China's Sinopharm Vaccine|url=https://www.rferl.org/a/serbia-covid-vaccine-china-sinopharm/31053091.html|website=RadioFreeEurope/RadioLiberty}}</ref> # Sierra Leone<ref>{{#invoke:Cite web||last1=Thomas|first1=Abdul Rashid|date=15 March 2021|title=Sierra Leone's President Bio leads the way in taking COVID-19 Vaccine|url=https://www.thesierraleonetelegraph.com/sierra-leones-president-bio-leads-the-way-in-taking-covid-19-vaccine/|access-date=16 March 2021|work=Sierra Leone Telegraph}}</ref> # Singapore<ref>{{#invoke:Cite web||title=11 Singapore private healthcare providers allowed to bring in Sinopharm COVID-19 vaccine|url=https://www.channelnewsasia.com/news/singapore/sinopharm-covid-19-hsa-special-access-route-vaccine-sinovac-15337454|access-date=30 July 2021|website=CNA}}</ref> # Solomon Islands<ref>{{#invoke:Cite web||title=Health Ministry Prepares for Sinopharm Roll Out - Solomon Times Online|url=https://www.solomontimes.com/news/health-ministry-prepares-for-sinopharm-roll-out/10856|access-date=21 May 2021|website=SolomonTimes}}</ref> # Somalia<ref>{{#invoke:Cite web||last=|date=15 April 2021|title=Somalia rolls out Sinopharm vaccines to boost fight against COVID-19|url=https://newsghana.com.gh/somalia-rolls-out-sinopharm-vaccines-to-boost-fight-against-covid-19/|access-date=18 April 2021|website=News Ghana}}</ref> # South Sudan<ref>{{cite web|date=27 August 2021|title=South Sudan to receive 100,000 doses of Sinopharm vaccines from China|url=https://jubaecho.com/2021/08/27/south-sudan-to-receive-100000-doses-of-sinopharm-vaccines-from-china/|access-date=29 August 2021|website=Juba echo|archive-date=29 August 2021|archive-url=https://web.archive.org/web/20210829043217/https://jubaecho.com/2021/08/27/south-sudan-to-receive-100000-doses-of-sinopharm-vaccines-from-china/|url-status=dead|accessdate=6 October 2021|archivedate=29 August 2021|archiveurl=https://web.archive.org/web/20210829043217/https://jubaecho.com/2021/08/27/south-sudan-to-receive-100000-doses-of-sinopharm-vaccines-from-china/}}</ref> # Sri Lanka<ref>{{#invoke:Cite web||date=19 March 2021|title=NMRA approves sinopharm vaccine for emergency use|url=https://colombogazette.com/2021/03/19/nmra-approves-sinopharm-vaccine-for-emergency-use/|access-date=29 March 2021|website=Colombo Gazette}}</ref> # Sudan<ref>{{#invoke:Cite web||title=China To Provide Sudan With 250,000 Doses Of Sinopharm Vaccine On Friday – Ambassador|url=https://www.urdupoint.com/en/world/china-to-provide-sudan-with-250000-doses-of-1203394.html|access-date=14 April 2021|website=UrduPoint}}</ref><ref>{{#invoke:Cite web||title=StackPath|url=https://dailynewsegypt.com/2021/03/28/china-donated-sinopharm-covid-19-vaccines-arrive-in-sudan/|access-date=14 April 2021|website=dailynewsegypt}}</ref> # Syria<ref name="whotracker"/> # Tanzania<ref name="whotracker"/> # Thailand<ref>{{#invoke:cite news|| title = FDA approves use of Sinopharm vaccine | date = 28 May 2021 | url = https://www.bangkokpost.com/thailand/general/2123307/fda-approves-use-of-sinopharm-vaccine | work = [[Bangkok Post]]}}</ref> # Tunisia<ref>{{#invoke:Cite web||title=China's Sinopharm COVID-19 vaccine approved for marketing in Tunisia - Xinhua &#124; English.news.cn|url=http://www.xinhuanet.com/english/africa/2021-07/13/c_1310057298.htm|access-date=21 July 2021|website=xinhuanet}}</ref> # Turkmenistan<ref>{{#invoke:Cite web||title=В Туркменистане от COVID бесплатно прививают китайской вакциной, российский "Спутник" можно купить|url=https://rus.azathabar.com/a/31190974.html|access-date=9 May 2021|website=Радио Азатлык|language=ru}}</ref> # Vanuatu<ref>{{#invoke:Cite web||title=PM to receive Sinopharm jab today|url=https://dailypost.vu/news/pm-to-receive-sinopharm-jab-today/article_353ada2c-cd65-11eb-96db-9308a7cd2ac1.html|access-date=15 June 2021|website=Vanuatu Daily Post}}</ref> # Venezuela<ref>{{#invoke:cite news||last1=Sequera|first1=Vivian|date=1 March 2021|title=Venezuela approves use of China's Sinopharm coronavirus vaccine|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-venezuela-vaccine-idUSKCN2AT3T2|access-date=2 March 2021}}</ref> # Vietnam<ref>{{#invoke:Cite web||date=4 June 2021|title=Vietnam approves China's Sinopharm vaccine for use against COVID-19|url=https://www.reuters.com/business/healthcare-pharmaceuticals/vietnam-approves-chinas-sinopharm-vaccine-use-against-covid-19-media-2021-06-04/|access-date=4 June 2021|website=Reuters}}</ref> # Zambia<ref>{{#invoke:Cite web||last=Sachiti|first=Roselyne|title=Zambia to get Sinopharm COVID-19 vaccines|url=https://www.herald.co.zw/zambia-to-get-sinopharm-covid-19-vaccines/|access-date=21 May 2021|website=The Herald}}</ref> # Zimbabwe<ref>{{#invoke:Cite web||last1=Mutsaka|first1=Farai|date=18 February 2021|title=Zimbabwe starts administering China's Sinopharm vaccines|url=https://www.thestar.com/news/world/africa/2021/02/18/zimbabwe-starts-administering-chinas-sinopharm-vaccines.html|access-date=20 February 2021|work=Toronto Star}}</ref> '''{{nowrap|[[Caribbean Public Health Agency|CARPHA]] countries}}'''<ref>https://www.carpha.org/Portals/0/Documents/COVID-19%20Vaccine%20Updates/CARPHA%20COVID-19%20Vaccine%20Update%20045%20November%2022%202021.pdf {{Bare URL PDF|date=March 2022}}</ref> # Antigua and Barbuda # Bahamas # Barbados # Belize # Dominica # Grenada # Guyana # Haiti # Jamaica # Saint Kitts and Nevis # Saint Lucia # Saint Vincent and the Grenadines # Suriname # Trinidad and Tobago <br />'''[[List of ISO 3166-1 codes|Non-country entities]]'''<!-- not counted --> * Anguilla{{efn|name=carphance}} * Aruba{{efn|name=carphance}} * British Virgin Islands{{efn|name=carphance}} * Bermuda{{efn|name=carphance}} * Caribbean Netherlands{{efn|name=carphance}} * Cayman Islands{{efn|name=carphance}} * Curaçao{{efn|name=carphance}} * Macau<ref>{{#invoke:Cite web||date=7 February 2021|title=Macau receives first batch of COVID-19 vaccines|url=https://www.asgam.com/index.php/2021/02/08/macau-receives-first-batch-of-covid-19-vaccines/|access-date=24 February 2021|website=IAG}}</ref> * Montserrat{{efn|name=carphance}} * Sint Maarten{{efn|name=carphance}} * Turks and Caicos Islands{{efn|name=carphance}} * ''[[World Health Organization]]''<ref>{{cite press release | title=WHO lists additional COVID-19 vaccine for emergency use and issues interim policy recommendations | publisher=[[World Health Organization]] (WHO) | date=7 May 2021 | url=https://www.who.int/news/item/07-05-2021-who-lists-additional-covid-19-vaccine-for-emergency-use-and-issues-interim-policy-recommendations | access-date=7 May 2021}}</ref><ref name=WHOEUA>{{cite news | last=Taylor | first=Adam | title=WHO grants emergency use authorization for Chinese-made Sinopharm coronavirus vaccine | newspaper=[[The Washington Post]] | date=7 May 2021 | url=https://www.washingtonpost.com/world/2021/05/07/who-sinopharm-emergency-use/ | access-date=7 May 2021}}</ref> </div> ;Travel-only {{div col|colwidth=18em}} * Andorra<ref name="auto24">{{cite web|url=https://visitandorra.com/en/covid-19-in-andorra/faq-if-you-re-spending-a-few-days-in-andorra/|title=FAQ|website=Andorra Tourism|accessdate=2021-12-25|archivedate=2021-12-27|archiveurl=https://web.archive.org/web/20211227065841/https://visitandorra.com/en/covid-19-in-andorra/faq-if-you-re-spending-a-few-days-in-andorra/}}</ref> * Australia<ref name="AU recognized">{{cite web | title=International COVID-19 vaccines recognised by Australia | website=Therapeutic Goods Administration (TGA) | url=https://www.tga.gov.au/international-covid-19-vaccines-recognised-australia | access-date=26 November 2021 | accessdate=25 December 2021 | archivedate=7 February 2022 | archiveurl=https://web.archive.org/web/20220207080016/https://www.tga.gov.au/international-covid-19-vaccines-recognised-australia }}</ref><ref name="tga-covaxin-bibp">{{cite press release |date=1 November 2021 |title=TGA recognises two more COVID-19 vaccines not registered in Australia but used widely internationally |url=https://www.tga.gov.au/media-release/tga-recognises-two-more-covid-19-vaccines-not-registered-australia-used-widely-internationally |publisher=Therapeutic Goods Administration |access-date=11 November 2021}}</ref> * Austria<ref name="auto10">{{cite web|url=https://www.austria.info/en/service-and-facts/coronavirus-information/entry-regulations|title=Coronavirus: Entry Regulations to Austria|website=www.austria.info}}</ref> (only for entry) * Bulgaria<ref>https://www.mh.government.bg/media/filer_public/2021/08/30/order_01-733_en_final.pdf {{Webarchive|url=https://web.archive.org/web/20211123001345/https://www.mh.government.bg/media/filer_public/2021/08/30/order_01-733_en_final.pdf |date=2021-11-23 }} {{Bare URL PDF|date=March 2022}}</ref> * Canada<ref name="auto31">{{cite web|url=https://travel.gc.ca/travel-covid/travel-restrictions/covid-vaccinated-travellers-entering-canada|title=COVID-19 vaccinated travellers entering Canada - Travel restrictions in Canada|first=Global Affairs|last=Canada|date=8 April 2021|website=travel.gc.ca}}</ref> * Chile<ref>{{cite web|url=https://www.chile.travel/en/traveltochileplan/|title=Travel to Chile Plan|first=Mi|last=Bajón}}</ref> * Costa Rica<ref name="auto41">{{cite web|url=https://www.visitcostarica.com/es/costa-rica/planning-your-trip/entry-requirements|title=Requisitos de entrada|date=8 June 2016|website=Visit Costa Rica|accessdate=25 December 2021|archivedate=25 December 2021|archiveurl=https://web.archive.org/web/20211225175407/https://www.visitcostarica.com/es/costa-rica/planning-your-trip/entry-requirements}}</ref> * Croatia<ref name="auto19">{{cite web|url=https://mup.gov.hr/uzg-covid/english/286212|title=English|website=mup.gov.hr}}</ref> * Cyprus<ref name="auto15">{{cite web |url=https://cyprusflightpass.gov.cy/en/vaccinated-passengers |title=Vaccinated Passengers |publisher=Cyprus Flight Pass |date= |access-date=2022-03-04 |accessdate=2021-12-25 |archivedate=2022-03-06 |archiveurl=https://web.archive.org/web/20220306213314/https://cyprusflightpass.gov.cy/en/vaccinated-passengers }}</ref> * Czech Republic<ref>{{cite web|author=Čeština |url=https://koronavirus.mzcr.cz/en/recognition-of-vaccination-certificates-from-other-countries/ |title=Recognition of vaccination certificates from other countries – Aktuální informace o COVID-19 |publisher=Koronavirus.mzcr.cz |date=2021-04-21 |access-date=2022-03-04}}</ref> (only for Hungarian citizens and EU nationals vaccinated in Hungary) * Estonia<ref name="auto26">{{cite web|url=https://kkk.kriis.ee/en/faq/covid-19-vaccination/vaccines#q10069311|title=Questions and answers on coronavirus, related decisions and changes: Vaccines|website=kkk.kriis.ee|accessdate=2021-12-25|archivedate=2021-12-25|archiveurl=https://web.archive.org/web/20211225084747/https://kkk.kriis.ee/en/faq/covid-19-vaccination/vaccines#q10069311}}</ref> (only if approved in a person's country of origin) * Finland<ref name="auto37">{{cite web|title=Vaccine series accepted in Finland - Infectious diseases and vaccinations - THL|url=https://thl.fi/en/web/infectious-diseases-and-vaccinations/what-s-new/coronavirus-covid-19-latest-updates/travel-and-the-coronavirus-pandemic/which-vaccines-are-accepted-at-the-points-of-entry-into-the-country-|access-date=16 November 2021|website=Finnish Institute for Health and Welfare (THL), Finland|accessdate=25 December 2021|archivedate=16 November 2021|archiveurl=https://web.archive.org/web/20211116182910/https://thl.fi/en/web/infectious-diseases-and-vaccinations/what-s-new/coronavirus-covid-19-latest-updates/travel-and-the-coronavirus-pandemic/which-vaccines-are-accepted-at-the-points-of-entry-into-the-country-}}</ref> * Greece<ref name="auto27">{{cite web|url=https://news.gtp.gr/2021/08/11/greece-accepting-most-covid-19-vaccines-for-travel/|title=Greece Accepting Most Covid-19 Vaccines for Travel|date=11 August 2021|website=GTP Headlines|accessdate=25 December 2021|archivedate=8 December 2021|archiveurl=https://web.archive.org/web/20211208101400/https://news.gtp.gr/2021/08/11/greece-accepting-most-covid-19-vaccines-for-travel/}}</ref> * Grenada<ref name="auto8">{{cite web |url=https://covid19.gov.gd/vaccinated-travellers/ |title=Vaccinated Travellers – Ministry Of Health – Government of Grenada |publisher=Covid19.gov.gd |date=2020-11-06 |access-date=2022-03-04 |accessdate=2021-12-25 |archivedate=2022-03-18 |archiveurl=https://web.archive.org/web/20220318190925/https://covid19.gov.gd/vaccinated-travellers/ }}</ref> * Hong Kong<ref name="HK"/> * Iceland<ref name="auto18">{{cite web|url=https://www.landlaeknir.is/um-embaettid/greinar/grein/item44162/certificate-of-vaccination-against-covid-19-accepted-at-the-border|title=Certificates of vaccination accepted at the border in Iceland for exemption of border measures due to COVID-19|website=www.landlaeknir.is|accessdate=2021-12-25|archivedate=2021-11-05|archiveurl=https://web.archive.org/web/20211105184914/https://www.landlaeknir.is/um-embaettid/greinar/grein/item44162/certificate-of-vaccination-against-covid-19-accepted-at-the-border}}</ref> * Ireland<ref name="auto11">{{cite web|url=https://www.gov.ie/en/publication/77952-government-advice-on-international-travel/|title=Government advice on international travel|website=www.gov.ie|accessdate=2021-12-25|archivedate=2021-11-16|archiveurl=https://web.archive.org/web/20211116193913/https://www.gov.ie/en/publication/77952-government-advice-on-international-travel/}}</ref> * Latvia<ref>{{cite web |url=https://www.spkc.gov.lv/lv/valstu-saslimstibas-raditaji-ar-covid-19-0 |title=Valstu saraksti |language=lv |publisher=SPKC |date= |access-date=2022-03-04}}</ref> * Liechtenstein<ref name="auto28">{{cite web|url=https://tourismus.li/en/our-country/about-liechtenstein/current-information-on-covid-19-in-the-principality-of-liechtenstein/|title=Current information on COVID-19 in the Principality of Liechtenstein|website=tourismus.li|accessdate=2021-12-25|archivedate=2021-12-27|archiveurl=https://web.archive.org/web/20211227065825/https://tourismus.li/en/our-country/about-liechtenstein/current-information-on-covid-19-in-the-principality-of-liechtenstein/}}</ref> * New Zealand<ref name="auto9">{{cite web|url=https://covid19.govt.nz/international-travel/travel-to-new-zealand/vaccination-requirements-for-travel-to-new-zealand/|title=Vaccination requirements for travel to New Zealand|website=Unite against COVID-19}}</ref> * Oman<ref name="auto36">https://presspage-production-content.s3.amazonaws.com/uploads/2571/travelguideen-ar3.pdf?10000 {{Webarchive|url=https://web.archive.org/web/20211019030610/https://presspage-production-content.s3.amazonaws.com/uploads/2571/travelguideen-ar3.pdf?10000 |date=2021-10-19 }} {{Bare URL inline|date=March 2022}}</ref> * Panama<ref name="auto35">{{cite web|url=https://es.tourismpanama.com/planea-tus-vacaciones/avisos/|title=Protocolos COVID-19|website=tourismpanama}}</ref> * Portugal<ref name="visitmadeira1">{{cite web|url=https://www.visitmadeira.pt/en-gb/useful-info/corona-virus-(covid-19)/information-to-visitors-(covid-19)|title = Information COVID 19}}</ref> (only in Madeira) * Qatar<ref>{{#invoke:Cite news||author1=Arslan|title=Qatar gives conditional approval for Sinopharm Vaccine|url=https://covid19.moph.gov.qa/EN/travel-and-return-policy/Pages/default.asp|publisher=qaziarslantariq|date=1 August 2021}}</ref> * Saudi Arabia (for short visits, [[Hajj]] and [[Umrah]] only)<ref>{{cite web |url=https://covid19.cdc.gov.sa/update-vaccinated-individuals-for-the-purpose-of-coming-to-the-kingdom-december-2021/# |title=Update vaccinated individuals (for the purpose of coming to the kingdom) December 2021 - Public Health Authority |publisher=Covid19.cdc.gov.sa |date= |access-date=2022-03-04 }}{{Dead link|date=January 2025 |bot=InternetArchiveBot |fix-attempted=yes }}</ref> * Slovakia<ref name="auto29">{{cite web|url=https://www.mic.iom.sk/en/news/637-covid-19-measures.html|title=COVID-19: official measures and important information (updated continually) - IOM Migration information center|website=www.mic.iom.sk|accessdate=2021-12-25|archivedate=2021-12-25|archiveurl=https://web.archive.org/web/20211225104008/https://www.mic.iom.sk/en/news/637-covid-19-measures.html}}</ref> * Slovenia<ref name="auto30">{{cite web|url=https://www.gov.si/en/topics/coronavirus-disease-covid-19/border-crossing/|title=Border Crossing &#124; GOV.SI|website=Portal GOV.SI}}</ref> * South Korea<ref name="auto42">https://www.koreanair.com/kr/en/travel-update/covid19/travel-restriction/korea {{Webarchive|url=https://web.archive.org/web/20210730154938/https://www.koreanair.com/kr/en/travel-update/covid19/travel-restriction/korea |date=2021-07-30 }} {{Bare URL inline|date=March 2022}}</ref> * Spain<ref name="auto40">{{cite web|title=Certificado Covid Digital De La Ue Y Otros Certificados|url=https://www.mscbs.gob.es/profesionales/saludPublica/sanidadExterior/CHS/Pdf/FAQs_CERTIFICADO_DIGITAL_COVID-19-UE_y_OTROS_CERTIFICADOS_ES_071021_v6.pdf|accessdate=2021-12-25|archivedate=2021-11-30|archiveurl=https://web.archive.org/web/20211130032702/https://www.mscbs.gob.es/profesionales/saludPublica/sanidadExterior/CHS/Pdf/FAQs_CERTIFICADO_DIGITAL_COVID-19-UE_y_OTROS_CERTIFICADOS_ES_071021_v6.pdf}}</ref> * St. Kitts and Nevis<ref name="auto33">{{cite web|url=https://covid19.gov.kn/travel-protocols/|title=Travel Protocols – GOVERNMENT OF ST. KITTS AND NEVIS}}{{Dead link|date=March 2025 |bot=InternetArchiveBot |fix-attempted=yes }}</ref> * St. Lucia<ref name="auto17">{{cite web|url=https://www.stlucia.org/en/covid-19/faqs/|title=NEW-FAQs|website=Saint Lucia Tourism Authority|accessdate=2021-12-25|archivedate=2022-12-08|archiveurl=https://web.archive.org/web/20221208103421/https://www.stlucia.org/en/covid-19/faqs/}}</ref> * St. Vincent and the Grenadines<ref name="auto21">http://health.gov.vc/health/images/PDF/SVG_Health_Services_Subcommittee_Protocol_for_Fully_Vaccinated_Travelers_to_SVG_10112021.pdf {{Bare URL PDF|date=March 2022}}</ref> * Sweden<ref name="auto38">{{cite web|title=Certificate requirements for foreign nationals travelling to Sweden - The Public Health Agency of Sweden|url=https://www.folkhalsomyndigheten.se/the-public-health-agency-of-sweden/communicable-disease-control/covid-19/if-you-are-planning-to-travel/negative-covid-19-test-required-for-entry-into-sweden/|access-date=16 November 2021|website=www.folkhalsomyndigheten.se|accessdate=25 December 2021|archivedate=16 November 2021|archiveurl=https://web.archive.org/web/20211116182910/https://www.folkhalsomyndigheten.se/the-public-health-agency-of-sweden/communicable-disease-control/covid-19/if-you-are-planning-to-travel/negative-covid-19-test-required-for-entry-into-sweden/}}</ref> * Switzerland<ref name="auto39">{{cite web|url=https://www.bag.admin.ch/bag/en/home/krankheiten/ausbrueche-epidemien-pandemien/aktuelle-ausbrueche-epidemien/novel-cov/empfehlungen-fuer-reisende/quarantaene-einreisende.html|title=Coronavirus: Entering Switzerland|first=Federal Office of Public Health|last=FOPH|website=www.bag.admin.ch|accessdate=2021-12-25|archivedate=2020-07-24|archiveurl=https://web.archive.org/web/20200724080307/https://www.bag.admin.ch/bag/en/home/krankheiten/ausbrueche-epidemien-pandemien/aktuelle-ausbrueche-epidemien/novel-cov/empfehlungen-fuer-reisende/quarantaene-einreisende.html}}</ref> * The Netherlands<ref name="auto25">{{cite web|url=https://www.government.nl/topics/coronavirus-covid-19/visiting-the-netherlands-from-abroad/requirements-for-proof-of-vaccination|title=Travelling to the Netherlands with proof of vaccination - Coronavirus COVID-19 - Government.nl|first=Ministerie van Algemene|last=Zaken|date=12 November 2021|website=www.government.nl}}</ref> * Turkey<ref name="auto12">{{cite web|url=https://www.visasturkey.com/vaccinations-for-turkey/|title=Vaccinations for Turkey: Do I need an Approved COVID Vaccine?|date=10 April 2019|accessdate=25 December 2021|archivedate=16 November 2021|archiveurl=https://web.archive.org/web/20211116191928/https://www.visasturkey.com/vaccinations-for-turkey/}}</ref> * Ukraine<ref name="auto22">{{cite web|url=https://visitukraine.today/|title=Visit Ukraine - Information and Rules|website=Visit Ukraine}}</ref> * United Kingdom<ref name="auto34">{{cite web|url=https://www.gov.uk/government/news/travel-updatenew-guidance-for-people-vaccinated-under-who-emergency-use-listing-and-under-18s|title=Travel update: new guidance for people vaccinated under WHO Emergency Use Listing and under 18s|website=GOV.UK}}</ref> * United States<ref name="auto16">{{cite web|url=https://www.cdc.gov/coronavirus/2019-ncov/travelers/proof-of-vaccination.html|title=COVID-19 and Your Health|date=11 February 2020|website=U.S. [[Centers for Disease Control and Prevention]] (CDC)}}</ref> * Uruguay<ref name="auto14">{{cite web|url=https://www.gub.uy/ministerio-salud-publica/comunicacion/publicaciones/requisitos-para-ingreso-uruguay-personas-nacionales-extranjeras|title=Requisitos para el ingreso a Uruguay de personas nacionales o extranjeras|website=Ministerio de Salud Pública}}</ref> (only if approved in a person's country of origin) {{div col end}} {{-}} == Sputnik V == <section begin="sputnikauthmap" /> {{infobox | image = {{Graph:Map|scale=65|defaultValue=gainsboro |AE=dodgerblue|AG=dodgerblue|AM=dodgerblue|AO=dodgerblue|AR=dodgerblue|AU=turquoise|AZ=dodgerblue |BA=dodgerblue|BD=dodgerblue|BH=dodgerblue|BO=dodgerblue|BR=dodgerblue|BY=dodgerblue |CG=dodgerblue|CI=dodgerblue|CL=dodgerblue|CM=dodgerblue|CY=turquoise |DJ=dodgerblue|DZ=dodgerblue |EE=turquoise|EC=dodgerblue|EG=dodgerblue |GA=dodgerblue|GH=dodgerblue|GM=dodgerblue|GN=dodgerblue|GR=turquoise|GT=dodgerblue|GY=dodgerblue |HK=turquoise|HN=dodgerblue|HU=dodgerblue |ID=dodgerblue|IL=turquoise|IN=dodgerblue|IQ=dodgerblue|IR=dodgerblue |JO=dodgerblue |KE=dodgerblue|KG=dodgerblue|KH=dodgerblue|KZ=dodgerblue |LA=dodgerblue|LB=dodgerblue|LK=dodgerblue|LY=dodgerblue |MA=dodgerblue|MD=dodgerblue|ME=dodgerblue|MK=dodgerblue|ML=dodgerblue|MM=dodgerblue|MN=dodgerblue|MU=dodgerblue|MV=dodgerblue|MX=dodgerblue|MY=turquoise |NA=dodgerblue|NG=dodgerblue|NI=dodgerblue|NP=dodgerblue |OM=dodgerblue|NZ=turquoise |PA=dodgerblue|PE=dodgerblue|PH=dodgerblue|PK=dodgerblue|PS=dodgerblue|PY=dodgerblue |RS=dodgerblue|RU=blueviolet|RW=dodgerblue |SA=turquoise|SC=dodgerblue|SI=turquoise|SK=darkorange|SM=dodgerblue|SY=dodgerblue |TH=turquoise|TJ=dodgerblue|TM=blueviolet|TN=dodgerblue|TR=dodgerblue |UZ=blueviolet |VC=dodgerblue|VE=dodgerblue|VN=dodgerblue |ZA=red|ZW=dodgerblue }} | caption = {{leftlegend|blueviolet|Full authorization}} {{leftlegend|dodgerblue|Emergency authorization}} {{leftlegend|darkorange|Authorization expired}} {{leftlegend|turquoise|Allowed for travel}} {{leftlegend|red|Rejected}} }} <section end="sputnikauthmap" /> The [[Sputnik V COVID-19 vaccine]] is a [[viral vector vaccine]]<ref name="NCT04436471">{{cite journal|date=17 June 2020|title=An Open Study of the Safety, Tolerability and Immunogenicity of the Drug "Gam-COVID-Vac" Vaccine Against COVID-19|url=https://clinicaltrials.gov/ct2/show/NCT04436471|access-date=5 March 2021|website=[[ClinicalTrials.gov]]|publisher=[[United States National Library of Medicine]]|id=NCT04436471}}</ref> produced by the Russian [[Gamaleya Research Institute of Epidemiology and Microbiology]]. ;Full (<section begin="Sputnik V_FN" />3<section end="Sputnik V_FN" />) # Russia<ref name="burki">{{cite journal|vauthors=Burki TK|date=November 2020|title=The Russian vaccine for COVID-19|journal=The Lancet. Respiratory Medicine|volume=8|issue=11|pages=e85–e86|doi=10.1016/S2213-2600(20)30402-1|pmc=7837053|pmid=32896274|doi-access=free|title-link=doi}}</ref><ref>{{Cite news|date=4 February 2022|title=Sputnik V vaccine granted full permanent approval in Russia|work=[[PR Newswire]]|url=https://www.prnewswire.com/in/news-releases/sputnik-v-vaccine-granted-full-permanent-approval-in-russia-879907727.html|access-date=8 February 2022}}</ref> # Turkmenistan<ref>{{cite news|date=18 January 2021|title=Turkmenistan is the first in Central Asia to have registered 'Sputnik V' vaccine|work=Orient|url=https://orient.tm/en/turkmenistan-is-the-first-in-central-asia-to-have-registered-sputnik-v-vaccine/|accessdate=7 July 2021|archivedate=27 January 2021|archiveurl=https://web.archive.org/web/20210127203020/https://orient.tm/en/turkmenistan-is-the-first-in-central-asia-to-have-registered-sputnik-v-vaccine/}}</ref><ref>{{cite news|date=22 January 2021|title=Session of the Cabinet of Ministers of Turkmenistan |work=Turkmenistan today |url=https://tdh.gov.tm/en/post/25815/objectives-of-increasing-national-health-system%E2%80%99s-potential-discussed}}</ref> # Uzbekistan<ref>{{cite news|date=17 February 2021|title=Uzbekistan Certifies Russia's Sputnik Vaccine For Mass Use|publisher=Agence France-Presse (Barron's)|url=https://www.barrons.com/news/uzbekistan-certifies-russia-s-sputnik-vaccine-for-mass-use-01613559912}}</ref> {{-}} ;Emergency (<section begin="Sputnik V_EN" />76<section end="Sputnik V_EN" />) <div style="margin-top: 0.3em; column-width: 15em;"> # Albania<ref name=":0" /> # Algeria<ref>{{cite news|date=10 January 2021|title=Covid19: National Pharmaceuticals Agency registers Sputnik V vaccine|work=Algeria Press service|url=https://www.aps.dz/en/health-science-technology/37478-covid19-national-pharmaceuticals-agency-registers-sputnik-v-vaccine}}</ref> # Angola<ref name="Reuters idUSR4N2K301A" /> # Antigua and Barbuda<ref>{{cite press release|title=Antigua and Barbuda authorizes Sputnik V|url=https://sputnikvaccine.com/newsroom/pressreleases/antigua-and-barbuda-authorizes-sputnik-v/|website=sputnikvaccine.com|date=26 March 2021}}</ref> # Argentina<ref>{{cite press release|title=Argentina has registered the Sputnik V vaccine based on Russian clinical trial data|url=https://sputnikvaccine.com/newsroom/pressreleases/argentina-has-registered-the-sputnik-v-vaccine-based-on-russian-clinical-trial-data-/|access-date=1 January 2021|publisher=Gamaleya Center}}</ref> # Armenia<ref>{{cite news|date=1 February 2021|title=Armenia approves Russia's Sputnik V coronavirus vaccine -Russia's RDIF|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-russia-vaccine-armeni/armenia-approves-russias-sputnik-v-coronavirus-vaccine-russias-rdif-idUSR4N2J304T|access-date=1 February 2021}}</ref> # Azerbaijan<ref>{{cite news|date=12 March 2021|title=Azerbaijan approves Russia's Sputnik V vaccine for use against COVID-19 -Azeri health ministry|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-russia-azerbaijan/azerbaijan-approves-russias-sputnik-v-vaccine-for-use-against-covid-19-azeri-health-ministry-idUSR4N2IW02L}}</ref><ref>{{#invoke:Cite web||title=Russian Direct Investment Fund|url=https://rdif.ru/Eng_fullNews/6524/|access-date=1 April 2021|website=rdif.ru}}</ref> # Bahrain<ref>{{cite news|date=10 February 2021|title=Bahrain authorises Sputnik V COVID-19 vaccine for emergency use – Bahrain TV|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-bahrain-vaccine-int-idUSKBN2AA1GW|access-date=19 February 2021}}</ref> # Bangladesh<ref>{{cite news|date=27 April 2021|title=Bangladesh approves Russia's Sputnik V Covid-19 vaccine for emergency use|publisher=[[Dhaka Tribune]]|url=https://www.dhakatribune.com/bangladesh/2021/04/27/bangladesh-approves-russia-s-sputnik-v-vaccine-for-emergency-use|access-date=27 April 2021}}</ref> # Belarus<ref>{{cite news|date=21 December 2020|title=Belarus registers Sputnik V vaccine, in first outside Russia – RDIF|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-vaccine-belarus/belarus-registers-sputnik-v-vaccine-in-first-outside-russia-rdif-idINKBN28V0ZG|access-date=22 December 2020}}</ref> # Bolivia<ref>{{cite news|title=Ministerio de Salud de Bolivia – Bolivia y Rusia firman contrato para adquirir 5,2 millones de dosis de la vacuna Sputnik-V contra la COVID-19|work=minsalud.gob.bo|url=https://www.minsalud.gob.bo/5114-bolivia-y-rusia-firman-contrato-para-adquirir-5-2-millones-de-dosis-de-la-vacuna-sputnik-v-contra-el-covid-19|access-date=1 January 2021}}</ref> # Bosnia and Herzegovina<ref name="Tass 20210205">{{#invoke:Cite web||date=5 February 2021|title=Sputnik V vaccine registered in Bosnia and Herzegovina's Republika Srpska|url=https://tass.com/world/1253307|access-date=8 February 2021|agency=TASS}}</ref> # Brazil<ref name="g1.globo.com">{{cite news |title=Anvisa aprova, com restrições, a importação excepcional de doses da Covaxin e Sputnik V |trans-title=Anvisa approves import of doses of Covaxin and Sputnik V, with restrictions |url=https://g1.globo.com/bemestar/vacina/noticia/2021/06/04/anvisa-covaxin-sputnik-v.ghtml |access-date=4 June 2021 |work=G1 |agency=Globo |date=4 June 2021 |language=Portuguese}}</ref> ''(restricted)'' # Cambodia<ref name="auto20">{{cite web|title=Russian Direct Investment Fund|url=https://rdif.ru/Eng_fullNews/7138/|access-date=5 November 2021|website=rdif.ru|archive-date=5 November 2021|archive-url=https://web.archive.org/web/20211105013012/https://rdif.ru/Eng_fullNews/7138/|url-status=dead}}</ref> # Cameroon<ref>{{cite news|date=19 March 2021|title=Cameroon approves Russia's Sputnik V coronavirus vaccine for use – RDIF|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-vaccine-russia-camero-idUSR4N2HG02H}}</ref> # Chile<ref>{{#invoke:Cite web||title=Instituto de Salud Pública de Chile|url=https://www.ispch.cl/noticia/isp-aprueba-uso-de-emergencia-e-importacion-de-la-vacuna-sputnik-v/|access-date=21 July 2021}}</ref> # Congo-Brazzaville<ref name="Reuters idUSR4N2K301A" /> # Djibouti<ref name="Reuters idUSR4N2K301A">{{cite news |title=Angola, Congo Republic and Djibouti approve Russia's Sputnik V vaccine |url=https://www.reuters.com/article/health-coronavirus-russia-vaccine-angola-idUSR4N2K301A |publisher=Reuters |date=3 March 2021 }}</ref> # Ecuador<ref>{{cite news|title=Arcsa autoriza el ingreso al Ecuador de vacuna Sputnik V|work=www.controlsanitario.gob.ec|url=https://www.controlsanitario.gob.ec/arcsa-autoriza-el-ingreso-al-ecuador-de-vacuna-sputnik-v/|date=14 May 2021|access-date=15 May 2021}}</ref> # Egypt<ref name="Gulf News">{{cite news|title=COVID-19: Egypt authorises Sputnik V, AstraZeneca virus jabs|work=Gulf News|url=https://gulfnews.com/world/mena/covid-19-egypt-authorises-sputnik-v-astrazeneca-virus-jabs-1.1614189861208|access-date=24 February 2021}}</ref> # Gabon<ref>{{cite press release|title=Sputnik V authorised in Gabon|url=https://sputnikvaccine.com/newsroom/pressreleases/sputnik-v-authorized-in-gabon/|access-date=17 February 2021|publisher=Gamaleya Center}}</ref> # Gambia<ref>{{cite web|title=Farmacovigilancia de vacunas para COVID-19 - Gamaleya Sputnik V; Sputnik Light|url=https://covid-19pharmacovigilance.paho.org/|access-date=9 October 2021|website=Farmacovigilancia de vacunas para COVID-19}}</ref> # Ghana<ref>{{cite news|date=20 February 2021|title=Ghana approves Russia's Sputnik V vaccine for emergency use – RDIF|agency=[[Reuters]]|url=https://news.trust.org/item/20210220072758-kzlw8/|accessdate=7 July 2021|archivedate=19 March 2021|archiveurl=https://web.archive.org/web/20210319084048/https://news.trust.org/item/20210220072758-kzlw8/}}</ref> # Guatemala<ref>{{#invoke:Cite web||title=Guatemala authorizes Sputnik V|url=https://www.pharmiweb.com/press-release/2021-02-26/guatemala-authorizes-sputnik-v|access-date=1 April 2021|website=PharmiWeb}}</ref> # Guinea<ref>{{cite news|date=31 December 2020|title=Guinea Begins Administering Russia's Sputnik V Covid-19 Vaccine|work=Africa news|url=https://www.africanews.com/2020/12/31/guinea-begins-administering-russia-s-sputnik-v-covid-19-vaccine/}}</ref> # Guyana<ref>{{cite news|date=3 March 2021|title=Russia's Sputnik V vaccine expands its reach in Latin America|publisher=CNN|url=https://edition.cnn.com/2021/03/03/americas/sputnik-latin-america-spreads-intl-latam/index.html}}</ref> # Honduras<ref>{{cite news|date=25 February 2021|title=Honduras approves use of Sputnik V vaccine against COVID-19|publisher=Xinhuanet|url=http://www.xinhuanet.com/english/2021-02/25/c_139764745.htm|accessdate=7 July 2021|archivedate=10 March 2021|archiveurl=https://web.archive.org/web/20210310013921/http://www.xinhuanet.com/english/2021-02/25/c_139764745.htm}}</ref> # Hungary<ref>{{cite news |title=Hungarian drug regulator approves Sputnik V vaccine: website |url=https://www.themoscowtimes.com/2021/02/07/hungary-approves-russias-sputnik-v-vaccine-a72853 |work=The Moscow Times |date=7 February 2021 }}</ref><ref name="Tass 20210205" /><ref name="WashPost Hungary">{{cite news | last=Spike | first=Justin | title=Hungary approves 2 more vaccines from outside EU amid spike |agency=Associated Press |website=ABC News | date=22 March 2021 | url=https://abcnews.go.com/Health/wireStory/hungary-approves-vaccines-eu-amid-spike-76604743 | access-date=14 July 2021 |name-list-style=vanc}}</ref> # India<ref>{{cite news |title=India approves Russia's 'Sputnik V' COVID-19 vaccine: Economic Times |url=https://www.reuters.com/article/health-coronavirus-india-vaccine/india-approves-russias-sputnik-v-covid-19-vaccine-economic-times-idUSKBN2BZ11Y |publisher=Reuters |date=12 April 2021 }}</ref> # Indonesia<ref>{{cite web|last=|first=|date=25 August 2021|title=BPOM Terbitkan Izin Darurat Vaksin Rusia Sputnik-V|url=https://www.cnnindonesia.com/nasional/20210825111626-20-685041/bpom-terbitkan-izin-darurat-vaksin-rusia-sputnik-v|access-date=25 August 2021|website=CNN Indonesia|language=id-ID}}</ref> # Iran<ref>{{cite news|date=26 January 2021|title=Iran approves Russian coronavirus vaccine Sputnik V|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-russia-iran/iran-approves-russian-coronavirus-vaccine-sputnik-v-for-use-idUSKBN29V1A8}}</ref> # Iraq<ref>{{cite press release|title=Sputnik V authorized in Iraq|url=https://www.pharmiweb.com/press-release/2021-03-05/sputnik-v-authorized-in-iraq|publisher=PharmiWeb.com|date=4 March 2021}}</ref> # Ivory Coast<ref name="whotracker" /> # Jordan<ref>{{cite press release|title=Jordan approves Russia's Sputnik V vaccine for use against COVID-19|url=https://www.reuters.com/article/health-coronavirus-russia-jordan-vaccine/jordan-approves-russias-sputnik-v-vaccine-for-use-against-covid-19-idUSL1N2L8241|publisher=Reuters|date=10 March 2021}}</ref> # Kazakhstan<ref>{{#invoke:Cite web||date=1 February 2021|title=Kazakhstan begins mass vaccination by Russian Sputnik V|url=https://www.neweurope.eu/article/kazakhstan-has-began-mass-vaccination-by-russian-sputnik-v/|access-date=19 February 2021}}</ref> # Kenya<ref>{{cite news|date=10 March 2021|title=Morocco, Kenya approve Russian coronavirus vaccine for use – RDIF|url=https://www.reuters.com/article/uk-health-coronavirus-vaccine-russia-ken-idUSKBN2B2130|access-date=12 March 2021}}</ref> # Kyrgyzstan<ref>{{cite press release|title=Sputnik V registered in Kyrgyzstan|url=https://sputnikvaccine.com/newsroom/pressreleases/sputnik-v-registered-in-kyrgyzstan/|website=Gamaleya Center|date=23 February 2021}}</ref> # Laos<ref name="auto1">{{#invoke:Cite web||title=Laos declares Covid-19 vaccinations safe, more to be inoculated next week |url=https://www.thestar.com.my/aseanplus/aseanplus-news/2021/01/06/laos-declares-covid-19-vaccinations-safe-more-to-be-inoculated-next-week|access-date=19 February 2021|website=The Star|location=Malaysia}}</ref> # Lebanon<ref>{{cite news|date=5 February 2021|title=Lebanon authorises emergency use of Russia's Sputnik V vaccine|agency=[[Reuters]]|url=https://news.trust.org/item/20210205151526-w0bv2/|accessdate=7 July 2021|archivedate=19 March 2021|archiveurl=https://web.archive.org/web/20210319084134/https://news.trust.org/item/20210205151526-w0bv2/}}</ref> # Libya<ref name="auto4" /><ref name="auto5" /> # Maldives<ref>{{cite news|title=Maldives approves Russia's Sputnik V COVID-19 vaccine|url=https://www.reuters.com/article/health-coronavirus-vaccine-russia-maldiv/maldives-approves-russias-sputnik-v-covid-19-vaccine-idUSR4N2MN00D|website=reuters.com|date=13 May 2021|access-date=13 May 2021}}</ref> # Mali<ref>{{cite news|date=30 March 2021|title=Mali approves Russia's Sputnik V vaccine – Russian sovereign wealth fund|publisher=Reuters|url=https://www.reuters.com/article/uk-health-coronavirus-russia-mali-vaccin/mali-approves-russias-sputnik-v-vaccine-russian-sovereign-wealth-fund-idUSKBN2BM0Y5}}</ref> # Mauritius<ref>{{cite news|date=22 March 2021|title=Mauritius approves Russia's Sputnik V coronavirus vaccine – Russian RDIF fund|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-vaccine-russia-maurit/mauritius-approves-russias-sputnik-v-coronavirus-vaccine-russian-rdif-fund-idUSR4N2KP01G}}</ref> # Mexico<ref>{{cite news|date=3 February 2021|title=Mexico, Germany warm to Russia's Sputnik V virus vaccine|work=The Jakarta Post|url=https://www.thejakartapost.com/news/2021/02/03/mexico-germany-warm-to-russias-sputnik-v-virus-vaccine-.html}}</ref> # Moldova<ref name=":2" /> # Mongolia<ref>{{cite news|date=9 February 2021|title=Mongolia Approves Russia's Sputnik V Coronavirus Vaccine – RDIF|publisher=Urdu Point|url=https://www.urdupoint.com/en/world/mongolia-approves-russias-sputnik-v-coronavi-1163730.html}}</ref> # Montenegro<ref>{{cite news|date=12 February 2021|title=Montenegro and St. Vincent approve Russia's Sputnik V vaccine – RDIF|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-russia-vaccine-mon/montenegro-and-st-vincent-approve-russias-sputnik-v-vaccine-rdif-idUSKBN2AC0QZ}}</ref> # Morocco<ref>{{cite news|date=11 March 2021|title=Morocco orders one million doses of Russia's Sputnik V vaccine|publisher=Yabiladi|url=https://en.yabiladi.com/articles/details/107075/morocco-orders-million-doses-russia-s.html}}</ref> # Myanmar<ref>{{#invoke:Cite web||title=Myanmar registers Russia's Sputnik V COVID-19 vaccine|url=https://tass.com/world/1253415|access-date=19 February 2021|publisher=Tass}}</ref> # Namibia<ref>{{#invoke:Cite web||title=Russian Direct Investment Fund|url=https://rdif.ru/Eng_fullNews/6520/|access-date=1 April 2021|website=rdif.ru}}</ref> # Nepal<ref>{{Cite news|author=Reuters Staff|date=20 April 2021|title=Nepal approves Russia's Sputnik V COVID-19 vaccine|work=[[Reuters]]|url=https://www.reuters.com/article/health-coronavirus-nepal-idINL4N2MD3KU|access-date=23 April 2021}}</ref> # Nicaragua<ref>{{cite news|date=3 February 2021|title=Nicaragua approves Russian COVID-19 vaccine|work=Associated Press|url=https://apnews.com/article/nicaragua-europe-russia-health-coronavirus-pandemic-82f9744bcf62d1689683c56455ecf15a |access-date=2 June 2021}}</ref> # Nigeria<ref>{{cite news |title=Sputnik V vaccine approved in Nigeria |url=https://rdif.ru/fullNews/6937/ |access-date=18 July 2021 |work=Russian Direct Investment Fund |date=15 July 2021 |archive-date=18 July 2021 |archive-url=https://web.archive.org/web/20210718122835/https://rdif.ru/fullNews/6937/ |url-status=dead }}</ref> # North Macedonia<ref>{{#invoke:Cite web||date=7 March 2021|title=NRussia's Sputnik V COVID 19 vaccine registered in North Macedonia|url=https://tass.com/coronavirus-outbreak-in-china/1263509|publisher=[[TASS]]}}</ref> # Oman<ref name="oman-coronavac-sputnik"/> # Pakistan<ref>{{cite news|date=24 January 2021|title=Govt okays Russian vaccine for 'emergency use'|work=Dawn|url=https://www.dawn.com/news/1603273}}</ref> # Palestine<ref>{{cite news|date=11 January 2021|title=Palestine has become the first country in the Middle East to register Sputnik V vaccine|work=RFID|url=https://rdif.ru/Eng_fullNews/6279/}}</ref> # Panama<ref>{{cite news |title=Panama approves use of Russian vaccine |url=https://www.newsroompanama.com/news/panama-approves-use-of-russian-vaccine |access-date=2 April 2021 |work=Newsroom Panama |date=1 April 2021}}</ref> # Paraguay<ref>{{cite news|date=15 January 2021|title=Paraguay approves Russia's Sputnik V vaccine: RDIF|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-russia-vaccine-paragu/paraguay-approves-russias-sputnik-v-vaccine-rdif-idUSR4N2J303Y|access-date=15 January 2021}}</ref> # Peru<ref>{{#invoke:Cite web||date=20 July 2021|title=Perú anuncia acuerdo para compra de 20 millones de dosis de la vacuna Sputnik V|url=https://elperuano.pe/noticia/125005-gobierno-firma-contrato-para-compra-de-20-millones-de-dosis-de-la-vacuna-sputnik-v|access-date=5 August 2021|website=[[El Peruano]]}}</ref> # Philippines<ref>{{cite web |url=https://cnnphilippines.com/news/2021/3/19/Russia-Gamaleya-emergency-use-PH.html |title=Russia's Sputnik V approved for emergency use in PH |date=19 March 2021 |website=[[CNN Philippines]] |access-date=19 March 2021 |accessdate=7 July 2021 |archivedate=19 March 2021 |archiveurl=https://web.archive.org/web/20210319023615/https://cnnphilippines.com/news/2021/3/19/Russia-Gamaleya-emergency-use-PH.html }}</ref> # Rwanda<ref name="whotracker"/> # Saint Vincent and the Grenadines<ref name="auto2">{{#invoke:Cite web||date=11 February 2021|title=Public Health (Emergency Authorisation of COVID-19 Vaccine) Rules, 2021|url=https://www.gov.vc/images/pdf_documents/SRO-Public_Health_Emergency_Authorisation_of_Covid-19_Vaccine.pdf|access-date=12 February 2021|website=Government of Saint Vincent and the Grenadines}}</ref> # San Marino<ref>{{cite news|date=20 February 2021|title=San Marino buys the Sputnik vaccine: "First doses already in the next few days"|work=Unioneonline|url=https://www.unionesarda.it/en/articolo/news/mondo/2021/02/19/san-marino-acquista-il-vaccino-sputnik-prime-dosi-gia-nei-prossim-137-1117575.html|accessdate=7 July 2021|archivedate=19 March 2021|archiveurl=https://web.archive.org/web/20210319083816/https://www.unionesarda.it/en/articolo/news/mondo/2021/02/19/san-marino-acquista-il-vaccino-sputnik-prime-dosi-gia-nei-prossim-137-1117575.html}}</ref><ref>{{cite news|date=12 April 2021|title=San Marino reopens thanks to Sputnik covid vaccine from Russia |work=Wanted in Rome|url=https://www.wantedinrome.com/news/san-marino-reopens-thanks-to-sputnik-covid-vaccine-from-russia.html}}</ref> # Serbia<ref>{{cite news|date=31 December 2020|title=Agencija odobrila uvoz ruske vakcine Sputnjik V u Srbiju|language=sr-RS|work=N1|url=https://rs.n1info.com/vesti/agencija-odobrila-uvoz-ruske-vakcine-sputnjik-v-u-srbiju/}}</ref> # Seychelles<ref>{{cite news|date=19 March 2021|title=Sputnik V vaccine approved in Seychelles|agency=[[TASS]]|url=https://tass.com/world/1268131}}</ref> # Sri Lanka<ref>{{cite news|date=4 March 2021|title=Sri Lanka approves Russia's Sputnik V vaccine|work=The Hindu|url=https://www.thehindu.com/news/international/sri-lanka-approves-russias-sputnik-v-vaccine/article33987742.ece}}</ref> # Syria<ref>{{cite news|date=22 February 2021|title=Syria authorizes use of Sputnik-V|publisher=Roya|url=https://en.royanews.tv/news/25728/2021-02-22|accessdate=2021-07-07|archivedate=2021-03-03|archiveurl=https://web.archive.org/web/20210303142243/https://en.royanews.tv/news/25728/2021-02-22}}</ref> # Tajikistan<ref name="whotracker"/> #Tanzania<ref>{{Cite news|last=Mohammed|first=Omar|date=2021-06-17|title=Tanzania poised to join COVAX vaccine-sharing facility - WHO|language=en|work=Reuters|url=https://www.reuters.com/world/africa/tanzania-submit-request-join-covax-vaccine-sharing-facility-2021-06-17/|access-date=2022-01-13}}</ref> # Tunisia<ref>{{cite press release|title=Sputnik V vaccine authorized in Tunisia|url=https://sputnikvaccine.com/newsroom/pressreleases/sputnik-v-vaccine-authorized-in-tunisia/|access-date=30 January 2021|publisher=Gamaleya Center}}</ref> # Turkey (limited use)<ref>{{Cite news|author=Merve Aydogan|date=30 April 2021|title=Turkey OKs emergency use of Sputnik-V vaccine|work=[[Anadolu Agency]]|url=https://www.aa.com.tr/en/latest-on-coronavirus-outbreak/turkey-oks-emergency-use-of-sputnik-v-vaccine/2225824}}</ref><ref>{{Cite news|title=Erdogan unimpressed by Putin's COVID-19 antibodies, Sputnik V vaccine booster offer|url=https://english.alarabiya.net/coronavirus/2021/09/29/Erdogan-unimpressed-by-Putin-s-COVID-19-antibodies-Sputnik-V-vaccine-booster-offer|date=29 September 2021|access-date=11 January 2022|publisher=[[Al Arabiya English]]}}</ref> # United Arab Emirates<ref>{{cite news|date=21 January 2021|title=UAE approves Russia's Sputnik vaccine for emergency use|work=Khaleej Times|url=https://www.khaleejtimes.com/coronavirus-pandemic/uae-approves-russias-sputnik-vaccine-for-emergency-use|access-date=21 January 2021}}</ref> # Venezuela<ref>{{cite news|date=29 December 2020|title=Venezuela firma contrato para la adquisición de la vacuna rusa Sputnik V|language=es|publisher=Reuters|url=https://www.reuters.com/article/salud-coronavirus-venezuela-rusia-idLTAKBN2931X2}}</ref> # Vietnam<ref name="vnexpress.net">{{cite news|title=Vietnam approves Russia Covid-19 vaccine for emergency use|publisher=[[VnExpress]]|url=https://vnexpress.net/news/news/vietnam-approves-russia-covid-19-vaccine-for-emergency-use-4240528.html|access-date=2 April 2021}}</ref> # Zimbabwe<ref name="news24.com-zimbabwe-ssv">{{cite news|date=9 March 2021|title=Covid-19: Zimbabwe authorises Sputnik V, Sinovac vaccines for emergency use|publisher=news24.com|url=https://www.news24.com/news24/africa/news/covid-19-zimbabwe-authorises-sputnik-v-sinovac-vaccines-for-emergency-use-20210309}}</ref> <br />'''[[List of ISO 3166-1 codes|Non-country entities]]''' * Abkhazia<ref>{{#invoke:Cite web||url=https://civil.ge/archives/417592|title = Russia's COVID Vaccine Delivered to Tskhinvali Region, Abkhazia|date = 4 May 2021}}</ref> * South Ossetia<ref>{{#invoke:Cite web||url=https://tass.com/world/1285695|title=First batch of Sputnik V vaccine delivered to South Ossetia}}</ref> </div> <br /> <div style="margin-top: 0.3em; column-width: 15em;"> ;Expired * Slovakia<ref>{{Cite news|date=1 March 2021|title=Povolenie na terapeutické použitie neregistrovaného lieku|url=https://www.health.gov.sk/Zdroje?/Sources/kategorizacia/doku_kl/ziad_lieky/sputnik.pdf|access-date=8 July 2021}}</ref><ref>{{cite web|date=14 April 2021|title=Zmätky s vakcínami pokračujú. Aký Sputnik máme v skladoch?|url=https://spravy.pravda.sk/domace/clanok/584380-zmatky-s-vakcinami-pokracuju-aky-sputnik-mame-v-skladoch/|access-date=8 July 2021|website=Pravda.sk|language=sk-SK}}</ref> ;Rejected * South Africa<ref name="SAHPRA Oct 21">{{cite book |title=Update on the SAHPRA review of the Sputnik V vaccine |date=18 October 2021 |publisher=South African Health Products Regulatory Agency |url=https://www.sahpra.org.za/news-and-updates/update-on-the-sahpra-review-of-the-sputnik-v-vaccine/ |access-date=20 April 2022}}</ref><ref>{{cite web|last=AfricaNews|date=20 October 2021|title=South Africa rejects Russian-made coronavirus vaccine Sputnik V|url=https://www.africanews.com/2021/10/20/south-africa-rejects-russian-made-coronavirus-vaccine-sputnik-v/|access-date=22 October 2021|website=Africanews|accessdate=25 December 2021|archivedate=10 December 2021|archiveurl=https://web.archive.org/web/20211210175107/https://www.africanews.com/2021/10/20/south-africa-rejects-russian-made-coronavirus-vaccine-sputnik-v/}}</ref> ;Travel-only * Australia<ref>{{cite web|title=Vaccines we recognise for the purpose of travel to Australia|url=https://www.tga.gov.au/international-covid-19-vaccines-recognised-australia|access-date=17 January 2022|website=Therapeutic Goods Administration|accessdate=25 December 2021|archivedate=7 February 2022|archiveurl=https://web.archive.org/web/20220207080016/https://www.tga.gov.au/international-covid-19-vaccines-recognised-australia}}</ref> * Cyprus<ref>{{cite web|title=Vaccinated/Recovered Passengers|url=https://cyprusflightpass.gov.cy/en/vaccinated-passengers|accessdate=2021-12-25|archivedate=2022-03-06|archiveurl=https://web.archive.org/web/20220306213314/https://cyprusflightpass.gov.cy/en/vaccinated-passengers}}</ref> * Estonia<ref>{{cite web|title=Questions and answers on coronavirus, related decisions and changes: Vaccines|url=https://kkk.kriis.ee/en/faq/covid-19-vaccination/vaccines#q10069311|access-date=24 November 2021|website=kkk.kriis.ee|accessdate=25 December 2021|archivedate=25 December 2021|archiveurl=https://web.archive.org/web/20211225084747/https://kkk.kriis.ee/en/faq/covid-19-vaccination/vaccines#q10069311}}</ref> * Greece<ref>{{cite web|date=11 August 2021|title=Greece Accepting Most Covid-19 Vaccines for Travel|url=https://news.gtp.gr/2021/08/11/greece-accepting-most-covid-19-vaccines-for-travel/|access-date=20 November 2021|website=GTP Headlines|accessdate=25 December 2021|archivedate=8 December 2021|archiveurl=https://web.archive.org/web/20211208101400/https://news.gtp.gr/2021/08/11/greece-accepting-most-covid-19-vaccines-for-travel/}}</ref> * Hong Kong<ref name="HK"/> * Israel<ref>{{cite web|title=Entry to Israel - Non-Israeli Citizens: Air Travel|url=https://corona.health.gov.il/en/directives/air-travel-covid19-green/?tab=by-air|access-date=24 November 2021|website=Corona Traffic Light Model (Ramzor) Website}}</ref> * Malaysia<ref name="MY">{{cite web|title=Travellers must have MySejahtera to enter Malaysia|url=https://themalaysianreserve.com/2022/03/25/travellers-must-have-mysejahtera-to-enter-malaysia/amp/|date=25 March 2022|publisher=The Malaysian Reserve|access-date=25 March 2022|website=themalaysianreserve.com}}</ref> * New Zealand<ref name="auto9"/> * Saudi Arabia<ref>{{cite web |title=Saudi Arabia has joined more than 100 countries accepting visitors vaccinated with Sputnik V following extensive work between Ministry of Health of Saudi Arabia and RDIF, supported by the Ministry of Investments of Saudi Arabia |url=https://sputnikvaccine.com/newsroom/pressreleases/saudi-arabia-has-joined-more-than-100-countries-accepting-visitors-vaccinated-with-sputnik-v/ |access-date=10 December 2021 |date=5 December 2021}}</ref> * Slovenia<ref>{{cite web|title=Border Crossing {{!}} GOV.SI|url=https://www.gov.si/en/topics/coronavirus-disease-covid-19/border-crossing/|access-date=24 November 2021|website=Portal GOV.SI}}</ref> * St. Lucia<ref>{{cite web|title=NEW-FAQs|url=https://www.stlucia.org/en/covid-19/faqs/|access-date=24 November 2021|website=Saint Lucia Tourism Authority|accessdate=25 December 2021|archivedate=8 December 2022|archiveurl=https://web.archive.org/web/20221208103421/https://www.stlucia.org/en/covid-19/faqs/}}</ref> * Thailand<ref>{{cite web|title=THAILAND'S ENTRY REGULATIONS|url=https://thaiembassy.at/en/coe.html|access-date=20 December 2021|website=Royal Thai Embassy in Vienna}}</ref> </div> == CoronaVac == <section begin="coronavacauthmap"/> {{infobox | image = {{Graph:Map|scale=65|defaultValue=gainsboro |AD=turqoise|AE=turqoise|AF=limegreen|AG=dodgerblue|AL=dodgerblue|AM=dodgerblue|AO=dodgerblue|AR=dodgerblue|AT=turquoise|AU=turquoise|AZ=limegreen |BA=dodgerblue|BB=dodgerblue|BD=dodgerblue|BF=dodgerblue|BH=limegreen|BI=dodgerblue|BJ=limegreen|BN=dodgerblue|BO=dodgerblue|BR=dodgerblue|BS=limegreen|BT=dodgerblue|BW=dodgerblue|BZ=dodgerblue |CA=turquoise|CD=limegreen|CF=limegreen|CG=dodgerblue|CH=turquoise|CI=dodgerblue|CL=dodgerblue|CM=dodgerblue|CN=blueviolet|CO=dodgerblue|CR=limegreen|CU=dodgerblue|CV=dodgerblue|CY=turquoise |DJ=dodgerblue|DM=dodgerblue|DO=dodgerblue|DZ=dodgerblue |EC=dodgerblue|EE=turquoise|EG=dodgerblue|ES=turquoise|ET=dodgerblue |FI=turquoise|FJ=limegreen|FM=limegreen |GA=dodgerblue|GB=turquoise|GD=limegreen|GE=dodgerblue|GH=limegreen|GM=dodgerblue|GN=dodgerblue|GQ=dodgerblue|GR=turquoise|GT=limegreen|GW=dodgerblue|GY=dodgerblue |HN=limegreen|HR=turquoise|HT=limegreen|HU=dodgerblue |ID=dodgerblue|IE=turquoise|IN=limegreen|IQ=dodgerblue|IR=limegreen|IS=turquoise |JM=limegreen|JO=dodgerblue |KE=dodgerblue|KG=dodgerblue|KH=dodgerblue|KI=dodgerblue|KM=dodgerblue|KN=limegreen|KP=limegreen|KR=turquoise|KW=dodgerblue|KZ=dodgerblue |LA=dodgerblue|LB=dodgerblue|LC=limegreen|LI=turquoise|LK=dodgerblue|LR=limegreen|LS=dodgerblue|LY=dodgerblue |MA=dodgerblue|MC=limegreen|MD=dodgerblue|ME=dodgerblue|MG=dodgerblue|MH=limegreen|MK=dodgerblue|ML=limegreen|MM=dodgerblue|MN=dodgerblue|MO=blueviolet|MR=dodgerblue|MU=dodgerblue|MV=dodgerblue|MW=dodgerblue|MX=dodgerblue|MY=dodgerblue|MZ=dodgerblue |NA=dodgerblue|NE=dodgerblue|NG=dodgerblue|NI=limegreen|NL=turquoise|NO=turqoise|NP=dodgerblue|NR=limegreen|NZ=turquoise |OM=dodgerblue |PA=dodgerblue|PE=limegreen|PG=dodgerblue|PH=dodgerblue|PK=dodgerblue|PS=dodgerblue|PT=turquoise|PW=turquoise|PY=dodgerblue |QA=dodgerblue |RS=limegreen|RW=dodgerblue |SA=dodgerblue|SB=dodgerblue|SC=blueviolet|SD=dodgerblue|SE=turquoise|SG=dodgerblue|SI=turquoise|SK=turquoise|SL=dodgerblue|SN=dodgerblue|SO=dodgerblue|SR=dodgerblue|SS=limegreen|ST=limegreen|SV=dodgerblue|SY=dodgerblue|SZ=limegreen |TD=dodgerblue|TG=limegreen|TH=dodgerblue|TJ=limegreen|TL=limegreen|TM=dodgerblue|TN=dodgerblue|TO=limegreen|TR=dodgerblue|TT=dodgerblue|TV=limegreen|TZ=dodgerblue |UA=dodgerblue|UG=limegreen|US=turquoise|UY=dodgerblue|UZ=dodgerblue |VC=limegreen|VE=dodgerblue|VU=dodgerblue |WS=limegreen |XK=limegreen |YE=dodgerblue|VN=turquoise| |ZA=dodgerblue|ZM=dodgerblue|ZW=dodgerblue }} | caption = {{leftlegend|blueviolet|Full authorization}} {{leftlegend|dodgerblue|Emergency authorization}} {{leftlegend|turquoise|Allowed for travel}} {{leftlegend|limegreen|Eligible [[COVAX]] recipient}} }} <section end="coronavacauthmap"/> The [[CoronaVac]] COVID-19 vaccine is an [[inactivated vaccine|inactivated virus vaccine]]<ref name="NCT043835742">{{#invoke:Cite web||date=12 May 2020|title=Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection (COVID-19) (Renqiu)|url=https://clinicaltrials.gov/ct2/show/NCT04383574|url-status=live|archive-url=https://web.archive.org/web/20201011084809/https://clinicaltrials.gov/ct2/show/NCT04383574/|archive-date=11 October 2020|access-date=14 July 2020|website=[[ClinicalTrials.gov]]|publisher=[[United States National Library of Medicine]]|id=NCT04383574}}</ref> produced by the Chinese company [[Sinovac Biotech]].<ref name="NCT043835742"/><ref name="NCname= nct04456595=2">{{#invoke:Cite web||date=2 July 2020|title=Clinical Trial of Efficacy and Safety of Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals (PROFISCOV)|url=https://clinicaltrials.gov/ct2/show/NCT04456595|url-status=live|archive-url=https://web.archive.org/web/20201011084811/https://clinicaltrials.gov/ct2/show/NCT04456595/|archive-date=11 October 2020|access-date=3 August 2020|website=[[ClinicalTrials.gov]]|publisher=[[United States National Library of Medicine]]|id=NCT04456595}}</ref><ref name=":12">{{cite journal|last1=PT. Bio Farma|date=10 August 2020|title=A Phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-COV-2 inactivated vaccine in healthy adults aged 18–59 years in Indonesia|url=https://www.ina-registry.org/index.php?act=registry_trial_detail&code_trial=16202009080721WXFM0YX|journal=Registri Penyakit Indonesia|access-date=15 August 2020}} {{Webarchive|url=https://web.archive.org/web/20201011084814/https://www.ina-registry.org/index.php?act=registry_trial_detail&code_trial=16202009080721WXFM0YX%2F |date=11 October 2020 }} {{Cite web |title=Archive copy |url=https://www.ina-registry.org/index.php?act=registry_trial_detail&code_trial=16202009080721WXFM0YX%2F |accessdate=8 May 2025 |archivedate=11 October 2020 |archiveurl=https://web.archive.org/web/20201011084814/https://www.ina-registry.org/index.php?act=registry_trial_detail&code_trial=16202009080721WXFM0YX%2F }}</ref> ;Full (<section begin="CoronaVac_FN"/>1<section end="CoronaVac_FN"/>) # China<ref name="CoronaVacCN"/> {{-}} ;Emergency (<section begin="CoronaVac_EN"/>71<section end="CoronaVac_EN"/>) <div style="margin-top: 0.3em; column-width: 15em;"> # Albania<ref name=":0">{{#invoke:Cite web||last=Semini|first=Llazar|title=Albania starts mass COVID vaccinations before tourist season|url=https://abcnews.go.com/Business/wireStory/albania-starts-mass-covid-vaccinations-tourist-season-76733128|access-date=29 March 2021|website=ABC News}}</ref> # Algeria<ref name="whotracker"/> # Argentina<ref name="TrackVax"/> # Armenia<ref>{{#invoke:Cite web||title=В Армению отправлена китайская вакцина от COVID-19|url=https://ru.armradio.am/2021/04/30/%d0%b2-%d0%b0%d1%80%d0%bc%d0%b5%d0%bd%d0%b8%d1%8e-%d0%be%d1%82%d0%bf%d1%80%d0%b0%d0%b2%d0%bb%d0%b5%d0%bd%d0%b0-%d0%ba%d0%b8%d1%82%d0%b0%d0%b9%d1%81%d0%ba%d0%b0%d1%8f-%d0%b2%d0%b0%d0%ba%d1%86%d0%b8/|access-date=9 May 2021|website=Общественное Радио Армении|language=ru-RU}}</ref> # Azerbaijan<ref>{{#invoke:Cite web||last1=Aliyev|first1=Jeyhun|title=Azerbaijan kicks off COVID-19 vaccination|url=https://www.aa.com.tr/en/world/azerbaijan-kicks-off-covid-19-vaccination/2114591|access-date=7 February 2021|publisher=Anadolu Agency|name-list-style=vanc}}</ref> # Bangladesh<ref>{{#invoke:Cite web||title=Bangladesh approves Sinovac Covid-19 vaccine for emergency use|date=6 June 2021|url=https://www.dhakatribune.com/bangladesh/2021/06/06/sinovac-covid-19-vaccine-approved-for-emergency-use|access-date=6 June 2021|publisher=[[Dhaka Tribune]]|name-list-style=vanc}}</ref> # Benin<ref>{{#invoke:Cite web||last=Ayosso|first=Akpédjé|date=29 March 2021|title=Deux ministres vaccinés contre Covid-19|url=https://www.24haubenin.info/?Deux-ministres-vaccines-contre-Covid-19|access-date=7 April 2021|website=24haubenin.info|language=fr}}</ref> # Bolivia<ref>{{#invoke:Cite web||title=Bolívia autoriza uso de vacinas Sputnik V e CoronaVac contra covid-19|url=https://noticias.uol.com.br/internacional/ultimas-noticias/2021/01/06/bolivia-autoriza-uso-de-vacinas-sputnik-v-e-coronavac-contra-covid-19.htm|access-date=6 January 2021|website=noticias.uol.com.br|language=pt-br}}</ref> # Bosnia and Herzegovina<ref>{{#invoke:Cite web||last=Agency|first=Anadolu|date=28 March 2021|title=Turkey sends Chinese COVID-19 vaccines to Bosnia-Herzegovina|url=https://www.dailysabah.com/politics/diplomacy/turkey-sends-chinese-covid-19-vaccines-to-bosnia-herzegovina|access-date=14 April 2021|website=Daily Sabah}}</ref> # Botswana<ref>{{#invoke:Cite web||title=Botswana Could Be First African Country to Vaccinate Entire Adult Population |url=https://www.voanews.com/covid-19-pandemic/botswana-could-be-first-african-country-vaccinate-entire-adult-population|access-date=21 May 2021|website=Voice of America}}</ref> # Brazil<ref name="Covid-Vaccine">{{cite news|last1=McGeever|first1=Jamie|last2=Fonseca|first2=Pedro|date=17 January 2021|title=Brazil clears emergency use of Sinovac, AstraZeneca vaccines, shots begin|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-brazil-idUSKBN29M0M3|access-date=17 January 2021|name-list-style=vanc}}</ref> # Cambodia<ref>{{#invoke:Cite web||last1=Chanritheara|first1=Torn|title=Cambodia Approves AstraZeneca and Sinovac Vaccines for COVID-19 Emergency Use|url=https://cambodianess.com/article/cambodia-approves-astrazeneca-and-sinovac-vaccines-for-covid-19-emergency-use|access-date=12 February 2021|publisher=Cambodianess}}</ref> # Chile<ref>{{#invoke:Cite web||date=20 January 2021|title=Chile aprueba el uso de emergencia de la vacuna china de Sinovac contra covid-19|url=https://www.france24.com/es/minuto-a-minuto/20210120-chile-aprueba-el-uso-de-emergencia-de-la-vacuna-china-de-sinovac-contra-covid-19|access-date=30 January 2021|publisher=France 24}}</ref> # Colombia<ref>{{#invoke:Cite web||last1=Aliyev|first1=Jeyhun|title=Colombia approves emergency use of CoronaVac vaccine|url=https://www.aa.com.tr/en/americas/colombia-approves-emergency-use-of-coronavac-vaccine/2134570|access-date=7 February 2021|publisher=Anadolu Agency|name-list-style=vanc}}</ref> # Djibouti<ref>{{#invoke:Cite web||title=Djibouti Ministry of Health|url=https://twitter.com/minsantedj/status/1372948366137696270|access-date=30 March 2021|website=Twitter}}</ref> # Dominica<ref name="NYT vaccine tracker"/> # Dominican Republic<ref>{{#invoke:Cite web||title=Anticovid vaccines run out as Dominican Republic awaits arrival of more doses|url=https://dominicantoday.com/dr/covid-19/2021/03/08/anticovid-vaccines-run-out-as-dominican-republic-awaits-arrival-of-more-doses/|access-date=10 March 2021|publisher=DominicanToday}}</ref> # East Timor<ref>{{#invoke:Cite web||last=Martins|first=Filomeno|title=Government to launch Chinese Sinovac vaccine next week {{!}} TATOLI Agência Noticiosa de Timor-Leste|url=http://www.tatoli.tl/en/2021/06/11/government-to-launch-chinese-sinovac-vaccine-next-week/|access-date=15 June 2021}}</ref> # Ecuador<ref>{{#invoke:Cite web||title=Ecuador signs agreement with Sinovac for 2 million COVID-19 vaccine: minister|url=https://nationalpost.com/pmn/health-pmn/ecuador-signs-agreement-with-sinovac-for-2-million-covid-19-vaccine-minister|access-date=26 February 2021|work=National Post}}</ref> # Egypt<ref>{{#invoke:Cite web||title=Egypt approves Sinovac COVID-19 vaccine for emergency use|url=https://gulfnews.com/world/mena/egypt-approves-sinovac-covid-19-vaccine-for-emergency-use-1.1619472925063|access-date=27 April 2021|website=gulfnews}}</ref> # El Salvador<ref>{{#invoke:Cite web||title=Llegan a El Salvador un millón de dosis de la vacuna china CoronaVac contra el covid-19 de la farmacéutica Sinovac|url=https://www.laprensagrafica.com/elsalvador/Llegan-a-El-Salvador-un-millon-de-dosis-de-la-vacuna-china-contra-el-covid-19-de-la-farmaceutica-Sinovac-20210328-0004.html|access-date=29 March 2021|website=Noticias de El Salvador – La Prensa Gráfica {{!}} Informate con la verdad|language=es-ES}}</ref> # Equatorial Guinea<ref name="whotracker"/> # Fiji<ref>{{#invoke:Cite web||title=China to donate Sinovac Vaccine to Fiji|url=https://www.fbcnews.com.fj/news/china-to-donate-sinovac-vaccine-to-fiji/|access-date=22 March 2021|website=Fiji Broadcasting Corporation}}</ref> # Gabon<ref name="NYT vaccine tracker"/> # Georgia<ref>{{#invoke:Cite web||title=Covid-19 vaccination with Sinovac to start on May 24 in Georgia|url=https://agenda.ge/en/news/2021/1336|access-date=21 May 2021|website=Agenda.ge}}</ref> # Guinea<ref>{{#invoke:Cite web||title=Guinea receives purchase of 300,000 Sinovac COVID-19 vaccines|url=https://www.channelnewsasia.com/news/world/guinea-receives-purchase-of-300-000-sinovac-covid-19-vaccines-14649970|access-date=3 June 2021|website=CNA}}</ref> # Guyana<ref name="NYT vaccine tracker"/> # Hungary<ref name="whotracker"/> # Indonesia<ref name="StraitsTimes20210111">{{cite news|last=Soeriaatmadja|first=Wahyudi|date=11 January 2021|title=Indonesia grants emergency use approval to Sinovac's vaccine, local trials show 65% efficacy|work=[[The Straits Times]]|url=https://www.straitstimes.com/asia/se-asia/indonesia-grants-emergency-use-approval-to-sinovac-vaccine-local-trials-show-65|access-date=11 January 2021|name-list-style=vanc}}</ref><ref name="Tempo">{{cite news|date=11 January 2021|title=BPOM Grants Emergency Use Authorization for Sinovac Vaccine|work=[[Tempo (Indonesian magazine)|Tempo]]|url=https://en.tempo.co/read/1422220/bpom-grants-emergency-use-authorization-for-sinovac-vaccine|access-date=11 January 2021}}</ref> # Kazakhstan<ref>{{#invoke:Cite web||title=В Казахстан доставили первую партию китайской вакцины CoronaVac {{!}} Kazakhstan Today|url=https://www.kt.kz/rus/covid-19/v_kazahstan_dostavili_pervuyu_partiyu_kitayskoy_vaktsiny_1377916469.html|access-date=7 June 2021|website=www.kt.kz|language=ru}}</ref> # Laos<ref name="CoronaVacCN">{{cite news|last1=Liu|first1=Roxanne|date=6 February 2021|title=China approves Sinovac Biotech COVID-19 vaccine for general public use|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-vaccine-sinovac/china-approves-sinovac-biotech-covid-19-vaccine-for-general-public-use-idUSKBN2A60AY|access-date=7 February 2021|name-list-style=vanc}}</ref> # Libya<ref>{{#invoke:Cite web||last=|date=9 May 2021|title=Libya begins administrating China's Sinovac vaccine in Tripoli|url=https://www.libyanexpress.com/libya-begins-administrating-chinas-sinovac-vaccine-in-tripoli/|access-date=21 May 2021|website=Libyan Express}}</ref> # Malawi<ref name=":11" /> # Malaysia<ref>{{cite news|date=2 March 2021|title=Malaysia approves Sinovac, AstraZeneca COVID-19 vaccines for use|publisher=Reuters|url=https://www.reuters.com/business/healthcare-pharmaceuticals/malaysia-approves-sinovac-astrazeneca-covid-19-vaccines-use-2021-03-02/ |access-date=21 November 2021}}</ref> # Maldives<ref name="whotracker"/> # Mexico<ref name="AD5 mexico">{{cite news|last1=Barrera|first1=Adriana|date=11 February 2021|title=Mexico approves China's CanSino and Sinovac COVID-19 vaccines|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-mexico-cansino/update-2-mexico-approves-chinas-cansino-and-sinovac-covid-19-vaccines-idUSL1N2KG0NO|access-date=11 February 2021}}</ref> # Moldova<ref>{{Cite news|last=Tanas|first=Alexander|date=9 April 2021|title=Moldova to buy 400,000 doses of Sinovac COVID-19 vaccine|work=Reuters|url=https://www.reuters.com/article/health-coronavirus-moldova-sinovac-idUKL8N2M24JT|access-date=9 May 2021}}</ref> # Morocco<ref name="NYT vaccine tracker"/> # Myanmar<ref>{{#invoke:Cite web||last=Fishbein|first=Emily|title=Ethnic groups step in as Myanmar's COVID response falls apart|url=https://www.aljazeera.com/news/2021/5/10/ethnic-groups-step-in-as-myanmars-covid-response-falls-apart|access-date=23 July 2021|website=Al Jazeera}}</ref> # Nepal<ref>{{#invoke:Cite web||title=Nepal gives emergency use approval to China's Sinovac Covid-19 vaccine|url=https://kathmandupost.com/health/2021/06/04/nepal-gives-emergency-use-approval-to-china-s-sinovac-covid-19-vaccine|access-date=7 June 2021|website=kathmandupost}}</ref> # North Macedonia<ref>{{#invoke:Cite web||last=Testorides|first=Konstantin|date=27 June 2021|title=North Macedonia gets 500,000 doses of Sinovac vaccines|url=https://apnews.com/article/coronavirus-vaccine-coronavirus-pandemic-health-government-and-politics-business-1827f4b8b524449d72dd43e62a97ac63|access-date=28 June 2021|publisher=Associated Press}}</ref> # Oman<ref name="oman-coronavac-sputnik">{{#invoke:Cite web||title=COVID-19: Oman approves use of Sinovac and Sputnik vaccines|url=https://gulfnews.com/world/gulf/oman/covid-19-oman-approves-use-of-sinovac-and-sputnik-vaccines-1.80173049|access-date=25 June 2021|website=gulfnews}}</ref> # Pakistan<ref>{{#invoke:Cite web||title=DRAP allows emergency authorisation to fifth Covid-19 vaccine|url=https://www.thenews.com.pk/print/817278-drap-allows-emergency-authorisation-to-fifth-covid-19-vaccine|access-date=10 April 2021|website=The News International}}</ref> # Palestine<ref name="whotracker"/> # Panama<ref>{{cite news|date=9 April 2021|title=Panama approves emergency use of Chinese vaccine against COVID-19|publisher=Xinhuanet|url=http://www.xinhuanet.com/english/2021-04/10/c_139870805.htm|access-date=9 April 2021|accessdate=7 July 2021|archivedate=10 April 2021|archiveurl=https://web.archive.org/web/20210410031413/http://www.xinhuanet.com/english/2021-04/10/c_139870805.htm}}</ref> # Paraguay<ref>{{#invoke:Cite web||title=CoronaVac, vacuna de alta eficacia|url=https://www.mspbs.gov.py/portal/22762/coronavac-vacuna-de-alta-eficacia.html|website=Ministerio de Salud Publica Y Bienestar Social (Paraguay)}}</ref> # Philippines<ref>{{cite news|date=22 February 2021|title=Philippines approves Sinovac's COVID-19 vaccine for emergency use|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-philippines-vaccine/philippines-approves-sinovacs-covid-19-vaccine-for-emergency-use-idUSL4N2KL0UK}}</ref> # Rwanda<ref name="whotracker"/> # Saint Vincent and the Grenadines<ref name="NYT vaccine tracker"/> # Saudi Arabia<ref>{{Cite news|date=24 August 2021|title=MoH: Six COVID-19 vaccines approved in Saudi Arabia|work=[[Saudi Gazette]]|url=https://saudigazette.com.sa/article/610193|access-date=25 December 2021}}</ref> # Singapore<ref>{{cite web|author=Matthew Mohan|date=23 October 2021|title=Sinovac COVID-19 vaccine to be included in Singapore's national vaccination programme|url=https://www.channelnewsasia.com/singapore/sinovac-covid-19-vaccine-national-vaccination-programme-three-dose-singapore-2263787|access-date=23 October 2021|website=CNA}}</ref> # Somalia<ref name="cdctracker"/> # South Africa<ref>{{cite news|date=3 July 2021|title=SAHPRA authorises the CoronaVac vaccine with conditions|publisher=SAHPRA|url=https://www.sahpra.org.za/press-releases/sahpra-authorises-the-coronavac-vaccine-with-conditions/}}</ref> # Sri Lanka<ref>{{#invoke:Cite web||title=Sri Lanka approves China's Sinovac COVID-19 vaccine for emergency use|url=http://www.colombopage.com/archive_21A/Jul17_1626497465CH.php|access-date=18 July 2021|website=ColomboPage}}</ref> # Sudan<ref name="cdctracker"/> # Syria<ref name="whotracker"/> # Tajikistan<ref>{{#invoke:Cite web||title=Китайской вакциной в Таджикистане первоначально будут прививать людей старше 60 лет {{!}} Новости Таджикистана ASIA-Plus|url=https://asiaplustj.info/ru/news/tajikistan/society/20210621/kitaiskoi-vaktsinoi-v-tadzhikistane-pervonachalno-budut-privivat-lyudei-starshe-60-let|access-date=13 July 2021|website=asiaplustj.info}}</ref> # Tanzania<ref>{{#invoke:Cite web||last=|first=|date=13 July 2021|title=Vaccine-Holdout Tanzania Begins Inoculations With Sinovac Doses - BNN Bloomberg|url=https://www.bnnbloomberg.ca/vaccine-holdout-tanzania-begins-inoculations-with-sinovac-doses-1.1628276|access-date=13 July 2021|website=Bloomberg}}</ref> # Thailand<ref>{{cite news|last1=Thepgumpanat|first1=Panarat|date=22 February 2021|title=Thailand allows emergency use of Sinovac's COVID-19 vaccine|publisher=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-thailand/thailand-allows-emergency-use-of-sinovacs-covid-19-vaccine-idUSKBN2AM1BX|access-date=23 February 2021}}</ref> # Togo<ref>{{#invoke:Cite web||last=|title=Le CoronaVac pour les étudiants du public|url=https://www.republicoftogo.com/Toutes-les-rubriques/Education/Le-CoronaVac-pour-les-etudiants-du-public|access-date=23 May 2021|website=République Togolaise|language=fr}}</ref> # Trinidad and Tobago<ref name="newsday.co.tt">{{cite web|date=8 November 2021|title=Health Ministry: Covaxin vaccine approved use in Trinidad and Tobago|url=https://newsday.co.tt/2021/11/08/health-ministry-covaxin-vaccine-approved-use-in-trinidad-and-tobago/|access-date=30 November 2021|website=Trinidad and Tobago Newsday}}</ref> # Tunisia<ref>{{#invoke:Cite web||date=5 March 2021|title=Tunisia approva vaccino cinese Sinovac|url=https://www.ansa.it/sito/notizie/mondo/dalla_cina/2021/03/05/covid-tunisia-approva-vaccino-cinese-sinovac_9ba5fbb3-4ee9-48de-9327-c37a3931f5d1.html|access-date=7 March 2021|publisher=Agenzia Nazionale Stampa Associata (in Italian)|language=it}}</ref> # Turkey<ref>{{cite news|date=14 January 2021|title=Turkey grants emergency authorization to Sinovac's CoronaVac|url=https://www.reuters.com/article/us-health-coronavirus-turkey-vaccine-idUSKBN29I29F|access-date=9 January 2022|publisher=Reuters}}</ref> # Turkmenistan<ref>{{#invoke:Cite web||last=turkmenportal|title=В Туркменистан поступила крупная партия китайской вакцины "CoronaVac" |url=https://turkmenportal.com/blog/36504/v-turkmenistan-postupila-krupnaya-partiya-kitaiskoi-vakciny-coronavac|access-date=7 June 2021|website=Туркменистан, интернет портал о культурной, деловой и развлекательной жизни в Туркменистане|language=ru}}</ref> # Uganda<ref name="whotracker"/> # Ukraine<ref>{{cite news|last1=Zinets|first1=Natalia|date=9 March 2021|title=Ukraine approves China's Sinovac COVID-19 vaccine|url=https://www.reuters.com/article/us-health-coronavirus-ukraine-vaccine-idUSKBN2B11H6|access-date=10 March 2021|publisher=Reuters}}</ref> # Uruguay<ref name="CoronaVacCN" /> # Uzbekistan<ref>{{#invoke:Cite web||title=Uzbekistan plans to obtain Sinovac coronavirus vaccine|url=https://akipress.com/news:658218:Uzbekistan_plans_to_obtain_Sinovac_coronavirus_vaccine/|access-date=21 May 2021|website=akipress}}</ref> # Venezuela<ref>{{#invoke:Cite web||date=30 June 2021|title=COVID-19 Information|url=https://ve.usembassy.gov/covid-19-information/|access-date=23 August 2021|website=U.S. Embassy in Venezuela}}</ref> # Yemen<ref name="whotracker"/> # Zimbabwe<ref name="news24.com-zimbabwe-ssv" /> <!-- not counted --> <br />'''[[List of ISO 3166-1 codes|Non-country entities]]''' * Hong Kong<ref>{{#invoke:Cite web||date=18 February 2021|title=Use of Sinovac vaccine authorised|url=https://www.news.gov.hk/eng/2021/02/20210218/20210218_111857_034.html|access-date=19 February 2021|publisher=Government of Hong Kong}}</ref> * Northern Cyprus<ref name=":4" /> * ''[[World Health Organization]]''<ref>{{cite news |last=Nebehay |first=Stephanie |title=WHO approves Sinovac COVID vaccine, the second Chinese-made dose listed |url=https://www.reuters.com/article/us-health-coronavirus-who-sinovac/who-approves-sinovac-covid-vaccine-the-second-chinese-made-dose-listed-idUSKCN2DD3V5 |access-date=1 June 2021 |work=Reuters |date=1 June 2021 |location=Geneva}}</ref><ref name="WHO recommendation">{{cite web | title=WHO recommendation Sinovac COVID-19 vaccine (Vero Cell [Inactivated]) – CoronaVac | website=[[World Health Organization]] (WHO) | date=1 May 2021 | url=https://extranet.who.int/pqweb/vaccines/who-recommendation-sinovac-covid-19-vaccine-vero-cell-inactivated-coronavac | access-date=1 June 2021 | accessdate=7 July 2021 | archivedate=2 June 2021 | archiveurl=https://web.archive.org/web/20210602213345/https://extranet.who.int/pqweb/vaccines/who-recommendation-sinovac-covid-19-vaccine-vero-cell-inactivated-coronavac }}</ref><ref name="WHO PR 20210601">{{cite press release | title=WHO validates Sinovac COVID-19 vaccine for emergency use and issues interim policy recommendations | website=[[World Health Organization]] (WHO) | url=https://www.who.int/news/item/01-06-2021-who-validates-sinovac-covid-19-vaccine-for-emergency-use-and-issues-interim-policy-recommendations | access-date=1 June 2021}}</ref> </div> ;Travel-only {{div col|colwidth=18em}} * Andorra<ref name="auto24"/> * Australia<ref name="AU recognized" /><ref>{{cite news|date=1 October 2021|title=Australia set to restart international travel in November, Scott Morrison says|work=[[The Guardian]]|url=https://www.theguardian.com/australia-news/2021/oct/01/australia-set-to-restart-international-travel-in-november-scott-morrison-says|access-date=21 November 2021}}</ref> * Austria<ref name="auto10"/> (only for entry) * Canada<ref name="auto31"/> * Costa Rica<ref name="auto41"/> * Croatia<ref name="auto19"/> * Cyprus<ref name="auto15"/> * Estonia<ref name="auto26"/> (only if approved in a person's country of origin) * Finland<ref name="auto37"/> * Greece<ref name="auto27"/> * Grenada<ref name="auto8"/> * Iceland<ref name="auto18"/> * Ireland<ref name="auto11"/> * Liechtenstein<ref name="auto28"/> * Norway<ref>{{cite web|url=https://www.helsenorge.no/en/coronavirus/international-travels/#who-can-travel-to-norway|title=CInternational travels to Norway|date=23 March 2020}}</ref> * New Zealand<ref name="auto9"/> * Norway<ref name="police1">{{cite web|url=http://www.police.hu/en/content/information-on-general-rules-of-border-crossing|title=INFORMATION ON GENERAL RULES OF BORDER CROSSING – National Police Headquarters of Hungary}}</ref> * Palau<ref name="palaugov.pw">{{cite web|url=https://www.palaugov.pw/travel/|title=COVID-19 Pandemic Entry Requirements – PalauGov.pw}}</ref> * Panama<ref name="auto35"/> * Portugal<ref name="visitmadeira1"/> (only in Madeira) * Slovakia<ref name="auto29"/> * Slovenia<ref name="auto30"/> * South Korea<ref name="auto42"/> * Spain<ref name="auto40"/> * St. Kitts and Nevis<ref name="auto33"/> * St. Lucia<ref name="auto17"/> * St. Vincent and the Grenadines<ref name="auto21"/> * Sweden<ref name="auto38"/> * Switzerland<ref name="auto39"/> * The Netherlands<ref name="auto25"/> * Ukraine<ref name="auto22"/> * United Arab Emirates<ref name="mohap.gov.ae">{{cite web|url=https://www.mohap.gov.ae/en/services/travelers-vaccination|title=Travelers Vaccinations - Ministry of Health and Prevention - UAE|website=www.mohap.gov.ae|accessdate=2021-12-25|archivedate=2021-11-22|archiveurl=https://web.archive.org/web/20211122031706/https://www.mohap.gov.ae/en/services/travelers-vaccination}}</ref> * United Kingdom<ref name="auto34"/> * United States<ref name="auto16"/> * Vietnam<ref>{{cite news|date=21 October 2021|title=Việt Nam temporarily approves COVID-19 vaccine certificates by 72 countries, territories: Foreign ministry|work=[[Việt Nam News]]|url=https://vietnamnews.vn/politics-laws/1063197/viet-nam-temporarily-approves-covid-19-vaccine-certificates-by-72-countries-territories-foreign-ministry.html|access-date=8 January 2022}}</ref> {{div col end}} {{clear}} {{-}} == Novavax == <section begin="NVXauthmap"/> {{infobox | image = {{Graph:Map|scale=65|defaultValue=gainsboro |AF=limegreen|AG=limegreen|AL=limegreen|AM=limegreen|AO=limegreen|AR=limegreen|AT=dodgerblue|AU=blueviolet|AZ=limegreen |BA=limegreen|BB=limegreen|BD=dodgerblue|BE=dodgerblue|BF=limegreen|BG=dodgerblue|BJ=limegreen|BN=limegreen|BO=limegreen|BR=limegreen|BS=limegreen|BT=limegreen|BZ=limegreen |CA=blueviolet|CD=limegreen|CG=limegreen|CH=dodgerblue|CI=limegreen|CL=limegreen|CM=limegreen|CO=limegreen|CR=limegreen|CV=limegreen|CY=dodgerblue|CZ=dodgerblue |DE=dodgerblue|DK=dodgerblue|DJ=limegreen|DM=limegreen|DO=limegreen|DZ=limegreen |EC=limegreen|EE=dodgerblue|EG=limegreen|ES=dodgerblue |FI=dodgerblue|FJ=limegreen|FM=limegreen|FR=dodgerblue |GD=limegreen|GE=limegreen|GH=limegreen|GM=limegreen|GN=limegreen|GR=dodgerblue |HN=limegreen|HR=dodgerblue|HT=limegreen|HU=dodgerblue |ID=dodgerblue|IE=dodgerblue|IQ=limegreen|IS=dodgerblue|IT=dodgerblue |JM=limegreen|JO=limegreen|JP=blueviolet |KE=limegreen|KH=limegreen|KI=limegreen|KM=limegreen|KN=limegreen|KP=limegreen|KR=blueviolet| |LA=limegreen|LB=limegreen|LC=limegreen|LR=limegreen|LS=limegreen|LT=dodgerblue|LU=dodgerblue|LV=dodgerblue|LY=limegreen |MA=limegreen|MC=limegreen|MD=limegreen|ME=limegreen|MH=limegreen|MK=limegreen|ML=limegreen|MR=limegreen|MT=dodgerblue|MU=limegreen|MV=limegreen|MW=limegreen|MY=limegreen|MZ=limegreen |NA=limegreen|NE=limegreen|NG=limegreen|NL=dodgerblue|NO=dodgerblue|NR=limegreen|NZ=dodgerblue |PA=turquoise|PE=limegreen|PG=limegreen|PH=dodgerblue|PK=limegreen|PL=dodgerblue|PT=dodgerblue |QA=limegreen |RO=dodgerblue|RS=limegreen|RW=limegreen |SB=limegreen|SD=limegreen|SE=dodgerblue|SG=dodgerblue|SI=dodgerblue|SK=dodgerblue|SL=limegreen|SN=limegreen|SO=limegreen|SR=limegreen|SS=limegreen|ST=limegreen|SV=limegreen|SY=limegreen|SZ=limegreen |TD=limegreen|TG=limegreen|TH=dodgerblue|TJ=limegreen|TL=limegreen|TN=limegreen|TO=limegreen |TR=turquoise|TV=limegreen |UA=limegreen|UG=limegreen|GB=dodgerblue|UY=limegreen|UZ=limegreen |VC=limegreen|VU=limegreen |WS=limegreen|XK=limegreen|YE=limegreen|ZA=limegreen|ZM=limegreen|IN=dodgerblue |US=turquoise|AE=turquoise|SA=limegreen|ET=limegreen|CF=limegreen|KG=limegreen |BW=limegreen|ZW=limegreen|MX=limegreen|PY=limegreen|VE=limegreen|IR=limegreen|NI=limegreen|GY=limegreen|MM=limegreen|VN=limegreen|MG=limegreen|LK=limegreen|GT=limegreen }} | caption = {{leftlegend|blueviolet|Full authorization}} {{leftlegend|dodgerblue|Emergency authorization}} {{leftlegend|turquoise|Allowed for travel}} {{leftlegend|limegreen|Eligible [[COVAX]] recipient}} }} <section end="NVXauthmap"/> The [[Novavax COVID-19 vaccine]], codenamed NVX-CoV2373, is a subunit COVID-19 vaccine candidate developed by [[Novavax]] and the [[Coalition for Epidemic Preparedness Innovations]], that is undergoing trials in India under the brand name Covovax. It requires two doses and is stable at 2 to 8&nbsp;°C (36 to 46&nbsp;°F) refrigerated temperatures. NVX-CoV2373 has been described as both a [[Protein subunit|protein]] [[subunit vaccine]] and a [[virus-like particle#Vaccines|virus-like particle vaccine]], though the producers call it a "recombinant nanoparticle vaccine". ;Full (<section begin="Novavax_FN"/>4<section end="Novavax_FN"/>) # Australia<ref>{{cite web|title=TGA provisionally approves Novavax (Biocelect Pty Ltd's) COVID-19 vaccine NUVAXOVID|url=https://www.tga.gov.au/media-release/tga-provisionally-approves-novavax-biocelect-pty-ltds-covid-19-vaccine-nuvaxovid|access-date=20 January 2022|website=Therapeutic Goods Administration|date=20 January 2022|accessdate=6 July 2022|archivedate=28 January 2022|archiveurl=https://web.archive.org/web/20220128170700/https://www.tga.gov.au/media-release/tga-provisionally-approves-novavax-biocelect-pty-ltds-covid-19-vaccine-nuvaxovid}}</ref> # Canada<ref>{{Cite news|last=Reuters|date=2022-02-17|title=Canada approves Novavax's COVID-19 vaccine for adults|language=en|work=Reuters|url=https://www.reuters.com/business/healthcare-pharmaceuticals/canada-approves-novavaxs-covid-19-vaccine-2022-02-17/|access-date=2022-02-17}}</ref> # Japan<ref>{{Cite news|date=2022-04-19|title=Japan approves Novavax as 4th COVID vaccine amid new surge|language=en|work=ABC News|url=https://abcnews.go.com/Health/wireStory/japan-approves-novavax-covid-19-vaccine-84159564|access-date=2022-04-21}}</ref> # South Korea<ref>{{Cite news|date=2022-01-12|title=South Korea Ministry of Food and Drug Safety Approves Novavax COVID-19 Vaccine|language=en|work=Novavax, Inc.|url=https://ir.novavax.com/2022-01-12-South-Korea-Ministry-of-Food-and-Drug-Safety-Approves-Novavax-COVID-19-Vaccine|access-date=2022-01-22}}</ref> {{-}} <div style="margin-top: 0.3em; column-width: 15em;"> ;Emergency (<section begin="Novavax_EN"/>40<section end="Novavax_EN"/>) # Bangladesh<ref>{{cite news |title=Novavax Reports First Quarter 2022 Financial Results and Operational Highlights |url=https://finance.yahoo.com/news/novavax-reports-first-quarter-2022-200200347.html |work=Novavax, Inc. |date=9 May 2022}}</ref> # India<ref name="vacxine2">{{cite news |last1=Achom |first1=Debasish |title=India Clears 2 New Vaccines And Merck's Covid Pill |url=https://www.ndtv.com/india-news/coronavirus-2-more-vaccines-covovax-and-corbevax-and-anti-viral-drug-molnupiravir-cleared-in-india-2675170 |work=NDTV.com |date=28 December 2021}}</ref> # Indonesia<ref>{{Cite news|last1=O'donnell|first1=Carl|last2=Nadeem|first2=Dania|date=1 November 2021|title=Novavax COVID-19 vaccine gets first authorization; expects more within weeks, CEO says|work=Reuters|url=https://www.reuters.com/business/healthcare-pharmaceuticals/novavax-covid-19-vaccine-receives-emergency-use-authorization-indonesia-2021-11-01/|access-date=1 November 2021}}</ref> # New Zealand<ref>{{cite news|last1=The Associated Press Staff|date=3 February 2022|title=Novavax's COVID-19 shot receives provisional approval in New Zealand|agency=Associated Press|url=https://www.ctvnews.ca/world/novavax-s-covid-19-shot-receives-provisional-approval-in-new-zealand-1.5767524|access-date=4 February 2022|accessdate=6 July 2022|archivedate=21 March 2022|archiveurl=https://web.archive.org/web/20220321110739/https://www.ctvnews.ca/world/novavax-s-covid-19-shot-receives-provisional-approval-in-new-zealand-1.5767524}}</ref> # Philippines<ref>{{cite news |title=Philippines approves emergency use of Novavax's COVID-19 vaccine |url=https://www.reuters.com/business/healthcare-pharmaceuticals/philippines-approves-emergency-use-novavaxs-covid-19-vaccine-2021-11-17/ |access-date=17 November 2021 |publisher=Reuters |date=17 November 2021}}</ref> # Singapore<ref>{{cite web|author=Clara Chong|date=14 February 2022|title=Novavax Covid-19 vaccine approved for those aged 18 and above in Singapore|url=https://www.straitstimes.com/singapore/novavax-covid-19-vaccine-approved-for-those-aged-18-and-above-to-arrive-in-the-next-few-months|access-date=14 February 2022|website=[[The Straits Times]]|language=en}}</ref> # Switzerland<ref>{{cite news |title=Swissmedic grants temporary authorisation for the Nuvaxovid COVID-19 vaccine from Novavax |url=https://www.swissmedic.ch/swissmedic/en/home/news/coronavirus-covid-19/zl-nuvaxovid-novovax.html |work=Swissmedic |date=13 April 2022}}</ref> # Thailand<ref>{{cite web|title=Novavax and Serum Institute of India Receive Emergency Use Authorization for Novavax' COVID-19 Vaccine in Thailand|url=https://finance.yahoo.com/news/novavax-serum-institute-india-receive-130000777.html|access-date=2022-04-11|website=[[Yahoo! Finance]]|language=en}}</ref> # Taiwan<ref>{{Cite web |last=News |first=Taiwan |date=2022-06-19 |title=Novavax cleared for use by Taiwan FDA {{!}} Taiwan News {{!}} 2022-06-19 11:45:00 |url=https://www.taiwannews.com.tw/en/news/4574660 |access-date=2022-06-24 |website=Taiwan News}}</ref> # United Kingdom<ref>{{cite web|title=Novavax COVID-19 vaccine Nuvaxovid approved by MHRA|url=https://www.gov.uk/government/news/novavax-covid-19-vaccine-nuvaxovid-approved-by-mhra|access-date=2022-02-03|website=GOV.UK|language=en}}</ref> '''{{nowrap|[[European Medicines Agency|EMA]] countries}}'''<ref>{{cite web|date=20 December 2021|title=EMA recommends Nuvaxovid for authorisation in the EU|url=https://www.ema.europa.eu/en/news/ema-recommends-nuvaxovid-authorisation-eu|publisher=European Medicines Agency}}</ref> # Austria # Belgium # Bulgaria # Croatia # Cyprus # Czech Republic # Denmark # Estonia # Finland # France # Germany # Greece # Hungary # Iceland # Ireland # Italy # Latvia # Liechtenstein # Lithuania # Luxembourg # Malta # Netherlands # Norway # Poland # Portugal # Romania # Slovakia # Slovenia # Spain # Sweden <!-- not counted --> <br />'''[[List of ISO 3166-1 codes|Non-country entities]]''' * ''[[World Health Organization]]''<ref name="WHO PR 20211217">{{cite press release | title=WHO lists 9th COVID-19 vaccine for emergency use with aim to increase access to vaccination in lower-income countries | website=[[World Health Organization]] (WHO) | url=https://www.who.int/news/item/17-12-2021-who-lists-9th-covid-19-vaccine-for-emergency-use-with-aim-to-increase-access-to-vaccination-in-lower-income-countries | access-date=17 December 2021}}</ref><ref>{{cite news |title=WHO issues emergency use listing to Novavax-Serum Institute's COVID-19 vaccine |url=https://www.reuters.com/business/healthcare-pharmaceuticals/who-issues-emergency-use-listing-novavax-serum-institutes-covid-19-vaccine-2021-12-17/ |work=Reuters |date=17 December 2021 }}</ref> ;Travel-only * Hong Kong<ref name="HK"/> * Palau<ref name="palaugov.pw"/> * Panama<ref name="auto35"/> * St. Kitts and Nevis<ref name="auto33"/> * St. Lucia<ref name="auto17"/> * St. Vincent and the Grenadines<ref name="auto21"/> * Switzerland<ref name="auto39"/> * Turkey<ref name="auto12"/> * United Arab Emirates<ref name="mohap.gov.ae"/> * United States<ref name="auto16"/> {{clear}} </div> == VLA2001 == [[Valneva COVID-19 vaccine|VLA2001]] is an inactivated vaccine developed by [[Valneva SE]] and Dynavax Technologies. ;Full (<section begin="VLA2001_FN" />31<section end="VLA2001_FN" />) # United Kingdom<ref>|url= https://www.bbc.co.uk/news/health-61104594</ref> '''{{nowrap|[[European Medicines Agency|EMA]] countries}}'''<ref name="Valneva EPAR">{{cite web |date=20 June 2022 |title=COVID-19 Vaccine (inactivated, adjuvanted) Valneva EPAR |url=https://www.ema.europa.eu/en/medicines/human/EPAR/covid-19-vaccine-inactivated-adjuvanted-valneva |url-status=live |archive-url=https://web.archive.org/web/20220628005530/https://www.ema.europa.eu/en/medicines/human/EPAR/covid-19-vaccine-inactivated-adjuvanted-valneva |archive-date=28 June 2022 |access-date=28 June 2022 |website=[[European Medicines Agency]] (EMA)}}</ref> # Austria # Belgium # Bulgaria # Croatia # Cyprus # Czech Republic # Denmark # Estonia # Finland # France # Germany # Greece # Hungary # Iceland # Ireland # Italy # Latvia # Liechtenstein # Lithuania # Luxembourg # Malta # Netherlands # Norway # Poland # Portugal # Romania # Slovakia # Slovenia # Spain # Sweden ;Emergency (<section begin="VLA2001_EN" />2<section end="VLA2001_EN" />) # Bahrain<ref>|url=https://www.bbc.co.uk/news/health-61104594</ref> # United Arab Emirates<ref>{{Cite web |date=2022-05-17 |title=Valneva receives EUA from UAE for its inactivated COVID-19 vaccine |url=https://www.expresspharma.in/valneva-receives-eua-from-uae-for-its-inactivated-covid-19-vaccine/ |access-date=2022-06-20 |website=Express Pharma |language=en-US}}</ref> ;Travel-only * Malaysia<ref name="MY" /> * New Zealand<ref name="auto9" /> * Turkey<ref name="visasturkey.com" /> == Sputnik Light == <section begin="sputniklightauthmap"/> {{infobox|image={{Graph:Map|scale=65|defaultValue=gainsboro |AO=dodgerblue|AE=dodgerblue|AR=dodgerblue |BH=dodgerblue|BJ=dodgerblue|BY=dodgerblue |CG=dodgerblue |EG=dodgerblue |IR=dodgerblue |IN=dodgerblue |KG=dodgerblue|KH=dodgerblue|KZ=dodgerblue |LA=dodgerblue |MN=dodgerblue|MU=dodgerblue|MY=turquoise |NI=dodgerblue|NZ=turquoise |PH=dodgerblue|PS=dodgerblue |RU=dodgerblue |SM=dodgerblue|SY=dodgerblue |TM=dodgerblue|TN=dodgerblue|TR=turquoise|TZ=dodgerblue |VC=dodgerblue|VE=dodgerblue }} |caption= {{leftlegend|blueviolet|Full authorization}} {{leftlegend|dodgerblue|Emergency authorization}} {{leftlegend|turquoise|Allowed for travel}} }} <section end="sputniklightauthmap"/> [[Sputnik Light]] is a [[viral vector vaccine]],<ref name="Ryumin">{{cite news|last=Ryumin|first=Alexander|date=20 February 2021|title=Russia registers its third COVID-19 vaccine CoviVac|publisher=[[TASS]]|location=Moscow|url=https://tass.com/society/1258859|access-date=6 March 2021}}</ref> produced by the Russian Gamaleya Research Institute of Epidemiology and Microbiology. It consists of the first dose of the [[Sputnik V COVID-19 vaccine|Sputnik V vaccine]], which is based on the Ad26 vector.<ref>{{cite press release |date=6 May 2021 |title=Single dose vaccine, Sputnik Light, authorized for use in Russia |url=https://rdif.ru/Eng_fullNews/6763/ |publisher=Russian Direct Investment Fund |access-date=11 May 2021}}</ref> ;Full (<section begin="Sputnik Light_FN"/>0<section end="Sputnik Light_FN"/>) ;Emergency (<section begin="Sputnik Light_EN"/>28<section end="Sputnik Light_EN"/>) <div style="margin-top: 0.3em; column-width: 15em;"> # Angola<ref>{{cite news |title=Sputnik Light Vaccine Approved For Use In Angola |url=https://sputnikvaccine.com/newsroom/pressreleases/sputnik-light-vaccine-approved-for-use-in-angola/ |access-date=13 May 2021 |publisher=Sputnik V vaccine |date=12 May 2021}}</ref> # Argentina<ref>{{cite web|title=BOLETIN OFICIAL REPUBLICA ARGENTINA - MINISTERIO DE SALUD - Resolución 3451/2021|url=https://www.boletinoficial.gob.ar/detalleAviso/primera/253978|access-date=7 December 2021|website=www.boletinoficial.gob.ar}}</ref> # Armenia<ref>{{cite web|title=Armenia approves Russian one-dose Sputnik Light vaccine|url=https://en.armradio.am/2021/09/06/armenia-approves-russian-one-dose-sputnik-light-vaccine/|access-date=8 December 2021|website=Public Radio of Armenia}}</ref> # Bahrain<ref>{{cite news|date=11 May 2021|title=Bahrain authorizes emergency use of one-shot Sputnik-Light COVID-19 vaccine|publisher=Reuters|url=https://www.reuters.com/world/middle-east/bahrain-authorizes-emergency-use-one-shot-sputnik-light-covid-19-vaccine-2021-05-11/|access-date=12 May 2021}}</ref> # Belarus<ref>{{cite news |title=Belarus registers Russia's Sputnik Light vaccine for use |url=https://www.reuters.com/business/healthcare-pharmaceuticals/belarus-registers-russias-sputnik-light-vaccine-use-2021-06-03/ |access-date=4 June 2021 |date=3 June 2021}}</ref> # Benin<ref>{{Cite news|date=14 January 2022|title=Sputnik Light vaccine authorized in Benin, says Russian Direct Investment Fund|work=[[TASS]]|url=https://tass.com/world/1388289|access-date=7 February 2022}}</ref> # Cambodia<ref name="auto20"/> # Congo-Brazzaville<ref>{{cite web |title=Single-dose Sputnik Light vaccine approved for use in the Republic of the Congo |url=https://rdif.ru/Eng_fullNews/6878/ |publisher=Russian Direct Investment Fund |website=rdif.ru |date=7 June 2021 |access-date=7 June 2021 |archive-date=7 June 2021 |archive-url=https://web.archive.org/web/20210607175016/https://rdif.ru/Eng_fullNews/6878/ |url-status=dead }}</ref> # Egypt<ref>{{cite web|title=The single-component Sputnik Light vaccine authorized in Egypt|url=https://sputnikvaccine.com/newsroom/pressreleases/the-single-component-sputnik-light-vaccine-authorized-in-egypt/|access-date=1 October 2021|website=sputnikvaccine}}</ref> # Iran<ref name="TrackVax"/> # India<ref>{{cite web|title=Sputnik Light: DCGI nod to emergency use of single-dose Covid vaccine|url=https://www.livemint.com/news/india/sputnik-light-dcgi-nod-to-emergency-use-of-single-dose-covid-vaccine-11644160096963.html|website=Livemint|date=2 February 2022}}</ref> # Kazakhstan<ref>{{cite news |title=Kazakhstan approves Russia's single-dose Sputnik Light vaccine |url=https://www.reuters.com/world/asia-pacific/kazakhstan-approves-russias-single-dose-sputnik-light-vaccine-rdif-2021-07-15/ |access-date=15 July 2021 |work=Reuters |date=15 July 2021 |location=Moscow}}</ref> # Kyrgyzstan<ref>{{#invoke:Cite web||title=Single-dose Sputnik Light vaccine registered in Kyrgyzstan|url=https://sputnikvaccine.com/newsroom/pressreleases/single-dose-sputnik-light-vaccine-registered-in-kyrgyzstan/|access-date=25 June 2021|website=sputnikvaccine}}</ref> # Laos<ref name="whotracker"/> # Mauritius<ref>{{cite news |title=Russia's Sputnik Light vaccine approved for use in Mauritius |url=https://www.reuters.com/business/healthcare-pharmaceuticals/russias-sputnik-light-vaccine-approved-use-mauritius-rdif-2021-06-02/ |access-date=4 June 2021 |work=Reuters |date=2 June 2021}}</ref> # Mongolia<ref>{{cite press release |title=Single-dose Sputnik Light vaccine registered in Mongolia |url=https://rdif.ru/Eng_fullNews/6907/ |location=Moscow |publisher=Russian Direct Investment Fund |access-date=25 June 2021 |date=11 June 2021 |archive-date=29 June 2021 |archive-url=https://web.archive.org/web/20210629205823/https://rdif.ru/Eng_fullNews/6907/ |url-status=dead }}</ref> # Nicaragua<ref>{{cite news |title=Single-dose Sputnik Light vaccine approved for use in Nicaragua |url=https://rdif.ru/Eng_fullNews/6846/ |publisher=Russian Direct Investment Fund |date=20 May 2021 |access-date=1 June 2021 |archive-date=3 June 2021 |archive-url=https://web.archive.org/web/20210603092124/https://rdif.ru/Eng_fullNews/6846/ |url-status=dead }}</ref> # Palestine<ref>{{cite news |title=Russia's Sputnik Light vaccine approved for use in Palestinian territories |url=https://www.reuters.com/article/health-coronavirus-russia-israel-palesti-idUSR4N2NB01F |access-date=4 June 2021 |work=Reuters |date=31 May 2021}}</ref> # Philippines<ref>{{cite news|title=Philippines approves emergency use of Russia's Sputnik Light vaccine|url=https://www.reuters.com/world/asia-pacific/philippines-approves-emergency-use-russias-sputnik-light-vaccine-2021-08-23/ |access-date=23 August 2021 |work=Reuters |date=23 August 2021}}</ref> # Russia<ref>{{cite news |title=Russia Approves Single-Dose Sputnik Light Covid Vaccine For Use |url=https://www.ndtv.com/world-news/russia-approves-single-dose-sputnik-light-covid-19-vaccine-for-use-2436470 |publisher=NDTV Coronavirus |date=6 May 2021}}</ref> # Saint Vincent and the Grenadines<ref name="whotracker"/> # San Marino<ref>{{cite web|title=Russian Direct Investment Fund|url=https://rdif.ru/Eng_fullNews/7171/|access-date=30 November 2021|website=rdif.ru|archive-date=30 November 2021|archive-url=https://web.archive.org/web/20211130200937/https://rdif.ru/Eng_fullNews/7171/|url-status=dead}}</ref> # Syria<ref>{{cite news |title=Batch of Russia's Sputnik Light vaccine delivered to Syria |url=https://tass.com/world/1317383 |access-date=31 July 2021 |work=TASS |date=24 July 2021 |location=Damascus}}</ref> # Tanzania<ref name="TrackVax"/> # Tunisia<ref name="TrackVax"/> # Turkmenistan<ref name="TrackVax"/><ref>[https://turkmenportal.com/blog/42752/turkmenistan-zaregistriroval-oblegchennyi-variant-rossiiskoi-vakciny-sputnik-v Туркменистан зарегистрировал облегченный вариант российской вакцины «Спутник V»]</ref> # United Arab Emirates<ref>{{cite web|date=6 October 2021|title=UAE authorises Sputnik Light COVID-19 vaccine -Russia's RDIF|url=https://www.reuters.com/world/middle-east/uae-authorises-sputnik-light-covid-19-vaccine-russias-rdif-2021-10-06/|access-date=23 October 2021|website=[[Reuters]]}}</ref> # Venezuela<ref>{{cite press release|title=Single-dose Sputnik Light vaccine approved for use in Venezuela |url=https://sputnikvaccine.com/newsroom/pressreleases/single-dose-sputnik-light-vaccine-approved-for-use-in-venezuela/|access-date=15 May 2021|publisher=Gamaleya Center}}</ref> <br />'''Non-country entities''' * Abkhazia<ref>{{Cite news|date=28 October 2021|title=In Abkhazia, 3,638 People Were Covid-19 Vaccination With Satellite Light |url=https://minzdrav.apsny.land/novosti/item/801-v-abkhazii-privivku-ot-covid-19-sputnikom-lajt-sdelali-3638-chelovek}}</ref> * Donbass Region (unofficially)<ref>{{cite web |url=https://warsawinstitute.org/moscow-plays-donbas-part-ukraine-conflict/ |title=Moscow Plays Up Donbas As Part Of The Ukraine Conflict |publisher=Warsaw Institute |date=2021-07-30 |access-date=2022-03-04 |accessdate=2022-07-06 |archivedate=2021-08-04 |archiveurl=https://web.archive.org/web/20210804163629/https://warsawinstitute.org/moscow-plays-donbas-part-ukraine-conflict/ }}</ref> </div> ;Travel-only * Malaysia<ref name="MY"/> * New Zealand<ref name="auto9"/> * Turkey<ref name="visasturkey.com"/> {{clear}} == Covaxin == <section begin="covaxinauthmap"/> {{infobox | image = {{Graph:Map|scale=65|defaultValue=gainsboro |AF=limegreen|AG=limegreen|AL=limegreen|AM=limegreen|AO=limegreen|AR=limegreen|AZ=limegreen|AU=turquoise |BA=limegreen|BB=limegreen|BD=limegreen|BF=limegreen|BH=dodgerblue|BJ=limegreen|BN=limegreen|BO=limegreen|BR=limegreen|BS=limegreen|BT=limegreen|BW=dodgerblue|BZ=limegreen |CD=limegreen|CF=dodgerblue|CG=limegreen|CI=limegreen|CL=limegreen|CM=limegreen|CO=limegreen|CR=limegreen|CV=limegreen |DJ=limegreen|DM=limegreen|DO=limegreen|DZ=limegreen |EC=limegreen|EE=turquoise|EG=limegreen|ET=dodgerblue| |FJ=limegreen|FM=limegreen|FI=turquoise |GD=limegreen|GB=turquoise|GE=limegreen|GH=limegreen|GM=limegreen|GN=limegreen|GR=turquoise|GT=dodgerblue|GY=dodgerblue |HK=dodgerblue|HN=limegreen|HT=limegreen |ID=limegreen|IN=blueviolet|IQ=limegreen|IR=dodgerblue|IS=turquoise |JM=limegreen|JO=limegreen |KE=limegreen|KG=turquoise|KH=limegreen|KI=limegreen|KM=dodgerblue|KN=limegreen|KP=limegreen|KR=limegreen| |LA=limegreen|LB=limegreen|LC=limegreen|LK=turquoise|LR=limegreen|LS=limegreen|LY=limegreen |MA=limegreen|MC=limegreen|MD=limegreen|ME=limegreen|MH=limegreen|MK=limegreen|ML=limegreen|MM=dodgerblue|MN=turquoise|MR=limegreen|MU=dodgerblue|MV=limegreen|MW=limegreen|MX=dodgerblue|MY=dodgerblue|MZ=limegreen |NA=limegreen|NE=limegreen|NG=limegreen|NI=dodgerblue|NP=dodgerblue|NR=limegreen|NZ=turquoise |OM=turquoise |PA=limegreen|PE=limegreen|PG=limegreen|PH=dodgerblue|PK=limegreen|PS=turquoise|PY=dodgerblue |QA=limegreen |RS=limegreen|RW=limegreen |SA=turquoise|SB=limegreen|SD=limegreen|SG=turquoise|SL=limegreen|SN=limegreen|SO=limegreen|SR=limegreen|SS=limegreen|ST=limegreen|SV=limegreen|SY=limegreen|SZ=limegreen |TD=limegreen|TG=limegreen|TH=turquoise|TJ=limegreen|TL=limegreen|TN=limegreen|TO=limegreen|TT=dodgerblue|TV=limegreen |UA=limegreen|UG=limegreen|US=turquoise|UY=limegreen|UZ=limegreen|CH=turquoise|TR=turquoise| |VC=limegreen|VE=dodgerblue|VN=dodgerblue|VU=limegreen |WS=limegreen |XK=limegreen |YE=limegreen |ZA=limegreen|ZM=limegreen|ZW=dodgerblue |AD=turquoise|AT=turquoise|CA=turquoise|HR=turquoise|CY=turquoise|IE=turquoise|LI=turquoise|NL=turquoise|SI=turquoise|SK=turquoise|ES=turquoise|SE=turquoise }} | caption = {{leftlegend|blueviolet|Full authorization}} {{leftlegend|dodgerblue|Emergency authorization}} {{leftlegend|turquoise|Allowed for travel}} {{leftlegend|limegreen|Eligible [[COVAX]] recipient}} }} <section end="covaxinauthmap"/> [[Covaxin]] is an [[inactivated vaccine|inactivated virus vaccine]] produced by the Indian company [[Bharat Biotech]] in collaboration with the [[Indian Council of Medical Research]]–[[National Institute of Virology]]. ;Full (<section begin="Covaxin_EN"/>1<section end="Covaxin_EN"/>) # India<ref name=":1"/> ;Emergency (<section begin="Covaxin_EN"/>19<section end="Covaxin_EN"/>) <div style="margin-top: 0.3em; column-width: 18em;"> # Bahrain<ref>{{Cite news|date=11 November 2021|title=Bahrain authorizes COVAXIN for emergency use|work=[[Bahrain News Agency]]|url=https://www.bna.bh/en/BahrainauthorizesCOVAXINforemergencyuse.aspx?cms=q8FmFJgiscL2fwIzON1%2bDvdCpVGdtuusfPwcuTv4D1k%3d|access-date=29 January 2022|accessdate=6 July 2022|archivedate=29 September 2022|archiveurl=https://web.archive.org/web/20220929020808/https://www.bna.bh/en/BahrainauthorizesCOVAXINforemergencyuse.aspx?cms=q8FmFJgiscL2fwIzON1%2BDvdCpVGdtuusfPwcuTv4D1k%3D}}</ref> # Botswana<ref name="cov-200421">{{#invoke:Cite web||url=https://timesofindia.indiatimes.com/india/covid-19-bharat-biotech-ramps-up-covaxin-capacity-to-700-million-doses-per-annum/articleshow/82162467.cms|title=Covid-19: Bharat Biotech ramps up Covaxin capacity to 700 million doses per annum &#124; India News |website=The Times of India}}</ref> # Central African Republic<ref name="cdctracker"/> # Comoros<ref name="cdctracker"/> # Ethiopia<ref name="whotracker" /> # Guatemala<ref name="cov-200421"/> (not used)<ref name="auto23">{{cite web|url=https://ais.paho.org/imm/IM_DosisAdmin-Vacunacion.asp|title=COVID-19 vaccine doses administered in the Americas|website=ais.paho.org}}</ref> # Guyana<ref name="cov-200421"/> (not used)<ref name="auto23"/> # Iran<ref>{{cite news |title=Iran issues permit for emergency use for three other COVID-19 vaccines: Official |url=https://en.irna.ir/news/84233593/Iran-issues-permit-for-emergency-use-for-three-other-COVID-19 |work=IRNA English |date=17 February 2021 }}</ref> # Malaysia<ref>{{cite web|url= https://www.nst.com.my/news/nation/2022/02/770394/covaxin-given-conditional-approval-under-emergency-use-protocols|title=Covaxin given conditional approval under emergency use protocols|website=nst.com.my|publisher=[[New Straits Times]]|date=10 February 2021|access-date=10 February 2022}}</ref> # Mauritius<ref name="auto32">{{cite web|last=Livemint|date=1 November 2021|title=5 more countries recognise India's Covid vaccination certificate. Details here|url=https://www.livemint.com/news/india/five-more-countries-recognise-india-s-covid-vaccination-certificate-details-here-11635766929707.html|access-date=1 November 2021|website=mint}}</ref> # Mexico<ref>{{#invoke:Cite web||url=https://www.excelsior.com.mx/nacional/mexico-autoriza-covaxin-vacuna-de-emergencia-india/1441874|title=México autoriza Covaxin, la vacuna india contra covid-19|publisher=Excelsior|date=6 April 2021}}</ref> (not used)<ref name="auto23"/> # Myanmar<ref>{{cite news |title=Myanmar sees over 130,000 Covid-19 recoveries, just over 7,000 still in hospital |url=https://elevenmyanmar.com/news/myanmar-sees-over-130000-covid-19-recoveries-just-over-7000-still-in-hospital |work=[[Eleven Media Group]] |date=19 February 2021}}</ref> # Nepal<ref>{{cite news|last=Sharma|first=Gopal|date=19 March 2021|title=Nepal becomes third country to give emergency nod to Indian vaccine COVAXIN|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-nepal-india-idUSKBN2BB1KN|access-date=19 March 2021}}</ref> # Nicaragua<ref name="cov-200421"/> (not used)<ref name="auto23"/> # Paraguay<ref name="covaxin-py">{{#invoke:Cite web||url=https://www.hindustantimes.com/india-news/covid19-india-provides-100-000-doses-of-covaxin-vaccine-to-paraguay-101617057324587.html|title=India provides 100,000 doses of Covaxin vaccine to Paraguay|work=Hindustan Times|date=30 March 2021}}</ref><ref>{{cite tweet|number=1376615865068752896|user=MaritoAbdo|title=Acaban de llegar 100.000 dosis de vacunas contra el Covid-19, provenientes de la India. La prioridad es avanzar hacia la inmunización de todo el personal de blanco y luego la población de riesgo. Gracias a la República de la India por el apoyo.|date=30 March 2021}}</ref> # Philippines<ref>{{cite news |title=Philippine FDA issues full EUA to Bharat Biotech's Covaxin |url=https://mb.com.ph/2021/06/23/philippine-fda-issues-full-eua-to-bharat-biotechs-covaxin/ |publisher=Manila Bulletin |date=23 June 2021}}</ref><ref>{{cite news |title=FDA grants full emergency use authorization for Covaxin |url=https://cnnphilippines.com/news/2021/6/25/COVAXIN-EUA-Philippines.html |publisher=CNN Philippines |date=25 June 2021 |accessdate=7 July 2021 |archivedate=3 July 2021 |archiveurl=https://web.archive.org/web/20210703070449/https://cnnphilippines.com/news/2021/6/25/COVAXIN-EUA-Philippines.html }}</ref> # Trinidad and Tobago<ref name="newsday.co.tt"/> # Venezuela<ref name="cov-200421"/> (not used)<ref name="auto23"/> # Vietnam<ref name="hk-vn-covaxin">{{cite news |title=Covid-19: Hong Kong, Vietnam latest to approve Covaxin for emergency use |url=https://www.hindustantimes.com/india-news/covid19-hong-kong-vietnam-latest-to-approve-covaxin-for-emergency-use-101636530349366.html |work=Hindustan Times |date=10 November 2021 }}</ref> # Zimbabwe<ref>{{#invoke:Cite web||date=4 March 2021|title=Zimbabwe approves Covaxin, first in Africa to okay India-made Covid-19 vaccine|url=https://www.hindustantimes.com/world-news/zimbabwe-approves-covaxin-first-in-africa-to-okay-india-made-covid-19-vaccine-101614859597880.html|access-date=3 July 2021|website=Hindustan Times}}</ref> <!-- not counted --> <br />'''[[List of ISO 3166-1 codes|Non-country entities]]''' * ''[[World Health Organization]]''<ref>{{cite news |title=India's first homegrown COVID-19 shot wins WHO emergency use listing |url=https://www.reuters.com/world/india/whos-advisory-group-recommends-emergency-listing-indias-first-homegrown-covid-19-2021-11-03/ |work=Reuters |date=3 November 2021 }}</ref><ref name="WHO PR 20211103">{{cite press release | title=WHO issues emergency use listing for eighth COVID-19 vaccine | website=[[World Health Organization]] (WHO) | url=https://www.who.int/news/item/03-11-2021-who-issues-emergency-use-listing-for-eighth-covid-19-vaccine | access-date=3 November 2021}}</ref> </div> ;Travel-only {{div col|colwidth=18em}} * Andorra<ref name="auto24"/> * Australia<ref name="AU recognized" /><ref name="tga-covaxin-bibp"/> * Austria<ref name="auto10"/> (only for entry) * Canada<ref name="auto31"/> * Costa Rica<ref name="auto41"/> * Croatia<ref name="auto19"/> * Cyprus<ref name="auto15"/> * Estonia<ref name="auto26"/> (only if approved in a person's country of origin) * Finland<ref name="auto37"/> * Greece<ref name="auto27"/> * Grenada<ref name="auto8"/> * Hong Kong<ref name="HK"/> * Iceland<ref name="auto18"/> * Ireland<ref name="auto11"/> * Kyrgyzstan<ref name="auto32"/> * Liechtenstein<ref name="auto28"/> * Mongolia<ref name="auto32"/> * New Zealand<ref name="auto9"/> * Norway<ref name="police1"/> * Oman<ref name="auto36"/> * Palestine<ref name="auto32"/> * Palau<ref name="palaugov.pw"/> * Panama<ref name="auto35"/> * Portugal<ref name="visitmadeira1"/> (only in Madeira) * Saudi Arabia<ref>{{cite web |url=https://keralakaumudi.com/en/news/mobile/news.php?id=701543&u= |title=Relief for expatriates: Saudi Arabia approves four more vaccines, including Covaxin |date=6 December 2021 |publisher=[[Kerala Kaumudi]]}}</ref> * Singapore<ref name="channelnewsasia.com"/> * Slovakia<ref name="auto29"/> * Slovenia<ref name="auto30"/> * South Korea<ref name="auto42"/> * Spain<ref name="auto40"/> * Sri Lanka<ref>{{cite news |title=Sri Lanka green light for Covaxin: Opens quarantine free for fully jabbed Indian tourists |url=https://m.timesofindia.com/business/international-business/sri-lanka-green-light-for-covaxin-opens-quarantine-free-for-fully-jabbed-indian-tourists/articleshow/85594554.cms |newspaper=[[The Times of India]] |date=24 August 2021}}</ref> * St. Kitts and Nevis<ref name="auto33"/> * St. Lucia<ref name="auto17"/> * St. Vincent and the Grenadines<ref name="auto21"/> * Sweden<ref name="auto38"/> * Switzerland<ref name="auto39"/> * Thailand<ref name="ThailandPass">{{cite web |title=Thailand Pass FAQs |url=https://consular.mfa.go.th/th/content/thailand-pass-faqs-2 |website=Department of Consular Affairs |access-date=11 January 2022 |accessdate=6 July 2022 |archivedate=30 June 2022 |archiveurl=https://web.archive.org/web/20220630074407/https://consular.mfa.go.th/th/content/thailand-pass-faqs-2 }}</ref> * The Netherlands<ref name="auto25"/> * Turkey<ref name="auto12"/> * Ukraine<ref name="auto22"/> * United Kingdom<ref name="auto34"/> * United States<ref name="auto16"/> {{div col end}} {{clear}} == Convidecia == <section begin="convideciaauthmap"/> {{infobox|image={{Graph:Map|scale=50|defaultValue=gainsboro |AR=dodgerblue |CL=dodgerblue |CN=blueviolet |EC=dodgerblue |HK=turquoise |HU=dodgerblue |ID=dodgerblue |MD=dodgerblue |MX=dodgerblue |MY=dodgerblue |NZ=turquoise |PK=dodgerblue |TR=turquoise }} |caption= {{leftlegend|blueviolet|Full authorization}} {{leftlegend|dodgerblue|Emergency authorization}} {{leftlegend|turquoise|Allowed for travel}} }} <section end="convideciaauthmap"/> [[Ad5-nCoV|Convidecia]] is a [[viral vector vaccine]]<ref name="zhu7-20">{{cite journal|display-authors=6|vauthors=Zhu FC, Guan XH, Li YH, Huang JY, Jiang T, Hou LH, Li JX, Yang BF, Wang L, Wang WJ, Wu SP, Wang Z, Wu XH, Xu JJ, Zhang Z, Jia SY, Wang BS, Hu Y, Liu JJ, Zhang J, Qian XA, Li Q, Pan HX, Jiang HD, Deng P, Gou JB, Wang XW, Wang XH, Chen W|date=August 2020|title=Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial|journal=Lancet|volume=396|issue=10249|pages=479–88|doi=10.1016/s0140-6736(20)31605-6|pmc=7836858|pmid=32702299|doi-access=free|title-link=doi}}</ref> produced by the Chinese company [[CanSino Biologics]] and the Beijing Institute of Biotechnology of the [[Academy of Military Medical Sciences]]. ;Full (<section begin="Convidecia_FN"/>1<section end="Convidecia_FN"/>) # China<ref>{{cite news |title=China approves two more domestic COVID-19 vaccines for public use |url=https://www.reuters.com/article/us-health-coronavirus-china-vaccine-idUSKBN2AP1MW |access-date=16 March 2021 |publisher=Reuters |date=25 February 2021}}</ref> ;Emergency (<section begin="Convidecia_EN"/>9<section end="Convidecia_EN"/>) # Argentina<ref>{{#invoke:Cite web||date=11 June 2021|title=Argentina issues emergency approval to China's single-dose Cansino COVID-19 vaccine|url=https://www.reuters.com/world/americas/argentina-issues-emergency-approval-chinas-single-dose-cansino-covid-19-vaccine-2021-06-11/|access-date=11 June 2021|website=Reuters}}</ref> # Chile<ref name=":7">{{#invoke:Cite web||title=ISP Approves Emergency Use And Importation Of Cansino Vaccine To Fight COVID-19|url=https://www.ispch.cl/noticia/isp-aprueba-uso-de-emergencia-e-importacion-de-la-vacuna-covid-19-de-laboratorio-cansino/|access-date=8 April 2021|website=Institute of Public Health of Chile}}</ref> # Ecuador<ref>{{#invoke:Cite web||date=15 June 2021|title=Ecuador authorizes use of China's CanSino vaccine against COVID-19|url=https://www.reuters.com/world/americas/ecuador-authorizes-use-chinas-cansino-vaccine-against-covid-19-2021-06-15/|access-date=16 June 2021|website=Reuters}}</ref> # Hungary<ref>{{cite web | title=China's CanSino Biologics COVID-19 vaccine receives emergency use approval in Hungary | publisher=MSN | date=22 March 2021 | url=https://www.msn.com/en-xl/europe/top-stories/china-s-cansino-biologics-covid-19-vaccine-receives-emergency-use-approval-in-hungary/ar-BB1eOIEV | access-date=22 March 2021}}</ref><ref name="WashPost Hungary" /> # Indonesia<ref name="auto6"/> # Malaysia<ref>{{#invoke:Cite web||title=Govt approves Pfizer jabs for 12-year-olds and above, CanSino and Johnson & Johnson vaccines get conditional registration, says Health DG|url=https://www.thestar.com.my/news/nation/2021/06/15/govt-approves-pfizer-jabs-for-12-year-olds-and-above-conditional-approval-for-cansino-and-johnson--johnson-vaccines-says-health-dg|access-date=15 June 2021|website=The Star}}</ref> # Mexico<ref name="AD5 mexico"/> # Moldova<ref name="msmps.gov.md"/> # Pakistan<ref>{{cite news | last1=Shahzad |first1=Asif |title=Pakistan approves Chinese CanSinoBIO COVID vaccine for emergency use |url=https://www.reuters.com/article/us-health-coronavirus-pakistan-vaccine/pakistan-approves-chinese-cansinobio-covid-vaccine-for-emergency-use-idUSKBN2AC1FG |publisher=Reuters |access-date=12 February 2021 |date=12 February 2021}}</ref> <!-- not counted --><br />'''[[List of ISO 3166-1 codes|Non-country entities]]''' * ''[[World Health Organization]]'' ;Travel-only * Hong Kong<ref name="HK"/> * New Zealand<ref name="auto9"/> * Turkey<ref name="visasturkey.com"/> {{clear}} == Sinopharm WIBP == <section begin="wibpauthmap"/> {{infobox|image={{Graph:Map|scale=50|defaultValue=gainsboro |AE=dodgerblue |CN=blueviolet |HK=turquoise |MK=dodgerblue |MY=turquoise |NZ=turquoise |PE=dodgerblue |PH=dodgerblue |TR=turquoise |VE=dodgerblue }} |caption= {{leftlegend|blueviolet|Full authorization}} {{leftlegend|dodgerblue|Emergency authorization}} {{leftlegend|turquoise|Allowed for travel}} }} <section end="wibpauthmap"/> The [[Sinopharm WIBP COVID-19 vaccine]] is an [[inactivated vaccine|inactivated virus vaccine]] produced by the [[China National Pharmaceutical Group]] (Sinopharm) and its [[Wuhan Institute of Biological Products]]. ;Full (<section begin="Sinopharm-WIBP_FN"/>1<section end="Sinopharm-WIBP_FN"/>) # China<ref>{{Cite news|last=Wee|first=Sui-Lee|date=25 February 2021|title=China approves two more Covid-19 vaccines.|work=The New York Times|url=https://www.nytimes.com/live/2021/02/25/world/covid-19-coronavirus|access-date=1 April 2021}}</ref> ;Emergency (<section begin="Sinopharm-WIBP_EN"/>5<section end="Sinopharm-WIBP_EN"/>) # North Macedonia<ref name="whotracker"/> # Peru<ref name="whotracker"/> # Philippines<ref>{{cite news |author1=De Vera, Analou |title=FDA grants EUA to COVID-19 vaccine Sinopharm manufactured by Wuhan affiliate |url=https://mb.com.ph/2021/08/25/fda-grants-eua-to-covid-19-vaccine-sinopharm-manufactured-by-wuhan-affiliate/ |publisher=Manila Bulletin |date=25 August 2021}}</ref> # United Arab Emirates<ref name="NYT vaccine tracker" /> # Venezuela<ref name="whotracker"/> ;Travel-only * Hong Kong<ref name="HK"/> * Malaysia<ref name="MY"/> * New Zealand<ref name="auto9"/> * Turkey<ref name="visasturkey.com"/> {{clear}} == Abdala == <section begin="abdalaauthmap"/> {{infobox|image={{Graph:Map|scale=50|defaultValue=gainsboro |CU=dodgerblue |GY=turquoise |KH=turquoise |LC=turquoise |MX=dodgerblue |MY=turquoise |NI=dodgerblue |NZ=turquoise |TR=turquoise |UY=turquoise |VC=turquoise |VE=dodgerblue |VN=dodgerblue }} |caption= {{leftlegend|blueviolet|Full authorization}} {{leftlegend|dodgerblue|Emergency authorization}} {{leftlegend|turquoise|Allowed for travel}} }} <section end="abdalaauthmap"/> [[Abdala (vaccine)|Abdala]] is a [[subunit vaccine]] developed by the [[Center for Genetic Engineering and Biotechnology]] in [[Cuba]]. ;Full (<section begin="Abdala_FN"/>0<section end="Abdala_FN"/>) ;Emergency (<section begin="Abdala_EN"/>6<section end="Abdala_EN"/>) # Cuba<ref name="Cubarollout">{{Cite news|date=9 July 2021|title=COVID: Cuba approves emergency use of own Abdala vaccine|work=Deutsche Welle|url=https://www.dw.com/en/covid-cuba-approves-emergency-use-of-own-abdala-vaccine/a-58222105|access-date=9 July 2021}}</ref><ref>{{#invoke:Cite web||title=Aprueba el CECMED el Autorizo de Uso de Emergencia del candidato vacunal cubano ABDALA {{!}} CECMED|url=https://www.cecmed.cu/noticias/aprueba-cecmed-autorizo-uso-emergencia-candidato-vacunal-cubano-abdala|access-date=9 July 2021|website=www.cecmed.cu|language=es}}</ref> # Mexico<ref>{{cite web|date=29 December 2021|title=Cofepris emite autorización para uso de emergencia de vacuna Abdala|url=https://www.gob.mx/cofepris/articulos/cofepris-emite-autorizacion-para-uso-de-emergencia-de-vacuna-abdala|access-date=29 December 2021|website=www.gob.mx/cofepris|language=es}}</ref> # Nicaragua<ref>{{cite news|title=Nicaragua authorises two COVID-19 vaccines from Cuba, Cuban firm says|url=https://www.reuters.com/business/healthcare-pharmaceuticals/nicaragua-authorises-two-covid-19-vaccines-cuba-cuban-firm-says-2021-10-02/ |access-date= 4 October 2021|publisher=Reuters |date=2 October 2021}}</ref> # St. Vincent and the Grenadines<ref>{{cite web|title=Vincentians have access to Cuban Abdala vaccine {{!}} Loop Caribbean News|url=https://caribbean.loopnews.com/content/vincentians-have-access-cuban-abdala-vaccine|access-date=28 December 2021|website=Loop News}}</ref><ref>{{Cite news|date=28 December 2021|title=St Vincent, The Grenadines to use Cuba's Abdala vaccine|work=Political Lore|url=https://www.politicallore.com/st-vincent-the-grenadines-to-use-cubas-abdala-vaccine/27626|access-date=13 January 2022|accessdate=6 July 2022|archivedate=12 August 2022|archiveurl=https://web.archive.org/web/20220812182942/https://www.politicallore.com/st-vincent-the-grenadines-to-use-cubas-abdala-vaccine/27626}}</ref> # Venezuela<ref>{{cite news |title=Venezuela receives first shipment of Cuban coronavirus vaccine |url=https://www.reuters.com/world/americas/venezuela-receives-first-shipment-cuban-coronavirus-vaccine-2021-06-24/ |access-date=3 July 2021 |publisher=Reuters |date=25 June 2021}}</ref> # Vietnam<ref name="NYT vaccine tracker"/> ;Travel-only * Cambodia<ref>{{cite web|url=https://www.khmertimeskh.com/50971131/list-of-covid-19-vaccines-recognised-by-cambodia-for-quarantine-free-international-entry/|title = List of COVID-19 vaccines recognised by Cambodia for quarantine free international entry - Khmer Times|date = 15 November 2021}}</ref> * Colombia<ref>{{cite web|title=Conozca las 20 vacunas aceptadas para el ingreso de viajeros a Colombia|url=https://www.cali.gov.co/publicaciones/165988/conozca-las-20-vacunas-aceptadas-para-el-ingreso-de-viajeros-a-colombia/|access-date=15 December 2021|website=www.cali.gov.co|language=es}}</ref> * Guyana<ref name=":9">{{cite web |date=November 2021 |title=Requirements for Port Entry into Guyana |url=https://www.health.gov.gy/images/travel_requirement.pdf#page=2 |access-date=2 March 2022 |website=www.health.gov.gy/index.php/component/k2/item/304-travel-guidelines |language=en }}{{Dead link|date=December 2024 |bot=InternetArchiveBot |fix-attempted=yes }}</ref><ref name=":14">{{cite web |date=19 January 2022 |title=Travel Restrictions Entering Guyana from Cuba |url=https://airheart.com/travel-bans/from/cuba/to/guyana |access-date=2 March 2022 |website=airheart.com/travel-bans |language=en |accessdate=6 July 2022 |archivedate=2 March 2022 |archiveurl=https://web.archive.org/web/20220302141904/https://airheart.com/travel-bans/from/cuba/to/guyana }}</ref> * Malaysia<ref name="MY"/> * New Zealand<ref name="auto9"/> * St. Lucia<ref name="auto17"/> * Turkey<ref name="visasturkey.com"/> * Uruguay<ref name="auto14"/> (only if accepted in the country of the person's origin) {{clear}} == EpiVacCorona == <section begin="epivac-coronaauthmap"/> {{infobox|image={{Graph:Map|scale=50|defaultValue=gainsboro |TM=blueviolet|TR=turquoise |RU=dodgerblue |BY=dodgerblue |NZ=turquoise |KH=dodgerblue |VE=dodgerblue |MY=turquoise }} |caption= {{leftlegend|blueviolet|Full authorization}} {{leftlegend|dodgerblue|Emergency authorization}} {{leftlegend|turquoise|Allowed for travel}} }} <section end="epivac-coronaauthmap"/> [[EpiVacCorona]] is a [[peptide vaccine]] produced by the Russian [[State Research Center of Virology and Biotechnology VECTOR]]<wbr />.<ref name="NCT045275753">{{#invoke:Cite web||date=22 September 2020|title=Study of the Safety, Reactogenicity and Immunogenicity of "EpiVacCorona" Vaccine for the Prevention of COVID-19 (EpiVacCorona)|url=https://clinicaltrials.gov/ct2/show/NCT04527575|access-date=16 November 2020|website=[[ClinicalTrials.gov]]|publisher=[[United States National Library of Medicine]]|id=NCT04368988}}</ref> ;Full (<section begin="EpiVacCorona_FN"/>1<section end="EpiVacCorona_FN"/>) # Turkmenistan<ref>{{cite news |title= Turkmenistan registers vaccines for the prevention of infectious diseases |url=https://tdh.gov.tm/en/post/25911/turkmenistan-registers-vaccines-prevention-infectious-diseases |work=Turkmenistan Today |date=29 January 2021 }}</ref><ref>{{cite news |title=Russian vaccine "EpiVacCorona" was registered in Turkmenistan |url=https://www.en24news.com/e/2021/01/russian-vaccine-epivaccorona-was-registered-in-turkmenistan.html |work=EN24 |date=29 January 2021 |accessdate=7 July 2021 |archivedate=19 March 2021 |archiveurl=https://web.archive.org/web/20210319140314/https://www.en24news.com/error }}</ref> ;Emergency (<section begin="EpiVacCorona_EN"/>4<section end="EpiVacCorona_EN"/>) # Belarus<ref>{{#invoke:Cite web||date=3 February 2021|title=Belarus receives Russia's EpiVacCorona vaccine|url=https://eng.belta.by/society/view/belarus-receives-russias-epivaccorona-vaccine-137131-2021/|access-date=5 April 2021|website=Belta}}</ref> # Cambodia<ref name="TrackVax"/> # Russia<ref>{{cite web | title = О регистрации вакцины ФБУН ГНЦ ВБ "Вектор" Роспотребнадзора "ЭпиВакКорона" | website = Rospotrebnadzor | url = https://www.rospotrebnadzor.ru/region/rss/rss.php?ELEMENT_ID=15660 | date = 14 October 2020 | language = ru | accessdate = 7 July 2021 | archivedate = 1 November 2020 | archiveurl = https://web.archive.org/web/20201101010437/https://www.rospotrebnadzor.ru/region/rss/rss.php?ELEMENT_ID=15660 }}</ref><ref>{{cite web | title = Russia's EpiVacCorona vaccine post-registration trials started | publisher=The Pharma Letter |url = https://www.thepharmaletter.com/article/russia-s-epivaccorona-vaccine-post-registration-trials-started |date=18 November 2020 }}</ref> # Venezuela<ref name="TrackVax"/> ;Travel-only * Malaysia<ref name="MY"/> * New Zealand<ref name="auto9"/> * Turkey<ref name="visasturkey.com"/> {{clear}} == Zifivax == <section begin="rbd-dimerauthmap"/> {{infobox|image={{Graph:Map|scale=50|defaultValue=gainsboro |CN=dodgerblue |HK=turquoise |ID=dodgerblue |MY=turquoise |NZ=turquoise |PK=dodgerblue |TR=turquoise |UZ=dodgerblue }} |caption= {{leftlegend|blueviolet|Full authorization}} {{leftlegend|dodgerblue|Emergency authorization}} {{leftlegend|turquoise|Allowed for travel}} }} <section end="rbd-dimerauthmap"/> [[ZF2001|Zifivax]] is a [[subunit vaccine]] produced by the Chinese company [[Anhui Zhifei Longcom Biopharmaceutical]].<ref name="london2">{{#invoke:Cite web||date=1 March 2021|title=COVID-19 vaccine development pipeline (Refresh URL to update)|url=https://vac-lshtm.shinyapps.io/ncov_vaccine_landscape/|access-date=10 March 2021|publisher=Vaccine Centre, London School of Hygiene and Tropical Medicine}}</ref> ;Full (<section begin="Zifivax_FN"/>0<section end="Zifivax_FN"/>) ;Emergency (<section begin="Zifivax_EN"/>5<section end="Zifivax_EN"/>) # China<ref>{{cite news|last=Liu|first=Roxanne|date=15 March 2021|title=China IMCAS's COVID-19 vaccine obtained emergency use approval in China|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-china-vaccine-idUSL4N2LD3BZ|access-date=15 March 2021}}</ref> # Colombia<ref>{{Cite web |last=de 2022 |first=26 de Enero |title=Invima recomienda el uso de emergencia de Zifivax, otra vacuna anticovid producida en China |url=https://www.infobae.com/america/colombia/2022/01/27/invima-recomienda-el-uso-de-emergencia-de-zifivax-otra-vacuna-anticovid-producida-en-china/ |access-date=2022-06-24 |website=infobae |language=es-ES}}</ref> # Indonesia<ref>{{cite web|date=7 October 2021|title=BPOM Setujui Penggunaan Dalam Kedaruratan Vaksin Zifivax|url=https://republika.co.id/berita/nasional/umum/r0ljxq436/bpom-setujui-penggunaan-dalam-kedaruratan-vaksin-zifivax|access-date=7 October 2021|work=Republika.co.id|language=id}}</ref> # Pakistan<ref>{{cite web|title=Pakistan gears up for China's "ZF-2001 vaccine"--China Economic Net|url=http://en.ce.cn/Insight/202111/08/t20211108_37068436.shtml|access-date=30 November 2021|website=en.ce.cn}}</ref> # Uzbekistan<ref>{{cite news | last1=Mamatkulov |first1=Mukhammadsharif |title=Uzbekistan approves Chinese-developed COVID-19 vaccine |url=https://www.reuters.com/article/uzbekistan-china-coronavirus-vaccine/uzbekistan-approves-chinese-developed-covid-19-vaccine-idUSS0N2IK00P |publisher=Reuters |access-date=2 March 2021 |date=1 March 2021}}</ref> ;Travel-only * Hong Kong<ref name="HK"/> * Malaysia<ref name="MY"/> * New Zealand<ref name="auto9"/> * Turkey<ref name="visasturkey.com"/> {{clear}} == Soberana 02 == <section begin="soberana2authmap"/> {{infobox|image={{Graph:Map|scale=50|defaultValue=gainsboro |CU=dodgerblue |GY=turquoise |HU=turquoise |IR=dodgerblue |MY=turquoise |NI=dodgerblue|NZ=turquoise |TR=turquoise |VE=dodgerblue }} |caption= {{leftlegend|blueviolet|Full authorization}} {{leftlegend|dodgerblue|Emergency authorization}} {{leftlegend|turquoise|Allowed for travel}} }} <section end="soberana2authmap"/> [[Soberana 02]], is a [[conjugate vaccine]] developed by the [[Finlay Institute]] in [[Cuba]].<ref name="finlayIran">{{cite web |title=Autorizo de emergencia SOBERANA 02 en Irán |url=https://www.finlay.edu.cu/blog/autorizo-de-emergencia-soberana-02-en-iran/ |website=finlay.edu.cu |publisher=Instituto Finlay de Vacunas |access-date=6 July 2021 |date=1 July 2021}}</ref> ;Full (<section begin="Soberana 02_FN"/>0<section end="Soberana 02_FN"/>) ;Emergency (<section begin="Soberana 02_EN"/>4<section end="Soberana 02_EN"/>) # Cuba<ref>{{cite news |title=Cuba grants emergency approval to second homegrown COVID-19 vaccine |url=https://www.gmanetwork.com/news/scitech/science/800262/cuba-grants-emergency-approval-to-second-homegrown-covid-19-vaccine/story/ |publisher=GMA News |date=21 August 2021}}</ref> # Iran<ref name="finlayIran"/> # Nicaragua<ref>{{cite news |title=Nicaragua authorises two COVID-19 vaccines from Cuba, Cuban firm says|url=https://www.reuters.com/business/healthcare-pharmaceuticals/nicaragua-authorises-two-covid-19-vaccines-cuba-cuban-firm-says-2021-10-02/|publisher=Reuters |date =2 October 2021}}</ref> # Venezuela<ref name="TrackVax"/> ;Travel-only * Guyana<ref name=":9" /><ref name=":14" /> * Hungary<ref name="hungarytoday.hu">{{cite web|date=16 December 2021|title=Iran and Hungary to Mutually Honour Immunity Certificates|url=https://hungarytoday.hu/hungary-iran-immunity-certificate-szijjarto/|access-date=19 December 2021|website=Hungary Today}}</ref> * Malaysia<ref name="MY"/> * New Zealand<ref name="auto9" /> * Turkey<ref name="visasturkey.com"/> == CoviVac == <section begin="covivacauthmap" /> {{infobox | image = {{Graph:Map|scale=50|defaultValue=gainsboro |BY=dodgerblue |KH=dodgerblue |MY=turquoise |NZ=turquoise |RU=dodgerblue |TR=turquoise }} | caption = {{leftlegend|blueviolet|Full authorization}} {{leftlegend|dodgerblue|Emergency authorization}} {{leftlegend|turquoise|Allowed for travel}} }} <section end="covivacauthmap" /> [[CoviVac (Russia COVID-19 vaccine)|CoviVac]] is an [[inactivated vaccine|inactivated virus vaccine]]<ref name="Ryumin" /> produced by the Chumakov Centre at the [[Russian Academy of Sciences]].<ref>{{#invoke:Cite web||date=18 January 2021|title=Briefing with Deputy Prime Minister Tatyana Golikova, Health Minister Mikhail Murashko and Head of Rospotrebnadzor Anna Popova|url=http://government.ru/en/news/41342/|access-date=20 February 2021|publisher=Government of Russia}}</ref> ;Full (<section begin="CoviVac_FN" />0<section end="CoviVac_FN" />) ;Emergency (<section begin="CoviVac_EN" />3<section end="CoviVac_EN" />) # Belarus<ref>{{#invoke:Cite web||date=16 December 2021|title=Минздрав выдал разрешение на ввоз и применение вакцины КовиВак|url=http://minzdrav.gov.by/ru/novoe-na-sayte/minzdrav-vydal-razreshenie-na-vvoz-i-primenenie-vaktsiny-kovivak/|publisher=Ministry of Health of the Republic of Belarus|language=RU}}</ref> # Cambodia<ref name="TrackVax" /> # Russia<ref>{{cite news |date=20 February 2021 |title=Russia approves its third COVID-19 vaccine, CoviVac |publisher=Reuters |url=https://www.reuters.com/article/us-health-coronavirus-russia-vaccine/russia-approves-its-third-covid-19-vaccine-covivac-idUKKBN2AK07H}}</ref> ; Travel-only * Malaysia<ref name="MY" /> * New Zealand<ref name="auto9" /> * Turkey<ref name="visasturkey.com" /> == QazCovid-in == <section begin="qazcovid-inauthmap"/> {{infobox|image={{Graph:Map|scale=50|defaultValue=gainsboro |KZ=dodgerblue |KG=dodgerblue |MY=turquoise |NZ=turquoise |TR=turquoise }} |caption= {{leftlegend|blueviolet|Full authorization}} {{leftlegend|dodgerblue|Emergency authorization}} {{leftlegend|turquoise|Allowed for travel}} }} <section end="qazcovid-inauthmap"/> [[QazCovid-in]], also known as QazVac, is an [[inactivated vaccine|inactivated virus vaccine]] developed by the Research Institute for Biological Safety Problems in Kazakhstan.<ref name="qazvac">{{cite web |title=A new vaccine on the scene: Kazakhstan begins rollout of homegrown QazVac |date=26 April 2021 |url=https://fortune.com/2021/04/26/new-covid-19-vaccine-kazakhstan-qazvac/ |website=Fortune}}</ref> ;Full (<section begin="QazCovid-in_FN"/>0<section end="QazCovid-in_FN"/>) ;Emergency (<section begin="QazCovid-in_EN"/>2<section end="QazCovid-in_EN"/>) # Kazakhstan<ref name="qazvac"/> # Kyrgyzstan<ref>{{cite news | title=Vaccination against COVID-19: QazVac registered in Kyrgyzstan |url=https://24.kg/english/204508_Vaccination_against_COVID-19_QazVac_registered_in_Kyrgyzstan/ |publisher=24.kg |date=19 August 2021 }}</ref><ref>{{cite news | title=Kyrgyzstan to start using Kazakh-made QazVac after expert review|url=https://www.eureporter.co/world/kazakhstan/2021/08/19/kyrgyzstan-to-start-using-kazakh-made-qazvac-after-expert-review/ |publisher=Eureporter |date=19 August 2021 }}</ref><ref>{{cite news |title=The Covid-19 Vaccine Qazvac Is Firstly Registrated Abroad |url=https://www.biosafety.kz/en/uncategorized/%d0%b2%d0%b0%d0%ba%d1%86%d0%b8%d0%bd%d0%b0-qazvac-%d0%bf%d1%80%d0%be%d1%82%d0%b8%d0%b2-covid-19-%d0%bf%d0%be%d0%bb%d1%83%d1%87%d0%b8%d0%bb%d0%b0-%d0%bf%d0%b5%d1%80%d0%b2%d1%83%d1%8e-%d1%80%d0%b5%d0%b3/ |publisher=Biosafety.kz |date=18 August 2021 |accessdate=6 October 2021 |archivedate=18 April 2022 |archiveurl=https://web.archive.org/web/20220418235422/https://www.biosafety.kz/en/uncategorized/%d0%b2%d0%b0%d0%ba%d1%86%d0%b8%d0%bd%d0%b0-qazvac-%d0%bf%d1%80%d0%be%d1%82%d0%b8%d0%b2-covid-19-%d0%bf%d0%be%d0%bb%d1%83%d1%87%d0%b8%d0%bb%d0%b0-%d0%bf%d0%b5%d1%80%d0%b2%d1%83%d1%8e-%d1%80%d0%b5%d0%b3/ }}</ref> ;Travel-only * Malaysia<ref name="MY"/> * New Zealand<ref name="auto9"/> * Turkey<ref name="visasturkey.com"/> {{-}} == Minhai == <section begin="Minhaiauthmap"/> {{infobox|image={{Graph:Map|scale=50|defaultValue=gainsboro |CN=dodgerblue |ID=dodgerblue |MY=turquoise |NZ=turquoise |TR=turquoise }} |caption= {{leftlegend|blueviolet|Full authorization}} {{leftlegend|dodgerblue|Emergency authorization}} {{leftlegend|turquoise|Allowed for travel}} }} <section end="Minhaiauthmap"/>[[Minhai COVID-19 vaccine]], is an [[inactivated vaccine|inactivated virus vaccine]] developed by Minhai Biotechnology Co. and [[Shenzhen Kangtai Biological Products]] Co. Ltd. in China.<ref name="MinhaiEUA">{{Cite news|author=Reuters Staff|date=14 May 2021|title=Kangtai Biological's COVID-19 vaccine gets emergency use approval in China|work=Reuters|url=https://www.reuters.com/article/us-health-coronavirus-vaccine-kangtai-idUSKBN2CV1F6|access-date=20 May 2021}}</ref> ;Full (<section begin="Minhai_FN"/>0<section end="Minhai_FN"/>) ;Emergency (<section begin="Minhai_EN"/>2<section end="Minhai_EN"/>) # China<ref name="MinhaiEUA"/> # Indonesia<ref>{{cite web|last=Co.,Ltd|first=Shenzhen Kangtai Biological Products|title=BioKangtai's adenovirus vector COVID-19 vaccine obtained EUA in Indonesia|url=https://www.prnewswire.com/news-releases/biokangtais-adenovirus-vector-covid-19-vaccine-obtained-eua-in-indonesia-301415162.html|access-date=30 November 2021|website=PR Newswire}}</ref> ;Travel-only * Hong Kong<ref name="HK"/> * Malaysia<ref name="MY"/> * New Zealand<ref name="auto9"/> * Turkey<ref name="visasturkey.com"/> == Medigen == <section begin="medigenauthmap" /> {{infobox | image = {{Graph:Map|scale=50|defaultValue=gainsboro |BZ=turquoise |ID=turquoise |MY=turquoise |NZ=turquoise |PW=turquoise |PY=dodgerblue |SOMALILAND=dodgerblue |TH=turquoise |TR=turquoise |TW=dodgerblue }} | caption = {{leftlegend|blueviolet|Full authorization}} {{leftlegend|dodgerblue|Emergency authorization}} {{leftlegend|turquoise|Allowed for travel}} }} <section end="medigenauthmap" /> [[MVC COVID-19 vaccine|MVC-COV1901]], is a [[Protein subunit|protein subunit vaccine]] developed by [[Taiwan]]'s Medigen Vaccine Biologics and Dynavax Technologies.<ref name="MVCTW">{{cite web |date=19 July 2021 |title=Taiwan approves Medigen's COVID-19 vaccine candidate |url=https://www.reuters.com/world/asia-pacific/taiwan-approves-production-medigens-covid-19-vaccine-candidate-2021-07-19/ |access-date=19 July 2021 |publisher=Reuters}}</ref> ;Full (<section begin="Medigen_FN" />0<section end="Medigen_FN" />) ;Emergency (<section begin="Medigen_EN" />2<section end="Medigen_EN" />) # Taiwan<ref name="MVCTW" /> # Paraguay<ref>{{cite news |date=2022-02-14 |title=Paraguay aprueba vacuna taiwanesa Medigen para uso de emergencia |agency=Diario HOY |url=https://www.hoy.com.py/nacionales/paraguay-aprueba-vacuna-taiwanesa-medigen-para-uso-de-emergencia}}</ref> ;Non-country entities * Somaliland<ref>{{cite web |date=28 December 2021 |title=Taiwan to donate domestic COVID-19 vaccines to Somaliland |url=https://focustaiwan.tw/politics/202112280007 |access-date=7 January 2022 |website=Focus Taiwan}}</ref> ;Travel-only * Belize<ref>{{cite web |date=30 November 2021 |title=MOHW Approves Entry for Persons with the Taiwanese Medigen Jab |url=https://lovefm.com/mohw-approves-entry-for-persons-with-the-taiwanese-medigen-jab/ |access-date=8 January 2022 |website=Love FM News |accessdate=6 July 2022 |archivedate=7 January 2022 |archiveurl=https://web.archive.org/web/20220107161153/https://lovefm.com/mohw-approves-entry-for-persons-with-the-taiwanese-medigen-jab/ }}</ref> * Indonesia<ref>{{cite web |date=16 November 2021 |title=Negara yang mengakui vaksin Medigen menjadi 4 negara |url=https://news.pts.org.tw/article/554169 |access-date=8 January 2022 |website=PTS news}}</ref> * Malaysia<ref name="MY" /> * New Zealand<ref name="auto9" /> * Palau<ref>{{cite web |title=COVID-19 Pandemic Entry Requirements – PalauGov.pw |url=https://www.palaugov.pw/travel/ |access-date=24 December 2021}}</ref> * Thailand<ref name="ThailandPass" /> * Turkey<ref name="visasturkey.com" /> == Corbevax == [[Corbevax]] is a [[Protein subunit|protein]] [[subunit vaccine]] developed by Texas Children's Hospital at the [[Baylor College of Medicine]] in [[Houston, Texas]], and licensed to Indian biopharmaceutical firm [[Biological E. Limited]] (BioE) for development and production.<ref name="vacxine2" /><ref>{{cite news |last=Raghavan |first=Prabha |name-list-style=vanc |date=10 June 2021 |title=Explained: How is Biological E's Corbevax different? |website=The Indian Express |url=https://indianexpress.com/article/explained/corbevax-vaccine-biological-e-india-7344928/ |access-date=29 December 2021}}</ref> ;Full (<section begin="Corbevax_FN" />0<section end="Corbevax_FN" />) ;Emergency (<section begin="Corbevax_EN" />2<section end="Corbevax_EN" />) # India<ref name="vacxine2" /> # Botswana<ref>{{Cite news |date=2022-03-28 |title=Botswana Approves Corbevax Covid Vaccine, Plans Local Output |language=en |work=Bloomberg.com |url=https://www.bloomberg.com/news/articles/2022-03-28/botswana-approves-corbevax-covid-vaccine-plans-local-output |access-date=2022-06-29}}</ref> ;Travel-only * Malaysia<ref name="MY" /> * New Zealand<ref name="auto9" /> * Turkey<ref name="visasturkey.com" /> == COVIran Barekat == <!-- <section begin="coviranauthmap"/> {{infobox|image={{Graph:Map|scale=50|defaultValue=gainsboro |HU=turquoise |IR=dodgerblue |MY=turquoise |NZ=turquoise |TR=turquoise }} |caption= {{leftlegend|blueviolet|Full authorization}} {{leftlegend|dodgerblue|Emergency authorization}} {{leftlegend|turquoise|Allowed for travel}} }} <section end="coviranauthmap"/> --> [[COVIran Barekat]], is an [[inactivated vaccine|inactivated virus vaccine]] developed by Shifa Pharmed Industrial Co. in Iran.<ref name="ShifaEUA">{{#invoke:Cite web||date=14 June 2021|title=Iran issues license on its coronavirus vaccine|url=https://en.trend.az/iran/society/3439812.html|access-date=14 June 2021|website=Trend.Az}}</ref> ;Full (<section begin="COVIran Barakat_FN"/>0<section end="COVIran Barakat_FN"/>) ;Emergency (<section begin="COVIran Barekat_EN"/>1<section end="COVIran Barekat_EN"/>) # Iran<ref name="ShifaEUA"/> ;Travel-only * Malaysia<ref name="MY"/> * New Zealand<ref name="auto9"/> * Hungary<ref name="ReferenceB">{{cite web|date=16 December 2021|title=Iran and Hungary to Mutually Honour Immunity Certificates|url=https://hungarytoday.hu/hungary-iran-immunity-certificate-szijjarto/|access-date=18 December 2021|website=Hungary Today}}</ref> *Turkey<ref>{{cite web|date=10 April 2019|title=Vaccinations for Turkey: Do I need an Approved COVID Vaccine?|url=https://www.visasturkey.com/vaccinations-for-turkey/|access-date=26 December 2021|website=Turkey Visa|accessdate=25 December 2021|archivedate=16 November 2021|archiveurl=https://web.archive.org/web/20211116191928/https://www.visasturkey.com/vaccinations-for-turkey/}}</ref> == Chinese Academy of Medical Sciences == <!-- <section begin="Chinese Academy of Medical Sciences authmap"/> {{infobox|image={{Graph:Map|scale=50|defaultValue=gainsboro |CN=dodgerblue |HK=turquoise |NZ=turquoise }} |caption= {{leftlegend|blueviolet|Full authorization}} {{leftlegend|dodgerblue|Emergency authorization}} {{leftlegend|turquoise|Allowed for travel}} }} <section end="Chinese Academy of Medical Sciences authmap"/> --> [[Chinese Academy of Medical Sciences COVID-19 vaccine]], is an [[inactivated vaccine|inactivated virus vaccine]] developed by [[Peking Union Medical College|Chinese Academy of Medical Sciences]].<ref name="IMBCAMSEUA">{{cite news |last1=Liu |first1=Roxanne |last2=Woo |first2=Ryan |title=China builds new plant for IMBCAMS COVID-19 vaccine -state media |url=https://www.reuters.com/world/asia-pacific/china-builds-new-plant-imbcams-covid-19-vaccine-state-media-2021-06-09/ |access-date=15 June 2021 |work=Reuters |date=9 June 2021}}</ref> ;Full (<section begin="Chinese Academy of Medical Sciences_FN"/>0<section end="Chinese Academy of Medical Sciences_FN"/>) ;Emergency (<section begin="Chinese Academy of Medical Sciences_EN"/>1<section end="Chinese Academy of Medical Sciences_EN"/>) # China<ref name="IMBCAMSEUA"/> ;Travel-only * Hong Kong<ref name="HK"/> * New Zealand<ref name="auto9"/> * Turkey<ref name="visasturkey.com"/> * == ZyCoV-D == [[ZyCoV-D]], is a [[DNA vaccine|DNA plasmid]] based [[COVID-19 vaccine]] developed by the Indian pharmaceutical company [[Cadila Healthcare]] with support from the [[Department of Biotechnology|Biotechnology Industry Research Assistance Council]].<ref name="zycov-d">{{cite news |title=India gives emergency approval for world's first COVID-19 DNA vaccine |url=https://www.reuters.com/business/healthcare-pharmaceuticals/india-approves-zydus-cadilas-covid-19-vaccine-emergency-use-2021-08-20/ |work=Reuters |date=20 August 2021 }}</ref> ;Full (<section begin="ZyCoV-D_FN"/>0<section end="ZyCoV-D_FN"/>) ;Emergency (<section begin="ZyCoV-D_EN"/>1<section end="ZyCoV-D_EN"/>) # India<ref name="zycov-d"/> ;Travel-only * Malaysia<ref name="MY"/> * New Zealand<ref name="auto9"/> * Turkey<ref name="visasturkey.com"/> == FAKHRAVAC == <!--<section begin="fakhravacauthmap"/> {{infobox|image={{Graph:Map|scale=50|defaultValue=gainsboro |IR=dodgerblue |NZ=turquoise |HU=turquoise }} |caption= {{leftlegend|blueviolet|Full authorization}} {{leftlegend|dodgerblue|Emergency authorization}} }} <section end="fakhravacauthmap"/> --> [[FAKHRAVAC]] (or MIVAC), is an [[inactivated vaccine|inactivated virus vaccine]] developed in Iran by the [[Organization of Defensive Innovation and Research]], an organization of [[Ministry of Defence and Armed Forces Logistics (Iran)|Iran's Ministry of Defense]].<ref name="FakhraVacEUA">{{cite web|date=9 September 2021|title=Iran Authorizes Emergency Use of Third Homegrown Vaccine - Defense news|url=https://www.tasnimnews.com/en/news/2021/09/09/2568712/iran-authorizes-emergency-use-of-third-homegrown-vaccine|url-status=live|archive-url=https://web.archive.org/web/20210909123956/https://www.tasnimnews.com/en/news/2021/09/09/2568712/iran-authorizes-emergency-use-of-third-homegrown-vaccine|archive-date=9 September 2021|access-date=9 September 2021|website=Tasnim News Agency}}</ref> ;Full (<section begin="FAKHRAVAC_FN"/>0<section end="FAKHRAVAC_FN"/>) ;Emergency (<section begin="FAKHRAVAC_EN"/>1<section end="FAKHRAVAC_EN"/>) # Iran<ref name="FakhraVacEUA"/> ;Travel-only * Hungary<ref name="ReferenceB"/> * Malaysia<ref name="MY"/> * New Zealand<ref name="auto9"/> * Turkey<ref name="visasturkey.com"/> == COVAX-19 == <!-- <section begin="COVAX19authmap"/> {{infobox|image={{Graph:Map|scale=50|defaultValue=gainsboro |IR=dodgerblue |MY=turquoise |NZ=turquoise |HU=turquoise }} |caption= {{leftlegend|blueviolet|Full authorization}} {{leftlegend|dodgerblue|Emergency authorization}} }} <section end="COVAX19authmap"/> --> [[COVAX-19]], also known as SpikoGen, is a [[subunit vaccine|protein subunit vaccine]] jointly developed by Australian-based company Vaxine and Iran-based company [[Cinnagen|CinnaGen]].<ref name="COVAX19EUA">{{cite news |title=Iran issues emergency permit for new local Covid-19 vaccine |url=https://en.mehrnews.com/news/179432/Iran-issues-emergency-permit-for-new-local-Covid-19-vaccine |access-date=12 October 2021 |publisher=[[Mehr News Agency]] |date= 6 October 2021}}</ref> ;Full (<section begin="COVAX-19_FN"/>0<section end="COVAX-19_FN"/>) ;Emergency (<section begin="COVAX-19_EN"/>1<section end="COVAX-19_EN"/>) # Iran<ref name="COVAX19EUA"/> ;Travel-only * Hungary<ref name="hungarytoday.hu"/> * Malaysia<ref name="MY"/> * New Zealand<ref name="auto9"/> * Turkey<ref name="visasturkey.com"/> == Razi Cov Pars == <!-- <section begin="RaziCovParsauthmap"/> {{infobox|image={{Graph:Map|scale=50|defaultValue=gainsboro |IR=dodgerblue |NZ=turquoise |HU=turquoise |MY=turquoise }} |caption= {{leftlegend|blueviolet|Full authorization}} {{leftlegend|dodgerblue|Emergency authorization}} }} <section end="RaziCovParsauthmap"/> --> [[Razi Cov Pars]] is a [[subunit vaccine|protein subunit vaccine]] developed by [[Razi Vaccine and Serum Research Institute]].<ref name="Razieua">{{cite web|date=1 November 2021|title=Two homegrown vaccines receive emergency use license|url=https://www.tehrantimes.com/news/466570/Two-homegrown-vaccines-receive-emergency-use-license|access-date=27 November 2021|website=Tehran Times}}</ref> ;Full (<section begin="Razi Cov Pars_FN"/>0<section end="Razi Cov Pars_FN"/>) ;Emergency (<section begin="Razi Cov Pars_EN"/>1<section end="Razi Cov Pars_EN"/>) # Iran<ref name="Razieua"/> ;Travel-only * Hungary<ref name="ReferenceB"/> * Malaysia<ref name="MY"/> * New Zealand<ref name="auto9"/> * Turkey<ref name="visasturkey.com"/> == Turkovac == <!--<section begin="turkovacsauthmap"/> {{infobox|image={{Graph:Map|scale=50|defaultValue=gainsboro |TR=dodgerblue |NZ=turquoise |MY=turquoise }} |caption= {{leftlegend|blueviolet|Full authorization}} {{leftlegend|dodgerblue|Emergency authorization}} }} <section end="turkovacauthmap"/>--> [[Turkovac]] is an [[inactivated vaccine]] developed by [[Ministry of Health (Turkey)|Health Institutes of Turkey]] and [[Erciyes University]].<ref name="Turkoeua">{{cite news |last1=Aliyev |first1=Jeyhun |last2=Nur Duz |first2=Zehra |title=Turkey's domestic COVID-19 vaccine Turkovac approved for emergency use |url=https://www.aa.com.tr/en/latest-on-coronavirus-outbreak/turkeys-domestic-covid-19-vaccine-turkovac-approved-for-emergency-use/2454638 |access-date=26 December 2021 |agency=Anadolu Agency |date=22 December 2021}}</ref> ;Full (<section begin="TurkoVac_FN"/>0<section end="TurkoVac_FN"/>) ;Emergency (<section begin="TurkoVac_EN"/>1<section end="TurkoVac_EN"/>) # Turkey<ref name="Turkoeua"/> ;Travel-only * Malaysia<ref name="MY"/> * New Zealand<ref name="auto9"/> == Sinopharm CNBG == [[Sinopharm CNBG COVID-19 vaccine]] is a [[Recombinant vaccine|recombinant]] [[Protein subunit|protein]] [[subunit vaccine]] developed by China National Biotec Group (CNBG), a subsidiary of [[Sinopharm (company)|Sinopharm]].<ref name="CNBG">{{Cite news|date=27 December 2021|title=Emergency use of Sinopharm's new CNBG protein vaccine approved in UAE|work=[[Gulf News]]|url=https://gulfnews.com/uae/emergency-use-of-sinopharms-new-cnbg-protein-vaccine-approved-in-uae-1.84628476|access-date=27 December 2021}}</ref> ;Full (<section begin="CNBG_FN"/>0<section end="CNBG_FN"/>) ;Emergency (<section begin="CNBG_EN"/>1<section end="CNBG_EN"/>) # United Arab Emirates<ref name="CNBG" /> ;Travel-only * Malaysia<ref name="MY"/> * Turkey<ref name="visasturkey.com"/> == Soberana Plus == [[Soberana Plus]] is a single-dose of [[conjugate vaccine]] developed by the [[Finlay Institute]] in [[Cuba]].<ref name="CubBoost">{{cite news | vauthors = Dönmez BB |title=Cuba grants emergency use to 2 virus vaccines |url=https://www.aa.com.tr/en/latest-on-coronavirus-outbreak/cuba-grants-emergency-use-to-2-virus-vaccines/2341850 |access-date=23 September 2021 |agency=Anadolu Agency |date=21 August 2021}}</ref> ;Full (<section begin="Soberana Plus_FN"/>0<section end="Soberana Plus_FN"/>) ;Emergency (<section begin="Soberana Plus_EN"/>1<section end="Soberana Plus_EN"/>) # Cuba<ref name="CubBoost"/> ;Travel-only * Guyana<ref name=":9" /><ref name=":14" /> * Malaysia<ref name="MY"/> * New Zealand<ref name="auto9"/> * Turkey<ref name="visasturkey.com"/> == CoVLP == [[CoVLP]] is a [[Virus-like particle|Virus-Like Particle]] vaccine grown in an Australian weed, [[Nicotiana benthamiana]]. It is marketed under the name [https://medicago.com/en/press-release/covifenz/ Covifenz] {{Webarchive|url=https://web.archive.org/web/20220224161443/https://medicago.com/en/press-release/covifenz/ |date=2022-02-24 }}. ;Full (<section begin="CoVLP_FN" />1<section end="CoVLP_FN" />) # Canada ;Emergency (<section begin="CoVLP_EN" />0<section end="CoVLP_EN" />) ;Travel-only * Malaysia<ref name="MY"/> * New Zealand<ref name="auto9"/> * Turkey<ref name="visasturkey.com"/> == Noora == [[Noora (vaccine)|Noora]] is a protein-based vaccine developed by the [[Baqiyatallah University of Medical Sciences]]. ;Full (<section begin="Noora_FN" />0<section end="Noora_FN" />) ;Emergency (<section begin="Noora_EN" />1<section end="Noora_EN" />) # Iran<ref>{{Cite news |date=1 March 2022 |title="Noora" vaccine receives emergency use license |work=[[Tehran Times]] |url=https://www.tehrantimes.com/news/470601/Noora-vaccine-receives-emergency-use-license |access-date=2 March 2022}}</ref> ;Travel-only * Malaysia<ref name="MY"/> * Turkey<ref name="visasturkey.com"/> == SKYCovione == [[SKYCovione]] is a protein subunit vaccine developed by [[SK Group|SK Bioscience]]. ;Full (<section begin="SKYCovione_FN" />0<section end="SKYCovione_FN" />) ;Emergency (<section begin="SKYCovione_EN" />1<section end="SKYCovione_EN" />) # South Korea<ref>{{Cite news |last=Kim |first=Tong-Hyung |date=29 June 2022 |title=South Korea approves first homemade COVID-19 vaccine |work=[[Associated Press]] |url=https://apnews.com/article/covid-health-pandemics-public-db128bb38e561e45f477035b0e0f7524 |access-date=29 June 2022}}</ref> == Тэмдэглэл == {{reflist|group=lower-alpha}} == Зүүлтэ == {{reflist}} {{COVID-19 pandemic}} {{Vaccines}} [[Категори:COVID-19-дэ эсэргүү вакцина| ]] [[Категори:Медицинскэ шэнжэлэлгэ]] l21k51us9qwd6swsjqqvpx5z98q26ze